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I. SUMMARY 
Bacterial mastitis is caused by invasion of the udder, bacterial multiplication and induction of 
inflammatory responses in the bovine mammary gland. Disease severity and the cause of disease are 
influenced by environmental factors, the cow’s immune response as well as bacterial 
traits. Escherichia coli (E. coli) is one of the main causes of acute bovine mastitis, but although 
pathogenic E. coli strains can be classified into different pathotypes, E. coli causing mastitis cannot 
unambiguously be distinguished from commensal E. coli nor has a common set of virulence factors 
been described for mastitis isolates. This project focussed on the characterization of virulence-
associated traits of E. coli mastitis isolates in comprehensive analyses under conditions either 
mimicking initial pathogenesis or conditions that E. coli mastitis isolates should encounter while 
entering the udder. 
Virulence-associated traits as well as fitness traits of selected bovine mastitis or faecal E. coli strains 
were identified and analyzed in comparative phenotypic assays. Raw milk whey was introduced to 
test bacterial fitness in native mammary secretion known to confer antimicrobial effects. 
Accordingly, E. coli isolates from bovine faeces represented a heterogeneous group of which some 
isolates showed reduced ability to survive in milk whey whereas others phenotypically resembled 
mastitis isolates that represented a homogeneous group in that they showed similar survival and 
growth characteristics in milk whey. In contrast, mastitis isolates did not exhibit such a uniform 
phenotype when challenged with iron shortage, lactose as sole carbon source and lingual 
antimicrobial peptide (LAP) as a main defensin of milk. Reduced bacterial fitness could be related to 
LAP suggesting that bacterial adaptation to an intramammary lifestyle requires resistance to host 
defensins present in mammary secretions, at least LAP. 
E. coli strain 1303 and ECC-1470 lack particular virulence genes associated to mastitis isolates. To find 
out whether differences in gene expression may contribute to the ability of E. coli variants to cause 
mastitis, the transcriptome of E. coli model mastitis isolates 1303 and ECC-1470 were analyzed to 
identify candidate genes involved in bacterium-host interaction, fitness or even pathogenicity during 
bovine mastitis. 
DNA microarray analysis was employed to assess the transcriptional response of E. coli 1303 and 
ECC-1470 upon cocultivation with MAC-T immortalized bovine mammary gland epithelial cells to 
identify candidate genes involved in bacterium-host interaction. Additionally, the cell adhesion and 
invasion ability of E. coli strain 1303 and ECC-1470 was investigated. The transcriptonal response to 
the presence of host cells rather suggested competition for nutrients and oxygen between E. coli and 
MAC-T cells than marked signs of adhesion and invasion. Accordingly, mostly fitness traits that may 
also contribute to efficient colonization of the E. coli primary habitat, the gut, have been utilized by 
the mastitis isolates under these conditions. 
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In this study, RNA-Seq was employed to assess the bacterial transcriptional response to milk whey. 
According to our transcriptome data, the lack of positively deregulated and also of true virulence-
associated determinants in both of the mastitis isolates indicated that E. coli might have adapted by 
other means to the udder (or at least mammary secretion) as an inflammatory site. We identified 
traits that promote bacterial growth and survival in milk whey. The ability to utilize citrate promotes 
fitness and survival of E. coli that are thriving in mammary secretions. According to our results, 
lactoferrin has only weak impact on E. coli in mammary secretions. At the same time bacterial 
determinants involved in iron assimilation were negatively regulated, suggesting that, at least during 
the first hours, iron assimilation is not a challenge to E. coli colonizing the mammary gland. It has 
been hypothesized that cellular iron stores cause temporary independency to extracellular accessible 
iron. According to our transcriptome data, this hypothesis was supported and places iron uptake 
systems beyond the speculative importance that has been suggested before, at least during early 
phases of infection. It has also been shown that the ability to resist extracytoplasmic stress, by 
oxidative conditions as well as host defensins, is of substantial importance for bacterial survival in 
mammary secretions. 
In summary, the presented thesis addresses important aspects of host-pathogen interaction and 
bacterial conversion to hostile conditions during colonization of the mastitis inflammatory site, the 
mammary gland. 
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I.b. ZUSAMMENFASSUNG 
Bei der bakteriellen Mastitis handelt es sich um eine Infektion der bovinen Milchdrüse, ausgelöst 
durch Eintritt und Wachstum der Bakterien im Euter der Kuh. Krankheitsverlauf und Ursache werden 
beeinflusst durch Umweltfaktoren, das Immunsystem des Wirtes und die Eigenschaften des 
bakteriellen Erregers. Die Spezies Escherichia coli (E. coli) ist einer der häufigsten Erreger der akuten 
bovinen Mastitis. Generell können pathogene E. coli -Stämme entsprechend ihres Infektionsortes in 
verschiedene Pathotypen klassifiziert werden, die durch eine individuelle Kombination verschiedener 
Virulenzfaktoren gekennzeichnet sind. Eine eindeutige Unterscheidung von E. coli –Mastitiserregern 
und kommensalen E. coli -Stämmen ist bisher nicht beschrieben. Diese Studie befasst sich mit der 
Charakterisierung virulenz-assozierter Eigenschaften von E. coli –Isolaten der bovinen Mastitis. Dazu 
wurden Untersuchungen unter Bedingungen durchgeführt, die denen während der Anfangsphase der 
Mastitis entsprechen.  
Die Virulenz und Fitness-assoziierten Eigenschaften ausgewählter E. coli Mastitis- und Fäkalisolate 
wurden in vergleichenden phenotypischen Assays identifiziert und analysiert. Zur Untersuchung der 
bakteriellen Fitness in Milchdrüsensekreten wurde native Molke mit antimikrobiellen Eigenschaften 
von Rohmilch genutzt. Dabei stellte sich heraus dass E. coli Fäkalisolate eine heterogene Gruppe 
bilden. Innerhalb dieser Gruppe wiesen einige Isolate eine verminderte Überlebensrate auf. Andere 
Fäkalisolate zeigten eine höhere Überlebensrate, ähnlich der Überlebensrate von Mastitiserregern. 
Im Gegensatz zum ihrem grundsätzlich guten  Überleben in Molke zeigten Mastitisisolate keine 
einheitlichen phänotypischen Merkmale bei Wachstum mit 1) Lactose als einziger Kohlenstoffquelle, 
2) Eisenlimitierung, oder 3) unter Einfluss von lingualem antimikrobiellem Peptid (LAP), einem 
bedeutenden Defensin der Wirtsantwort im Euter. Die verminderte Fähigkeit in Milchdrüsensekreten 
zu überleben korrelierte mit der konzentrationsabhängigen Überlebensfähigkeit in Gegenwart von 
LAP. Dies lässt vermuten dass eine Anpassung der Bakterien an die Lebensbedingungen in der 
bovinen Milchdrüse der Resistenz gegenüber Defensinen (u.a. LAP) bedarf. 
Den Mastitis-isolaten E. coli 1303 und ECC-1470 fehlen diverse Virulenzgene die bereits mit Mastitis 
assoziiert werden konnten. Um zu bestimmen ob Unterschiede in der Genexpression beider E. coli 
Isolate dazu beitragen Mastitis auszulösen, wurden Transkriptomanalysen durchgeführt. Dabei 
sollten vor allem Kandidatengene bestimmt werden, die an der Wirt-Pathogen-Interaktion beteiligt 
sind oder zur bakteriellen Fitness oder Virulenz der Erreger beitragen. 
Auf der Basis von DNA Microarrays wurde die Genexpression von E. coli 1303 und ECC-1470 in 
Gegenwart von immortalisierten Zellen des bovinen Milchdrüsenepithels (MAC-T) bestimmt. 
Zusätzlich wurde die Fähigkeit zur Zelladhäsion und Internalisierung beider Isolate untersucht. Die 
bakterielle Transkriptionsantwort in Gegenwart der Wirtszellen ergab, dass Erreger und Wirtszellen 
eher um den Bedarf an Nährstoffen und Sauerstoff konkurrierten, anstatt deutliche Anzeichen der 
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Zelladhäsion oder Invasion zu zeigen. Beide Isolate nutzten vornehmlich Fitnesseigenschaften, die 
auch bei der Besiedlung des Darms als dem primären Habitat von E. coli verwendet werden. 
In dieser Studie wurde außerdem die Genexpression von E. coli 1303 und ECC-1470 in Reaktion auf 
Molke aus Rohmilch mittels Gesamt-Transkriptom-Sequenzierung (RNA Seq) untersucht. Die 
Transkriptomanalyse ergab keine wirklich deregulierten virulenz-assozierten Gene in einer der 
beiden E. coli Mastitis Isolate. Ferner konnten Eigenschaften identifiziert werden, die zum Wachstum 
und Überleben in nativer Molke beitragen. Die Fähigkeit, Citrat zu verwerten, begünstigt das 
erfolgreiche Überleben in Milchdrüsensekten und stellt einen wichtigen Fitnessfaktor dar. Unsere 
Transkriptomdaten bestätigen dass Lactoferrin nur geringen Einfluss auf das Wachstum, von E. coli in 
Milchdrüsensekreten, hat. Die Expression bakterieller Determinanten, die an der Aufnahme von 
Eisen beteiligt sind, wurde herunterreguliert. Dies lässt darauf schließen dass Eisenaufnahme in den 
ersten Stunden der Kolonisierung durch die Erreger keine essentielle Fitnesseigenschaft darstellt. 
Vermutlich reicht die intrazelluläre Menge an Eisen aus, um eine zeitweise Unabhängigkeit von 
extrazellular verfügbarem Eisen zu ermöglichen. Diese These konnte durch unsere 
Transkriptomdaten gestützt werden und stellt eine wichtige Entdeckung in Bezug auf die 
Verfügbarkeit von Eisen während der Kolonisierung der Milchdrüse dar. Unsere Daten zeigen, dass 
die Resistenz gegenüber extrazellulärem Stress durch oxidative Bedingungen und Defensine des 
Wirtes von großer Bedeutung für das bakterielle Überleben in Milchdrüsensekreten ist. 
Die vorliegende Thesis befasst sich mit wichtigen Aspekten der Wirt-Pathogen-Interaktion und der 
Anpassung an die antimikrobiellen Bedingungen während der Kolonisierung der Milchdrüse als Ort 
der Infektion. 
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II. INTRODUCTION 
This study presents the identification and characterization of virulence-associated traits of E. coli 
bovine mastitis isolates.  
II.1. Epidemiology of bovine mastitis 
Bovine mastitis is defined as an inflammation of the mammary gland tissue caused by 
microorganisms, usually bacteria that have overcome the cow´s immune defense. It is induced when 
the pathogens enter the udder, multiply and produce metabolites or toxins that cause harm to the 
mammary gland tissue. Damaged tissue allows for increased vascular permeability. This results in 
altered milk composition accompanied by a reduction in milk yield (Hill, 1994). Both changes may 
differ vastly as their extent depends on the severity of the inflammatory response (Kitchen, 2009; 
Seegers et al., 2003; Pyörälä, 2003), mainly influenced by the causative pathogen (Zadoks et al., 
2011). A broad variety of organisms has been identified as potential mastitis pathogens and is 
distinguished into either major or minor pathogens. The main mastitis-causing pathogens are 
Escherichia coli, Streptococcus uberis and Staphylococcus aureus. These bacteria have been termed 
major pathogens because of their association to clinical mastitis (CM). In contrast, other bacteria may 
be present in the udder and often have an overall beneficial effect by protecting against infection 
caused by major pathogens. These bacteria produce natural anti-bacterial substances or interfere 
with the growth of major pathogens and are thus termed minor pathogens. Because of their complex 
interaction with the mammary gland these minor pathogens can contribute to increased somatic cell 
counts (SCCs) and thus to the incidence of sub-clinical mastitis (SCM), but they usually do not cause 
CM. 
II.1.1. Severity and duration 
The course of mastitis is either acute, i.e. severe and sudden in onset, or chronic, which is defined as 
a long-developing syndrome that worsens over months and results in development of fibrous tissue 
(Gröhn et al., 1990). Usually mastitis is classified according to its pathogenesis in either CM or SCM, 
which is considered the most prevalent form of mastitis (Gianneechini et al., 2002; Akers, 2002).  
CM shows visible signs which are further distinguished in mild and severe signs. Flakes or clots in the 
milk and a discoloration of the teat of the infected udder quarter which may have slight swelling are 
mild signs. Severe signs are abnormal watery secretion as well as a hot and swollen udder. More 
systemic symptoms are fever, rapid pulse, loss of appetite, dehydration, depression and fatal 
consequences. 
On the contrary, SCM is not accompanied with visible signs of an infection and both, milk and udder, 
appear normal although stagnation in milk has been reported (Mungube et al., 2005). Therefore SCM 
can be harder to detect although the SCCs in the milk increase likewise in CM. To date, the SCC 
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proved to be the most useful diagnostic technique to detect the presence and occurrence of bovine 
mastitis and especially for bovine subclinical mastitis (Schukken et al., 2011). 
Generally, bacteria associated to CM have been termed major pathogens (Djabri et al., 2002) 
whereas minor pathogens do not usually cause clinical forms of the disease but are associated to 
SCM due to increased SCCs. These bacteria are meant to be present in the udder and often have an 
overall beneficial effect on protection from infection by major pathogens, due to the production of 
natural anti-bacterial substances, induced leukocytosis and competitive growth with other bacteria 
(Reyher et al., 2012). 
II.1.2. Origin of infection 
Mastitis causing pathogens have been broadly classified into either environmental or contagious 
pathogens (Radostits et al., 2007). 
Contagious pathogens are meant to be intramammary survivors and are spread from cow to cow. 
Environmental pathogens originate from bedding materials, manure and soil and are considered to 
be opportunistic invaders with no specialized survival properties. This view becomes obsolete, when 
taking into account that mastitis causing E. coli, which are considered environmental pathogens, are 
indeed able to persist for prolonged periods within the udder and also cause either chronic or 
recurrent forms of mastitis (Almeida et al., 2011; Döpfer et al., 2001 and 2000). Hence, a spread from 
one host to another due to inappropriate post-milking teat disinfection is most likely. Based on the 
situation that environmental mastitis pathogens are present in the housing and bedding, they can 
easily be transferred during milking or between milkings when the cow is foraging or lying down.  
 Physiology and Invasion of the Udder  
A basic knowledge of the bovine udder anatomy and physiology allows for a better understanding of 
mastitis development (Figure 1). The histologically divided quarters of a bovine udder are composed 
of a teat cistern, gland cistern, milk ducts and surrounding glandular tissue. This secretory tissue 
includes millions of microscopic sacs, designated as alveoli and lined by milk-producing epithelium, 
which is supplied with nutrients by surrounding blood vessels. Muscle cells encircle each alveolus and 
squeeze the milk to the milk ducts and further through the teat canal and duct during milking. In 
between the milkings, milk accumulates in alveolar spaces, milk ducts and gland cistern. 
Bacteria might either invade the udder through lesions, as teat damage is known to increase 
susceptibility of mastitis, or more frequently breach the teat canal in several ways (Schroeder, 2010). 
Between milkings bacteria multiply inside teat duct and are introduced into the gland cistern via the 
teat canal by their motility properties or pressure placed on the teat end caused by physical 
movement of the cow. Another opportunity is that bacteria may be propelled into or through the 
teat canal during machine milking. 
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Figure 1: Scheme of the mammary gland modified from Schroeder, 2010. (A) Teat with gland cistern, 
milk ducts, and secretory glandular tissue. (B) Alveolus encircled by muscle cells and blood vessel. 
 
 
II.1.3. Factors increasing mastitis susceptibility 
The susceptibility to mastitis increases in dependence of various genetic and physiological ´cow 
factors´ as well as environmental factors (Hopster et al., 1998; Waller, 2000). Mastitis is therefore 
designated a multifactorial disease.  
 Environmental or Management factors 
There is rarely an infection known unaffected by the environment. For instance the season affects 
the susceptibility to mastitis and there is consistency in the literature that CM occurs more 
frequently within the winter months (Steeneveld et al., 2008; Olde Riekerink et al., 2007). 
Another factor, that is even more important, is poor hygiene which is directly correlated to infectious 
diseases and increases the risk of mastitis development (Schreiner and Ruegg, 2003). Intensive 
livestock breeding of dairy cattle implies high cow densities per unit and bad ventilation, and also the 
selection of bedding materials may facilitate bacterial growth (Ericsson Unnerstad et al., 2009). Given 
that stables are an environment which promotes bacterial spread, milking equipment might also be 
contaminated itself and enables bacteria to invade the udder (Hovinen and Pyörälä, 2011; Hässig et 
al., 2011). Moreover, dairy cattle suffering from stress generated by inappropriate human handling is 
known to be more susceptible to mastitis (Breuer et al., 2003). As a result it is unquestionable that 
management practices have been associated to CM (Parker et al., 2007; Barnouin et al., 2005; 
Barkema et al., 1999). Accordingly, the management of dairy herds is a comprehensible factor to 
lower the risks and provide more sustainable protection protocols to mastitis. Hence, there are still 
various anthropogenic factors to consider.  
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 Cow factors 
Besides environmental factors there are cow-specific factors to consider. The cow factors are defined 
by the cow´s immune response and genetic makeup and may conclude the cow´s age, SCC, parity, 
lactation stage, nutritional and metabolic status, CM history and genetic resistance. Selective 
breeding, focused on enhanced milk production, causes metabolic stresses relative to an increased 
milk yield and can be correlated to compromised mastitis resistance (Waller, 2000; Seegers et al., 
2003). It is a known fact that cows with high milk yield are more likely to develop CM rather than 
cows with less milk yield (Gröhn et al., 2004). 
Pathogens may infect cows both during the dry period and in lactation. The lactation stage has 
significant impact on the cow´s susceptibility to mastitis (Rinaldi et al., 2008; Mallard et al., 1998; 
Shafer-Weaver et al., 1996). It has been reported that the risk of developing CM is highest in early 
lactation (Steeneveld et al., 2008). Contrary, the risk of SCM increases with days in milk (Busato et al., 
2000). Within the periparturient period of the lactation stage, the cow´s defense mechanisms are 
impaired and therefore the cow is at higher risk of developing mastitis with impact on subsequent 
intramammary infections (Breen et al., 2009; Oliver and Sordillo, 1988; Kehrli et al., 1989). It is known 
that multiparous cows show higher incidence of mastitis (Rajala-Schultz et al., 1999) and there is 
evidence that increasing parity correlates with increased susceptibility (Steeneveld et al., 2008). 
 
Both, environmental and cow factors, are interdependent, whereas the relative impact of each factor 
is considerably influenced by the causative pathogen (Zadoks et al., 2011; Djabri et al., 2002).   
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II.1.4. Host defense mechanisms and pathogen recognition 
The bovine mammary gland is protected by several defense mechanisms at the anatomical and 
cellular level. At the anatomical level the teat end is considered to be the first line of defense against 
invading bacteria that cause mastitis. The sphincter muscles at the end of the teat ducts should be 
tightly closed between milkings and thus inhibit bacterial penetration. The teat canal is lined with a 
waxy antimicrobial coating termed keratin, which functions as a physical barrier for invading bacteria 
(Nickerson, 1987; Treece et al., 1966). Both, dysfunctional sphincter muscles and diminished keratin 
lining of the teat canal have been independently shown to increase the risk bacterial invasion and 
colonization (Lefcourt, 1982; Capuco et al., 1992). 
Bacteria that have overcome the anatomical defense mechanisms are then confronted with the 
bovine immune system. The mammary immune factors have been characterized into cellular and 
soluble components. At the cellular level we know about the functions of leukocytes which can be 
further distinguished into neutrophils, macrophages and lymphocytes. The cellular and soluble 
factors and their biological functions are listed in Table 1 (Sordillo and Streicher, 2002). These 
defense mechanisms are further differentiated into innate immune and specific immune responses. 
 Innate immune response 
The innate immune response is non-specific and rapidly eliminates bacteria before the specific 
immune system is activated. Abnormalities, e.g., changes in the milk composition do not occur. The 
non-specific responses are mediated by the physical barrier of the teat end, macrophages, 
neutrophils, natural killer cells, and particular soluble factors (Sordillo and Streicher, 2002). The 
soluble factors of the innate immune response include the bacteriostatic complement factors 
defensins, lysozyme, lactoferrin and cytokines.  
The complement system represents the first defense line of innate immunity. The function of the 
mammalian complement system is to maintain homeostasis by recognition and removal of damaged 
or modified self-material and pathogenic microbes (Zipfel et al., 2013). However, complement is also 
of importance in the specific immune response. The complement system is composed of plasma 
proteins, which are also present in milk and mainly coat the surface of a pathogen for its recognition 
by cells of the specific immune system. During innate immune response the complement accounts 
for lysis of Gram-negative bacteria. Among these, E. coli has been reported to be sensitive to lysis by 
complement (Korhonen et al., 2000).  
Additionally, the defensins, also referred to as antimicrobial peptides (AMP), are an evolutionarily 
conserved component of the innate immune response. Defensins are diverse oligopeptides (<100 
amino acids), contributing to the antimicrobial action of granulocytes, mucosal and epithelial host 
defense (Ganz, 2003; Peschel and Sahl, 2006). 
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Of the soluble mammary gland defense components lactoferrin is a predisposing antimicrobial 
protein reported to increase in concentration when an inflammation occurs (Sordillo et al., 1987). 
Lactoferrin contributes to neutralization of cytotoxic effects mediated by lipopolysaccharides 
(Pecorini et al., 2010). Moreover, the main function of lactoferrin is to inhibit the growth of certain 
bacteria by binding of iron, an essential factor required for bacterial growth. This growth hindering 
effect of lactoferrin has already been reported for Gram-negative bacteria such as E. coli in ruminants 
(Chaneton et al., 2008; Rainard, 1986).  
Cytokines are immunomodulating molecules that account for cell signaling. They are produced after 
antigen detection by certain cells of the immune system, mainly by leukocytes. The different 
cytokines (e.g. TNFα and IL1β) have a matching cell-surface receptor thus subsequently affecting 
intracellular signaling cascades and consequently mediating alterations of cellular functions. Figure 2 
shows the involvement of the inflammatory cytokines TNFα and IL1β in the immune response on 
putative mammary pathogenic E. coli (Shpigel et al., 2008) as possibly induced by lipid A recognition 
by the TLR4-MD-2 receptor complex (Maeshima and Fernandez, 2013). However, the specific effect 
of a particular cytokine depends on both, the cytokine´s and its receptor´s abundance followed by 
the activated downstream signaling cascade which can vary in different cell types. In general 
cytokines are considered redundant, in that many cytokines appear to share similar functions. These 
might include either direct regulation of genes or regulation by their transcription factors and further 
result in production of other cytokines, receptor expression for other molecules, or suppression of 
their own effect by feedback inhibition. Certain cytokines also participate in the specific immune 
response. 
 Specific immune response 
If the infecting bacteria evade the innate immune response or are not completely eliminated, the 
specific or acquired immune response is triggered.  
In contrast to the innate immune response the specific immune system needs to recognize the 
pathogens by specific antigens and therefore it takes time to be prepared. Once a specific response is 
created, due to the immunological memory, the immunity state is quickly established, intensive and 
enduring when the same antigen is recognized again. This results in a more effective elimination of 
the pathogen. Thereby, the most important soluble effectors of the specific immune response are 
antibodies produced by B lymphocytes after antigen recognition. The advantages of the acquired 
immune response are for example used as basis for vaccination.  
Also in the mammary gland the innate and the acquired immune system are coordinated in synergy 
to prevent mastitis.  
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Table 1: Cellular and soluble defenses of the mammary gland 
Cellular defense factors Biological function Immune system 
Neutrophils Phagocytosis and intracellular killing of bacteria;  
  secretion of antibacterial factors 
innate 
Macrophages Phagocytosis and intracellular killing of bacteria;  
  antigen presentation in conjunction with MHC 
innate & specific 
Natural killer cells Non-immune lymphocytes that secrete antibacterial 
  Proteins upon activation 
innate 
T lymphocytes 
 
 
       CD4C (T helper) 
 
Production of immunoregulatory cytokines following  
  antigen recognition with MHC class II molecules;  
  memory cells following antigen recognition 
specific 
       CD8C (T cytotoxic) Lysis of altered or damaged host cells when complexed  
  with MHC class I molecules;  
  production of cytokines that can down-regulate certain  
  leukocyte functions 
specific 
γδ T lymphocytes Biological role in the mammary gland is speculative specific 
B lymphocytes  
 
       Mature B cells 
 
Display membrane-bound antibody molecules to facilitate  
  antigen presentation;  
  memory cells following antigen interactions 
specific 
       Plasma cell Terminally differentiated B lymphocytes that synthesize 
  and secrete antibody against a specific antigen 
specific 
   
Soluble defense factors Biological function Immune system 
Cytokines Proinflammatory and immunoregulatory factors innate 
Complement Bacteriolytic and/or facilitates phagocytosis innate & specific 
Lysozyme Cleaves carbon bonds and disrupts bacterial cell walls innate 
Lactoferrin 
 
Sequesters iron to prevent bacterial uptake;  
  disrupts bacterial cell wall;  
  regulates mammary leukocyte activity 
innate 
Antibodies  
 
      IgG1 Selectively transported into mammary secretions;  
  opsonizes bacteria to enhance phagocytosis 
innate 
      IgG2 Transported into secretions during neutrophil diapedesis;  
  opsonizes bacteria to enhance phagocytosis 
innate 
      IgA 
 
Associated with the fat portion of milk;  
  does not bind complement or opsonize particles;  
  can cause agglutination, prevent bacterial colonization,  
  and neutralize toxin 
innate 
      IgM 
 
Efficient at complement fixation, opsonization, 
  agglutination and toxin neutralization; 
  only opsonic for neutrophils in presence of complement 
innate 
Table modified from Sordillo and Streicher, 2002   
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 Pathogen recognition 
Rapid pathogen recognition is essential for activation of the innate and the specific immune 
response. Generally, immune cells as well as non-immune cells are able to sense pathogens by 
particular pathogen recognition receptors (PRR). These receptors can be displayed either on the 
surface or intracellularly, and recognize so called pathogen-associated molecular patterns (PAMPs). 
PAMPs are small molecular motifs, which are conserved within a class of microbes such as 
lipoteichoic acids in Gram-positive and LPS in Gram-negative bacteria (Kumar et al., 2011).  
After binding to PAMPs, the PRRs subsequently initiate intracellular signaling cascades or directly 
promote the attachment, ingestion and destruction of the pathogens. Table 2 shows a general view 
of these pathogen recognition receptors. Additionally, two lymphocytes types of the specific immune 
system (also referred to as memory B cells and memory T cells) are able of pathogen recognition 
when sensing a previously encountered antigen allowing for a rapid immune response (Sordillo and 
Streicher, 2002; Sordillo et al., 1997). Of the extracellular PRRs the so called Toll-like receptors (TLRs) 
have a key role in activation of the innate and specific immune response. For instance when a specific 
PAMP such as LPS interacts with its particular TLR it induces, via TNFα, NF-κB signaling and the MAP 
kinase pathway followed by the release of cytokines and elicitors that will pass on the TLR activation 
signal to other immune cells (Doyle and O’Neill, 2006). 
 
Table 2: Pathogen recognition receptors 
Factor Role 
Innate Immunity  
   CD14 
 
 
 
Binds LPS. Membrane version is expressed on several cells including monocytes, macrophages, 
neutrophils, dendritic cells, and B cells. The soluble version may compete with mCD14 for LPS 
and is essential in the activation of non-mCD14 expressing cells, including epithelial and 
endothelial cells, by LPS. 
   PGRP Expressed in differentiated, lactating epithelium where it binds and hydrolyzes peptidoglycans. 
   TLR2 
 
 
 
Recognizes peptidoglycan and LTA from Gram-positive bacteria and lipoarabinomannan from 
mycobacteria. May form a heterodimer with TLR1 to recognize triacylated lipopeptides from 
Gram-negative bacteria and Mycoplasma or with TLR6 to recognize diacylated lipopeptides 
from Gram-positive bacteria and Mycoplasma.  
   TLR3 Detects double-stranded RNA. 
   TLR4 Recognizes LPS of Gram - bacteria, heat-shock proteins, fibrinogen, and polypeptides. 
   TLR5 Recognizes bacterial flagellin. 
   TLR9 Intracellular recognition of CpG-containing oligodeoxynucleotides (ODNs). 
Acquired Immunity  
   Fc Receptor 
 
Expressed on macrophages, neutrophils, and natural killer cells and recognize antibodies of 
infected cells or pathogens. 
Table modified from Aitken et al., 2011 
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The recognition of a presumed mammary pathogenic E. coli (MPEC hereafter) is schematically shown 
in Figure 2. TLR2 and TLR4 are the most significant receptors during bacterial mastitis and are 
primarily activated in response to Gram-positive and Gram-negative infections, respectively (Aitken 
et al., 2011; Günther et al., 2011; Yang et al., 2008; Goldammer et al., 2004).  
Notably, even though both S. aureus and E. coli are able to trigger TLR2 and TLR4, only E. coli is 
capable of inducing NF-κB signaling in mammary gland epithelial cells followed by quick induction of 
TNF-α. It is still not known whether the diminished NF-κB activation potential in immune relevant 
cells is a molecular defect, or depends on virulent traits of the particular pathogen, associated with 
subclinical mastitis. 
Figure 2: Pathophysiological scheme of presumed mammary pathogenic E. coli (MPEC) replicating in 
the mammary alveolar space, modified from Shpigel et al., 2008. LPS/TLR4 signaling on alveolar 
macrophages (MΦ) elicits production of inflammatory cytokines (TNFα and IL1β) and chemokines (KC 
and MIP2), resulting in recruitment of blood neutrophils (PMN) trafficking across the polar alveolar 
epithelium (TJ, tight junction) into the alveolar space. Recruited neutrophils are killing the bacteria by 
phagocytosis and neutrophil extracellular traps (NETs). Bacterial epithelial invasion is abrogated by 
LPS/TLR4 signaling on MΦ possibly mediated by nitric oxide (NO) produced by MΦ and myoepithelial 
cells. Epithelial invasion by bacteria induce epithelial megalocytosis, necrosis and apoptosis. 
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II.2. Escherichia coli 
Escherichia coli (E. coli) represents from an evolutionary point of view a comparably young bacterial 
species linked to the appearance of animals. Usually, a commensal resident of the intestinal 
microflora of warm blooded animals, E. coli can become pathogenic by acquisition of virulence 
factors (VFs) (Hacker et al., 2003). Specific pathotypes of E. coli are defined by successful 
combinations of VFs, often located on pathogenicity islands (PAIs) or smaller inserts. Pathotypes are 
capable of causing a broad spectrum of diseases in healthy individuals (Kaper et al., 2004). Besides 
specific pathotypes (Table 3), the major categories are: intestinal pathogenic E. coli (IPEC), 
extraintestinal E. coli (ExPEC), depending on the site of infection, and commensal E. coli (Dobrindt, 
2005; Köhler and Dobrindt, 2011). Notably, E. coli pathotypes cannot always be unambiguously 
grouped by phylogeny. They often arose in parallel evolution and were spread polyphyletically (Reid 
et al., 2000). E. coli strains can be classified according to their phylogeny into clonal groups (A, B1, B2, 
C-I to C-V, D E and F) and cryptic clades (Clermont et al., 2000 and 2013; Walk et al., 2009). 
Moreover, E. coli strains can be distinguished by their serotype, defined by the combination of their 
surface antigens LPS (O antigen), flagellin (H antigen) and capsule (K antigen) (Kauffmann, 1965). 
Serotyping is an approved diagnostic tool which allows to associate E. coli strains of a specific 
serotype to certain clinical manifestations. However, the classification by serotype does not allow 
conclusions concerning virulence (Jacks and Glantz, 1967). Instead the serotype correlates to the 
strains phylogeny and often provides valuable information on its pathotype (Iguchi et al., 2008). 
Altogether, the different pathotypes, high phylogenetic diversity and various serotypes of E. coli 
result from substantial genome plasticity. 
 
Table 3: Intestinal und extraintestinal Escherichia coli pathotypes. 
Intestinal pathogenic E. coli (IPEC) Extraintestinal pathogenic E. coli (ExPEC) 
Adherent invasive E. coli (AIEC) Avian pathogenic E. coli (APEC) 
Diffusely adherent E. coli (DAEC) Meningitis-associated E. coli (NMEC) 
Enterotoxigenic E. coli (ETEC) Septicemia-associated E. coli (SEPEC) 
Enteropathogenic E. coli (EPEC) Uropathogenic E. coli (UPEC) 
Enteroinvasive E. coli (EIEC) putative  Mammary pathogenic E. coli (MPEC) 
Enteroaggregative E. coli (EAEC) 
Enterohemorrhagic E. coli (EHEC) 
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II.2.2. E. coli genome structure and plasticity 
The E. coli genome is varying from approximately 4.6 to 5.5 × 106 bp in size. It can be distinguished 
into a core genome, present in all E. coli strains, and a strain-specific dispensable genome also 
referred to as flexible gene pool. Obviously, the core genome comprises the so called housekeeping 
genes, encoding for proteins of translation, transcription and replication, as well genes of the basic 
metabolism. Moreover, it can be suggested that some genes of the core genome are important in the 
lifestyle within the gut as the main E. coli habitat. Once estimated with about 3,100 genes, more 
recent calculations report only about 2,000 genes of high homology comprised by the core genome 
of E. coli (Dobrindt et al., 2003; Touchon et al., 2009). On the other hand, the flexible gene pool 
(16,000 genes) accounts for the different genome sizes of E. coli and thereby comprises genes that 
are required for adaptation to often changing environmental conditions provided by the habitat. 
These genes are often localized on mobile genetic elements, such as plasmids, prophages, 
transposons or genomic islands (GEIs). GEIs may serve as integration hotspots for different mobile 
genetic elements. They are discrete genetic units of 10-200 kb, flanked by direct repeats and 
insertion sequences and frequently associated with tRNA-encoding genes. Their GC-content differs 
from that of the core genome. Additionally, GEIs comprise genes coding for integrases and 
transposases, which facilitate the insertion into the chromosome of recipient E. coli strains. If a GEI 
comprises virulence genes and if this GEI is present in the genome of a pathogenic E. coli, but absent 
in non-pathogenic strains, this GEI is referred to as a pathogenicity island (PAI). Both, the core 
genome and the dispensable genome constitute the E. coli pangenome (approximately 18,000 genes) 
(Dobrindt et al., 2003 and 2004; Hacker et al., 1990, 1997 and 2003; Leimbach et al., 2013; Medini et 
al., 2005; Tenaillon et al., 2010, Touchon et al., 2009). 
The substantial genome plasticity makes E. coli a highly versatile species which is able to constantly 
alter its genome content by horizontal gene transfer (HGT) and deletion events in order to provide 
adaptation, fitness and competitiveness to different growth conditions and habitats . 
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II.2.3. ExPEC: Commensal E. coli with increased potential to cause extraintestinal disease 
The acronym ExPEC designates certain E. coli strains that cause extraintestinal infections (EIs). Hence, 
a specific E. coli strain would be defined as ExPEC if it exhibits enhanced virulence in an appropriate 
extraintestinal infection model or if harboring multiple extraintestinal VFs (Table 4). Isolation of an 
E. coli strain from an extraintestinal infection does not per se determine an ExPEC, since also 
commensal strains of E. coli are able to cause EI when the host is compromised. Likewise the specific 
pathotypes of E. coli (Table 3), the major category ExPEC is defined by successful combinations of 
VFs, depending on the number, type and synergistic effect of these VFs (Russo and Johnson, 2000; 
Kaper et al., 2004; Köhler and Dobrindt, 2011). 
 
 
Table 4: ExPEC virulence factors as illustrated by Köhler and Dobrindt, 2011 
Functional category Virulence factor 
Adhesin Type 1 fimbriae (Fim) 
P fimbriae (Pap/Prf) 
S/F1C fimbriae (Sfa/Foc) 
N-Acetyl D-glucosamine-specific fimbriae (Gaf) 
M-agglutinin (Bma) 
bifunctional enterobactin receptor/adhesin (Iha) 
afimbrial adhesin (Afa) 
temperature sensitive hemagglutinin (Tsh) 
Invasin invasion of brain endothelium (IbeA) 
Iron acquisition siderophore receptor IreA 
aerobactin (Iuc) 
yersiniabactin (Ybt) 
salmochelin (Iro) 
periplasmic iron binding protein (SitA) 
Toxins alpha-hemolysin (HlyA) 
cytolethal distending toxin I (CDT 1) 
cytotoxic necrotizing factor 1 (CNF-1) 
colibactin (Clb) 
serine protease autotransporters Sat, Pic 
Protectins group II capsule incl. K1 capsule 
conjugal transfer surface exclusion protein (TraT) 
outer membrane protease T (OmpT) 
increased serum survival (Iss) 
colicin V (Cva) 
Others D-serine deaminase (DsdA) 
maltose and glucose-specific PTS transporter subunit 
flagella 
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It seems clear that the flexible E. coli gene pool serves the purpose to acquire and discard genes as a 
result of selective pressures of the habitat. This opens up a rather new perspective of discriminating 
pathogens from commensals. While IPEC strains can be reliably discriminated from ExPEC or 
commensal E. coli based on genome content and phenotypic traits, an unambiguous distinction 
between ExPEC and commensals proves to be difficult (Leimbach et al., 2013). This is easy to 
understand as ExPEC originate from the microflora of healthy individuals by acquisition of novel 
traits. Or changing the perspective: Commensals constitute as reservoir of E. coli that can become 
ExPEC. 
In terms of commensalism advantageous traits are referred to as colonization and fitness factors, 
whereas traits contributing to pathogenicity have been designated virulence factors (VFs). The 
literature refers to VFs as molecular mechanisms expressed by pathogens enabling them to thrive in 
pathogenesis (Donnenberg, 2002). VFs might facilitate the colonization of a niche in the host (e.g. the 
teat duct or the urinary tract) including the adhesion to host cells or actually mediate 
immunoevasion (evasion of the host's immune response), e.g. by invasion/entry into host cells. They 
might also enable nutrient acquisition from the host or cause inhibition of the host's immune 
response also referred to as immunosuppression. As PAIs may carry multiple virulence-associated 
gene clusters, its acquisition might turn a before benign E. coli strain into a pathogenic one in a single 
step (Dobrindt et al., 2004). 
Anyhow, it is an ongoing discussion whether particular traits should be considered VFs or fitness 
factors depending on their contribution to either one or being involved in both ExPEC virulence and 
commensal fitness. For instance Leimbach et al. exemplified prevalent VFs of ExPEC that are also 
found in commensal E. coli (Table 5). Furthermore, they pointed out that commensal E. coli of 
phylogroups B2 and D resemble typical ExPEC with regard to the prevalence of their virulence- or 
fitness-associated traits. This is supported by data suggesting that extraintestinal virulence emerged 
as a coincidental by-product of commensalism (Le Gall et al., 2007; Tenaillon et al., 2010). And, of 
course, it seems convincing that some of these virulence-associated traits (e.g. adhesins) are 
important not only for pathogens but also for commensals within the gut. The odd situation that 
many previously described virulence-associated traits were announced VFs, although contributing to 
commensalism, may be due to the focus on pathogens in former studies. Notably, in this study the 
traits contributing to bacterial virulence and survival within the bovine udder, which are not known 
to be indispensable for ExPEC virulence, will be announced virulence-associated traits hereafter. 
Nevertheless, there some indications may be helpful to distinguish between ExPEC and commensals: 
Commensals are highly adapted to a particular niche, like a specific gut region. It seems natural that 
characteristics of a rather persistant commensal depend on the site of the habitat, while a transient 
pathogen may be not that well-adapted to this niche (Abraham et al., 2012). The acquisition of novel 
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genes as well as genome reduction, are reflected by variable genome sizes. However, the genome 
size of commensal E. coli has been reported to be usually smaller than that of pathogenic E. coli 
variants (Chaudhuri and Henderson, 2012; Bergthorsson and Ochman, 1995). Another opportunity 
might be the characterization of source-specific alleles (e.g. of iss or genes of extracellular 
polysaccharides) that presumably differ and could improve discrimination of ExPEC and commensal 
E. coli (Johnson et al., 2008a; Duda et al., 2013). As afore mentioned VFs are often localized on PAIs 
or plasmids, some commensals might be distinguished from ExPEC according to their plasmid content 
(Dufour et al., 2011), although mobile elements should not account as unambiguous marker. The pks 
island for example, a designated PAI, was associated with multiple ExPEC-associated virulence genes 
identified in an especially high-virulence subset of phylogroup B2 (Johnson et al., 2008b). The same 
authors found that ExPEC and commensal E. coli differ in their antimicrobial susceptibilities and 
plasmid replicon possession (colicin plasmid) suggesting that in ExPEC, multi drug resistance (MDR) is 
frequently associated with plasmids (Johnson et al., 2012). In summary: We know that improved 
adaptability and competitiveness may promote intestinal colonization as well as extraintestinal 
infection by E. coli (Leimbach et al., 2013). As a consequence extraintestinal virulence and intestinal 
fitness traits overlap. In the era of genomics discrimination of ExPEC and commensal E. coli should be 
further improved by either 1) extended studies on the prevalence of source-specific alleles or 2) 
assessment of gene regulation of the traits involved in both fitness and virulence related processes. 
 
Table 5: Fitness and virulence traits of ExPEC adapted from Leimbach et al., 2013 
Trait Example Role during infection Role during commensalism 
or in secondary habitat 
Adhesins Type 1 fimbriae Adhesion, 
niche tropism, 
biofilm formation 
Adhesion, 
niche tropism, 
biofilm formation 
Siderophore 
            receptors 
Yersiniabactin 
          receptor 
Salmochelin 
          receptor irgA 
homolog 
           adhesin (Iha) 
Iron acquisition, 
adhesion, 
invasion, 
biofilm formation 
 
Iron acquisition, 
adhesion, 
biofilm formation 
 
Extracellular 
    polysaccharides, 
    cellulose, 
    capsule, 
    LPS 
Capsule, cellulose, LPS Serum resistance, 
protection against 
immune response; 
interaction with 
eukaryotic cells 
Protection against 
predation, desiccation, 
intestinal colonization 
 
Toxins α-Hemolysin  Cell/tissue destruction, 
release of nutrients 
Signaling 
Flagella  Motility/chemotaxis Motility/chemotaxis 
Metabolic traits Utilization of D-serine, 
fructooligosaccharides 
Growth advantage, 
niche colonization 
Growth advantage, 
niche colonization 
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II.2.4. Virulence factors of mammary pathogenic E. coli 
This study focuses on virulence-associated traits of E. coli strains capable of causing bovine mastitis. 
Therefore, typical VFs of ExPEC will be discussed in relation to MPEC.  
Figure 3: Scheme of different typical VFs of extraintestinal pathogenic E. coli (ExPEC) in comparison 
to a mammary pathogenic E. coli (MPEC) and its suggested VFs. 
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It was mentioned before (section II.2.2), that alterations of the E. coli genome content due to HGT 
and genome reduction can result in adaptation, improved fitness and competitiveness to different 
growth conditions and niches. Thus, a PAI conferring virulence traits might turn a benign E. coli strain 
into a pathogenic one in a single step (Dobrindt et al., 2004). A study conducted by Dufour et al. 
reports on the presence of GEIs in the bovine mastitis E. coli strain P4. The complete characterization 
of one GEI revealed genes that clearly distinguish E. coli P4 from the E. coli K-12 strain MG1655 and 
which are present in other pathogenic E. coli strains (Dufour et al., 2011). Indeed, knowledge of the 
presence or absence of GEIs or designated PAIs might allow us to distinguish between commensal 
E. coli or such with the ability to cause mammary gland infection (MPEC) as suggested by Shpigel et 
al. (Shpigel et al., 2008). 
 The Type Three Secretion System ETT2 
The E. coli type three secretion system 2 (ETT2)-encoding island is a designated PAI, which is 
distributed among many E. coli (Ren et al., 2004). The 29.9 kb ETT2 PAI was first discovered in the 
genome of EHEC O157:H7 serotype strain EDL933 (Perna et al., 2001) and mainly associated with 
pathogenic E. coli (Makino et al., 2003; Miyazaki et al., 2002). Later, the ETT2 gene cluster was found 
either in total or in part in the majority of E. coli strains. However,  according to its genetic structure 
it seems often to encode a non-functional secretion system (Ren et al., 2004; Perna et al., 2001). The 
intact ETT2 locus encodes for at least 35 genes, including yqe, yge, etr, epr, epa, eiv, etc., which are 
similar to genes included in PAIs of Salmonella (Cheng et al., 2012; Hansen-Wester and Hensel, 2001; 
Blanc-Potard et al., 1999; Galán, 1996). The presence of ETT2 was previously associated with 
bacterial invasion and intracellular survival of MNEC and was therefore believed to be involved in the 
pathogenesis of extraintestinal infection (Yao et al., 2009). In general, the type three secretion 
system (T3SS) is exclusively present in Gram-negative bacteria and is involved in the transport of 
bacterial virulence-associated proteins across the bacterial membranes, but also across the host cell 
barriers directly into the host cell cytoplasm (Cornelis, 2002; Lee, 1997). On the contrary, the specific 
role of the ETT2-encoded proteins and their functions in pathogenesis remains to be investigated in 
detail. Interestingly, a recent study on the prevalence and isoforms of ETT2 revealed a significantly 
higher presence of ETT2 (86 %, n= 92) among E. coli isolates of porcine origin than that (47 %, n= 76) 
of bovine mastitis origin. Even more interesting is the correlation of the presence of the intact ETT2 
in the isolates from cases of porcine edema and/or diarrhea. In contrast, the majority of isolates from 
bovine mastitis carried corrupted EET2 isoforms and showed no distinct association with other VFs, 
e.g., the presence/absence of heat-labile enterotoxin(LT1), heat-stabile enterotoxin(ST2), cytotoxic 
necrotizing factor type 2(CNF2), pili (Tra), catalase-peroxidase(HPI) and hemolysin(Hly) (Cheng et al., 
2012). 
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 Adhesins 
The VFs enabling the bacteria to adhere to host epithelial cells are referred to as adhesins. Adhesins 
can be divided into fimbrial and afimbrial adhesins. Fimbriae (also pili) are thin, rod shaped fibers 
composed of different protein subunits (Sauer et al., 2000; Schilling et al., 2001).  
 Type 1 fimbriae 
The type 1 fimbriae represent the most prevalent fimbrial-type in E. coli and are encoded by the fim 
gene cluster comprising nine fim genes. Among them is fimH which encodes for the adhesion and is 
located at the very tip of the fimbriae. The FimH subunit has been reported to mediate specific 
binding to α-mannoside structures on different animal host epithelial cells (Klemm et al., 1985; 
Johnson, 1991; Pourbakhsh et al., 1997). Additionally, binding to IgA, laminin and also to the CD 11 
and CD 18 complex of leukocytes and macrophages was observed. Interestingly, the comparison of 
fimH genes of E. coli strains from bovine, avian and porcine clinical cases revealed a substantial 
homology (>99%) among fimH genes from the different animal species origins. Moreover, specific 
mutations were found, some of which were present more frequently in bovine or avian or porcine 
strains respectively (Vandemaele et al., 2004). 
 Long polar fimbriae 
The long polar fimbriae (lpf gene cluster) were first discovered in Salmonella typhimurium. The 
designation reflects the observation of long fimbriae inserted at the poles of the bacterium upon 
expression of the fimbrial operon by a non-piliated E. coli strain (Bäumler and Heffron, 1995). Despite 
this, a fimbrial cluster of high sequence similarity to the lpf gene cluster of Salmonella and several 
IPEC strains has been identified in ExPEC. This operon exhibits homology regarding the nucleotide 
sequence and the genetic organization relative to the type I fimbrial gene cluster. Furthermore, the 
ExPEC lpf cluster was reported to be functional and involved in adherence and invasion to kidney 
epithelial cells(Ideses et al., 2005).  
Regarding mastitis, the presence of the lpfA gene was associated with invasion of cultured bovine 
mammary gland epithelial cells by E. coli isolates from both, transient and persistent, mastitis cases 
(Dogan et al., 2012). A recent study determined the lpfA gene as one of the most prevalent VF genes 
detected in E. coli isolates from bovine mastitis (Blum and Leitner, 2013). This study found lpfA 
prevalent in 52 % of the mastitis isolates (n= 63) and 67 % of the environmental isolates (n= 24) 
investigated. Both studies support the idea of long polar fimbriae being an important factor in the 
pathogenesis of mastitis-causing E. coli. However, this is still a matter of speculation and needs to be 
reinforced by in vivo experiments as well as more extended studies on the prevalence of the lpf gene 
cluster. 
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 F1C, P and S -fimbriae 
Also distributed in ExPEC isolates are fimbriae of S-, F1C-, and P-type, which also possess an adhesin 
present at the tip mediating binding to sugar entities of certain host cell receptors (Johnson, 1991). In 
contrast to many other VFs, they are exclusively encoded on the bacteria´s chromosome (Hacker, 
1992).These fimbriae were observed to contribute to the virulence of pathogenic E. coli strains, but 
they are not necessarily sufficient to cause disease (Mobley et al., 1994). However, P-fimbriae 
account for host responses resulting in inflammation (van den Bosch et al., 1993; Bergsten et al., 
2005). The P-fimbriae are encoded by the pap gene cluster and are reported to be less often 
expressed in ExPEC compared to type 1 fimbriae expression (Hacker, 1992). There is evidence that P-
fimbrial adhesins may be associated with the virulence of avian pathogenic E. coli (APEC) 
(Kariyawasam and Nolan, 2011).  
The S fimbriae (encoded by the sfa gene cluster) and F1C fimbriae (encoded by the foc gene cluster) 
are members of the S-fimbriae superfamily of adhesins. S fimbriae mediate agglutination (mannose-
resistant hemagglutination /MRHA) of human erythrocytes. The S and F1C fimbriae show specific 
binding to sialosyl oligosaccharide chains (Ott et al., 1988; Prasadarao et al., 1993). Studies on the 
prevalence of the S fimbriae among ExPEC strains reported greatly varying frequencies of the sfa 
genes reaching from 9.2 to 97 % in APEC strains and 50 to 100 % prevalence in human ExPEC isolates 
(Ewers et al., 2007; Moulin-Schouleur et al., 2006).  
For S- and P-fimbriae, there is a merely slight prevalence (7-8 %, n= 155 and 160) in E. coli bovine 
mastitis isolates from Finland reported (Lehtolainen et al., 2003; Kaipainen et al., 2002). In contrast, a 
more recent study on bovine mastitis isolates found none of the isolates containing genes for F17a-A, 
intimin, P or S fimbriae (Ghanbarpour and Oswald, 2010). Notably, this would lead to the suggestion 
that mastitis pathogenesis does not require these particular adhesins. 
 F17 fimbriae 
F17 fimbriae were mainly reported in pathogenic E. coli strains responsible for diarrhea or septicemia 
in cattle and sheep and more recently associated with APEC (Oswald et al., 1991; Lintermans et al., 
1988; Le Bouguénec and Bertin, 1999; Stordeur et al., 2002). Although F17-positive APEC strains were 
pathogenic for chicken and caused characteristic lesions of avian colibacillosis (Stordeur et al., 2004), 
there is still doubt that the observed contribution is not an effect of other known VFs. F17 fimbrial-
related genes were identified in other ExPEC, e.g. human UPEC and bovine SEPEC isolates (Martin et 
al., 1997; Le Bouguénec and Bertin, 1999) and were also detected in E. coli bovine mastitis isolates 
(20 %, n= 127) (Ghanbarpour and Oswald, 2010). Again, there is a contrast to the Finnish E. coli 
bovine mastitis isolates which showed a slight prevalence of F17 fimbriae (8-9 %, n= 155 and 160) 
(Lehtolainen et al., 2003; Kaipainen et al., 2002).  
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 Mat fimbriae 
The Mat (meningitis-associated and temperature regulated) fimbriae were originally identified in 
O18:K1:H7 NMEC isolates and are known to be encoded by the mat gene cluster (Pouttu et al., 2001). 
Later, expression of a structurally related fimbria was observed in both pathogenic and non-
pathogenic E. coli strains and thus the name E. coli common pilus (ECP) was introduced (Rendón et 
al., 2007). Nowadays, we know that the mat gene cluster has an identical chromosomal location as 
well as an overall 98% DNA sequence identity across different pathovars and phylogenetic groups of 
E. coli. Therefore the mat gene cluster belongs to the so-called persistent genes that are present in 
nearly all isolates of a species (Touchon et al., 2009; Fang et al., 2005). To date, the Mat fimbriae 
were frequently observed to mediate binding to particular epithelial cells (Rendón et al., 2007; 
Lasaro et al., 2009; Saldaña et al., 2009; Avelino et al., 2010). Just recently EcpD/MatE was presumed 
to be responsible for the attachment to epithelial cells. This suggests the presence of a tip-associated 
adhesin like in case of other fimbrial adhesins (Garnett et al., 2012). Furthermore, Mat fimbriae are 
needed for biofilm formation by NMEC and UPEC (Lehti et al., 2010; Garnett et al., 2012). Given that 
Mat fimbriae are essential for the colonization of infant mice by the probiotic isolate E. coli Nissle 
1917 (Lasaro et al., 2009), the Mat fimbria is considered rather an important colonization factor of 
E. coli than a virulence factor. However, although there is no relation to putative MPEC reported to 
date, the Mat fimbriae could be an advantageous factor in mastitis pathogenesis when facilitate 
binding to mammary epithelial cells. 
 Curli 
Curli are thin, filamentous structures frequently displayed on the surface of ExPEC, which are 
encoded by the csgBAC operon. The adhesive subunit CsgA facilitates binding to serum proteins and 
proteins of the extracellular matrix (e.g. laminin, fibronectin, plasminogen), but also interacts with 
major histocompatibility complex molecules (Olsén et al., 1998 and 1989). E. coli mastitis isolates, 
deprived of mannose-sensitive and mannose-resistant adhesins, were able to produce curli fimbriae 
under aerobic and anaerobic conditions at room and higher temperature, which suggests that these 
adhesins may be involved in the pathogenesis of bovine mastitis (Karczmarczyk et al., 2008). Curli 
expression was detected in 55-57 % of the clinical mastitis isolates tested (Dyer et al., 2007; Olsén et 
al., 1989). However, phenotypic curli expression in clinical isolates did not affect recovery of the 
cows’ milk yield to premastitis production levels. This suggested that the clinical severity of E. coli 
mastitis is more dependent on cow-related factors than on bacterial virulence (Dyer et al., 2007). 
Nevertheless, curli enable bacterial adherence to multiple cell lines, and curli fibers themselves 
interact with many host proteins and are potent inducers of the host inflammatory response 
(Barnhart and Chapman, 2006). The role of curli expression in E. coli pathogenesis during mastitis 
remains yet unclear. 
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 Afimbrial adhesins 
Structures that facilitate binding, but are not assembled into fimbria structures are designated 
afimbrial adhesins. The first reported afimbrial adhesin was that encoded by the afa gene cluster and 
was observed to mediate UPEC binding to epithelial cells of the urinary tract (Labigne-Roussel et al., 
1984). Afa and the closely related adhesins from Dr adhesin superfamily and the mannose resistant 
non-fimbrial hemagglutinin(NFA) are expressed by ExPEC and IPEC from both human and domestic 
animals (Le Bouguénec and Bertin, 1999; Girardeau et al., 2003). Another study suggested Afa to be 
associated with EPEC (Keller et al., 2002), but afa genes were rarely (1 %) detected in E. coli isolates 
from bovine mastitis (Kaipainen et al., 2002). Similarly, other afimbrial adhesins have been associated 
rather with IPEC than ExPEC (e.g. CS6 and CS31A adhesins). The CS31A adhesion for example is 
mainly expressed by pathogenic E. coli strains also producing the F17 fimbriae which were only rarely 
detected (<1 %) in putative MPEC (Ghanbarpour and Oswald, 2010; Kaipainen et al., 2002). 
 Flagella 
The flagella are long surface structures composed of polymerized flagellin subunits encoded by fliC. 
Flagella mediated motility and were shown to affect the pathogenesis of UTI caused by UPEC (Lane et 
al., 2005). Furthermore, flagella were reported to enhance colonization of the urinary tract by UPEC 
and enable ascending infections (Lane et al., 2007). Beside their impact on ExPEC pathogenesis, 
flagella have been associated with invasion into intestinal epithelial cells of domestic animals by IPEC 
(ETEC, EPEC and STEC) (Xu et al., 2013; Duan et al., 2012 and 2013; Girón et al., 2002; Murinda et al., 
2004). Anyhow, flagella might provide the motility required by putative MPEC to ascend the milk 
ducts. Just recently, fliC was for the first time reported in context of mastitis; found to be present in 
80 % of isolates from bovine mastitis (n= 20) (Silva et al., 2013). It has to be further elucidated 
whether fliC is expressed and thus impact mastitis or not. 
  Serum and complement resistance 
E. coli strains that cause extraintestinal infections are challenged with anatomical barriers and early 
stages of host defense (section II.1.4). In order to resist to the host´s complement system during an 
infection bacteria might either utilize polysaccharides (e.g. K-antigens and O-antigens) or proteins 
(e.g. Omp or Iss). Additionally, bacteria have evolved different mechanisms to resist the serum killing 
by defensins (also AMP) (Peschel and Sahl, 2006).  
 Capsules; K-antigens 
In the past, various functions have been assigned to cell coating capsular polysaccharides of different 
bacterial species. These include adhesion, transmission, resistance to innate host defenses, 
resistance to the host's adaptive immune response (e.g. complement-mediated killing) and 
intracellular survival (Roberts, 1996). The capsules or so called K-antigens are known to mediate 
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serum resistance and protection from complement by either inhibition of the complement activation 
cascade or due to steric effects and masking of the cell surface. Either way, the mediated resistance 
is likely to involve a number of cell surface structures which contribute to the overall effect (Burns 
and Hull, 1998 and 1999). 
In general capsules consist of linear polymers of repeating carbohydrate subunits that might also 
comprise an amino acid or lipid component. For E. coli more than 80 different K-antigens were 
determined and distinguished into four groups based on biochemical and genetic data (Whitfield and 
Roberts, 1999). The expression of certain K-antigens (kps genes) in ExPEC is strongly associated with 
particular infections: 
The E. coli K1 antigen (encoded by the neu & kps gene clusters) is reported to be essential for 
intracellular survival and crossing of the blood-brain-barrier and found to be present in most MENEC 
(Kim, 2002 and 2003). Specifically, the K1 antigen affects E. coli-containing vacuoles inside 
endothelial cells and prevents their fusion with lysosomes (Kim et al., 2003). As such, the K1 antigen 
plays a crucial role in meningitis. Another study reported on APEC enabled to escape phagocytosis by 
expression of the K1 antigen, the O78 LPS antigen and P-fimbriae (Mellata et al., 2003). Meanwhile, 
the K1 antigen is known to avoid serum killing by complement inhibition and is a barrier for the 
bacteriophage T7 (Wooster et al., 2006; Scholl et al., 2005). However, rather small frequencies of the 
antigens K1 and K5 in have been reported in UPEC. 1499 E. coli isolates from patients with UTIs have 
been investigated for the presence of K1 antigen and K5 antigen. K1 was detected in 10.5% and K5 in 
6.1% of the strains examined (Nimmich et al., 1985). Neither the K1 antigen nor the K5 antigen was 
detected in any of 273 screened E. coli isolates from bovine mastitis (Kaipainen et al., 2002). 
Besides antigens K1 and K5, the K2 antigen is known to contribute to ExPEC virulence. A study 
reported that expression of the K2 capsule by UPEC isolates accounts for the protection against 
complement-mediated killing and thus affects the pathogenesis of UTIs (Buckles et al., 2009). 
However, the various functions mediated by the K antigens might be advantageous in mastitis 
pathogenesis. 
 Lipopolysaccharides; O-antigens 
The lipopolysaccharides (LPS) are the major component of the outer membrane of Gram-negative 
bacteria comprising three regions (Figure 4): (1) the lipid A (endotoxin), which anchors the LPS in the 
outer membrane, (2) the core oligosaccharide, and (3) the O-antigen or O-polysaccharide (Raetz and 
Whitfield, 2002; Amor et al., 2000). Lipid A is the most conserved part of LPS and is known to be 
recognized by the CD14/TLR4/MD-2 receptor complex on host cells (Raetz and Whitfield, 2002; 
Kawai and Akira, 2010). The O-antigenic polysaccharide (OPS) is highly polymorphic and specific for 
each serotype. For E. coli, more than 180 different O-antigens have been described (Stenutz et al., 
2006). They are considered advantageous in colonizing specific niches and essential for the full 
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function and virulence of bacteria (Moran et al., 2009). Bacteria modify their O-antigens by adding 
positively charged moieties that prevent the electrostatic interaction of defensins with bacterial 
surfaces (Thomassin et al., 2012). Moreover, the surface-displayed LPS accounts for many virulence-
associated properties: Such as resistance to detergents, hydrophobic antibiotics or organic acids 
(Barua et al., 2002), adherence to eukaryotic cells (Jacques, 1996; Cohen et al., 1985) and serum 
resistance due to complement inhibition (Reeves, 1995). Especially the latter is believed to be 
dependent on the O-polysaccharide chain length (Reeves, 1995; Porat et al., 1992).  
Recent studies on the O-antigenic polysaccharide of the bovine mastitis isolate E. coli serotype O174 
suggest different subtypes of the O174 O-antigen. This supports the idea of evolutionary pressure 
due to host-pathogen interactions (Duda et al., 2013). 
Figure 4: Structural organization of LPS (from Maeshima and Fernandez, 2013). The three regions of 
LPS from the bottom: lipid A (chair structure indicates di-glucosamine head group, red circles indicate 
phosphate groups, squiggly lines indicate acyl chains), core sugars and O-antigen, which consists of 
repeating units (denoted in brackets with an “n”) of oligosaccharides. 
 
 
For bovine neutrophils it has been reported that binding of LPS to membrane-bound CD14 causes 
release of TNFα and sepsis (Paape et al., 2003). It is common knowledge that Lipid A as component of 
LPS acts as prototypical endotoxin, because it binds to the CD14/TLR4/MD2 receptor complex, which 
promotes the secretion of pro-inflammatory cytokines in many cell types, but especially in 
macrophages and B cells (Raetz and Whitfield, 2002; Kawai and Akira, 2010). This recognition 
promotes the secretion of pro-inflammatory cytokines in many cell types, but especially in 
macrophages and B cells (see also section  .0.0). The term "LPS challenge" refers to the process of 
exposing a subject to LPS that may act as a toxin and is a proposed method to elicit the immune 
INTRODUCTION  27 
 
response within in the udder by LPS induction (Schmitz, 2004; Elazar et al., 2010). In contrast to other 
virulence-associated factors, LPS is supposed to be a key factor of mastitis pathogenesis. It can be 
anticipated that modulation of the highly polymorphic O-antigen might affect both pathogen 
recognition and severity of mastitis pathogenesis and may thus differentiate between putative MPEC 
causing either acute or persistent mastitis. 
 Outer membrane proteins  
Besides the K-antigens and O-antigens mentioned above, certain outer membrane proteins (Omp) 
are known mediate serum resistance: 
 
Iss is a lipoprotein in the outer membrane and is encoded by iss often located on ColV plasmids 
(Chuba et al., 1989). It has been demonstrated that three alleles of iss occur among E. coli isolates 
possibly evolved from a common bor precursor of bacteriophage lambda (Johnson et al., 2008a). Iss 
(Increased serum survival) expression was first associated to confer resistance after the iss gene was 
introduced into an E. coli K-12 strain, and consequently the resistance to bactericidal serum was 
observed to be increased (Binns et al., 1982). It has been supposed that Iss plays a less important role 
for serum resistance than the K1 capsule due to observations made by exposure of E. coli K1 deletion 
mutants compared to iss isogenic mutants (Tivendale et al., 2004). The iss gene is found to be highly 
prevalent in different ExPEC pathogroups. A study reported that 82.7 % of 451 APEC isolates tested 
were iss-positive whereas only a minority (18.3 %) of E. coli isolates from avian faeces was tested 
positive on iss (Rodriguez-Siek et al., 2005). The frequency of iss in APEC compared to the 
environmental isolates (avian faeces) lead to the suggestion that strains in possession of iss are likely 
to become extraintestinal pathogenic.  
Notably, one of the type 3 iss alleles was reported to occur in the genomes of all sequenced ExPEC 
strains (known at the time of publication of the study) on a prophage element. When the distribution 
of all the three iss alleles was examined among 487 E. coli isolates, the iss type 3 gene occurred at a 
high frequency among ExPEC isolates, irrespective of the host source. Moreover, the plasmid-borne 
iss allele (designated type 1) was highly prevalent among APEC and NMEC isolates, but not among 
UPEC isolates (Johnson et al., 2008a). Studies that investigate the prevalence of iss, ignoring host- or 
source-specific alleles, might lead to confusion when trying to correlate the presence of iss to 
particular a pathotype. Possibly for this reason two studies on iss prevalence in E. coli isolates from 
bovine mastitis have inconsistent results: In one study isolates from mastitic cows (n=63) and from 
different places of cowsheds (n=24 environmental isolates) showed 33 % frequency of iss (Blum and 
Leitner, 2013). In another study the iss prevalence was determined to be 16.7 % in the tested E. coli 
isolates (n=144) from bovine mastitis (Suojala et al., 2011). However, both studies claim that Iss was 
among the three most prevalent VFs found in the E. coli isolates from bovine mastitis.  
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OmpA is a structural protein and probably one of the most prevalent proteins of the outer 
membrane of E. coli. It is important for the outer membrane stability and is composed of two 
domains: an N-terminal domain anchored within the outer membrane and a C-terminal domain, 
which is located within the periplasm (Koebnik et al., 2000). It was suggested that OmpA provides 
physical linkage between the outer membrane and the underlying peptidoglycan layer until a more 
specific function of OmpA was observed: E. coli K1 ompA-deletion mutants were significantly more 
sensitive to sodium dodecyl sulfate (SDS), cholate, acidic environment, high osmolarity, and pooled 
human serum. Mutations that caused structural changes to the extracellular loops of OmpA did not 
affect the viability of E. coli, while changes at the OmpA beta-barrel, that provides the structural 
integrity, decreased E. coli resistance to environmental stresses (Wang, 2002). The same study 
showed that ompA mutants survived significantly better within brain microvascular endothelial cells 
than the wild-type strain what anticipates OmpA as major target in mammalian host cell defense. 
However, OmpA expression was observed by both E. coli strains associated with acute and persistent 
bovine mastitis upon cocultivation with primary bovine mammary gland epithelial cells (Dego et al., 
2012). The OmpA expression levels in either acute or persistant isolates were almost equal. 
 
OmpT is another outer membrane protein that provides resistance to defensins by a different 
mechanism. Particularly defensins can be proteolytically degraded and inactivated by surface or 
secreted proteases of the outer membrane such as omptins (Thomassin et al., 2012). The E. coli K-12 
OmpT was reported to efficiently degrade protamine of defensins (Stumpe et al., 1998). Another 
study reported that the EHEC and EPEC OmpT proteins contribute differently to the degradation of 
helical AMPs. Only the EHEC OmpT degraded and inactivated AMPs completely to promote bacterial 
survival, whereas EPEC OmpT poorly degraded the defensins exposed to (Thomassin et al., 2012). 
Given the fact that on the one hand, EHEC and EPEC are two genetically related bacteria and on the 
other hand, both EHEC and EPEC showed similar serum resistance statistics within the study, it was 
suggested that EPEC relies, at least partly, on other mechanisms to resist defensins (Thomassin et al., 
2012). Regarding the advantage of providing serum resistance by E. coli bovine mastitis isolates we 
might have a similar situation.  
 
Also TraT is supposed to be a surface exclusion lipoprotein and facilitates extracellular protease 
activity. The TraT lipoprotein is encoded by the traT gene carried on conjugative plasmids, such R6-5 
or CoIV of E. coli (Binns et al., 1982; Agüero et al., 1984). In particular, the resistance to complement 
is provided by structural and/or functional changes applied the complement proteins and therefore 
inhibition the interactions between complement bacterial surface (Agüero et al., 1984). TraT has 
been considered a virulence marker of ExPEC what is supported by the fact that the traT gene was 
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significantly more prevalent in E. coli isolates carrying certain antibiotic resistance genes (Lee et al., 
2010). In the past, the presence of traT (and also ompA) was correlated to E. coli causing clinical 
mastitis of sows, in comparison to isolates from faeces, suggesting a role in mastitis pathogenesis 
(Gerjets et al., 2011). Moreover, in a study on VFs of E. coli isolates from bovine clinical mastitis, traT 
was found in 37 % of the Finnish isolates tested (n=160) and 41 % of the Israeli isolates tested 
(n=113) (Kaipainen et al., 2002). It was therefore the most prevalent virulence factor identified within 
these two sets of E. coli isolates from bovine clinical mastitis.  
 Iron uptake systems 
Iron is essential for almost every living being and used in oxygen transport and storage, DNA 
synthesis, electron transport chain and peroxide metabolism. Due to the oxic environment, E. coli 
and other bacteria have to take up the merely soluble Fe(III) and then reduce it to Fe(II) which is 
highly soluble. This makes iron a limiting nutritional factor for survival and growth within the host 
niche such as body liquids (e.g. mammary secretions) (Chipperfield and Ratledge, 2000). It can also 
be limited, because of the host response to infection which further reduces the amount of iron 
available by iron-scavenging proteins such as lactoferrin (Latorre et al., 2010). Lactoferrin binds iron 
and makes it unavailable to bacteria (Smith and Schanbacher, 1977). In order to utilize the limited 
iron in the host niche, it has to be acquired by iron uptake systems. One option is to utilize the 
protein-bound iron complexes of the host such as hemoglobin, transferrin and lactoferrin by 
expression of specific receptors (Hanson et al., 1992). Another option is the use of siderophores, 
which compete with host iron-binding proteins.  
The siderophore gene clusters encoding the enzymes for enterobactin (ent) and the ferric di-citrate 
transport system (fec) have a common conserved localization in the E. coli core genome and might be 
found in pathogenic and non-pathogenic E. coli. They are therefore considered important fitness 
traits. Nonetheless, some siderophore gene clusters (e.g. chu, iro, iuc) are specific to genomic 
locations (e.g. pathogenicity islands) and/or isolates (Luck et al., 2001; Torres and Payne, 1997; 
Wyckoff et al., 1998; Bäumler et al., 1996; Dobrindt et al., 2003).  
Recently, the inactivation of the biosynthetic pathways of several siderophores (enterobactin, 
salmochelins and yersiniabactin) abolished the virulence of ExPEC in a mouse sepsis model and 
showed these pathways essential for the survival of ExPEC in vivo (Martin et al., 2013). This might be 
further supported by observations made on phagocytosis and serum susceptibility of E. coli bovine 
mastitis isolates cultured in iron-deplete and iron-replete media. Iron availability during cultivation 
altered the susceptibility of isolates to phagocytosis by neutrophils, but had no effect on the 
susceptibility of isolates to the bactericidal activity of serum (Wise et al., 2002). Therefore, iron 
acquisition of bacteria can be suggested advantageous for survival within milk, especially in presence 
of lactoferrin, and iron uptake systems might contribute to mastitis pathogenesis. 
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 Toxins 
Some E. coli pathotypes are associated with the presence and expression of certain toxins (EHEC: 
Stx1, Stx2, EAST1, EHly1, EHly2; EPEC: EAST1; ETEC: LT-I, LT-II, STa, STb; EAEC: ShET1, Pic, EAST1, Pet; 
UPEC: Sat, CNF-1, α-Hly). Several toxins are typically expressed by ExPEC: 
The cytotoxic necrotizing factor 1 (CNF-1) has been determined to activate RhoA, Rac1, and Cdc42 in 
epithelial cells (Schmidt et al., 1998; Aktories et al., 2000). Rho GTPases are required to maintain the 
function of tight junctions and thus the intestinal epithelial barrier function. Activation of Rac1 and 
Cdc42 exerts barrier-stabilizing effects whereas increased stimulation of RhoA/Rho kinase signaling 
causes intestinal epithelial barrier disruption (Schlegel et al., 2011). Thus, CNF-1 expression is 
advantageous in immunoevasion of E. coli. This might be important during intramammary infections. 
The CNF-1 gene (cnf1), was thought to be highly prevalent within ExPEC and are often associated 
with a pathogenicity island (Andreu et al., 1997). Specifically, this study reported a CNF-1 distribution 
of 44-63 % in E. coli isolates (total n= 150) from prostatitis, pyelonephritis, cystitis and UTI with 
predisposing factors. This is in strong contrast to results of a very recent study that reported CNF-1 
distribution of 0-3 % in isolates (n= 100) from pyelonephritis and cystitis (Tarchouna et al., 2013). 
Concerning bovine mastitis, the cnf1 prevalence was very low (5 %, n= 20) in E. coli isolates from 
mastitis. This suggests no important role for mastitis pathogenesis (Lipman et al., 1995). The 
α-hemolysin (hly) is considered to be an independent predictor of E. coli pathogenicity and belongs 
to the RTX toxin family (Lee et al., 2010). Often located on PAIs or plasmids, the hly gene cluster 
encodes for the toxin biosynthesis and components of its secretion system. The toxin lyzes red blood 
cells by damaging their cell membrane (Holland et al., 1990).The α-hemolysin is also believed to be 
widely distributed among ExPEC isolates. -Hemolysin production was significantly more common in 
ExPEC isolates from neonatal sepsis and meningitis as compared with faecal isolates (Korhonen et al., 
1985). This was further supported by 43-73 % -hemolysin positive E. coli isolates (total n= 150) from 
prostatitis, pyelonephritis, cystitis and UTI with predisposing factors (Andreu et al., 1997). In contrast, 
Tarchouna et al. (2013) detected the hly determinant in 19 % of the tested UPEC isolates (n= 90). For 
ExPEC other than UPEC, a study reported 98 % STEC isolates (n= 400) tested positive for the presence 
of the so-called EHEC hemolysin (Murinda et al., 2004). Among E. coli isolates from bovine mastitis 
(n= 76), 12 % were positive for hlyA (Cheng et al., 2012). Sat, the secreted autotransporter toxin is a 
member of the SPATE (serine protease autotransporters of Enterobacteriaceae) family. Besides 
serine protease activity, Sat causes cytopathic effects on various cell types and is predominantly 
found among UPEC strains (Guyer et al., 2000). Specifically, the active site of Sat is necessary for the 
protease and cytotoxic activities, contraction of the cytoskeleton, and loss of actin filaments in 
cultured bladder and kidney cells (Maroncle et al., 2006). Moreover, Sat was reported to degrade 
specific membrane/cytoskeletal and nucleus-associated proteins. Data on the contribution of Sat to 
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coliform bovine mastitis are not available so far. Likewise Sat, another ExPEC-associated toxin, the 
cytolethal distending toxin (CDT) could not related to mastitis (Fernandes et al., 2011). Above all, the 
toxins, which are not specific for ExPEC (CDT 1, EAST1, LT-I, LT-II, STa, STb, Stx1, Stx2, VT1, VT2) 
occurred in rather low frequencies or were completely absent among the mastitis isolates tested in 
various studies (Fernandes et al., 2011; Lipman et al., 1995; Ghanbarpour and Oswald, 2010; Suojala 
et al., 2011; Murinda et al., 2004; Reichardt and Dobrindt, unpublished data). Notably the 
consistency between the listed studies seems to be highly dependent of the particular origin. 
 Autotransporter proteins 
The toxin Sat is a member of the autotransporter (AT) protein family. AT proteins are surface-
exposed or secreted factors (i.e. Sat) that facilitate various virulence-associated functions to Gram-
negative pathogens. In E. coli, more than 18 different AT proteins have been identified (Zude et al., 
2014). All AT proteins share a characteristic structure consisting of three functional domains: (i) an 
N-terminal signal sequence, which initiates the SecA-dependent transport across the inner 
membrane into the periplasm, (ii) an α- or passenger domain, which encodes for functional traits, 
and (iii) an outer membrane embedded C-terminal β- or translocation domain (Desvaux et al., 2004; 
Benz and Schmidt, 2011). The AT subtype-specific translocation domain appears to be highly 
homologous, whereas ATs show substantial sequence diversity in their passenger domain that 
determines their individual functional properties. These various, often multiple functions were 
reported to contribute to adhesion (Benz and Schmidt, 1989), autoaggregation (Diderichsen, 1980), 
biofilm formation (Danese et al., 2000), haemagglutination, serum resistance (Henderson and 
Nataro, 2001), or exhibit protease activity (Pohlner et al., 1987) or toxin activity (Cover, 1996). In 
former studies these characteristics have been frequently correlated with pathogenesis and 
therefore, an application as biomarkers for individual extraintestinal pathogenic E. coli (ExPEC) or 
intestinal pathogenic E. coli (IPEC) has been proposed. Another study determined the highest 
prevalence of ATs per strain in phylogroup B2 isolates and showed that AT distribution correlates 
rather with phylogenetic lineages than with pathotypes. The AT protein UpaI and its positional 
ortholog EhaC were detected in 93 % of the E. coli strains tested (n= 111). Thus, UpaI is the most 
prevalent AT in E. coli irrespective of pathotype or phylogenetic background and was observed to 
mediate redundant functions in comparison to the ATs characterized within the study (Zude et al., 
2014). Specifically UpaI of UPEC strain 536 is contributing to autoaggregation, biofilm formation, and 
binding to extracellular matrix proteins. The functional redundancy and wide distribution of ATs 
among pathogenic and non-pathogenic E. coli indicates that ATs cannot generally be regarded as 
specific biomarkers and VFs per se. Nevertheless, AT proteins promote colonization of intestinal and 
extraintestinal sites by ExPEC and thus AT expression could be considered advantageous in mastitis 
pathogenesis.  
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II.2.5. What we know about mammary pathogenic E. coli 
Regardless pathogenic E. coli strains can be classified into different pathotypes according to distinct 
diseases (Kaper et al., 2004), E. coli causing mastitis represents itself peculiar. Specific E. coli 
serotypes involved in mastitis could neither be identified by epidemiological studies, nor could a 
common set of VFs be described for mastitis-causing E. coli strains. Furthermore, none of the 
previously studied phylogenetic groups, VFs or antimicrobial resistance traits were associated with 
clinical signs, persistence of intramammary infection or clinical recovery from mastitis (Blum and 
Leitner, 2013; Silva et al., 2013; Cheng et al., 2012; Dogan et al., 2012; Kerro Dego et al., 2012; 
Fernandes et al., 2011; Suojala et al., 2011; Ghanbarpour and Oswald, 2010; Dyer et al., 2007; Wenz 
et al., 2006; Bean et al., 2004; Lehtolainen et al., 2003; Kaipainen et al., 2002; Wise et al., 2002; 
Lipman et al., 1995; Sanchez-Carlo et al., 1984). Instead, it is thought that mastitis-causing E. coli are 
typical commensals (Suojala et al., 2011). However, commensal E. coli group mostly into phylogroup 
A while E. coli strains associated to mastitis are wide spread among different phylogenetic groups. 
Traditionally, the ‘cow factors’ are held responsible for differences in E. coli mastitis severity rather 
than variations in the bacterial set of VFs or their expression profile (Burvenich et al., 2003). In 
contrast to the widely accepted opinion that bacterial VFs are not involved in E. coli mastitis, large 
variations have been observed among field cases of E. coli mastitis in dairy animals. The severity of 
the disease can vary from a mild, self-curing to a fatal septic condition. Several field strains (e.g. P4) 
are highly virulent, and upon experimental infection consistently lead to severe septic mastitis in 
cows. In contrast, others cause mild mastitis and might result in latency or in chronically infected 
dairy animals (Döpfer et al., 1999, 2000 and 2001; Dogan et al., 2006). Nevertheless, in analogy to 
human and avian ExPEC isolates, the high geno- and phenotypic diversity among E. coli mastitis 
isolates may contribute to the variation in aetiopathology. Thus, mastitis-causing E. coli might make 
use of the same strategies used by other ExPEC including adhesion to and invasion into epithelial 
cells, immune evasion, replication, and tissue damage characterized by necrosis and apoptosis of 
epithelial cells. It also has been discussed that bacterial VFs may contribute to the disease (Shpigel et 
al., 2008). However, the different strains carry different sets of virulence genes and the accumulation 
of such traits may increase their virulence potential. 
 
II.3. Aims of this study 
Commensal and pathogenic E. coli variants adapt their gene expression contributing to survival and 
colonization during the transition between the environment and host. In the past, specific gene 
subsets and traits have been correlated with an increased potential of E. coli strains to either cause 
intestinal or extraintestinal diseases in humans and many animal hosts (Leimbach et al., 2013). 
However, to date a marked prevalence of many known virulence-associated genes of ExPEC and IPEC 
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among E. coli mastitis isolates has not been published. This indicates that the E. coli factors and traits 
required for the development of the variant forms of mastitis still remain unexplored or at least 
unidentified. 
This project aimed at the identification and characterization of virulence-associated traits from E. coli 
strains associated to bovine mastitis. Specifically, the E. coli model mastitis isolates 1303 (acute 
mastitis isolate) and ECC-1470 (persistent mastitis isolate) should be comprehensively examined. The 
main aim of this study was to study the distribution and regulation of virulence-associated factors in 
these isolates in order to better understand the molecular basis of pathogenesis during E. coli 
mastitis. For this purpose, transcriptomic analyses of the two mastitis isolates performed under 
different growth conditions should allow to screen for candidate genes involved in bacterium-host 
interaction, fitness or even pathogenicity during bovine mastitis. Specifically, the virulence-
associated gene content of the E. coli mastitis isolates 1303 and ECC-1470 should be assessed based 
on BLAST analyses of their draft genome sequences. A collection of E. coli isolates from bovine 
mastitis or from bovine faeces should be screened by PCR for the prevalence of selected 
autotransporter determinants. 
In order to study fitness traits and gene expression of E. coli mastitis isolates suitable in vitro test 
assays should be established, which mimic the environment and growth conditions in the bovine 
mammary gland in vivo. Fitness traits of selected bovine mastitis and/or faecal E. coli strains should 
be identified and analyzed in comparative phenotypic assays, i.e. the viability and growth under 
different conditions mimicking the environment during initial pathogenesis should be investigated. 
The transcriptional response of the mastitis isolates 1303 and ECC-1470 should be comprehensively 
assessed under growth conditions mimicking the initial stages of bovine mastitis pathogenesis by in 
vitro transcriptome analysis in order to identify (i) candidate genes involved in bacterium-host 
interaction upon cocultivation with MAC-T immortalized bovine mammary gland epithelial cells, (ii) 
candidate genes that enable mastitis isolates to quickly adapt to and survive the antimicrobial 
conditions within bovine native milk whey. 
As a prerequisite to study bacterial gene expression upon growth under in vivo-like conditions, i.e. in 
raw milk whey, protocols for the enrichment of bacterial cells from milk whey and for the purification 
of bacterial RNA from milk whey should be established. 
These data should allow us new insights into bacterial traits, which contribute to the adaptation of 
E. coli to host conditions in the bovine mammary gland and thus, may also contribute to mastitis.  
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III. MATERIAL 
III.1. STRAINS 
All bacterial strains used in this study are listed in Table 6. 
Table 6: Bacterial strains used in this study. 
Strain Source/origin Serotype Reference 
E. coli 1303 
ECC-1470 
UPEC 536 
MG1655 
RZ422 
RZ451 
RZ479 
RZ505 
RZ532 
HK8 
HK24 
RZ454 
20A1 
20A1U 
22A2 
22B2U 
J96 
J96-M1 
AD110 
AC/I 
2980 
E642 
CFT073 
764 
764-2 
E-B35 
7521/94-1 
RZ-436 
RZ-439 
RZ-441 
RZ-443 
RZ-446 
RZ-458 
RZ-468 
RZ-475 
RZ-495 
RZ-500 
RZ-525 
RZ-526 
ECOR 51 
ECOR 52 
ECOR 53 
acute bovine mastitis 
persistant bovine mastitis 
clinical pyelonephritis 
faeces 
clinical pyelonephritis 
clinical pyelonephritis 
clinical pyelonephritis 
clinical pyelonephritis 
clinical pyelonephritis 
sepsis 
sepsis 
clinical pyelonephritis 
faeces 
faeces 
clinical pyelonephritis 
clinical pyelonephritis 
clinical pyelonephritis 
clinical pyelonephritis 
clinical pyelonephritis 
sepsis (avian) 
clinical pyelonephritis 
sepsis 
clinical pyelonephritis 
faeces 
faeces 
clinical pyelonephritis 
clinical pyelonephritis 
clinical pyelonephritis 
clinical pyelonephritis 
clinical pyelonephritis 
clinical pyelonephritis 
clinical pyelonephritis 
clinical pyelonephritis 
clinical pyelonephritis 
clinical pyelonephritis 
clinical pyelonephritis 
clinical pyelonephritis 
clinical pyelonephritis 
clinical pyelonephritis 
faeces 
faeces 
faeces 
 
 
O6:K15:H31 
K-12 
O6:K14:H- 
O6:K+:H31 
O6:K+:H- 
O6:K14:H- 
O6:K-:H31 
- 
- 
O6:K2:H- 
- 
- 
- 
- 
O4:K:H5 
O4:K:H5 
O4:K6 
O78 
O18ac:K5 
- 
O6:K2:H1 
O18:K5:H5/11 
O18:K5:H5/11 
O4:K12:H5 
- 
O6:K13:H1 
O6:K5:H1 
O6:K5:H1 
O6:K5:H- 
O6:K53:H1 
O6:K2:H1 
O6:K5:H1 
O6:K5:H1 
O6:K5:H- 
O6:K5:H1 
O6:K5:H1 
O6:K5:H1 
O25:Hnt 
O25:H1 
O4:H- 
(Petzl et al., 2008) 
(Dogan et al., 2006) 
(Berger et al., 1982) 
(IMIB strain collection, Würzburg) 
(IMIB strain collection, Würzburg) 
(IMIB strain collection, Würzburg) 
(IMIB strain collection, Würzburg) 
(IMIB strain collection, Würzburg) 
(IMIB strain collection, Würzburg) 
(IMIB strain collection, Würzburg) 
(IMIB strain collection, Würzburg) 
(IMIB strain collection, Würzburg) 
(IMIB strain collection, Würzburg) 
(IMIB strain collection, Würzburg) 
(IMIB strain collection, Würzburg) 
(IMIB strain collection, Würzburg) 
(IMIB strain collection, Würzburg) 
(IMIB strain collection, Würzburg) 
(IMIB strain collection, Würzburg) 
(IMIB strain collection, Würzburg) 
(IMIB strain collection, Würzburg) 
(IMIB strain collection, Würzburg) 
(IMIB strain collection, Würzburg) 
(IMIB strain collection, Würzburg) 
(IMIB strain collection, Würzburg) 
(IMIB strain collection, Würzburg) 
(IMIB strain collection, Würzburg) 
(IMIB strain collection, Würzburg) 
(IMIB strain collection, Würzburg) 
(IMIB strain collection, Würzburg) 
(IMIB strain collection, Würzburg) 
(IMIB strain collection, Würzburg) 
(IMIB strain collection, Würzburg) 
(IMIB strain collection, Würzburg) 
(IMIB strain collection, Würzburg) 
(IMIB strain collection, Würzburg) 
(IMIB strain collection, Würzburg) 
(IMIB strain collection, Würzburg) 
(IMIB strain collection, Würzburg) 
(IMIB strain collection, Würzburg) 
(IMIB strain collection, Würzburg) 
(IMIB strain collection, Würzburg) 
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Strain Source/origin Serotype Reference 
ECOR 54 
ECOR 57 
ECOR 58 
ECOR 60 
ECOR 63 
ECOR 64 
ECOR 65 
2E2U 
3D5 
13A1 
HK54 
BK658 
1G1U 
1H1 
1H1U 
19A1 
1G1 
ECOR 66 
IHE3034 
IHE3036 
IHE3080 
RS218 
RS226 
B13155 
B616 
2E1U 
16A2U 
HK2 
W1825 
4405/1 
S5 
HK1 
HK58 
ECOR 7  
ECOR 62 
8B1 
Ve1140 
B10363 
E351 
F18 
F18Col - 
ECOR 50 
RS176 
Ve239 
ECOR 61 
RZ411 
E457 
1E2 
AE5 
faeces 
faeces 
faeces 
clinical pyelonephritis 
faeces 
clinical pyelonephritis 
faeces 
clinical pyelonephritis 
faeces 
faeces 
sepsis 
neonatal bacterial meningitis 
clinical pyelonephritis 
faeces 
clinical pyelonephritis 
faeces 
faeces 
faeces 
neonatal bacterial meningitis 
neonatal bacterial meningitis 
neonatal bacterial meningitis 
neonatal bacterial meningitis 
neonatal bacterial meningitis 
neonatal bacterial meningitis 
sepsis 
clinical pyelonephritis 
clinical pyelonephritis 
sepsis 
sepsis 
clinical pyelonephritis 
clinical pyelonephritis 
sepsis 
sepsis 
- 
clinical pyelonephritis 
clinical pyelonephritis 
neonatal bacterial meningitis 
neonatal bacterial meningitis blood cult 
sepsis, blood culture 
faeces 
faeces 
clinical pyelonephritis 
neonatal bacterial meningitis 
neonatal bacterial meningitis 
faeces 
clinical pyelonephritis 
sepsis 
faeces 
faeces 
O25:H1 
Ont:Hnt 
O112:H8 
O4:Hnt 
Ont:Hnt 
- 
Ont:H10 
- 
- 
- 
- 
O75:K1:H7 
- 
- 
- 
- 
- 
O4:H40 
O18:K1:H7/9 
O18:H7:K1 
O18:H7:K1 
O18ac:H7:K1 
O18ac:H7:K1 
- 
- 
- 
- 
- 
- 
- 
- 
- 
- 
- 
O2:H- 
- 
- 
- 
- 
- 
- 
O2:H- 
O7:K1 
- 
O2:H- 
O6:K-:H1 
- 
- 
- 
(IMIB strain collection, Würzburg) 
(IMIB strain collection, Würzburg) 
(IMIB strain collection, Würzburg) 
(IMIB strain collection, Würzburg) 
(IMIB strain collection, Würzburg) 
(IMIB strain collection, Würzburg) 
(IMIB strain collection, Würzburg) 
(IMIB strain collection, Würzburg) 
(IMIB strain collection, Würzburg) 
(IMIB strain collection, Würzburg) 
(IMIB strain collection, Würzburg) 
(IMIB strain collection, Würzburg) 
(IMIB strain collection, Würzburg) 
(IMIB strain collection, Würzburg) 
(IMIB strain collection, Würzburg) 
(IMIB strain collection, Würzburg) 
(IMIB strain collection, Würzburg) 
(IMIB strain collection, Würzburg) 
(IMIB strain collection, Würzburg) 
(IMIB strain collection, Würzburg) 
(IMIB strain collection, Würzburg) 
(IMIB strain collection, Würzburg) 
(IMIB strain collection, Würzburg) 
(IMIB strain collection, Würzburg) 
(IMIB strain collection, Würzburg) 
(IMIB strain collection, Würzburg) 
(IMIB strain collection, Würzburg) 
(IMIB strain collection, Würzburg) 
(IMIB strain collection, Würzburg) 
(IMIB strain collection, Würzburg) 
(IMIB strain collection, Würzburg) 
(IMIB strain collection, Würzburg) 
(IMIB strain collection, Würzburg) 
(IMIB strain collection, Würzburg) 
(IMIB strain collection, Würzburg) 
(IMIB strain collection, Würzburg) 
(IMIB strain collection, Würzburg) 
(IMIB strain collection, Würzburg) 
(IMIB strain collection, Würzburg) 
(IMIB strain collection, Würzburg) 
(IMIB strain collection, Würzburg) 
(IMIB strain collection, Würzburg) 
(IMIB strain collection, Würzburg) 
(IMIB strain collection, Würzburg) 
(IMIB strain collection, Würzburg) 
(IMIB strain collection, Würzburg) 
(IMIB strain collection, Würzburg) 
(IMIB strain collection, Würzburg) 
(IMIB strain collection, Würzburg) 
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Strain Source/origin Serotype Reference 
2A1 
2A2 
3B5 
3N1 
3N2 
3N5 
5A1 
8B2 
16A3 
16B1 
A284 
RB9 
HK4 
HK17 
HK19 
ECOR 1 
ECOR 23 
ECOR 25 
ECOR 28 
ECOR 31 
ECOR 32 
ECOR 40 
ECOR 42 
ECOR 48 
A12  
ECOR 56 
ECOR 71 
EDL1284 
76-5 
E2348/69 
179/2 
156A 
37-4 
933W 
86-24 
SF493/89 
3574/92 
2907/97 
5720/96 
3697/97 
ED142 
PIG E57 
Feb 45 
EDL880 
5714/96 
G1253 
147/1 
284/97 
297/87 
faeces 
faeces 
faeces 
faeces 
faeces 
faeces 
faeces 
faeces 
faeces 
faeces 
clinical pyelonephritis 
Sheep pathogen 
sepsis 
sepsis 
sepsis 
faeces 
faeces 
faeces 
faeces 
faeces 
faeces 
clinical pyelonephritis 
faeces 
clinical pyelonephritis 
- 
faeces 
clinical pyelonephritis 
EIEC 
EIEC 
EPEC 
EPEC 
EPEC 
EPEC 
EHEC 
EHEC 
EHEC 
EHEC 
EHEC 
EHEC 
EHEC 
EHEC 
EHEC 
EHEC 
EHEC 
EHEC 
ETEC 
ETEC 
ETEC 
ETEC 
- 
- 
- 
- 
- 
- 
- 
- 
- 
- 
- 
- 
- 
- 
- 
Ont:Hnt 
O86:H43 
Ont:Hnt 
O104:H- 
O79:H43 
O7:H21 
O7:H- 
Ont:H26 
- 
- 
O6:H1 
O78:H- 
O124:H- 
O143 
O127:H6 
O55:H6 
O55:H6 
O55:H- 
O157:H7 
O157:H7 
O157:H- 
O157:H7 
- 
O26:H11 
- 
O111 
- 
- 
- 
- 
- 
O128:H- 
- 
- 
(IMIB strain collection, Würzburg) 
(IMIB strain collection, Würzburg) 
(IMIB strain collection, Würzburg) 
(IMIB strain collection, Würzburg) 
(IMIB strain collection, Würzburg) 
(IMIB strain collection, Würzburg) 
(IMIB strain collection, Würzburg) 
(IMIB strain collection, Würzburg) 
(IMIB strain collection, Würzburg) 
(IMIB strain collection, Würzburg) 
(IMIB strain collection, Würzburg) 
(IMIB strain collection, Würzburg) 
(IMIB strain collection, Würzburg) 
(IMIB strain collection, Würzburg) 
(IMIB strain collection, Würzburg) 
(IMIB strain collection, Würzburg) 
(IMIB strain collection, Würzburg) 
(IMIB strain collection, Würzburg) 
(IMIB strain collection, Würzburg) 
(IMIB strain collection, Würzburg) 
(IMIB strain collection, Würzburg) 
(IMIB strain collection, Würzburg) 
(IMIB strain collection, Würzburg) 
(IMIB strain collection, Würzburg) 
(IMIB strain collection, Würzburg) 
(IMIB strain collection, Würzburg) 
(IMIB strain collection, Würzburg) 
(IMIB strain collection, Würzburg) 
(IMIB strain collection, Würzburg) 
(IMIB strain collection, Würzburg) 
(IMIB strain collection, Würzburg) 
(IMIB strain collection, Würzburg) 
(IMIB strain collection, Würzburg) 
(IMIB strain collection, Würzburg) 
(IMIB strain collection, Würzburg) 
(IMIB strain collection, Würzburg) 
(IMIB strain collection, Würzburg) 
(IMIB strain collection, Würzburg) 
(IMIB strain collection, Würzburg) 
(IMIB strain collection, Würzburg) 
(IMIB strain collection, Würzburg) 
(IMIB strain collection, Würzburg) 
(IMIB strain collection, Würzburg) 
(IMIB strain collection, Würzburg) 
(IMIB strain collection, Würzburg) 
(IMIB strain collection, Würzburg) 
(IMIB strain collection, Würzburg) 
(IMIB strain collection, Würzburg) 
(IMIB strain collection, Würzburg) 
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Strain Source/origin Serotype Reference 
164/82 
117/86 
6061/97 
5080/97 
4104/97 
8574/96 
1639/77 
E1392-75 
278485-2 
VM75688 
350 C1A 
7476 A 
E 34420 A 
Feb 45 
04259-01 
04037-01 
09282-01 
01594-01 
4738/96 
2851/96 
3937/97 
4789/97 
3115/97 
3172/97 
2455/99 
3117/98 
4736/98 
0653/99 
4941/97 
3615/99 
E25/02 
E57 
24059/97 
3229/98 
 
5157/96 
4356/96 
1530/99 
1676/99 
6416/87 
2514/99 
1226/65 
4791/97 
4794/97 
4141/96 
E 20738 A 
312/00 
540/00 
ECA-5019 
ETEC 
ETEC 
EHEC 
EHEC 
EHEC 
EHEC 
EHEC 
ETEC 
ETEC 
ETEC 
ETEC 
ETEC 
ETEC 
EHEC 
EHEC 
EHEC 
EHEC 
EHEC 
EHEC 
EHEC 
EHEC 
EHEC 
EHEC 
EHEC 
EHEC 
EHEC 
EHEC 
EHEC 
EHEC 
EHEC 
EHEC 
EHEC 
EHEC 
EHEC 
EIEC 
EHEC 
EHEC 
EHEC 
EHEC 
EHEC 
EHEC 
EHEC 
EHEC 
EHEC 
EHEC 
ETEC 
EPEC 
chronic bovine mastitis 
chronic bovine mastitis 
- 
- 
O26 
O26 
O26 
O26 
O111:H- 
O6:H16 
- 
- 
- 
- 
- 
- 
- 
- 
- 
- 
O113 
O103 
O62:H- 
O96:H- 
O128:H2 
O128:H2 
O128:H2 
O128:H- 
O128:H 
O128:Hnt 
Ont:H- (O26) 
O8:H10 
Ont:H19 
O138 
Ont:H10 
O8:H- 
O164 
O26:H11 
O26:H- 
O26:H11 
O26:H11 
O26:H- 
O26:H- 
O26:H11 
O111:H- 
O111:H- 
O111 
- 
Ont:Hnt 
O154:H4 
- 
(IMIB strain collection, Würzburg) 
(IMIB strain collection, Würzburg) 
(IMIB strain collection, Würzburg) 
(IMIB strain collection, Würzburg) 
(IMIB strain collection, Würzburg) 
(IMIB strain collection, Würzburg) 
(IMIB strain collection, Würzburg) 
(IMIB strain collection, Würzburg) 
(IMIB strain collection, Würzburg) 
(IMIB strain collection, Würzburg) 
(IMIB strain collection, Würzburg) 
(IMIB strain collection, Würzburg) 
(IMIB strain collection, Würzburg) 
(IMIB strain collection, Würzburg) 
(IMIB strain collection, Würzburg) 
(IMIB strain collection, Würzburg) 
(IMIB strain collection, Würzburg) 
(IMIB strain collection, Würzburg) 
(IMIB strain collection, Würzburg) 
(IMIB strain collection, Würzburg) 
(IMIB strain collection, Würzburg) 
(IMIB strain collection, Würzburg) 
(IMIB strain collection, Würzburg) 
(IMIB strain collection, Würzburg) 
(IMIB strain collection, Würzburg) 
(IMIB strain collection, Würzburg) 
(IMIB strain collection, Würzburg) 
(IMIB strain collection, Würzburg) 
(IMIB strain collection, Würzburg) 
(IMIB strain collection, Würzburg) 
(IMIB strain collection, Würzburg) 
(IMIB strain collection, Würzburg) 
(IMIB strain collection, Würzburg) 
(IMIB strain collection, Würzburg) 
(IMIB strain collection, Würzburg) 
(IMIB strain collection, Würzburg) 
(IMIB strain collection, Würzburg) 
(IMIB strain collection, Würzburg) 
(IMIB strain collection, Würzburg) 
(IMIB strain collection, Würzburg) 
(IMIB strain collection, Würzburg) 
(IMIB strain collection, Würzburg) 
(IMIB strain collection, Würzburg) 
(IMIB strain collection, Würzburg) 
(IMIB strain collection, Würzburg) 
(IMIB strain collection, Würzburg) 
(IMIB strain collection, Würzburg) 
(IMIB strain collection, Würzburg) 
(Schukken, Y., USA) 
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Strain Source/origin Serotype Reference 
ECA-O157 
ECC-Z 
ECA-727 
ECA-5641 
ECA-5549 
ECA-4789 
ECA-B 
ECA-5614 
ECA-3722 
ECA-4365 
ECA-4302 
ECC-M 
ECA-3471 
ECA-5579 
ECA-5406 
ECA-4707 
ECA-5362 
ECA-5523 
800/12d 
5366a 
5550d 
629/8b 
905/67B 
1223/A 
3290/C 
3290/D 
1223/6C 
3222A 
3222A 
2940C 
2772a 
3242/A 
3238/B+D 
1200/47C 
2906 d 
1111/18a 
1099/3a 
2940/C 
1196/158a 
1173/49A 
1139/6A 
118/12C 
0001/08 
725/07 
362/06 rot 
441/06 
390/06 
000/06 
278/06 
chronic bovine mastitis 
chronic bovine mastitis 
chronic bovine mastitis 
chronic bovine mastitis 
chronic bovine mastitis 
chronic bovine mastitis 
chronic bovine mastitis 
chronic bovine mastitis 
chronic bovine mastitis 
chronic bovine mastitis 
chronic bovine mastitis 
chronic bovine mastitis 
chronic bovine mastitis 
chronic bovine mastitis 
chronic bovine mastitis 
chronic bovine mastitis 
chronic bovine mastitis 
chronic bovine mastitis 
chronic bovine mastitis 
clinical bovine mastitis 
clinical bovine mastitis 
clinical bovine mastitis 
clinical bovine mastitis 
clinical bovine mastitis 
clinical bovine mastitis 
clinical bovine mastitis 
clinical bovine mastitis 
clinical bovine mastitis 
clinical bovine mastitis 
clinical bovine mastitis 
clinical bovine mastitis 
clinical bovine mastitis 
clinical bovine mastitis 
clinical bovine mastitis 
clinical bovine mastitis 
clinical bovine mastitis 
clinical bovine mastitis 
clinical bovine mastitis 
clinical bovine mastitis 
clinical bovine mastitis 
clinical bovine mastitis 
clinical bovine mastitis 
clinical bovine mastitis 
clinical bovine mastitis+sepsis) 
clinical bovine mastitis 
clinical bovine mastitis 
clinical bovine mastitis 
clinical bovine mastitis 
clinical bovine mastitis 
- 
- 
- 
- 
- 
- 
- 
- 
- 
- 
- 
- 
- 
- 
- 
- 
- 
- 
- 
- 
- 
- 
- 
- 
- 
- 
- 
- 
- 
- 
- 
- 
- 
- 
- 
- 
- 
- 
- 
- 
- 
- 
- 
- 
- 
- 
- 
- 
- 
(Dogan et al., 2006) 
(Dogan et al., 2006) 
(Dogan et al., 2006) 
(Schukken, Y., USA) 
(Schukken, Y., USA) 
(Schukken, Y., USA) 
(Dogan et al., 2006) 
(Schukken, Y., USA) 
(Schukken, Y., USA) 
(Schukken, Y., USA) 
(Schukken, Y., USA) 
(Dogan et al., 2006) 
(Schukken, Y., USA) 
(Schukken, Y., USA) 
(Schukken, Y., USA) 
(Schukken, Y., USA) 
(Schukken, Y., USA) 
(Schukken, Y., USA) 
(Schukken, Y., USA) 
(Tiergesundheitsdienst Bayern) 
(Tiergesundheitsdienst Bayern) 
(Tiergesundheitsdienst Bayern) 
(Tiergesundheitsdienst Bayern) 
(Tiergesundheitsdienst Bayern) 
(Tiergesundheitsdienst Bayern) 
(Tiergesundheitsdienst Bayern) 
(Tiergesundheitsdienst Bayern) 
(Tiergesundheitsdienst Bayern) 
(Tiergesundheitsdienst Bayern) 
(Tiergesundheitsdienst Bayern) 
(Tiergesundheitsdienst Bayern) 
(Tiergesundheitsdienst Bayern) 
(Tiergesundheitsdienst Bayern) 
(Tiergesundheitsdienst Bayern) 
(Tiergesundheitsdienst Bayern) 
(Tiergesundheitsdienst Bayern) 
(Tiergesundheitsdienst Bayern) 
(Tiergesundheitsdienst Bayern) 
(Tiergesundheitsdienst Bayern) 
(Tiergesundheitsdienst Bayern) 
(Tiergesundheitsdienst Bayern) 
(Tiergesundheitsdienst Bayern) 
(Tiergesundheitsdienst Bayern) 
(Tiergesundheitsdienst Bayern) 
(Tiergesundheitsdienst Bayern) 
(Petzel, W., Oberschleißheim) 
(Petzel, W., Oberschleißheim) 
(Petzel, W., Oberschleißheim) 
(Petzel, W., Oberschleißheim) 
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Strain Source/origin Serotype Reference 
UVM2 
588/06 
583/06 
500/06 
606/06 
465/06 
477/06 
461/06 
470/06 
22/2007 
75/2007 
95/06 
131/2007 
191/2007 
146/2007 
07-3793 
07-4003 
07-3969 
07-4080 
07-4097 
07-0307-778 
07-0314-305 
07-0509-284 
07-0314-727 
332/07 
263/07 
302/07 
294/07 
333/07 
297/07 
300/07 
5234 
5232 
5228 
5229 
5250 
5251 
5249 
5248 
5243 
5252 
5244 
5246 
5245 
5247 
5225 
5223 
5242 
5241 
clinical bovine mastitis 
clinical bovine mastitis 
clinical bovine mastitis 
clinical bovine mastitis 
clinical bovine mastitis 
clinical bovine mastitis 
clinical bovine mastitis 
clinical bovine mastitis 
clinical bovine mastitis 
clinical bovine mastitis 
clinical bovine mastitis 
clinical bovine mastitis 
clinical bovine mastitis 
clinical bovine mastitis 
clinical bovine mastitis 
clinical bovine mastitis 
clinical bovine mastitis 
clinical bovine mastitis 
clinical bovine mastitis 
clinical bovine mastitis 
chronic bovine mastitis 
subclinical bovine mastitis 
subclinical bovine mastitis 
clinical bovine mastitis 
clinical bovine mastitis 
clinical bovine mastitis 
clinical bovine mastitis 
clinical bovine mastitis 
clinical bovine mastitis 
clinical bovine mastitis 
clinical bovine mastitis 
clinical bovine mastitis 
clinical Mastitis 
clinical Mastitis 
clinical Mastitis 
clinical Mastitis 
clinical Mastitis 
clinical Mastitis 
clinical Mastitis 
clinical Mastitis 
clinical Mastitis 
clinical Mastitis 
clinical Mastitis 
clinical Mastitis 
clinical Mastitis 
clinical Mastitis 
clinical Mastitis 
clinical Mastitis 
clinical Mastitis 
- 
- 
- 
- 
- 
- 
- 
- 
- 
- 
- 
- 
- 
- 
- 
- 
- 
- 
- 
- 
- 
- 
- 
- 
- 
- 
- 
- 
- 
- 
- 
- 
- 
- 
- 
- 
- 
- 
- 
- 
- 
- 
- 
- 
- 
- 
- 
- 
- 
(Petzel, W., Oberschleißheim) 
(Wellnitz, O., Bern) 
(Petzel, W., Oberschleißheim) 
(Petzel, W., Oberschleißheim) 
(Petzel, W., Oberschleißheim) 
(Petzel, W., Oberschleißheim) 
(Petzel, W., Oberschleißheim) 
(Petzel, W., Oberschleißheim) 
(Petzel, W., Oberschleißheim) 
(Petzel, W., Oberschleißheim) 
(Petzel, W., Oberschleißheim) 
(Petzel, W., Oberschleißheim) 
(Petzel, W., Oberschleißheim) 
(Petzel, W., Oberschleißheim) 
(Petzel, W., Oberschleißheim) 
(Petzel, W., Oberschleißheim) 
(Petzel, W., Oberschleißheim) 
(Petzel, W., Oberschleißheim) 
(Petzel, W., Oberschleißheim) 
(Petzel, W., Oberschleißheim) 
(Petzel, W., Oberschleißheim) 
(Petzel, W., Oberschleißheim) 
(Petzel, W., Oberschleißheim) 
(Petzel, W., Oberschleißheim) 
(Petzel, W., Oberschleißheim) 
(Petzel, W., Oberschleißheim) 
(Petzel, W., Oberschleißheim) 
(Petzel, W., Oberschleißheim) 
(Petzel, W., Oberschleißheim) 
(Petzel, W., Oberschleißheim) 
(Petzel, W., Oberschleißheim) 
(Petzel, W., Oberschleißheim) 
(Wieler, L., Berlin) 
(Wieler, L., Berlin) 
(Wieler, L., Berlin) 
(Wieler, L., Berlin) 
(Wieler, L., Berlin) 
(Wieler, L., Berlin) 
(Wieler, L., Berlin) 
(Wieler, L., Berlin) 
(Wieler, L., Berlin) 
(Wieler, L., Berlin) 
(Wieler, L., Berlin) 
(Wieler, L., Berlin) 
(Wieler, L., Berlin) 
(Wieler, L., Berlin) 
(Wieler, L., Berlin) 
(Wieler, L., Berlin) 
(Wieler, L., Berlin) 
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Strain Source/origin Serotype Reference 
5237 
5241 
5224 
5226 
5239 
5235 
5236 
5238 
5227 
5231 
5233 
5238 
32 
81 
130 
131 
132 
133 
134 
135 
136 
137 
180 
184 
186 
189 
191 
193 
201 
204 
212 
213 
222 
224 
226 
856 
1070 
1080 
1102 
1109 
1111 
1115 
1116 
1121 
1122 
1136 
1176 
1192 
1366 
clinical Mastitis 
clinical Mastitis 
clinical Mastitis 
clinical Mastitis 
clinical Mastitis 
clinical Mastitis 
clinical Mastitis 
clinical Mastitis 
clinical Mastitis 
clinical Mastitis 
clinical Mastitis 
clinical Mastitis 
clinical Mastitis 
clinical bovine mastitis 
clinical bovine mastitis 
clinical bovine mastitis 
clinical bovine mastitis 
clinical bovine mastitis 
clinical bovine mastitis 
clinical bovine mastitis 
clinical bovine mastitis 
clinical bovine mastitis 
clinical bovine mastitis 
clinical bovine mastitis 
clinical bovine mastitis 
clinical bovine mastitis 
clinical bovine mastitis 
clinical bovine mastitis 
clinical bovine mastitis 
clinical bovine mastitis 
clinical bovine mastitis 
clinical bovine mastitis 
clinical bovine mastitis 
clinical bovine mastitis 
clinical bovine mastitis 
clinical bovine mastitis 
clinical bovine mastitis 
clinical bovine mastitis 
clinical bovine mastitis 
clinical bovine mastitis 
clinical bovine mastitis 
clinical bovine mastitis 
clinical bovine mastitis 
clinical bovine mastitis 
clinical bovine mastitis 
clinical bovine mastitis 
clinical bovine mastitis 
clinical bovine mastitis 
clinical bovine mastitis 
- 
- 
- 
- 
- 
- 
- 
- 
- 
- 
- 
- 
- 
- 
- 
- 
- 
- 
- 
- 
- 
- 
- 
- 
- 
- 
- 
- 
- 
- 
- 
- 
- 
- 
- 
- 
- 
- 
- 
- 
- 
- 
- 
- 
- 
- 
- 
- 
- 
(Wieler, L., Berlin) 
(Wieler, L., Berlin) 
(Wieler, L., Berlin) 
(Wieler, L., Berlin) 
(Wieler, L., Berlin) 
(Wieler, L., Berlin) 
(Wieler, L., Berlin) 
(Wieler, L., Berlin) 
(Wieler, L., Berlin) 
(Wieler, L., Berlin) 
(Wieler, L., Berlin) 
(Wieler, L., Berlin) 
(Wieler, L., Berlin) 
(Wieler, L., Berlin) 
(Wieler, L., Berlin) 
(Wieler, L., Berlin) 
(Wieler, L., Berlin) 
(Wieler, L., Berlin) 
(Wieler, L., Berlin) 
(Wieler, L., Berlin) 
(Wieler, L., Berlin) 
(Wieler, L., Berlin) 
(Wieler, L., Berlin) 
(Wieler, L., Berlin) 
(Wieler, L., Berlin) 
(Wieler, L., Berlin) 
(Wieler, L., Berlin) 
(Wieler, L., Berlin) 
(Wieler, L., Berlin) 
(Wieler, L., Berlin) 
(Wieler, L., Berlin) 
(Wieler, L., Berlin) 
(Wieler, L., Berlin) 
(Wieler, L., Berlin) 
(Wieler, L., Berlin) 
(Wieler, L., Berlin) 
(Wieler, L., Berlin) 
(Wieler, L., Berlin) 
(Wieler, L., Berlin) 
(Wieler, L., Berlin) 
(Wieler, L., Berlin) 
(Wieler, L., Berlin) 
(Wieler, L., Berlin) 
(Wieler, L., Berlin) 
(Wieler, L., Berlin) 
(Wieler, L., Berlin) 
(Wieler, L., Berlin) 
(Wieler, L., Berlin) 
(Wieler, L., Berlin) 
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Strain Source/origin Serotype Reference 
1367 
1436 
1472 
1476 
1477 
1486 
1487 
1493 
1501 
1503 
1504 
2567 
2585 
2606 
2607 
2608 
2609 
2805 
2869 
2873 
2875 
2882 
2907 
2910 
2913 
2914 
2917 
2919 
2922 
2924 
2925 
3243 
3352 
3884 
3887 
3888 
4616 
4618 
4631 
4833 
4841 
4908 
5120 
5121 
5289 
5330 
5335 
5337 
5364 
clinical bovine mastitis 
clinical bovine mastitis 
clinical bovine mastitis 
clinical bovine mastitis 
clinical bovine mastitis 
clinical bovine mastitis 
clinical bovine mastitis 
clinical bovine mastitis 
clinical bovine mastitis 
clinical bovine mastitis 
clinical bovine mastitis 
clinical bovine mastitis 
clinical bovine mastitis 
clinical bovine mastitis 
clinical bovine mastitis 
clinical bovine mastitis 
clinical bovine mastitis 
clinical bovine mastitis 
clinical bovine mastitis 
clinical bovine mastitis 
clinical bovine mastitis 
clinical bovine mastitis 
clinical bovine mastitis 
clinical bovine mastitis 
clinical bovine mastitis 
clinical bovine mastitis 
clinical bovine mastitis 
clinical bovine mastitis 
clinical bovine mastitis 
clinical bovine mastitis 
clinical bovine mastitis 
clinical bovine mastitis 
clinical bovine mastitis 
clinical bovine mastitis 
clinical bovine mastitis 
clinical bovine mastitis 
clinical bovine mastitis 
clinical bovine mastitis 
clinical bovine mastitis 
clinical bovine mastitis 
clinical bovine mastitis 
clinical bovine mastitis 
clinical bovine mastitis 
clinical bovine mastitis 
clinical bovine mastitis 
clinical bovine mastitis 
clinical bovine mastitis 
clinical bovine mastitis 
clinical bovine mastitis 
- 
- 
- 
- 
- 
- 
- 
- 
- 
- 
- 
- 
- 
- 
- 
- 
- 
- 
- 
- 
- 
- 
- 
- 
- 
- 
- 
- 
- 
- 
- 
- 
- 
- 
- 
- 
- 
- 
- 
- 
- 
- 
- 
- 
- 
- 
- 
- 
- 
(Wieler, L., Berlin) 
(Wieler, L., Berlin) 
(Wieler, L., Berlin) 
(Wieler, L., Berlin) 
(Wieler, L., Berlin) 
(Wieler, L., Berlin) 
(Wieler, L., Berlin) 
(Wieler, L., Berlin) 
(Wieler, L., Berlin) 
(Wieler, L., Berlin) 
(Wieler, L., Berlin) 
(Wieler, L., Berlin) 
(Wieler, L., Berlin) 
(Wieler, L., Berlin) 
(Wieler, L., Berlin) 
(Wieler, L., Berlin) 
(Wieler, L., Berlin) 
(Wieler, L., Berlin) 
(Wieler, L., Berlin) 
(Wieler, L., Berlin) 
(Wieler, L., Berlin) 
(Wieler, L., Berlin) 
(Wieler, L., Berlin) 
(Wieler, L., Berlin) 
(Wieler, L., Berlin) 
(Wieler, L., Berlin) 
(Wieler, L., Berlin) 
(Wieler, L., Berlin) 
(Wieler, L., Berlin) 
(Wieler, L., Berlin) 
(Wieler, L., Berlin) 
(Wieler, L., Berlin) 
(Wieler, L., Berlin) 
(Wieler, L., Berlin) 
(Wieler, L., Berlin) 
(Wieler, L., Berlin) 
(Wieler, L., Berlin) 
(Wieler, L., Berlin) 
(Wieler, L., Berlin) 
(Wieler, L., Berlin) 
(Wieler, L., Berlin) 
(Wieler, L., Berlin) 
(Wieler, L., Berlin) 
(Wieler, L., Berlin) 
(Wieler, L., Berlin) 
(Wieler, L., Berlin) 
(Wieler, L., Berlin) 
(Wieler, L., Berlin) 
(Wieler, L., Berlin) 
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Strain Source/origin Serotype Reference 
5386 
5415 
5420 
5430 
5432 
5436 
6404 
6433 
2275 
2276 
2278 
2279 
2280 
2281 
2282 
2283 
2284 
2285 
2286 
2287 
2288a 
2288b 
2289 
2292 
2295 
2298 
2299 
2300 
2305 
2306 
2307 
2308 
2309 
2310 
2311 
2312 
2315 
2318 
2319 
2320 
2322 
2323 
2325 
2326 
2327 
2328 
2329 
2330 
2331 
clinical bovine mastitis 
clinical bovine mastitis 
clinical bovine mastitis 
clinical bovine mastitis 
clinical bovine mastitis 
clinical bovine mastitis 
bovine faeces 
bovine faeces 
bovine faeces 
bovine faeces 
bovine faeces 
bovine faeces 
bovine faeces 
bovine faeces 
bovine faeces 
bovine faeces 
bovine faeces 
bovine faeces 
bovine faeces 
bovine faeces 
bovine faeces 
bovine faeces 
bovine faeces 
bovine faeces 
bovine faeces 
bovine faeces 
bovine faeces 
bovine faeces 
bovine faeces 
bovine faeces 
bovine faeces 
bovine faeces 
bovine faeces 
bovine faeces 
bovine faeces 
bovine faeces 
bovine faeces 
bovine faeces 
bovine faeces 
bovine faeces 
bovine faeces 
bovine faeces 
bovine faeces 
bovine faeces 
bovine faeces 
bovine faeces 
bovine faeces 
bovine faeces 
bovine faeces 
- 
- 
- 
- 
- 
- 
- 
- 
- 
- 
- 
- 
- 
- 
- 
- 
- 
- 
- 
- 
- 
- 
- 
- 
- 
- 
- 
- 
- 
- 
- 
- 
- 
- 
- 
- 
- 
- 
- 
- 
- 
- 
- 
- 
- 
- 
- 
- 
- 
(Wieler, L., Berlin) 
(Wieler, L., Berlin) 
(Wieler, L., Berlin) 
(Wieler, L., Berlin) 
(Wieler, L., Berlin) 
(Wieler, L., Berlin) 
(Wieler, L., Berlin) 
(Wieler, L., Berlin) 
(Petzel, W., Oberschleißheim) 
(Petzel, W., Oberschleißheim) 
(Petzel, W., Oberschleißheim) 
(Petzel, W., Oberschleißheim) 
(Petzel, W., Oberschleißheim) 
(Petzel, W., Oberschleißheim) 
(Petzel, W., Oberschleißheim) 
(Petzel, W., Oberschleißheim) 
(Petzel, W., Oberschleißheim) 
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Strain Source/origin Serotype Reference 
2332 
2333 
2335 
2338 
2339 
2340 
2341 
2342 
2343 
2344 
2345 
2346 
2350 
2351 
2352 
2353 
2354 
2355 
2356 
2357 
2358 
2359 
2360 
2363 
2364 
2365 
2366 
2367 
2370 
2371 
2372 
bovine faeces 
bovine faeces 
bovine faeces 
bovine faeces 
bovine faeces 
bovine faeces 
bovine faeces 
bovine faeces 
bovine faeces 
bovine faeces 
bovine faeces 
bovine faeces 
bovine faeces 
bovine faeces 
bovine faeces 
bovine faeces 
bovine faeces 
bovine faeces 
bovine faeces 
bovine faeces 
bovine faeces 
bovine faeces 
bovine faeces 
bovine faeces 
bovine faeces 
bovine faeces 
bovine faeces 
bovine faeces 
bovine faeces 
bovine faeces 
bovine faeces 
- 
- 
- 
- 
- 
- 
- 
- 
- 
- 
- 
- 
- 
- 
- 
- 
- 
- 
- 
- 
- 
- 
- 
- 
- 
- 
- 
- 
- 
- 
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III.2. OLIGONUCLEOTIDES 
All oligonucleotides used for PCR, RT-PCR and/or qPCR were purchased from Sigma-Genosys 
(Steinheim, Germany) and Eurofins MWG Operon (Ebersberg, Germany). The sequences and the 
application of all oligonucleotides are listed in Table 7. 
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Table 7: Oligonucleotides used in this study 
Primer Sequence [5´→3´] Application 
GapA_for(756) gttgtcgctgaagcaactgg DNase treatment control; target is gapA 
(Blumer et al., 2005) 
GapA_rev(757) agcgttggaaacgatgtcct DNase treatment control; target is gapA 
(Blumer et al., 2005) 
16SRNA_for aactgagacacggtccagact Control in qRT-PCR; target is 16S rRNA 
16SRNA_rev ttaacgcttgcaccctccgt Control in qRT-PCR; target is 16S rRNA 
27f gagtttgatcctggctca Control in qRT-PCR; target is 16S rRNA 
798r ccagggtatctaatcctgtt Control in qRT-PCR; target is 16S rRNA 
Sf0379 tcagcctgcagattagcgacgt Screening for upaB  
Sr0379 tatgtccggactgcaatggtca Screening for upaB 
F3LC0433 caatgccaatggcgatttcga Screening for upaC 
R3LC0433 ggtcaagctgttcggcgcaacat Screening for upaC 
Sf2276 gctgtcagtttcaaggttgg Screening for upaI 
Sr2276 tcttgccggaacgggagtcat Screening for upaI 
F2LC3703 gggtagtcaatccaatgcaaacggt Screening for upaJ 
R1LC3703 ccagggtatcaacgtccgcgttca Screening for upaJ 
0379cF tgctctagaaggaattgttatggagaatttct
tcatgaaa 
Amplification of upaB from E. coli 536 
0379cR cccaagcttagtcgacaggggaaccgactgct Amplification of upaB from E. coli 536 
0433cF tgctctagaaggaattgttatgcactcctgga
aaaagaaa 
Amplification of upaC from E. coli 536 
0433cR ccgctcgaggcccgtcaaatccttgacgggca Amplification of upaC from E. coli 536 
2276cF tgctctagaaggaattgttatgaatatgcgga
ttatcttt 
Amplification of upaI from E. coli 536 
2276cR cccaagcttcctgataaggcgtttacgccgca Amplification of upaI from E. coli 536 
3703cF tgctctagaaggaattgttatgaacaaaatat
ttaaagtt 
Amplification of upaJ from E. coli 536 
3703cR cccaagctttgctgaatcaccccgtaggcct Amplification of upaJ from E. coli 536 
Fp0379Fless gcggtatcaactacaccggttacattgg Mutagenesis of upaB with FLAG® tag 
Fp0379Rflag cttatcgtcgtcatccttgtaatcgttatcag
cagcgaatgctggtgc 
Mutagenesis of upaB with FLAG® tag 
Fless0433F acgaccgatttagtttggccgtatga Mutagenesis of upaC with FLAG® tag 
Flagprimer433R cttatcgtcgtcatccttgtaatcggtgttgt
catgataccccca 
Mutagenesis of upaC with FLAG® tag 
Fp2276Fless cagggatatgatatcaaagcgagctgtcagg Mutagenesis of upaI with FLAG® tag 
Fp2276Rflag cttatcgtcgtcatccttgtaatcacatgaat
caatgaccgc 
Mutagenesis of upaI with FLAG® tag 
Fp3703Fless gcgcttgatggtggtggggctagcg Mutagenesis of upaJ with FLAG® tag 
Fp3703Rflag cttatcgtcgtcatccttgtaatcggtcgatg
cttgtactccagacg 
Mutagenesis of upaJ with FLAG® tag 
RT_79_F ctccaccatcacagctcaa quantitative RT-PCR of target upaB 
RT_79_R accgccattaacaacaaca quantitative RT-PCR of target upaB 
RT_33_F gttgggtgatgtcgagtt quantitative RT-PCR of target upaC 
RT_33_R ggccggttgaatagaagaat quantitative RT-PCR of target upaC 
RT_76_F ggcgatattgtggtggaag quantitative RT-PCR of target upaI 
RT_76_R aggtggtgaaatcagagag quantitative RT-PCR of target upaI 
RT_03_F agcacaacacaacgcaaaa quantitative RT-PCR of target upaJ 
RT_03_R gcgcctctcccacattat quantitative RT-PCR of target upaJ 
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III.3. CHEMICALS AND ENZYMES 
All chemicals and enzymes used in this study were purchased from the following companies: 
 
AppliChem (Darmstadt, Germany), Carl Roth GmbH (Karlsruhe, Germany), Dianova (Hamburg, 
Germany), Difco (Augsburg, Germany), GE Healthcare/Amersham Biosciences (Freiburg, Germany), 
Gibco (Eggenstein, Germany), Invitrogen (Karlsruhe, Germany), MBI Fermentas (St.Leon-Roth, 
Germany), Merck (Darmstadt, Germany), New England Biolabs (Frankfurt am Main, Germany), Oxoid 
(Wesel, Germany), PAA (Cölbe, Germany), Roche Diagnostics (Mannheim, Germany), Roth (Karlsruhe, 
Germany), Serva and Sigma-Aldrich (Taufkirchen, Germany).  
 
The following commercial kits were used: 
- Plasmid Mini and Midi kit, QIAGEN (Hilden, Germany) 
- QIAquick MinElute PCR purification kit, QIAGEN (Hilden, Germany) 
- QIAquick MinElute Gel extraction kit, QIAGEN (Hilden, Germany) 
- RNeasy kit, QIAGEN (Hilden, Germany) 
- ABI Prism BigDye Terminator Cycle Sequencing Ready Reaction kit, Applied Biosystems (Foster City, 
USA) 
- ECL™ Direct Acid Labeling and Detection System, and ECL™ advance system, 
GE Healthcare/Amersham Biosciences (Freiburg, Germany) 
- OpArray Hybridization Buffer Kit, Operon (Cologne, Germany) 
- Agencourt AMPure XP Kit, Beckman Coulter Genomics (Krefeld, Germany) 
 
III.4. MEDIA, AGAR PLATES AND ANTIBIOTICS 
All media were autoclaved for 20 min at 120 °C, if not stated otherwise. Supplements for media and 
plates were sterile filtered through a 0.22 μm pore filter and added after cooling down the media to 
<50 °C. 
III.4.1. Media 
DMEM High Glucose with L-Glutamine - Dulbecco's Modified Eagle Medium was purchased either 
from Gibco or Lonza. 
 
LB medium (lysogeny broth) (Sambrook et al., 1989): 
10 g Tryptone from casein 
5 g Yeast extract 
5 g NaCl  ad 1 l dH2O 
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M63 minimal medium: 
Ingredient  stock  final concentration for 800 ml 
M63 salts  5x  1x   160 ml 
FeSO4   1 ‰  0.001 ‰  800 μl 
MgSO4   10 %  10 ‰   800 μl 
Thiamin  0.2 %   0.5 ‰   2 ml 
Glucose  20 %   0.4 %   16 ml 
Casamino acids  10 %  1 %   80 ml 
KOH   10 M pH 7    5.2 ml 
 
5 x M63 salts 
(NH4)2SO4 15 mM  8 g 
KH2PO4  100 mM 54.4 g add dH2O up to 800 ml and autoclave 
FeSO4   1 mg / 1 ml in H2O and sterile filtration 
MgSO4   10 g / 100 ml in H2O and autoclaving 
Thiamin  20 mg / 10 ml in H2O and sterile filtration 
Glucose  20 g / 100 ml in H2O and autoclaving 
Casamino acids  10g / 100 ml in H2O and autoclaving 
KOH   10 M in H2O and autoclaving 
 
MM9 minimal medium (Kalinowski et al., 2000):  
Ingredient  stock  final concentration for 1000 ml 
Tris (pH 6.8)  0.5 M  0.05 M   100 ml 
Casamino acids  10 % (w/v) 1 % (w/v)  100 ml  
Glucose  20 % (w/v) 0.4 % (w/v)    20 ml 
MgSO4   1 M     2 mM       2 ml 
CaCl2   1 M  0.1 mM   100 µl 
Thiamine  10 mM  3 µM   300 µl 
10 x MM9 salts       100 ml ad 1 l dH2O; sterile filtered 
KH2PO4    3 g / l  
NaCl    5 g / l 
NH4Cl  10 g / l 
 
Modified for lactose growth curve: No casamino acids and glucose, but 0.2 % lactose (20 ml 20 % w/v 
lactose) 
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Milk whey 
In collaboration with the Clinic for Ruminants of the Ludwig-Maximilians-University Munich 
(Oberschleißheim, Germany), we obtained raw milk from a generally udder healthy cow. After 
milking, raw milk was cooled to 4°C and processed to milk whey. For the preparation of milk whey, 
milk was centrifuged at 38,000 x g and 4°C for 30 min. The fat layer was removed with a spatula and 
the skim milk was decanted into a clean tube. A second centrifugation step followed as described 
above and the translucent supernatant was collected and stored at -80°C until use.  
The described process removes fat, cell debris and partially depletes casein-peptones. 
 
Milk whey from a cow challenged with LPS 
This medium refers to milk whey (see above), but was obtained from a cow, which received an 
infusion of purified E. coli LPS into the udder. The LPS endotoxin binds to the CD14/TLR4/MD2 
receptor complex, which promotes the secretion of pro-inflammatory cytokines in many cell types, 
but especially in macrophages and B cells.  
In immunology, the term "LPS challenge" refers to the process of exposing a subject to an LPS that 
may act as a toxin. For bovine neutrophils it has been reported that binding of LPS to membrane-
bound CD14 causes release of TNFα and sepsis (Paape et al., 2003). Therefore LPS challenge is a 
proposed method to elicit immune response within in the udder. 
III.4.2. Agar plates 
LB agar plates:  LB medium + 1.5 % (w/v) agar (Difco Augsburg, Germany) 
III.4.3. Antibiotics 
The isolates used in this study were not genetically manipulated. Hence, media and plates were not 
supplemented with any antibiotics. Instead, gentamycin (Sigma-Aldrich, Taufkirchen, Germany) was 
used in cell culture experiments to perform the gentamycin protection assay (section IV.5.3). 
III.4.4. DNA Markers 
In order to determine the size of DNA fragments in agarose gels, the “GenerulerTM” 1-kb DNA ladder, 
purchased from MBI Fermentas, was used (Figure 5). 
Figure 5: GenerulerTM, 1-kb DNA ladder 
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III.5. TECHNICAL EQUIPMENT 
Accu-Jet Pro Pipette Controller  BrandTech (Wertheim, Germany) 
AlphaImager 
®
 EP    Alpha Innotech Corp. (Santa Clara, USA) 
Autoclave     Tecnoclav biomedics Laborservice GmbH (Gießen, Germany) 
Bio-Rad C1000 Thermal Cycler  Bio-Rad (Munich, Germany) 
CFX96 RealTime System   Bio-Rad (Munich, Germany) 
Biofuge 13R,    Heraeus Sepatech instruments (Langenselbold, Germany) 
Bio-Rad Imager    Bio-Rad (Munich, Germany) 
Concentrator Plus SpeedVac  Eppendorf (Hamburg, Germany) 
Electrophoresis chambers   Bio-Rad (Munich, Germany) 
Fluostar Omega ELISA Reader  BMG Labtech (Offenburg, Germany) 
Gel documentation system   Intas (Göttingen, Germany) 
Hettich Rotanta 460RS centrifuge  Hettich Lab Technology (Tuttlingen, Germany) 
HiScanSQ NGS Sequencer   Illumina (San Diego, USA). 
Camera, Ixus 500    Canon (Krefeld) 
Refrigerated centrifuge, Megafuge10R Heraeus Sepatech instruments (Langenselbold, Germany) 
Refrigerated benchtop centrifuge, 
MultiNA microchip electropho. System Shimadzu (Duisburg, Germany). 
Lab901 TapeStation for NGS SampleQC Agilent Technologies (Waldbronn, Germany) 
Micropipettes     Eppendorf (Hamburg, Germany) 
Microtiter plates, 96 Well   Sarstedt (Nürnbrecht, Germany) 
Microtiter plates, 96 Well   Greiner (Solingen, Germany) 
Mains unit, Mighty slim
TM
, SX250   Hoefer (San Francisco, USA) 
PCR-Thermocycler, T3    Biometra (Göttingen, Germany) 
Precellys Homogeniser   Peqlab (Erlangen, Germany) 
Pipettes     Eppendorf (Hamburg, Germany) 
     Gilson AG (Mettmenstetten, Switzerland 
Shaking incubators    B. Braun Biotech (Melsungen, Germany) 
     GFL (Burgwedel, Germany) 
     New Brunswick Scientific/ Eppendorf (Hamburg, Germany) 
       Infors-HT (Bottmingen, Switzerland) 
Sequencer     Applied Biosystems (Foster City, USA) 
Sterile work bench    Nuaire (Plymouth, USA) 
Sterile filters, 0.22 μm   Millipore (Schwalbach, Germany) 
Spectrophotometer, ND-1000  Peqlab (Erlangen, Germany) 
Spectrophotometer, ND-2000  Peqlab (Erlangen, Germany) 
Thermo incubator   Liebisch (Bielefeld, Germany) 
     Eppendorf (Hamburg, Germany) 
Thermoshaker incubator   Peqlab (Erlangen, Germany) 
Tabletop centrifuge   Heraeus sepatech instruments (Langenselbold, Germany) 
     Eppendorf (Hamburg, Germany) 
Ultraspec 2100 Pro and 
Ultraspec 3100 Pro 
Spectral Photometer   GE Healthcare (Munich, Germany) 
UV-chamber     Bio-Rad (Munich, Germany) 
Vortexer     GFL (Burgwedel, Germany) 
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Water bath    Memmert (Schwabach, Germany) 
     GFL (Burgwedel, Germany) 
 
 
III.6. Software 
All software, databases and online resources used in this study are listed in Table 8. 
Table 8: Software, databases and online resources 
Resource Application 
Acuity 4.0 software (Molecular Devices, Sunnyvale, USA) Statistical validation and further analysis 
Artemis (Rutherford et al., 2000) Genome annotation 
Artemis Comparison Tool (Carver et al., 2005) Genome comparison 
BBF, β-barrel finder, (Zhai and Saier, 2002) Detection of outer membrane proteins  
BLAST (Altschul et al., 1990; Camacho et al., 2009) Basic Local Alignment Search Tool 
bROC Version 2 (BioFormatix, San Diego, USA) 
(BioFormatix, 2010) 
Discovery of differentially expressed 
genes (DEG) in RNA-Seq experiments 
CFX Manager™ Software Version 3.0  
(Bio-Rad, Munich, Germany) 
Experiment setup and data analysis 
software for CFX96™ 
CLC Genomics Workbench (Aarhus, Denmark) Read mapping and transcriptomic 
analyses 
Cluster 3.0 (Eisen et al., 1998) Hierarchical clustering 
FastQC Version 0.10.1 (Andrews, S.) 
http://www.bioinformatics.babraham.ac.uk/projects/fastqc/ 
Quality control tool for high throughput 
sequence data 
GenePix Pro 6.0 software  
(Molecular Devices, Sunnyvale, USA) 
Scanning of DNA microarrays 
Inkscape Version 0.48.4.1 (Inkscape Community) Vector graphic editing 
jSpecies Version 1.2.1 
(Richter and Rosselló-Móra, 2009; Goris et al., 2007) 
Prokaryotic genome similarity analysis 
Average Nucleotide Identity (ANI) 
MUMmer 3.0 (Kurtz et al., 2004) Genome comparison 
Office2007 Excel software (Microsoft, Redmond, USA) Statistical validation and analysis 
R Version 3.0.1 (R Foundation) http://www.R-project.org Statistical computing and analysis 
SortMeRNA Version 1.8 (Kopylova et al., 2012) Filtering of ribosomal RNAs in 
metatranscriptomic data 
TreeView (Page, 1996) Visualization of hierarchical clustering 
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IV. METHODS 
IV.1. Working with DNA 
Working with DNA required no extraordinary handling. In contrast to RNA work which required 
handling with special care in order to prevent contamination of the RNA samples with exogenous 
RNases.  
IV.1.1. Isolation of chromosomal DNA 
1 ml bacteria from an overnight culture were harvested by 4 min centrifugation at maximum speed in 
a tabletop centrifuge. Followed washing in 1 ml TNE buffer, cells were centrifuged for 4 min and 
resuspended in 270 μl TNE-X buffer. For lysis of the bacteria 30 μl lysozyme (5 mg ml-1) were added 
and samples were incubated for 20 min at 37°C. Subsequently 15 μl of proteinase K (20 mg ml-1) were 
added to the samples which were 2 h incubated at 65°C until. The solution should have become 
clear. The genomic DNA was precipitated by addition of 0.05 vol 5 M NaCl (15 μl) and 500 μl ice-cold 
ethanol and subsequently collected by centrifugation for 15 min. After washing two times with 1 ml 
70% (v/v) ethanol, the DNA pellets were air-dried and redissolved in 100 μl 100 dH2O (Clermont et 
al., 2000). 
TNE    TNE-X 
10 mM Tris   TNE + 1 % Triton X-100 
10 mM NaCl 
10 mM EDTA 
IV.1.2. Precipitation of DNA with alcohol 
The DNA was precipitated with ethanol and isopropanol. 
Precipitation with ethanol was performed with 0.1 volumes 3 M Na-acetate (pH 4.8), which were 
added to the sample followed by the addition of 2.5 volumes ice-cold 100 % (v/v) ethanol. The DNA 
pellet was washed with 70 % (v/v) ethanol, air-dried and resuspended in dH2O. 
Precipitation with isopropanol was performed by addition of 0.7 volumes isopropanol. The samples 
were incubated at -80°C before at least 20 min of centrifugation by 13,000 rpm at 4°C. The DNA 
pellet was washed with 70 % (v/v) ethanol, air-dried and resuspended in dH2O. 
IV.1.3. Determination of nucleic acid concentration and quality 
Nucleic acid concentrations were determined by using the NanoDrop® instrument which measures 
absorption at 260 nm. Absorption of 1.0 corresponds to 50 μg ml-1 double stranded DNA. The sample 
purity of the preparations was determined by measuring the absorption ratio of the respective 
sample. DNA samples were considered sufficiently pure when the ratio A260/A280 was higher than 
1.8, respectively. 
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IV.1.4. Polymerase chain reaction (PCR) 
A PCR-screening for the AT genes upaB, upaC, upaI and upaJ was performed by PCR. The primers 
were designed based on the specific α-domain-encoding nucleotide sequence of the respective 
autotransporter genes. By testing of various primers with chromosomal DNA as template multiple 
PCR products occurred. This problem was solved by selection of primers homologous to gene 
sections with a low prevalence of repetitive sequences and by usage of bacterial lysates as template 
DNA. Screening was performed using the primers listed in Table 7. 
 
The 25 µl screening-PCR mix for one template colony-PCR sample was: 
 
   14 µl H2O 
     5 µl Q-Solution 5×  
  2.5 µl Buffer 
     1 µl MgCl2 [25mM] 
  0.5 µl dNTPs (10µl per dNTP + 60µl H2O) 
  0.5 µl Primer 1 
  0.5 µl Primer 2 
0.15 µl Qiagen™ - TAQ-Polymerase 
      1 µl Template colony-PCR 
 
 
IV.1.5. Sequence analysis (Sanger) 
The nucleotide sequences of bacterial DNA were determined using fluorescent dye terminators 
(ABI prism BigDye terminator kit, Applied Biosystems) at the Institute for Molecular Infection Biology 
(IMIB), University of Würzburg. 
 
The sequencing-PCR mix for one sample was: 
30 ng  PCR product (or: 0.5 μg plasmid DNA) 
1.5 μl  10 pM primer 
2 μl  5 x buffer (kit component) 
2 μl  premix (kit component) ad 10 μl ABI-H2O 
The thermal cycling profile for the PCR reaction was: 40 cycles of denaturation at 96 °C for 30 s, 
annealing at 60 °C for 15 s, and extension at 60°C for 4 min, followed by final extension at 60 °C for 
2 min. The sequencing products were purified by ethanol precipitation and analyzed in an ABI prism 
sequencer (Perkin Elmer). 
Program: 
1:  94°C      180s 
2:  94°C        30s 
3: Tm°C       60s 
4:  72°C       60s /kb   -> 2  25-35cycles  
5:  72°C       600s 
6:  12°C       hold 
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IV.1.6. Separation of DNA fragments by gel electrophoresis  
DNA fragments were separated on a 0.8 % and 1 % (w/v) agarose gels (1 × TBE buffer with 1 mM 
urea) by horizontal electrophoresis. Afterwards DNA fragments in the gel were stained in an 
ethidium bromide solution (10 g/ml) and the gels were photographed on an UV-transilluminator. 
IV.2. Working with RNA 
The work with RNA required handling with special care in order to prevent contamination of the RNA 
samples with exogenous RNases. Therefore gloves were worn throughout conduction of RNA 
experiments. Furthermore, RNase-free pipette tips and reaction tubes were used. For all buffers and 
solutions, water was treated over night with 0.1 % (v/v) diethylpyrocarbonate (DEPC) at 37 °C and 
autoclaved twice to remove remaining DEPC. For dissolving RNA in water, nuclease free water from 
the kits listed in section III.4. was used. 
IV.2.1. Standard isolation of total RNA with Qiagen RNeasy Kit 
RNA preparation was performed by using the RNeasy Mini kit (Qiagen) following the manufacturer’s 
protocol. All subsequent steps of the RNeasy protocol were performed at room temperature. For 
RNA isolation bacteria were grown at 37 °C in either LB or DMEM medium until the optical density 
(OD600) reached 0.15. For RNA isolation from LB cultures, bacteria were grown without agitation at 
37°C in 25 ml until the OD600 reached 0.6.  
Four ml of the bacteria culture in either LB or DMEM respectively were taken and centrifuged at 
6000 rpm for 5 min. The supernatant was removed and pellets were resuspended in 4 ml of PBS and 
RNAprotect Bacteria Reagent™ (Qiagen) 1:1 (v/v), respectively. Samples were incubated at room 
temperature for 5 min and centrifuged at 6,000 rpm for 10 min. The collected bacterial pellets were 
either stored at -80°C or bacterial RNA was immediately isolated. Following immediate RNA isolation 
bacterial pellets were resuspended thoroughly in 100 μl of lysozyme-containing TE buffer (50 mg/ml) 
and incubated at 37°C for 5 s while vortexing every 2 min. The following steps of the protocol are 
consistent with those of the protocol supplied with the Qiagen RNeasy® Mini Kit. 
IV.2.2. Isolation of bacterial total RNA from milk whey 
Specific treatment allowed isolation of bacterial total RNA from milk whey spiked with E. coli. For this 
purpose 15 ml of prewarmed milk whey, inoculated with 1x109 colony forming units (CFU)/ml, were 
statically incubated for 1 h at 37°C. After cultivation the degradation of transcripts was inhibited by 
addition of two sample volumes of the RNA stabilizing reagent RNAprotect Bacteria 
Reagent™(Qiagen), followed by 5 min incubation at room temperature (15-25°C). Bacteria were 
harvested by centrifugation and the casein-peptone protein content was reduced by three times 
washing with 50 v/v % RNAprotect Bacteria Reagent (PBS). In detail, the reagent-milk whey mixture 
separates into a translucent fluid and precipitated proteins. The fluid supernatant containing the 
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major portion of bacteria was transferred into a new tube and centrifuged at 5,000 x g and 4 °C for 
10 min. The supernatant was then discarded and the pellet was washed with 30 ml 1:1 (v/v) 1 x PBS 
and RNAprotect Bacteria Reagent™ (Qiagen) by centrifugation with the previous settings. The 
obtained bacterial pellets were stored at -80 °C until further RNA isolation using the Qiagen RNeasy® 
Mini Kit. The bacterial pellets were resuspended thoroughly in 100 μl of lysozyme-containing TE 
buffer (50 mg/ml) and incubated at 37 °C for 5 s while vortexing every 2 min. Subsequently the 
manufacturer´s protocol was followed. 
This protocol allowed bacterial RNA isolation from milk whey with sufficient amounts of high 
integrity RNA. 
IV.2.3. Isolation of total RNA from bacteria upon cocultivation in cell culture 
This protocol has been used for the assessment of the bacterial transcriptome upon bacterium-host 
interaction by cocultivation with MAC-T immortalized bovine mammary gland epithelial cells. For this 
purpose the principle of column based RNA isolation utilized by the Qiagen RNeasy® Mini Kit has to 
be considered. Nucleic acids are competitively binding to silica membranes in which the kind of 
nucleic acids binding to silica membranes is mainly influenced by the ratio of sample to salts to 
ethanol. Clogging of the columns and contaminations due to genomic DNA mainly derived from the 
eukaryotes can be prevented by the use of gDNA Eliminator spin columns (Qiagen). This type of 
column, in combination with the optimized chaotropic high-salt buffer, allows efficient removal of 
genomic DNA. 
For total RNA isolation confluent 175-cm2 cell culture flasks with 15 ml DMEM containing 
approximately 1.5 x 107 cells each were inoculated, with a multiplicity of infection (MOI) of 100, from 
bacterial overnight cultures (grown in DMEM). The cocultivation period was either 1 h or 3 h at 37 °C. 
After cocultivation the degradation of transcripts was inhibited by addition of two sample volumes of 
the RNA stabilizing reagent RNAprotect Bacteria Reagent™(Qiagen), followed by 5 min incubation at 
room temperature (15-25 °C). Both, the supernatant cell culture medium DMEM containing 
planktonic bacteria and the MAC-T cells with adhering and invasive bacteria were harvested by 
scratching the cell culture flask with a cell culture spatula. The samples of 15 ml culture (containing 
bacteria and eukaryotic cells) were taken and centrifuged at 6,000 rpm for 5 min. The supernatant 
was removed and pellets were resuspended in 4 ml of PBS and RNAprotect Bacteria Reagent™ 
(Qiagen) 1:1 (v/v), respectively. Samples were incubated at room temperature for 5 min and 
centrifuged at 6000 rpm for 10 min. The collected pellets were either stored at -80 °C or bacterial 
RNA was immediately isolated. Following immediate RNA isolation the pellets were resuspended 
thoroughly in 400 μl of lysozyme-containing TE buffer (50 mg/ml) and incubated at 37 °C for 5 s while 
vortexing every 2 min. The lysate was divided into four subsamples and then passed through a gDNA 
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Eliminator spin column (Qiagen) respectively. The following steps of the protocol were consistent 
with those of the protocol supplied with the Qiagen RNeasy® Mini Kit. 
IV.2.4. RNA processing and quality control 
In order to use isolated RNA as template for further analyses such as qRT-PCR, DNA microarrays and 
RNA-Seq, the total RNA had to be processed to ensure that it meets the requirements in purity and 
integrity. 
 DNase treatment and RNA purification 
Contaminating DNA was removed from total RNA preparations by DNase I digestion. 15 μg RNA in a 
final volume of 85 μl were mixed with 10 μl 10 x DNase I buffer and 10 μl RNasefree DNase I (New 
England Biolabs). Samples were incubated for 1 h at 37 °C, followed by RNA cleanup using the 
RNeasy Mini kit (QIAGEN) according to the manufacturer’s instructions. Therefore, 350 μl RLT buffer 
supplemented with 10 μl ß-mercaptoethanol and 250 μl 100 % (v/v) ethanol were added to the 
DNase-treated RNA samples. Samples were loaded to the supplied purification columns and briefly 
centrifuged. In order to prevent any residual buffer, the columns were transferred to fresh collection 
tubes and washed twice with 500 μl RPE buffer. The purified RNA was then eluted from the column 
in 30 μl nuclease-free water. Elimination of DNA was verified on a CFX96 real-time PCR machine (BIO-
RAD, Munich, Germany) using SSoFast™ EvaGreen® Supermix (BIO-RAD) with the primers listed in 
Table 7. Therefore 2 μl of the DNase-treated RNA were used as a template in a PCR reaction with 
primers binding either within the coding sequence of the gapA or frr gene. The DNase treatment was 
considered successful if no product could be amplified from the RNA samples. Residual DNA was 
removed by repeating this protocol. 
 RNA quality control 
We evaluated the quality of RNA using the RNA integrity number (RIN) as generated by Agilent 
Technologies’ 2100 Expert Software. The RIN allows for an objective and standardized assessment of 
RNA. It is automatically generated and the number takes into account several features commonly 
ascribed to overall RNA quality (Schroeder et al., 2006).  
RNA concentrations were determined using the NanoDrop® instrument, which measures absorption 
at 260 nm. Absorption of 1.0 corresponds to 40 μg ml-1 RNA. The sample purity of the preparations 
was determined by measuring the absorption ratio of the respective sample. For this, RNA samples 
were considered sufficiently pure when the ratio A260/A280 was higher than 2.0. 
The RNA integrity was determined by capillary electrophoresis using either the Agilent 2100 
Bioanalyzer instrument or the Lab901 TapeStation for NGS Sample QC following the supplied 
protocols. RNA integrity values (RIN) > 7.0 were considered to meet the requirements for expression 
analyses (Schroeder et al., 2006; Imbeaud et al., 2005; Wilkes et al., 2010). 
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IV.2.5. cDNA synthesis by reverse transcription (RT)-PCR 
For further analyses the RNA has to be reversely transcribed by a RNA-dependent DNA polymerase in 
order to synthesize cDNA in a subsequent amplification by PCR. For the purpose of cDNA synthesis, 
the Superscript III reverse transcription kit (Invitrogen) was used. 2 μg of total RNA in a final volume 
of 10 μl were mixed with 1 μg of random hexamer primers (Amersham Biosciences). Primer 
annealing was carried out at 65 °C for 5 min. After 5 min cooling, 9 μl of a reverse transcription 
mixture were added to the samples. The RT-PCR-mix for on sample was pipetted as below: 
1 μl 25 mM deoxynucleotide mix 
1 μl 0.1 M dithiothreitol (DTT; kit component) 
4 μl 5 x first strand buffer (kit component) 
1 μl 40 U μl-1 RNase OUT recombinant RNase inhibitor (Invitrogen) 
1 μl 200 U μl-1 Superscript III reverse transcriptase (Kit component) 
The cDNA synthesis was performed at 52 °C for 60 min, followed by heat inactivation of the 
transcriptase at 70 °C for 15 min. 
IV.2.6. Quantitative Real-Time PCR 
The quantitative Real-Time PCR (qRT-PCR) was used to assess gene expression of specific genes. This 
method utilizes PCR to amplify gene transcripts in presence of the SYBR Green I dye (Bio-Rad). 
qRT-PCR detects the amount of product quantitatively and in real time enabled by fluorescent dye 
that intercalates into double stranded DNA and emits signals collected by the optical camera within 
the CFX96 RealTime System (Bio-Rad). The transcript levels were computed by means of cycles 
needed to traverse the fluorescent signal threshold (CT) line by (CFX Manager™ Software, Bio-Rad). 
The primers for the selected genes were designed by the following parameters: product length range 
from 190 to 300 nt; annealing temperature 57 - 59 °C (by either Fast PCR or CLC Workbench -
software) matching at least 90 % amplification efficiency. The cDNA samples derived from the RT-PCR 
were 100-fold diluted in dH2O and the qRT-PCR-mix for one reaction was pipetted as below: 
12.0 μl  cDNA 
12.5 μl  SYBR Green Mix 2 × 
0.25 μl  Primer 1 (10 μmol) 
0.25 μl  Primer 2 (10 μmol) 
The thermal cycler was programmed as follows: 
3 min  95 °C 
30 s  95 °C 
30 s  60 °C – 40 cycles 
20 s  72 °C 
30 s  95 °C – 57 °C (melting curve) 
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All PCR reactions were done in triplicates and primers either for the gene frr (ribosome recycling 
factor) or rrnB (encoding for 16 S RNA) were used as an internal control. 
IV.3. Transcriptome analysis by DNA-microarrays 
Expression profiling is a technique to study the relative amounts of all transcripts at a given time of 
sample collection. It thereby allows monitoring the expression level of every single gene detectable 
by the array with restriction to small RNAs which are lost during total RNA extraction and purification 
by the Qiagen RNeasy Kit. This protocol follows the main protocol established in the working group 
of Dobrindt and colleagues  
 Array Layout 
In order to comprehensively and quantitatively assess the transcriptional response of bacteria upon 
cocultivation with eukaryotic cells by expression profiling, customized oligonucleotide glass 
microarrays (Operon Biotechnologies, Inc.) were employed. A single Operon E. coli Custom 55156017 
array contains 10,816 longmer oligonucleotide probes covering the complete genomes of six E. coli 
strains (6 genomes and four plasmids). 
The number of open reading frames (ORFs) or genes represented is as follows: 
 
4,269 ORFs of non-pathogenic E. coli K-12strain MG1655, 
5,306 ORFs of enterohemorrhagic E. coli O157:H7 strain EDL933, 
5,251 ORFs of enterohemorrhagic E. coli O157:H7 strain Sakai, 
5,366 ORFs of uropathogenic E. coli strain CFT073, 
322 ORFs of uropathogenic E. coli strain 536, 
448 ORFs of uropathogenic E. coli strain UTI89, 
3 genes of EHEC plasmid OSAK1, 
10 genes of EHEC plasmid pO157_Sakai, 
97 genes of EHEC plasmid pO157_EDL933 and UPEC plasmid pUTI89. 
 
In addition, the array comprises also a number of positive and negative controls. Each probe contains 
an amino linker at the 5'- end. Probes are spotted as single spots in 32 blocks (4 columns, 8 rows), 
each block with 18 columns x 19 rows.  
 Sample preparation 
Total RNA samples were prepared from bacteria upon cocultivation with MAC-T immortalized bovine 
mammary gland epithelial cells followed by DNase treatment, as described in sections IV.2.3 and 
IV.2.4. All DNA microarray experiments were done in triplicates including the overnight culture. 
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For cDNA labeling all procedures involving fluorescent dyes had to be done quickly and by avoiding 
exposure to light because of photosensitivity. Reverse transcription was performed using 
SuperScript IIITM reverse transcriptase (Invitrogen) and the fluorescently labeled nucleotides Cy3- 
and Cy5-dCTP (GE Healthcare). All solutions were prepared with DEPC treated water. For primer 
annealing, the annealing mix for one reaction was prepared as below: 
10 μg  total RNA 
1 μg  hexamer oligos 
ad H2O (DEPC treated) to a total volume of 15 μl 
 
The annealing mix was heated for 10 minutes at 70 °C, then cooled down to room temperature for 
5 min followed by brief centrifugation to spin down condensate water. The reaction mix for one 
reaction was prepared as below: 
8 μl  5 x first strand buffer  
4 μl  0.1 x DTT  
4 μl  Nucleotide mastermix 
1 μl  RNaseOut  
1 μl  SuperScript III™ (200 U/μl) 
4 μl  RNase free H2O  
 
22 μl reaction mix and 15 μl annealing mix was immediately pipetted into a 50 μl PCR reaction tube. 
Either 4 μl Cy3- or Cy5-dCTP (1 mM) was added and the total mix of 41 μl was subsequently 
incubated for 1 h at 46 °C. After 25 min, another 1 μl of SuperScript IIITM reverse transcriptase 
(200 U/μl) was added. After incubation the reaction was stopped by addition of 5 μl EDTA (500 mM) 
and 10 μl NaOH (1 M) was added to hydrolyze the RNA following incubation at 65 °C for 15 min. The 
reaction mixture was cooled down to room temperature and 25 μl Tris-HCl (1M, pH 7.5) was added. 
The labeled targets were purified using the Qiaquick PCR Purification Kit (Qiagen) following the 
manufacturer’s instructions with minor changes. Briefly, 5 volumes of PB buffer were added and each 
sample was applied to a Qiaquick column and centrifuged at max speed for 30 s. The column was 
washed with 700 μl PE buffer and dried by centrifugation. cDNA was eluted in 30 μl dH2O and 
collected in a 1.5 ml Eppendorf tube. Of this, 1 μl was taken to control for quality and dye 
incorporation and quantification using the NanoDrop photometer. The remaining labeled cDNA was 
dried using a Concentrator Plus SpeedVac (Eppendorf). The cDNA pellet was resuspended in 2 μl 
dH20. 
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 Array pre-hybridization 
The Array slides were cleaned by compressed air from dust particles and pre-hybridized in pre-
warmed OPArray Pre-Hyb solution at 42 °C for 1 h. During that time Wash Solution 1 was prepared 
by diluting OpArray Wash B 1:40 (v/v) with chromatography grade ROTISOLV® HPLC water (Carl Roth 
GmbH). ROTISOLV® HPLC water was also used for all further wash solutions and array rinsing with 
water (further announced as dH2O). Arrays were washed for 5 min at 20-25 °C and immediately 
rinsed with dH2O for 30 s. This step was repeated twice. The slides were dried in 50 ml Falcon tubes 
with a hole in the bottom by centrifugation at 1200 rpm for 10 min. Residual liquid was removed by 
compressed air. 
 Array hybridization 
The hybridization chamber was rinsed with sterile dH2O and dried thoroughly. In the four corners of 
the chamber, 15 μl of sterile dH2O were added in order to keep the humidity during hybridization 
time. The OpArray was placed into the chamber with the DNA side up (barcode side up) and the 
spotted area was covered with a LifterSlip (Thermo Scientific). Cy5- and Cy3-labelled cDNA targets 
were mixed with 36 μl of OpArray Hyb Buffer, denatured at 65 °C for 5 min and then applied slowly 
to one end of the LifterSlip in order to disperse across the OpArray surface. The hybridization 
chamber was closed and the arrays were incubated in a water bath at 42 °C for 14-16 h. 
 Post-Hybridization washing 
For Post-Hybridization washing the following solutions were prepared: 
Wash Solution 2: 
50 ml  OpArray Wash A 
25 ml  OpArray Wash B 
Bring Wash Solution 2 final volume to 500 ml with sterile dH2O 
Wash Solution 3: 
50 ml  OpArray Wash A 
Bring Wash Solution 3 final volume to 500 ml with sterile dH2O  
Wash Solution 4: 
5 ml  OpArray Wash A 
Bring Wash Solution 4 final volume to 500 ml with sterile dH2O 
After hybridization, the arrays were washed in pre-warmed Wash Solution 2 at 42 °C for 10 min, 
transferred to Wash Solution 3 and shaken for another 10 min at RT. Subsequently, arrays were 
washed twice in Wash Solution 4 at RT for 5 min. Alike in the pre hybridization step, the microarrays 
were dried by centrifugation in 50-ml Falcon tubes for 10 min. The arrays were scanned 
subsequently. 
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 Array Scanning 
After hybridization, the array slides were scanned using a GenePix Model 4000B Microarray Scanner 
(Axon Instruments Inc., Union City, USA) with a resolution of 5 μm pixel size. The excitation 
frequencies of the two lasers were 532 nm and 635 nm, respectively. The gain settings for the 
photomultiplier tubes were adjusted to use the entire dynamic range of the instrument and to get 
comparable fluorescence yields in both channels. Images of Cy3 and Cy5 signals were recorded as 2 
layer 16bit TIFF files and analyzed using the GenePix Pro 6.0 software. 
 Data analysis 
For each experiment, at least three independent hybridizations were performed. Signals of bad 
quality spots were removed when matching any of the following criteria: 
Less than 70 % of foreground pixels were below background intensity plus 2 standard deviations in 
both channels. The signal to noise ratio were below 3 in both channels. The difference between ratio 
of medians and regression ratio exceeded 20 % in one of the channels. The remaining intensities 
were saved as *.gpr type output data files. For statistical validation and further analysis the Acuity 
4.0 software (Molecular Devices, Sunnyvale, USA) was used. For all data, the local background was 
subtracted from the intensity values of each spot on the array and normalized by both linear ratio-
based methods and non-linear lowess including print-tip groups. For statistical significance, the one 
sample t-test was applied and the resulting data set was exported to the Office2007 Excel software 
(Microsoft, Redmond, USA). Mean substance values (<-1 and >1) and a p value of 0.05 were 
employed as cut-off values. Hierarchical clustering of genes for visualization of expression patterns 
was performed with the CLUSTER software (Eisen et al., 1998). The data output was displayed with 
the software TREEVIEW (Eisen et al., 1998). 
For data analysis, a cut-off value of 1.7 was set although the threshold value sometimes referred to 
in literature is twofold (Wildsmith and Elcock, 2001; DeRisi et al., 1997). However, it has been shown 
(Pérez-Amador et al., 2001), that a lower cut-off ranging from 1.4 to 1.74 can be used reliably if the 
results are reproducible in more replicates.  
For the final evaluation of differential gene expression, the obtained expression data were aligned to 
E. coli 1303 and ECC-1470 genome data (A. Leimbach, unpublished data). 
IV.4. Transcriptome analysis by RNA-Seq 
In order to comprehensively and quantitatively assess the transcriptional response of bacteria 
surviving and growing in milk whey we utilized RNA-Seq. RNA-Seq is a technology that makes use of 
next-generation sequencing (NGS) to reveal a whole transcriptome by sequencing of cDNA prepared 
from total cellular RNA. The gene expression can be followed by RNA-Seq to the extent at which the 
corresponding mRNA sequence is retrieved.  
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 Sample preparation for RNA-Seq 
E. coli strains were cultured overnight in LB media at 37 °C with agitation. Bacteria were harvested by 
centrifugation at 5,000 rpm and subsequently washed with PBS. Afterwards 15 ml of prewarmed milk 
whey were inoculated with 1 x 109 CFU/ml of bacteria and statically incubated for 1 h at 37 °C.  
Growth was monitored by determining viable CFU by serial 10-fold dilution of cultures in PBS and 
plating onto LB agar. Plates were incubated overnight at 37 °C before colonies were counted. 
Bacterial total RNA was isolated from E. coli strains, likewise described in section IV.2.2, upon 
cultivation either in milk whey or various media as control. Contaminating DNA was removed from 
total RNA preparations by DNase I digestion to below levels detectable by PCR. Finally, the RNA was 
purified and controlled for quality and integrity as described in section IV.2.4. 
 cDNA synthesis 
The cDNA synthesis was carried out by vertis Biotechnologie AG (Freising, Germany). Briefly, the RNA 
samples were treated with terminator-5′-phosphate-dependent exonuclease (Epicentre 
Biotechnologies) to deplete processed RNAs. TEX degrades RNAs with a 5′ monophosphate (i.e., 
processed transcripts) but not with a 5′ triphosphate or 5′ CAP structure (i.e., primary, unprocessed 
transcripts). Afterwards the RNA samples were fragmented by ultrasound treatment (4-6 pulses of 
30 s at 4 °C). Samples were poly (A)-tailed using poly (A) polymerase and were then treated with 
tobacco acid pyrophosphatase (TAP) (Epicentre Biotechnologies) for 1 h at 37 °C to generate 5'-
monophosphates for linker ligation. After TAP treatment, a RNA oligonucleotide was ligated to the 5'-
monophosphates of the RNA molecules. First-strand cDNA synthesis was performed using an oligo 
(dT)-adapter primer and M-MLV H- reverse transcriptase. The resulting cDNAs were PCR-amplified to 
about 20-30 ng/μl using a high fidelity DNA polymerase (with cycle numbers according to sample 
concentration). The primers used for PCR amplification were designed for TruSeq sequencing 
according to the instructions of Illumina (San Diego, USA). The supplied barcode sequences were 
attached to the 5'-ends of the cDNAs. The cDNAs were purified using the Agencourt AMPure XP kit 
(Beckman Coulter Genomics) and the cDNA pools were analyzed by capillary electrophoresis on a 
MultiNA microchip electrophoresis system (Shimadzu, Duisburg, Germany). 
 Sequencing 
The sequencing of the cDNA pools was carried out at the core facility of LIFA (Leibniz-Institut für 
Arterioskleroseforschung, Münster, Germany). The prepared cDNA pools were sequenced in a 
flowcell on the HiScanSQ (Illumina) with 101 cycles plus 7 cycles index read using the Illumina 
protocol 1.5. The sequences of the obtained sequencing reads were demultiplexed and barcode 
trimmed. 
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IV.4.1. Handling of RNA-Seq data 
  
 rRNA depletion and quality control 
The raw reads of 101 bp of 23S and 16S rRNA were depleted using SortMeRNA 1.8 software with 
settings: r = 0.25, L = 18. The sequence reads were quality controlled with FastQC to assess the 
Sanger variant Phred scores (Figure 24). Phred scores Q assess the reliability of a base call and are 
defined as a property that is logarithmically related to the base calling error probabilities P: 
QSanger = − 10 log10 P 
 
Afterwards, the sequencing data were submitted to the CLC Genomics Workbench v6.0.3 and quality 
trimmed with a cut-off Phred score of 20. Additionally, the sequence reads were truncated from the 
90th base of the sequences and the resulting sequences were filtered by length and sequences short 
than 15 nt were discarded. Detailed quality statistics files were generated and summarized in 
Sequencing QC Reports. 
 Read mapping 
The remaining reads were aligned to the reference sequences using the CLC bio read mapping 
algorithm. The reference sequences for both isolates E. coli 1303 and ECC-1470 were acquired by 454 
Roche sequencing technology (A. Leimbach, unpublished) and the sequence reads of our samples 
have been generated with the Illumina platform. The 'embl' genome data files and 'gene only' 
annotations were used. The number of CDS (coding sequences) and genes (/pseudo genes) 
determined for the E. coli 1303 and the E. coli ECC-1470 genome are as follows: 
 
Acute mastitis isolate Ec 1303  chromosome:  4725 CDS 4903 (74) genes 
                                                             F-plasmid:    120 CDS   122  (2)  genes 
                                                    cryptic plasmid:        6 CDS       6   (?)  genes 
                                                              P1-phage:    120 CDS   124  (1)  genes 
Persistent mastitis isolate ECC-1470   chromosome: 4430 CDS 4582 (42) genes 
                                                                          F-plasmid:    120 CDS   121   (1)  genes 
 
The CLC bio read mapping parameters were set as follows: 
Reads were neither mapped to flanking regions of coding sequences (CDS) such as intergenic regions, 
nor extended annotated gene regions such as flanking upstream or downstream residues. 
 
The minimum length fraction was set to 0.9 which means that at least 90 % of the nucleotides had to 
be aligned to the reference. 
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The minimum similarity fraction specifies how exact the matching part of the read should be. This 
parameter was set to 0.8, and with the setting for the length fraction at 0.9, it means that 90 % of the 
read should have aligned with 80 % similarity in order to include the read. 
 
Strand-specific alignment was selected at forward orientation. This option specifies whether the 
reads were attempted to map only in their forward orientation what is appropriate when a strand-
specific protocol for read generation has been used. It also allowed assignment of the reads to the 
right gene in cases where overlapping genes were located on different strands. 
 
Reads that matched to more distinct places in the reference sequence than the ’Maximum number 
of hits for a read’ set at 10 were not mapped. If a read matches to multiple distinct places, but below 
the specified maximum number, it will be randomly assigned amongst the matching regions. The 
random distribution is weighted proportionally to the number of unique matches to the genes 
normalized by length. The gene that has the highest number of unique matches will thus get a 
greater proportion of the 10 reads.  
 
 
To ensure that genes with no unique matches have a chance of having multi-matches assigned to 
them, 1 will be used instead of 0 (for their count of unique matches). 
Reads mapped to rRNA genes (rrs, rrl and rrf) (Neidhard and Curtiss, 1996) and reads not mapped 
under the mentioned parameters were removed from further analysis. Mapping statistics were 
summarized in a Mapping Report (Table 12 , page 116). 
Mapped reads were visualized and subsequently analyzed using the CLC Genomics Workbench 6.0.3 
and subsequent analyses were performed using either Microsoft Excel 2007 or R version 3.0.1. 
 Quantification of gene expression – transformation and normalization 
Expression values for each gene were estimated by the number of reads that mapped within each 
annotated coding sequence (CDS). In consideration of gene expression being analyzed between 
different RNA-Seq samples the number of gene reads (either total or unique, as stated in the results 
section page 115 to Fehler! Textmarke nicht definiert.) was selected and quantile normalized. In 
quantile normalization, the distribution of read counts per sample (sequencing depth) is matched to 
a reference distribution defined in terms of median counts across the samples to compare (Gupta et 
al., 2012; Bullard et al., 2010). 
While normalized, expression values were log2-transformed to ensure that samples are comparable 
and to remove noise effects: 
Fold Change = log2 ( IA / IB ) 
IA and IB are meant to be the mean expression values measured for group A and group B, 
respectively. RNA-Seq data might contain null values and if not stated otherwise the data were unity 
shifted and log2-transformed: 
Fold Change = log2 [ ( IA +1) / ( IB +1) ] 
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The variability and similarity across samples as well as the distribution of expression measures 
between different genes within a sample were analyzed by expression values which take the gene 
length into account. Therefore the standard reads per kilobase of gene model per million mapped 
reads (RPKM) (Mortazavi et al., 2008) has been proposed as a useful metric that normalizes for 
variation in transcript length and sequence depth. Obtained expression measures were expressed as 
log2-transformed RPKM as they are normally distributed. 
Whenever possible, the total read count of the respective transcript was used as expression measure 
since in most experiments a particular transcript was compared to its corresponding transcript in the 
reference sample. Obviously, the samples were quantile normalized before to define the default 
level. The explicit considerations on when to use what particular metric are discussed in the Results 
section. 
 Analysis of differential expression of genes (DEG) 
Differential expression of genes (DEG) was identified using bootstrapped Receiver Operating 
Characteristic algorithm (bROC). bROC handles the instance of missing replicates by resampling 
(bootstrapping) the expression data to produce a larger number of simulated measurements that 
preserve the statistical properties of the original data. The ROC curve is supposed to be metric that 
ranks truly DEG ahead of non-DEG. This is evaluated by the area under ROC curve (AUC), as well as in 
terms of false discovery curves, depicting the number of false detections encountered while going 
through the list of genes ranked according to the evidence for differential expression (Soneson and 
Delorenzi, 2013). 
The total read count of each gene was determined and both E. coli 1303 and ECC-1470 were treated 
as biological replicates per state/condition. Sample data from both the isolates at the respective 
condition were used for bROC analysis. For DEG discovery two group experiments were performed 
using the bROC algorithm on quantile normalized read counts. Following this, the data were log2 –
transformed and unity shifted (+1) because the data included null values as well. The transformed 
read counts for both isolates in either milk whey or LPS challenged milk whey were compared to the 
transformed read counts measured for incubation in DMEM (or milk whey) in order to determine the 
log2-fold change of expression. Genes with a discrimination score of CONF > 0.95 were considered to 
be differentially expressed.   
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IV.5. MAC-T Cell Culture Experiments 
  
 Conditions  
The MAC-T immortalized bovine mammary gland epithelial cells were grown as described by Huynh 
et al., 1991 with modifications. The MAC-T cells were passed approximately 50 times prior to receipt 
for all assays. Briefly, MAC-T cells were grown on 175-cm2 plastic tissue culture flasks in Dulbecco's 
Modified Eagle Medium (DMEM High Glucose with 4 mM L-glutamine) (Lonza) containing 10 % fetal 
bovine serum (FCS, Cölbe, Germany). During culture, cocultivation and adhesion assays, MAC-T cells 
were incubated at 37 °C in 5 % CO2: 95 % air (v/v). Prior to passage, cells were washed with PBS 
(Gibco). Cells were released from plastic with trypsin solution (5 % trypsin in PBS) for approximately 
10 min at 37 °C until cells were released. Trypsinization was stopped by addition of growth medium 
plus FCS. Cells were not exactly of the same passage for each assay (passage 48 ±2). 
IV.5.2. Adhesion assay 
The adhesive abilities of E. coli model mastitis isolates 1303 and ECC-1470 were comprehensively 
assessed in an adhesion assay (Dogan et al., 2006, modified). The MAC-T cells were seeded in 24-well 
tissue culture plates (Cellstars, Frickenhausen, Germany) and incubated overnight at 37 °C in 5 % CO2: 
95 % air (v/v). Approximately 2 x 105 MAC-T cells were present per well during the adhesion assay. 
The wells were infected with a multiplicity of infection (MOI) of 10. Therefore 2 x 106 bacteria of an 
overnight culture were co-cultivated with the MAC-T cells for 2 h. E. coli strain HB101 was used as a 
negative control. After three washing steps with PBS (pH 7.4), eukaryotic cells were lysed in 1 % 
Triton X-100 for 20 min. Attached bacteria were plated on LB-agar and enumerated following 
overnight incubation at 37 °C. The colonies were counted following overnight incubation. Adhesion 
was determined by the total number of colony-forming units (CFU) recovered per well. Each assay 
was run in triplicate and repeated once. 
IV.5.3. Invasion assay 
In addition to the adhesive abilities of E. coli model mastitis isolates 1303  and ECC-1470 their 
invasive abilities were assessed by the gentamicin protection assay (Dogan et al., 2006, modified). 
Briefly, confluent monolayers of MAC-T cells (2 x 105 cells per well) were seeded in 24-well tissue 
culture plates (Cellstars) and incubated overnight at 37 °C in 5 % CO2: 95 % air (v/v). Cells were 
infected with E. coli at an MOI of 10 as described in the adhesion assay except that after the initial 
2 h infection period, cells were washed three times in PBS and then incubated for another 2 h with 
medium containing 100 mg/ml gentamicin (Sigma Aldrich) to kill any extracellular bacteria. The 
number of invasive bacteria in each well was determined as described above and the total number of 
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CFU recovered per well was expressed as percentage adhesion or invasion of the initial inoculum. 
Each assay was run in triplicate and repeated three times. 
IV.5.4. Statistical analysis 
All assay data were summarized using the mean of three or more replicates per experiment. Raw 
values from each experiment were used as input for the statistical analysis. To determine significant 
differences, between adhesion and inhibited adhesion or invasion of a single strain, the one tailed 
Student´s t-test was performed. Statistical significance was defined at P < 0.001. 
If necessary, the significance between different strains was determined. Considering differences in 
the initial inoculum of the respective strains, an analysis of covariance (One-Way ANCOVA for 
Independent Samples) was performed. The ANCOVA used k = 2 independent samples, where the 
individual samples, (e.g. E. coli strain 1303 and ECC-1470), represent k quantitative or categorical 
levels of the independent variable; DV = the dependent variable of interest; and CV = the 
concomitant variable whose effects one wishes to bring under statistical control (e.g. distinct 
inoculum). Statistical significance was defined at P < 0.001. 
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V. RESULTS AND DISCUSSION 
V.1. E. coli 1303 and ECC-1470 lack particular genes of virulence associated 
to mastitis isolates 
Former studies referred to particular virulence genes (shown in Table 9.) as the most prevalent 
virulence genes of E. coli isolates from either clinical or subclinical bovine mastitis. Thereby the 
frequency and combinations of virulence genes varied greatly among both the different studies and 
the individual isolates investigated. The presence of these particular genes among the genomes of 
E. coli 1303 and ECC-1470 was evaluated (via BLASTn and BLASTp) and indicated in Table 9. In the 
genomes of both the mastitis-causing E. coli strains, particular genes associated with iron acquisition 
and particular fimbriae are not present. Additionally, the genes encoding the heat-stable 
enterotoxins and Shiga toxin as well as the genes encoding for the regulator of the locus of 
enterocyte effacement (LEE) and the K1 antigen are missing in both strains. There are, however, 
many publications on the absence of known virulence-associated genes of ExPEC and IPEC among 
E. coli mastitis isolates. 
Table 9: The virulence factors associated with mastitis present in E. coli 1303 and ECC-1470 
Symbol Presence Trait Reference 
east1 †   heat-stable enterotoxin I Blum & Leitner, 2013 
bor/iss †   increased serum resistance Suojala et al., 2011, Blum and Leitner, 2013 
cs31a      CS31A fimbria Fernandes et al., 2011 
csgA †‡ large subunit of curli fimbriae Silva et al., 2013 
eaeH †‡ effector protein (intimin) Kerro Dego et al., 2012 
f17a      F17A fimbria Ghanbarpour & Oswald, 2010 
fimA †‡ major subunit of the fimbriae type 1 Silva et al., 2013 
fimH †‡ minor component of type 1 fimbria Fernandes et al., 2011 
fliC †‡ flagellin Silva et al., 2013, Kerro Dego et al., 2012 
irp2      iron regulatory protein 2 (yersiniabactin) Suojala et al., 2011 
iucD      siderophore biosynthesis protein (aerobactin) Suojala et al., 2011, Fernandes et al., 2011 
iutA      iron acquisition Kerro Dego et al., 2012 
kpsF      polysialic acid transport protein of K1 antigen Fernandes et al., 2011 
lee      LEE-encoded regulator 
regulator 
Kerro Dego et al., 2012 
lpfA   ‡ long polar fimbriae Blum and Leitner, 2013 Dogan et al., 2012 
ompC †‡ outer membrane porin protein C Kerro Dego et al., 2012 
ompA †‡ predominant cell surface antigen Kerro Dego et al., 2012 
papC      outer membrane usher protein of P fimbria Suojala et al., 2011 Fernandes et al., 2011 
SDH †‡ respiratory chain activity Kerro Dego et al., 2012 
stb      heat-stable enterotoxin II Fernandes et al., 2011 
stx1      Shiga toxin 1 Bean et al., 2004 
tolC †‡ multidrug expulsion(e.g. Hly, bile, fusaric acid) Kerro Dego et al., 2012 
† present in E. coli 1303 
‡ present in ECC-1470 
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Moreover, this indicates that there may be different ways to cause mastitis (Shpigel et al., 2008). A 
remarkable difference, that possibly impacts the outcome of phenotypic assays of the present study, 
is the presence of east1 and iss in E. coli 1303 but not in ECC-1470. Additionally, the ECC-1470 
genome but not that of E. coli 1303 contains the lpfA gene which was associated with adhesion of 
E. coli mastitis isolates (Dogan et al., 2012). A former study reported that lpfA, east1 and iss were the 
three most prevalent virulence factors found in the set of E. coli mastitis isolates analyzed in this 
study (Blum and Leitner, 2013). In summary, E. coli 1303 and ECC-1470 differ in the prevalence and 
combination of virulence genes described in E. coli mastitis isolates.  
 Genome comparison of E. coli 1303 and ECC-1470 
Do the differences in virulence gene content of E. coli strains 1303 and ECC-1470 individually affect 
the fitness and survival of these isolates? To assess their overall genome sequence similarity, despite 
the differences in virulence gene content, the average nucleotide identity (ANI) has been determined 
using the jSpecies software (Richter and Rosselló-Móra, 2009; Goris et al., 2007). Both strains 
exhibited more than 98 % ANI although they were obtained from mastitis cases of different outcome. 
The ANI data are particularly interesting for interstrain comparison, since E. coli strain 1303 and 
ECC-1470 might originate from different environmental habitats (e.g. faeces, soil, herd transmission). 
One should not be deceived by the fact that >98 % ANI suggest a high genome sequence identity, 
species related. Actually, both strains have a similar genome size of approximately 5.0 Mb 
(E. coli 1303: 4,971 CDS) and 4.9 Mb ECC-1470: 4,550 CDS). Moreover, HGT contributed to genome 
plasticity of both strains as indicated by the presence of integrated prophages and an F-plasmid. 
Disregarding mobile elements such as prophages and genomic islands, the P1 bacteriophage plasmid 
and a cryptic plasmid were identified in E. coli strain 1303, but not in isolate ECC-1470 (Leimbach et 
al., unpublished data). Since the genome plasticity of E. coli affects the genome content and confers 
adaptation to different growth conditions and habitats, the 98 % ANI is reflecting similarity and 
marked differences at the same time. In comparison, the ANI of two different Burkholderia 
cenocepacia strains isolated from different habitats (i.e. from a cystic fibrosis patient or from soil) 
was reported to be 99.8 % (Yoder-Himes et al., 2009). Thus, given the fact that E. coli 1303 and 
ECC-1470 are at least able to cause mastitis, the ANI of these two E. coli mastitis strains is quite low. 
To address the question whether de-regulated and phenotypically accessible determinants might 
play a role during host cell contact, adaptation and survival in the presence of host cells or in milk 
whey, the transcriptome of these strains as well as their fitness and competitiveness has been 
studied under suitable conditions.  
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V.2. From raw milk to milk whey  
We aimed at the comprehensive analysis of the transcriptional response of the bovine mastitis 
isolates E. coli 1303 and ECC-1470 under environmental conditions mimicking initial stages of 
pathogenesis. Therefore, we have tried to cultivate the investigated strains in raw milk and then 
isolate RNA from these bacteria grown in raw milk. Additionally, we performed growth and fitness 
assays in milk to identify phenotypic fitness- and virulence properties of mastitis isolates.  
Unfortunately, transcriptome analysis requires isolation of bacterial mRNA from raw milk of mastitic 
cows within minutes. Furthermore, mRNA has a short half-life due to enzymatic degradation which 
results in loss of transcripts. It has been shown that degraded mRNA does not rule out the 
performance of comparative gene expression analysis, as long as the samples being compared are of 
equal quality (Auer et al., 2003; Imbeaud et al., 2005). Another problem is that alterions of gene 
expression levels in response to the handling and processing of the sample, cannot be prevented.  
To minimize such unwanted effects, bacterial RNA can be stabilized and protected against 
degradation by the addition of RNA Protect Bacterial agent (Qiagen) before the bacterial cells are 
lyzed. Assuming that this is not easily applicable in milk, we comprehensively tested different 
experimental setups to establish reliable bacterial gene expression analysis in milk. As a result of the 
studies described in this section, we finally experienced that milk is an inappropriate growth medium 
to analyze either the bacterial transcriptome or phenotypic properties. Instead, we selected raw milk 
whey as a suitable medium mimicking in vivo growth conditions. 
V.2.1. Why milk is hard to deal with 
Understanding the biochemical basics of milk is essential if experiments are planned to be conducted 
in this medium. Milk is an emulsion or colloid of butterfat globules within a water-based fluid. Each 
fat globule is surrounded by a membrane consisting of phospholipids and proteins; these emulsifiers 
keep the individual globules from joining together into noticeable grains of butterfat and also protect 
the globules from the fat-digesting activity of enzymes found in the fluid portion of the milk. In non-
homogenized cow milk, the fat globules have an average diameter of about four micrometers (Jost, 
2000).  
When we conducted first cultivations of E. coli isolates in raw milk, we found that CFU enumerations 
varied greatly. In contrast, fractions of homogenized milk showed consistent CFU counts (data not 
shown). We therefore assumed an accumulation of bacterial cells in fat globules as reported for 
Gram-positive bacteria. It was observed that in raw milk S. aureus formed clusters associated with fat 
globules, while in heat-treated milk (which results in homogenization of milk), bacterial agglutination 
did not occur (O’Flaherty et al., 2005). In this context, immunoglobulins have also been reported 
much earlier to bond bacteria to fat globules (Walstra et al., 1984). In summary, bacterial growth in 
raw milk was not traceable by spectrophotometry or CFU enumeration on agar plates and, therefore, 
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interfered with most phenotypic assays in raw milk. However, we were evaluating the possibility of 
transcriptome analysis in this medium. 
The largest structures in the fluid portion of the milk are casein protein micelles: aggregates of 
several thousand protein molecules, bonded with the help of nanometer-scale particles of calcium 
phosphate. Each micelle is roughly spherical with a diameter of about 0.1 µm. There are four 
different types of casein proteins, and collectively they make up around 80% of the protein in milk, 
by weight. Most of the casein proteins are bound into the micelles (Jost, 2000). Another major 
protein fraction is provided by immunoglobulins. And at least, in case of mastitis, the increased 
amount of up to several millions of somatic cells per milliliter milk contributes to the difficulties 
arising in RNA isolation. 
Altogether, the size, weight and biochemical composition of the raw milk components made it 
impossible to use purchasable RNA isolation kits based on columns as they will be blocked by the 
milk components. It also turned out, that the use of commercial RNA stabilizing products was 
impossible as they cause unmanageable reactions (e.g. denaturation of the casein) and subsequently 
hindered extraction of RNA of sufficient quality in proper time. Consequently, a specific solution to 
rapidly isolate the bacterial mRNA was required. 
In order to isolate bacterial total RNA in appropriate amounts and quality for microbial transcriptome 
analysis, one major problem had to be solved: How to rapidly harvest the bacteria from raw milk 
without a considerable loss of bacteria? Taking the challenge, we were confronted with various 
techniques and auspicious options to overcome the difficulties of bacterial RNA isolation from raw 
milk.  
 Filtration and centrifugation 
Several attempts of filtration and centrifugation were unsuccessful, because of the size and weight of 
casein protein micelles and somatic cells. The filters were blocked by the somatic cells and the 
protein. Fractionated centrifugation was time consuming and could not sufficiently separate bacteria 
from milk protein and somatic cells. In all approaches the fat globules accumulated on top of the 
liquid solution as a viscous phase. This fat layer was easily removable, but enough fat remained to 
interfere with the use of column-based RNA isolation kits. 
Another possible approach was multi-stage filtration. It was assumed to remove somatic cells and 
protein micelles by consecutive filtration stages. Therefore, a vacuum pump together with the 
sequential use of Millipore™ filters made of nylon and hydrophobic PTFE with decreasing pore size 
was used to avoid clotted filter membranes. It turned out that the protein content exceeded the 
filters’ capacity and in consequence increased processing time.  
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 Non-column based RNA isolation 
We tested non-column based RNA isolation protocols in order to standardize RNA isolation for 
mastitis E. coli transcriptome investigation. But even RNA extraction methods based on the “one-step 
phenol-chloroform extraction method for RNA-isolation” (Chomczynski and Sacchi, 2006) failed as 
well as approaches based on salt precipitation like the Biozyme MasterPure™ Purification Kit. 
Accordingly, using commercially available non-column-based RNA purification methods did not allow 
to purify RNA in sufficient amount with high integrity. Alternatively, we evaluated the use of 
magnetic bead-attached E. coli-specific antibodies to enrich bacteria from raw milk. The binding and 
pull down of the bead-bound bacteria, however, took too much time, and bacteria were not 
selectively bound. 
 RNA transcript amplification 
The afore mentioned conventional methods of RNA isolation from raw milk provided mostly bad 
quality RNA but rarely bacterial RNA of sufficient quality in low amounts. It would have been possible 
amplify RNA from low amounts of high integrity RNA using T7-RNA-polymerase based in vitro 
transcription. Notably, this method requires the usage of random primers and thereby bias may 
compromise the quantification of transcripts in transcriptome analysis. 
So far the methodological potential to acquire bacterial RNA has been exploited.  
 Clarifying solution 
We also tried to optimize bacterial RNA isolation from raw milk by “clarifying solution”. This 
approach aimed at a reduced duration time of the bacterial isolation and rapid RNA stabilization 
when added to raw milk. To avoid aggregated casein protein micelles, a chelator was used. Because 
of its role as a chelating agent EDTA has been chosen to sequester metal ions such as Ca2+. Thus, 
EDTA binds Ca2+ ions and prevents that calcium phosphate promotes formation of casein protein 
micelles. Casein protein will then remain in the supernatant during centrifugation. 
Furthermore, to avoid that somatic cells will be pelleted together with bacteria by centrifugation, a 
detergent was added. Triton X-100 is a non-ionic surfactant, which can be used to permeabilize 
eukaryotic cell membranes. As a result, eukaryotic cells will disintegrate and their components 
remain in the supernatant upon centrifugation. Both, EDTA (0.25 M) and Triton X-100 (0.5 % v/v), 
have been combined in the clarifying solution. 
In order to test the clarifying solution, 0.5 volumes were added to raw milk spiked with bacteria (1 x 
107 CFU ml-1) as bacterial counts of mastitis derived milk were reported to range from > 104 CFU ml-1 
to 107 CFU ml-1 (Lues et al., 2010). Bacterial counts were determined by plating on LB-agar plates. 
Although this approach allowed subsequently to isolate bacterial RNA from raw milk, it also resulted 
in a considerable loss of bacteria. This was due to a severe reduction of bacterial survival when raw 
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milk was mixed with the clarifying solution (Figure 6). Control experiments where either raw milk or 
clarifying solution or both was replaced by PBS suggested, that raw milk provides a certain 
antimicrobial effect, but raw milk and clarifying solution that were mixed together completely 
decreased bacteria survival (Figure 6).  
Figure 6: Impact of raw milk or clarifying solution on survival of E. coli strain 1303.  0.5 volumes of 
PBS or clarifying solution were added to 1 volume of raw or PBS spiked with 1 x 107 CFU ml-1 of E. coli 
strain 1303 and incubated for 15 min incubation on ice, before the samples were centrifuged and the 
bacterial count in the pellet was determined.  
 
 
The different components of the clarifying solution were tested for their individual impact on 
bacterial survival (Figure 7). Accordingly, either EDTA or Triton X-100 was added to the raw milk and 
incubated for 15 min on ice.  
Figure 7: Survival of E. coli 1303 in raw milk upon addition of individual components of the clarifying 
solution. 0.5 volumes of EDTA (0.25 M) or Triton X-100 (0.5 % v/v) were added to 1 volume of raw 
milk spiked with 1 x 107 CFU ml-1 of E. coli strain 1303 and incubated for 15 min incubation on ice, 
before the samples were centrifuged and the bacterial count in the pellet was determined.  
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It turned out, that upon addition of EDTA (0.25 M) bacterial survival decreased by 70 %, whereas only 
20 % of the bacteria were killed by addition of Triton X-100 (0.5 % v/v). The addition of EDTA most 
likely interfered with the stability of the Gram-negative cell envelope and thus resulted in increased 
bacterial killing. Even the use of clarifying solutions with decreased concentrations of EDTA and 
Triton X-100 resulted in significant reduction of bacterial counts in raw milk. Consequently, clarifying 
solution was not further used for bacterial isolation from raw milk.  
V.2.2. Milk whey 
It was assumed that for the analysis of E. coli isolates from mastitis and bovine faeces as well as for 
the identification of putative virulence genes the same methodologies should be applied that were 
used to investigate the virulence of other E. coli pathotypes (Shpigel et al., 2008). Unfortunately, 
growth or incubation of bacteria in raw milk resulted in irreproducible data, and hampered bacterial 
isolation and purification of sufficient amounts of pure bacterial RNA. Lacking methods to harvest 
bacteria from raw milk without a considerable loss of bacteria, we looked for a test system which 
approximately corresponds to the infectiologically relevant conditions provided by raw milk. Milk 
whey, defined as the fluid portion of milk remaining after removal of cell debris, casein and fat, 
turned out to fulfill the criteria of mimicking the infectiologically relevant conditions provided by raw 
milk. One exception is, that milk whey lacks the cellular components, e.g. somatic cells found in raw 
milk. Nevertheless, milk whey still contains defensins. As part of the host defense, defensins are 
released by cells of the innate immune system and assist in killing phagocytized bacteria. Usually, 
they are released by neutrophil granulocytes as well as by mucosal and epithelial cells when induced 
upon infection. Some are, however, constantly present in milk (Isobe, Morimoto, et al., 2009; Ganz, 
2003). The replacement of raw milk by milk whey as a growth medium allowed us to assess various 
phenotypic and transcriptomic properties of E. coli isolates from bovine mastitis under conditions 
which mimic growth in raw milk, but circumvent the problems caused by fat, casein or somatic cells. 
 
V.3. Phenotypic properties of E. coli bovine mastitis isolates 
Virulence-associated traits as well as fitness traits of selected bovine mastitis or faecal E. coli strains 
were analyzed and identified in comparative phenotypic assays. For this purpose, we focused on 
comprehensive analyses at conditions either mimicking initial pathogenesis or conditions that E. coli 
mastitis isolates should encounter while entering the udder. 
V.3.1. E. coli fitness in milk whey 
For mastitis E. coli strains it is important to colonize the mammary gland. It has been suggested that 
bacterial multiplication is of high importance for the pathogenesis of E. coli bovine mastitis isolates. 
Rapid metabolical adaptation to mammary secretions subsequently leads to rapid increase of 
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bacteria numbers and elicits disease. Moreover, the severity of clinical mastitis and peak coliform 
counts in mammary secretions are positively correlated (Hogan and Smith, 2003). Before, however, 
mastitis causing E. coli are able to colonize milk ducts and mammary tissue, it is important to survive 
in milk. Bovine raw milk is known to exhibit antimicrobial activity and inhibits growth of E. coli which 
has been associated to the soluble, biologically active components in mammary secretions. These 
components mainly comprise Lingual Antimicrobial Peptide (LAP) and other AMP/defensins, 
lysozyme, lactoferrin and lactoglobulin (Isobe, Nakamura, et al., 2009; Piccinini et al., 1999; Chaneton 
et al., 2008). 
Blum and colleagues observed that E. coli mastitis isolates seemed to better multiply in the udder 
medium. They, however, used pasteurized milk to conduct their assay, so that antibacterial factors 
were probably neutralized (Blum et al., 2008).  
We hypothesized that our native milk whey preserved the antimicrobial effects provided by the 
soluble factors of the innate immune system that are present in raw milk. In order to test the 
bactericidal activity of milk whey, we performed growth experiments and subsequently tested the 
survival of selected strains in different concentrations of milk whey. 
 Growth of individual mastitis E. coli isolates relative to bovine faecal E. coli isolates 
The growth of E. coli isolates from bovine mastitis and bovine faeces in milk whey was 
comprehensively tested. For this purpose, we grew E. coli isolates aerobically in native milk whey at 
37 °C while shaking. The initial inoculum was taken from stationary phase cultures grown in LB 
medium. Growth was monitored by quantification of CFUs on LB agar plates, because the translucent 
milk whey did not allow the measurement of the optical density. The resulting growth curves are 
shown in Figure 8. Each line represents a sigmoidal fit of the corresponding growth data. The growth 
curves of individual E. coli mastitis isolates were similar. In contrast, bovine faecal E. coli isolates 
differed in their ability to grow in milk whey and could be divided into two groups based on their 
growth characteristics. Although comparable inoculi (1 x 108 bacteria) have been used, two groups of 
faecal strains could be distinguished based on their survival in raw milk whey, which differed by two 
orders of magnitude.  
The specific strain designation of the group 2 faecal isolates is indicated by red digits. The faecal 
isolates 2285, 2305, 2308 and 2340 exhibited substantially reduced bacterial numbers, which were 
by two orders of magnitude lower than that of group 1 faecal or mastitis isolates. Faecal isolate 2299 
was also classified as group 2, because it visually showed the same growth characteristic, although its 
colony counts were in between the two groups for the first two hours. 
Together, the fitness of group 2 faecal isolates in milk whey was reduced relative to that of group 1 
faecal isolates, which behaved like mastitis isolates. Selected isolates from the group 2 faecal isolates 
have been introduced in other phenotypic assays and are therein designated in particular. 
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Figure 8: Survival of individual mastitis E. coli or bovine faecal E. coli isolates in milk whey. Growth of 
different mastitis and faecal E. coli isolates was compared in milk whey upon incubation at 37 °C for 
up to 24 h by quantification of CFUs on LB agar plates. Data show CFU averages of at least three 
independent experiments with error bars representing the SD of CFUs for each time point. Error bars 
very close to their correspondent data point might not be visible. Red digits indicate the designation 
of selected faecal isolates. 
 
 
 Sensitivity of selected bovine faecal E. coli isolates to milk whey relative to E. coli 1303 
The survival properties in milk whey of the group 2 faecal isolates 2285, 2305, 2308 and 2340 were 
compared with those of mastitis E. coli strain 1303. For this purpose, we incubated the E. coli isolates 
aerobically in native milk whey at 37 °C without shaking for 10 minutes. Different ratios of native milk 
whey and LB medium (v/v) were used. The batches were inoculated as described before and the 
numbers of surviving bacteria were determined by CFU quantification on LB agar plates. The 
resulting survival characteristics are shown in Figure 9. The survival characteristics of the group 2 
faecal isolates 2285, 2305, 2308 and 2340 were similar. They showed decreased survival abilities up 
to one order of magnitude, depending on increasing milk whey concentration.  
In contrast mastitis E. coli strain 1303 did not differ in its ability to survive in milk whey and showed 
constant CFU counts when growing in up to 50 % milk whey. Regarding the short incubation time and 
the proportions of LB to milk whey, it is less likely that limited nutrients or iron shortage have 
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negatively influenced bacterial survival as both is sufficiently provided during the 10 minutes of 
incubation. 
We conclude that the faecal isolates of group 2 are sensitive to milk whey relative to group 1 faecal 
isolates or mastitis E. coli strain 1303.  
Figure 9: Sensitivity of selected bovine faecal E. coli isolates to milk whey relative to E. coli 1303. 
Survival of the different faecal E. coli isolates and mastitis E. coli strain 1303 was compared in milk 
whey upon incubation at 37 °C for 10 min by CFU quantification on LB agar plates. Data show CFU 
averages of at least three independent experiments with error bars representing the SD of CFU for 
each time point. Error bars very close to their correspondent data point might not be visible. 
 
 
V.3.2. Lactose: A limiting nutrient in mammary secretions? 
Life is strictly dependent on carbon and thus also E. coli has to utilize whatever carbon sources are 
available to fit its needs. In bovine milk, the major carbon source is lactose. Consequently, E. coli 
strains that are able to utilize lactose have a growth advantage in mammary secretions. 
Growth and lactose utilization of E. coli isolates from bovine mastitis and bovine faeces were tested. 
For this purpose, we grew E. coli isolates aerobically in casamino acid- and glucose-deficient MM9 
minimal medium at 37 °C. Lactose was used as the sole carbon source at a concentration of 
0.2 %w/v. The initial inoculum was taken from stationary phase cultures of unmodified MM9 minimal 
medium containing casamino acids and glucose. 
The resulting growth curves are shown in Figure 10. All strains were able to grow reasonably well, 
though the final cell density at OD600 differed from 0.24 to 0.57. Most cultures showed, however, no 
increase in their absorbance values in the first two hours of cultivation, probably due to adaptation 
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to the casamino acid- and glucose-deficient medium. After this lag-phase, growth proceeded 
normally. Interestingly, the group 2 faecal isolates 2299, 2340, 2308 and faecal isolate 2292 exhibited 
reduced fitness in comparison to the remaining faecal isolates, but did not differ from the several 
mastitis E. coli isolates. 
Figure 10: Growth of E. coli isolates on lactose. MM9 medium was supplemented with 0.2 % lactose 
as sole carbon source and strains were grown in aerobic batch cultures at 37 °C while shaking. Data 
points are shown as averages of at least three independent experiments with error bars representing 
the SD of absorbance values for each time point. Error bars very close to their correspondent data 
point might not be visible. Red digits indicate selected faecal isolates. 
 
 
V.3.3. Influence of lactoferrin on E. coli isolates from mastitis and faeces 
Lactoferrin is a major fraction of bovine milk and is known to bind iron, thus making it unavailable to 
bacteria (Clare and Swaisgood, 2000). Bacteriostatic activity of bovine lactoferrin in vitro was first 
observed by Reiter and Oram in 1967. Later, another study observed that lactoferrin had a 
bacteriostatic effect on all mastitis E. coli isolates tested, whereas only a few strains exhibited mild 
growth inhibition (Reiter and Oram, 1967; Rainard, 1986).  
The growth of group 2 faecal isolates 2305 and 2308 relative to mastitis E. coli strains 1303 and 
ECC-1470 was comprehensively tested. For this purpose, we cultivated E. coli isolates aerobically in 
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LB medium with 2 mg ml-1 lactoferrin at 37 °C for 7 hours. The batches were inoculated from 
stationary phase cultures in LB medium with 1 x 108 bacteria. Each strain was tested in duplicate with 
and without lactoferrin and bacterial growth was determined by quantification of CFU on LB agar 
plates. CFU data are shown in Figure 11. Although the standard deviations were quite high, the 
presence of lactoferrin exhibited no significant bacteriostatic effect on neither group 2 faecal isolates 
2305 and 2308 nor mastitis E. coli strains 1303 and ECC-1470.  
Figure 11: Influence of lactoferrin on growth and survival of mastitis E. coli isolates 1303 and 
ECC-1470 relative to milk whey-sensitive faecal E. coli isolates 2305 and 2308. Growth was compared 
in LB supplemented with a final concentration of 2 mg ml-1 lactoferrin upon incubation at 37 °C for 
7 h. Data show CFU averages of two independent experiments with error bars representing the SD. 
 
 
V.3.4. Influence of the lingual antimicrobial peptide (LAP) on survival of E. coli isolates 
from mastitis and faeces 
The lingual antimicrobial peptide (LAP) is a member of the β-defensin family, which belongs to the 
group of antimicrobial peptides (AMP). Schonwetter and colleagues reported LAP expression in 
mammary epithelium in response to mastitis suggesting that LAP plays a role in the innate immune 
response to mastitis. Later, this was corroborated by the presence of functional LAP in bovine milk 
providing antimicrobial activity against E. coli (Schonwetter et al., 1995; Isobe, Nakamura, et al., 
2009). ). In return bacteria have evolved different mechanisms to resist the defensin-dependent 
killing (Peschel and Sahl, 2006). For mastitis E. coli it is important to resist to LAP as a functional 
antimicrobial component of milk. We, therefore, hypothesized that E. coli growing in milk whey 
might also express defensin-resisting mechanisms and are less susceptible to LAP. In order to test this 
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hypothesis we comprehensively investigated the fitness and survival capabilities of individual mastitis 
E. coli isolates relative to bovine faecal E. coli isolates to LAP. E. coli isolates were incubated 
aerobically in LB medium with different concentrations of LAP at 37 °C for 30 minutes. The batches 
were inoculated with stationary phase cultures in LB medium with 1 x 104 bacteria. Bacterial survival 
was determined by quantification of CFU on LB agar plates normalized to the initial inoculum. The 
relative survival of the isolates tested is shown in Figure 12. 
Figure 12: Sensitivity of individual mastitis E. coli isolates relative to bovine faecal E. coli isolates to 
LAP. Survival was compared in LB supplemented with different concentrations of lactoferrin upon 
incubation at 37 °C for 30 min by quantification of CFU on LB agar plates. Data show averages of 
relative survival of at least three independent experiments, normalized to the initial inoculum. Purple 
triangles indicate group 2 faecal isolates. The red star indicates data out of scale. 
 
 
All isolates barely survived LAP concentrations higher than 80 nM. At concentrations below 20 nM 
LAP, relative survival of individual E. coli isolates is differing from 2.4 to 98.6 %. The colony counts of 
mastitis isolate E. coli 1303 exceeded the scale. Thus, E. coli 1303 exhibited the highest survival ability 
in presence of LAP. Additionally, all mastitis and most bovine faecal isolates showed substantial 
higher survival than group 2 faecal isolates 2305, 2308 and 2285 as well as E. coli K-12. In contrast, 
two out of the five group 2 faecal isolates, 2299 and 2340, survived equally relative to the mastitis 
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and the remaining faecal isolates. Together, we demonstrate that the presence of LAP resulted in 
significantly decreased bacterial numbers, though some faecal isolates were substantially more 
susceptible to LAP-mediated killing than all mastitis E. coli isolates and most faecal isolates tested. 
V.3.5. What can we learn from the phenotypic assays? 
E. coli mastitis strains are likely to originate from the faecal flora of the cow. There is evidence that 
their genetic and phenotypic variability is not reflected by E. coli environmental isolates of the cow, 
but might result from adaptation to an intramammary lifestyle (Bradley and Green, 2001; Dogan et 
al., 2006; Radostits et al., 2007; Blum et al., 2008). Metabolic adaptation to growth conditions in 
mammary secretions and the ability to rapidly multiply were suggested to be a prerequisite for E. coli 
bovine mastitis isolates. This is supported by a positive correlation between the severity of clinical 
mastitis and high bacterial counts in mammary secretions (Hogan and Smith, 2003). In the past, 
bactericidal activity and growth inhibition of E. coli by bovine raw milk have been associated to the 
activity of complement (Reiter and Brock, 1975). A broad diversity of biologically active components 
(e.g. macrophages, neutrophils, killer cells, immunoglobulins, complement, defensins, lysozyme, 
lactoferrin, cytokines) contribute to the antimicrobial effects provided by raw milk (Sordillo and 
Streicher, 2002). It is so far still difficult to experimentally determine their individual contribution to 
the overall antimicrobial and bacteriostatic effect, which is greater than the sum of the individual 
contributions due to their synergy. 
 Milk whey exhibits antimicrobial effects 
Mastitis and faecal E. coli isolates exhibited similar growth characteristics when cultivated in LB, but 
exhibited remarkable differences when cultivated in milk whey. We initially hypothesized that our 
native milk whey exhibits, at least in part, the antimicrobial effects of raw milk. We demonstrated 
not only a bacteriostatic but also a bactericidal activity of milk whey, which cannot be related to the 
cellular antimicrobial components, because they are absent in milk whey. The preparation of milk 
whey removed fat, cell debris and even partially depleted casein which is also known to be an 
antimicrobial component (Malkoski et al., 2001). Especially the removal of milk fat avoids binding to 
and bacteriostatic effects that have been associated to milk fat globules (Sánchez-Juanes et al., 2009; 
Schroten et al., 1992) and thus may have biased colony counts and evaluation of antimicrobial effects 
by milk in previous evaluations. 
Accordingly, in introducing milk whey to test the fitness and survival capability of E. coli isolates, we 
enabled comprehensive analyses which can specifically address virulence-associated traits important 
to resist the soluble biologically active components in mammary secretions. These components 
mainly comprise LAP and other AMP/defensins, lysozyme, lactoferrin and lactoglobulin (Isobe, 
Nakamura, et al., 2009; Piccinini et al., 1999; Chaneton et al., 2008).  
80  RESULTS AND DISCUSSION 
 
 E. coli environmental isolates provide a reservoir of potential mastitic E. coli  
A previous study reported E. coli mastitis isolates multiply better in milk than most environmental 
E. coli isolates. The authors further identified a subset of environmental isolates with growth rates 
similar to those of mastitic isolates. However, they used pasteurized milk so that antibacterial factors 
were probably neutralized (Blum et al., 2008). Thus, a particular causality remains unclear. 
We focused on the phenotypic characterization of mastitis E. coli isolates relative to isolates from 
bovine faeces of udder-healthy cows. We specifically addressed the question whether mastitis and 
environmental strains differ in their individual fitness traits upon selected conditions mimicking those 
in mammary secretions. On the one hand, we tested bacterial fitness in native milk whey, which we 
found to preserve antimicrobial effects in contrast to pasteurized milk. On the other hand, we 
respectively challenged selected isolates with iron shortage, lactose as sole carbon source and LAP as 
a main defensin of milk. 
We clearly demonstrated that bovine faecal E. coli isolates represent a heterogeneous group of 
which some isolates showed a substantially reduced ability to survive in milk whey whereas others 
reflected the fitness of mastitic isolates that constitute a homogeneous group in that they show 
similar growth characteristics (Figure 8). This corroborates a previous report on growth of mastitis 
E. coli isolates (Blum et al., 2008) and extends the data to a greater number of isolates. In spite of 
what may appear at first glance to simply reinforce the findings of Blum et al., revealed a different 
outcome and added interesting aspects regarding the causality of reduced fitness. 
 Impact of lactoferrin  
Lactoferrin is a predisposing antimicrobial protein of the soluble mammary gland defense 
components reported to increase in concentration in response to endotoxin (Schmitz, 2004; Sordillo 
et al., 1987). Due to its frequently observed growth inhibitory effect, which was suggested to be the 
main function of lactoferrin in previous studies (Chaneton et al., 2008; Chaneton et al., 2011; 
Rainard, 1986), we tested the susceptibility to lactoferrin on individual E. coli faecal isolates which we 
observed to exhibit reduced fitness in milk whey. Our data could neither proof nor deny this 
suggestion. The addition of lactoferrin to milk whey showed no significant bacteriostatic effect on 
either group, the faecal isolates of diminished fitness in milk whey or mastitis E. coli strain 1303 and 
ECC-1470 (Figure 11). We referred this to rather high standard deviations what obviously 
compromised unambiguous monitoring. Furthermore, it can be suggested that either LB is not a 
suitable laboratory medium to assess inhibitory effects of lactoferrin or that the utilized lactoferrin 
was corrupted. The first explanation would be supported by observations from Rainard and 
colleagues, who already emphasized the importance of the growth medium used in the inhibition 
assay. Specifically, lactoferrin was not causing complete bacteriostasis when the growth medium, 
consisting of casamino acids in PBS, was supplemented with 10% (v/v) brain heart infusion broth, 
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even when added in rather high concentrations 1 mg ml-1 (Rainard, 1986). It is, nonetheless, 
remarkable that the tremendously high concentration of 2 mg ml-1 lactoferrin relative to 0.1 mg ml-1 
used by Rainard (1986), had no significant or even a visible effect on bacterial growth (Figure 11). On 
one hand, this might indicate a corrupted enzymatic activity of the lactoferrin used in our assay. On 
the other hand, no iron shortage was indicated by the transcription profiles of E. coli isolates 1303 
and ECC-1470 incubated in milk whey.  
The particular contribution of lactoferrin to E. coli bacteriostasis in mammary secretions needs to be 
further characterized. We hypothesize that lactoferrin might be beneficial in ongoing mastitis, when 
the E. coli intracellular iron stocks are emptied. This might be tested in real-time PCRs on samples 
obtained from E. coli incubation in milk whey for at least two hours, since a previous study 
hypothesized that the initial lag time is needed for depletion of cellular iron (Martin and Imlay, 2011). 
 Low impact of lactoferrin during initial growth of E. coli 
In the present study we aimed for the characterization of virulence-associated traits, which may 
enable mastitis isolates as well as a subset of bovine faecal E. coli to successfully colonize the 
mammary gland and cause disease. When entering the mammary gland, the initial few hours are 
supposed to be most important for the outcome of the disease in that they are critical for bacterial 
survival. In contrast, an increase of lactoferrin gene expression and accumulation of the lactoferrin 
concentration in milk is known to occur rather late (Schmitz, 2004; Chaneton et al., 2008), suggesting 
other main roles of lactoferrin than inhibition of bacterial growth. An early investigation reported 
that high citrate levels during lactation compensate for the bactericidal effect of lactoferrin in milk 
due to the fact that citrate chelates iron thus providing a possibility for the bacteria to take 
advantage of this iron. In dry-periods citrate concentrations decrease and lactoferrin may then be 
responsible for maintaining bacteriostasis (Smith and Schanbacher, 1977). Besides its bactericidal 
effect, lactoferrin confers other properties such as detoxification by sequestering LPS and prevention 
of pro-inflammatory pathway activation by TLR4, sepsis and tissue damage (Latorre et al., 2010; 
Legrand et al., 2004). However, from the mastitis-causing bacteria species Staphylococcus aureus, 
Streptococcus agalactiae, Streptococcus uberis and Escherichia coli the species E. coli has been 
reported to be most susceptible to iron shortage (Rainard, 1986). Since we have not been able to 
detect lactoferrin-mediated bacteriostasis on our strains, this remains to be further investigated. We, 
however, presume that one or more iron uptake systems might enable mastitis-associated E. coli to 
overcome the inhibitory properties of lactoferrin. Notably, several genes associated with iron uptake 
could not be detected in E. coli 1303 and ECC-1470 (Table 9). Apart from that, other iron acquisition 
systems, such as enterobactin, seem to be conserved as it is commonly expressed by Gram-negative 
bacteria isolated from involuted mammary glands during the dry period. It has been shown that 
growth of E. coli was inhibited in mammary secretions by blocking iron uptake with antibodies 
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specific for the enterobactin receptor (Lin et al., 1999) indicating the importance of iron uptake 
systems in the context of mastitis. 
 Lactose fermentation: Not the key factor for survival in milk whey  
It was previously discussed that environmental isolates that exhibited reduced fitness in milk were 
either less resistant to the biologically active components present in milk, or that they were less able 
to utilize the nutrients available in it, or both (Blum et al., 2008). Due to the fact that Blum and 
colleagues utilized pasteurized milk for their growth assay, they concluded that it is unlikely that the 
biologically active components influence bacterial fitness. Hence they proposed that the 
environmental isolates that showed diminished fitness in milk were less well adapted to metabolize 
the available lactose in milk in contrast to glucose in nutrient broth. This might be further supported 
by previous studies, which reported lactose fermenters to reach much higher bacterial counts in milk 
and, moreover, a positive correlation of the growth of a mastitis-associated E. coli strain to the 
percentage of lactose available (Hogan and Smith, 2003; Kornalijnslijper et al., 2003).  
In contrast our findings considerably differed from those mentioned before due to the fact that the 
ability to grow on lactose did not unambiguously divided faecal isolates into one group with reduced 
fitness and into a second one that comprises mastitis isolates (Figure 10). Instead, faecal isolates with 
reduced fitness in milk whey did not differ from mastitis isolates regarding the distribution of the 
phenotypic ability to utilize lactose, though the overall growth performance on lactose greatly 
differed among all isolates tested (Figure 10). Especially, the faecal isolates 2285 and 2305 grew very 
well with lactose as sole carbon source, but showed reduced fitness in milk whey. This indicates that 
there is no direct correlation between multiplication in milk (whey) and a reduced ability to utilize 
lactose as it was suggested by Blum et al. Our finding is further supported by the fact that the general 
ability to use lactose seems to be a prevalent trait of E. coli as reported for disease-associated 
isolates as well as for faecal isolates of avian origin (Rodriguez-Siek et al., 2005). Furthermore, lactose 
is not the sole carbon source in bovine milk, which contains several oligosaccharides comprising 
galactose and glucose, which might be utilized by bacteria (Gopal and Gill, 2000). It is nevertheless of 
little doubt that especially mastitis E. coli which are adapted to an intramammary lifestyle, take 
advantage from using lactose as major carbon source Figure 10. At least, our finding that the faecal 
isolates were sensitive even to small portions of milk whey upon short incubation (Figure 9) indicated 
antimicrobial effects rather than nutrient shortage. Altogether, we report here that the ability to 
utilize lactose might at least promote fitness in milk whey, but is likely to be less important for 
successful mastitis than initially thought. 
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 Reduced bacterial fitness related to LAP 
Previous studies of E. coli growth inhibition in the mammary gland or mammary secretions focused 
on specific host defense mechanisms on the cellular level, but also suggested the action of 
complement, lactoferrin and lysozyme (Rainard and Riollet, 2006; Paape et al., 2003; Sordillo and 
Streicher, 2002). Analysis of bacterial growth depending on the availability of lactose and iron 
suggested nutrient shortage to be a bottle neck for E. coli multiplication (Chaneton et al., 2008; Blum 
et al., 2008; Rainard, 1986). The impact of antimicrobial properties present in mammary secretions is 
nonetheless questionable in that they provide an indispensable barrier effect to bacterial 
multiplication under physiological conditions.  
 E. coli mastitis isolates and most faecal isolates survive physiological LAP concentrations 
In the present study, we focused on the specific antimicrobial effects provided by physiological 
concentrations of LAP. The physiological concentrations of LAP in milk have been recently 
determined to be about 17 nM under udder-healthy conditions and roughly 50 nM when the udder is 
infected with E. coli. Furthermore, a direct correlation between LAP concentration and SSC was 
shown (Kawai et al., 2013). Given the fact that the milk whey, which was utilized in our growth 
assays, derived from an udder-healthy cow we anticipate a similar concentration of LAP. This is in 
accordance with our observation that isolates able to survive LAP concentrations of 20 nM also 
performed well in milk whey. This suggests that fitness of E. coli isolates in raw milk is related to the 
ability to resist LAP.  
LAP is a prominent β-defensins present in mammary secretions and its expression in mammary 
epithelial tissue is up-regulated during mastitis (Swanson et al., 2004). We demonstrated that the 
presence of LAP significantly decreased bacterial numbers (Figure 12). Furthermore, individual faecal 
isolates, which were also less fit in milk whey (Figure 9), were substantially more susceptible to killing 
by LAP than all mastitis E. coli isolates and most faecal isolates (Figure 12). This supports our 
hypothesis that LAP and other antimicrobial peptides are the main bactericidal agents in milk whey.  
 Adaption to an intramammary lifestyle requires resistance to LAP 
Likewise other β-defensins, LAP is assumed to function by binding to the cell membrane, followed by 
the formation of pore-like membrane defects, which promote efflux of essential ions and nutrients 
(Ganz, 2003; Peschel and Sahl, 2006). E. coli, which are about to colonize a new niche like the 
mammary gland have to adapt not only to metabolic changes but also have to counteract defensins. 
Many bacteria evolved efficient countermeasures to confer increased resistance indicating the 
evolutionary pressure to colonize and infect their hosts. This might also include membrane-
associated molecular mechanism to sense defensins and initiate transcription to express, e.g. 
extracellular proteases. The recognition of and resistance to host defensins is of high importance and 
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several studies correlated bacterial colonization to these particular traits. Specifically, defensin-
susceptible mutants of Gram-positive bacteria have been attenuated in different infection models 
(Nizet et al., 2001; Kristian et al., 2003; Weidenmaier et al., 2005). Similarly, defensin-susceptible 
Salmonella mutants were attenuated in two independent studies that reported about the pmr locus, 
which is necessary for LPS modification in defensin resistance, as well as PhoP/Q two component 
system (Gunn et al., 2000; Guina et al., 2000). PhoQ is a sensor kinase important for the pathogenesis 
of a number of Gram-negative bacterial species and via its cognate response regulator PhoP it 
constitutes a signal-transduction cascade that controls inducible resistance to host defensins (Bader 
et al., 2005). E. coli can develop resistance by modification of their O-antigens by adding positively 
charged moieties, thus preventing the electrostatic interaction of defensins with their surfaces. 
Furthermore, extracellular proteases such as OmpT are known to degrade α-helical AMPs thereby 
providing resistance to defensins (Thomassin et al., 2012; Stumpe et al., 1998). Moreover, biofilm, 
which is a common virulence-associated trait of many ExPEC, is also known to provide a generally 
protective coverage to antimicrobial effects including those of defensins (Otto, 2006).  
By identification of E. coli bovine faecal isolates, which are resistant to particular concentrations of 
LAP (Figure 12), we provided evidence for a subset of E. coli strains that could be phenotypically 
more adapted than other environmental strains to an intramammary lifestyle.  
 E. coli isolates conferring LAP resistance do not unambiguously thrive in milk whey 
Interestingly, two out of the five designated group two faecal isolates with reduced fitness in milk 
whey (Figure 9), exhibited equal survival ability to LAP likewise the mastitis E. coli isolates and the 
remaining faecal isolates (Figure 12). Hence, their reduced fitness in milk whey must rely on other 
factors than LAP resistance. A limited ability to utilize lactose was excluded due to the isolates´ 
reasonably well growth in the lactose utilization assay (Figure 10). Furthermore, growth inhibition by 
the bactericidal lactoglobulin can be excluded, because it was shown to inhibit the growth of 
S. aureus and S. uberis, but not of E. coli (Chaneton et al., 2011). It should also be noted that 
resistance to defensins might not be a general molecular mechanism, but can be highly specific to 
the particular defensin. We, therefore, suggest that the reduced fitness of faecal isolates 
unsusceptible to LAP resulted from susceptibility to other milk whey components, which have not 
been assessed such as other defensins present in milk. The contribution of lysozyme to the 
antimicrobial effect of mammary secretions was not evaluated to date whereas its concentration in 
bovine milk is extremely low (130 ng ml-1) when compared to human milk (10 mg ml-1) (Hettinga et 
al., 2011). In contrast, the number of discovered β-defensins is still increasing and to date the 
β-defensin family present in mammary secretions comprises not only LAP, but bovine neutrophil 
β-defensin, tracheal antimicrobial peptide, enteric β-defensin and bovine β-defensin (Kawai et al., 
2013). 
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 Considerations 
It is an ongoing discussion whether a specific set of E. coli constitutes a mammary pathogenic group 
of E. coli or if any E. coli is able to cause mastitis when the determining factors are relying on the 
host. Our data could neither proof nor deny either one of both suggestions. On the one hand, in vitro 
exposure of bacteria to slowly increasing defensin concentrations over several hundred generations 
has been shown to result in reversible physiological adaptation and/or spontaneous, inheritable 
resistance to the peptide used (Peschel and Sahl, 2006). On the other hand, we can only assume how 
fast such adaptations might occur in vivo and how efficient and specific these adaptations might be 
when taking into account that all mentioned defensins present in milk create simultaneous selective 
pressure. Previous studies reported a significant increase of LAP concentrations in response to LPS as 
well to E. coli, when injected into the mammary gland, which remained at high levels for two days 
(Isobe et al., 2009a and 2009b). A comparison of the growth curve regression slopes showed no 
evidence that mastitis E. coli isolates were multiplying significantly faster relative to faecal E. coli 
isolates in milk whey. This suggests that adaptation to mammary secretions is rather inherent than 
an adaption “on the run”. We propose further comprehensive investigations of mastitic E. coli and 
faecal isolates to test whether biofilm formation or susceptibility to further defensins are important 
for growth in mammary secretions.  
V.3.6. Adhesion and invasion of selected mastitis E. coli strains in vitro 
The pathogenesis of E. coli mastitis is assumed to resemble the pathogenesis of urinary tract 
infections in that the infection is also ascending (Kaipainen et al., 2002; Ghanbarpour and Oswald, 
2010). The E. coli isolates causing these infections are commonly classified as ExPEC, which often can 
adhere, invade and persist in host epithelia (e.g. UPEC and MNEC) (Kaper et al., 2004).  
In this study, the cell adhesion and invasion potential of model mastitis isolates, strain 1303 (acute 
mastitis isolate) and ECC-1470 (persistent mastitis isolate), were investigated. Additionally, we tested 
for effects of milk whey on E. coli cell adhesion. We expected results, which might be correlated with 
data from transcriptional analyses during cocultivation of E. coli mastitis isolates in the presence of 
mammary gland epithelial cells (section V.5). For this purpose we performed a cell adhesion assay 
and a gentamycin protection assay in parallel, as described in section IV.5.2 and IV.5.3. To examine 
effects of milk whey on bacterial adhesion to eukaryotic cells, we performed a second adhesion assay 
in parallel where the cell culture medium was in part replaced by milk whey. Different concentrations 
of raw milk whey were tested before and no inhibitory effects on MAC-T cells immortalized 
mammary gland epithelial cells was observed when cultivated in 60 % milk whey : 
40 % cell culture media (v/v) (Figure 13).  
No cytotoxicity was detected with the bacterial multiplicities of infection (MOI) used in the adhesion 
and invasion assays. The strains E. coli MG1655 ΔfimΔflu and S. typhimurium SL1344 were used as 
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controls. All strains were allowed to adhere to MAC-T cells for 2h. The bacterial numbers (colony 
formation units) observed were plotted in relation to the initial inoculum (Figure 14). 
Figure 13: Mammary gland epithelial cells in milk whey. The MAC-T cells were incubated in different 
ratios of sterile milk whey and cell culture media (DMEM high Glucose + 5 % FCS). The percentage of 
milk whey used is indicated in the individual wells (A) and their morphology was examined after20 h 
of incubation (B). MAC-T cells incubated in the presence of > 60 % milk occurred to be hypotonic. 
 
 
Figure 14: Adhesion and invasion of E. coli mastitis isolates to MAC-T mammary gland epithelial cells. 
The strains were allowed to adhere to or invade into MAC-T immortalized mammary gland epithelial 
cells for 2 h. The different assays were conducted in parallel. Data represent relative (i) adhesion 
(hatched) or (ii) adhesion in 60 % milk whey (grey) or iii) invasion (white), normalized respective the 
initial inoculum. Data are the mean ± standard deviation (SD) of at least three independent 
experiments in triplicate wells. Asterisks indicate a statistical significance (*, P < 0.03; **, P < 0.001).  
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 Adhesion to and invasion into bovine mammary gland epithelial cells in vitro 
The data displayed in Figure 14 show a significantly stronger interaction of E. coli strain 1303 and 
ECC-1470 with immortalized bovine mammary gland epithelial cells compared to the control strains 
E. coli MG1655 ΔfimΔflu and S. typhimurium 1344. The comparison of individual strains resulted in a 
wide range of differences between strains and either adhesion or invasion. The negative control 
E. coli K-12 strain MG1655 ΔfimΔflu showed less than 0.5 % adhesion and no significant 
internalization, which was expected. This strain lacks the Ag43 coding gene flu and the type 1 
fimbriae coding genes fimB-H avoiding expression of factors that could contribute to bacterial biofilm 
formation, autoaggregation, and/or adherence (Reidl et al., 2009). The control strain 
S. typhimurium 1344 showed a merely low adhesion rate of 2.22 %, which is in accordance with 
adhesion levels reported for S. typhimurium with respect to the utilized cell model (Gagnon et al., 
2013). The acute mastitis isolate E. coli 1303 showed a three times higher adhesion rate and was also 
2.5 times more invasive than the persistent mastitis isolate ECC-1470. Interestingly, the presence of 
60 % milk whey significantly reduced the adhesion to the mammary gland epithelial cells by 11.8 % 
for E. coli 1303 and 26.6 % for ECC-1470. 
 Different adhesion and invasion properties of E. coli strain 1303 and ECC-1470 
The adhesion of a clinical mastitis isolate (E. coli strain P4) to epithelial cells, from the teat and 
lactiferous sinuses of the udder, was first observed in 1978 by Harper et al.. At this time, the 
adhesion was demonstrated to be fimbria-dependent due to mannose inhibition. Another study 
observed that E. coli clinical mastitis isolates adhered to and invaded into cultured bovine mammary 
gland epithelial cells. Moreover, isolates from persistent intramammary infections with recurrent 
cases of clinical mastitis invaded comparatively faster and in larger numbers than the strains from 
single cases (Döpfer et al., 2000). This was corroborated by another study, which showed that 
persistent E. coli mastitis isolates, amongst others ECC-1470, adhered exhibited similar adhesion 
rates, but invaded more efficiently into mammary gland epithelial cells than transient E. coli mastitis 
isolates (Dogan et al., 2006). 
The results of the present study are in contradiction to this general message. We clearly 
demonstrated a substantially higher adherence and invasiveness of E. coli strain 1303, which has 
been classified as a transient mastitis strain in comparison to the persistent mastitis strain ECC-1470 
(Figure 14). Strain ECC-1470 exhibited a significantly higher invasion rate than E. coli 1303 in relation 
to their respective adhesion capacity (ANCOVA; F1,14= 291.69, P < 0.001, where the initial inoculum 
was included as a covariate). It can be hypothesized that this difference might even increase over 
time and confers a faster internalization of E. coli strain ECC-1470 into mammary gland epithelial cells 
than E. coli strain 1303 what might increase its persistence potential: In particular, the intracellular 
lifestyle and evasion from the host´s immune response. On the other hand, the transient mastitis 
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E. coli isolate 1303 has been shown to adhere and invade mammary gland epithelial cells in 
remarkably greater numbers than persistent mastitis isolate ECC-1470 (Figure 14). This leads to the 
assumption that E. coli strain 1303 expresses traits contributing to adherence and invasion different 
from ECC-1470. Whether these traits are more efficient per se or whether they confer enhanced 
adhesion due to synergistic effects required further verification. 
For mastitis E. coli strains it is important to colonize the mammary gland including the stratified 
epithelia lining the luminal walls of the teat canal and cistern, gland cistern, milk tubules and the 
specialized alveolar epithelium. This requires factors contributing to cell adhesion and invasion 
promoting virulence. Dogan et al. suggested that the phylogenetic group and the presence of long 
polar fimbriae (LpfA) influence the epithelial invasion by persistant E. coli mastitis isolates (Dogan et 
al., 2012). Interestingly, the corresponding gene lpfA is absent in transient E. coli mastitis strain 1303 
(phylogroup A), but present in persistent mastitis strain ECC-1470 (phylogroup B1) (Table 9). Its 
expression was not deregulated in the presence of bovine mammary epithelial cells relative to their 
absence (see section V.5). This suggests that the remarkably higher adhesion rate of E. coli 1303 is 
likely to be due to other factors since lpfA was related to persistent E. coli mastitis isolates such as 
ECC-1470, which exhibited less adhesion (Figure 14). Nevertheless, both strains carry 37 (E. coli 1303) 
to 52 (ECC-1470) genes within their genomes, which encode for fimbrial adhesins or predicted 
fimbrial-like adhesins. 
It is, however, questionable whether cell adhesion occurs in vivo in the lactating cow, because 
several studies reported a reduction of adherence of E. coli but also of Salmonella spp. by whole milk, 
milk fat globules and their components (Sánchez-Juanes et al., 2009; Guri et al., 2012; Schroten et al., 
1992; Atroshi et al., 1983; Harper et al., 1978). 
 Milk whey negatively influences bacterial adhesion to mammary gland epithelial cells 
The cocultivation of E. coli mastitis isolates and mammary gland epithelial cells in presence of milk 
whey was originally considered to allow comprehensive analyses in a setting that, at least partially, 
mimics the environment during initial mastitis pathogenesis. In order to examine effects of milk whey 
on cell adhesion, we performed an adhesion assay where the pure cell culture medium was replaced 
by 60 % milk whey. 
Our data clearly revealed a significantly reduced ability of all bacterial strains tested to adhere to 
cultured mammary gland epithelial cells (Figure 14). This effect was observed to be 2 times stronger 
for strain ECC-1470 than for E. coli 1303 (ANCOVA; F1,14= 2391.32, P < 0.001). It can be presumed that 
the substantially weaker cell adhesion by E. coli ECC-1470 caused by milk whey, might also be 
responsible for this strain’s more efficient invasion potential indicating its intracellular lifestyle. Due 
to our observations in the cell adhesion assay we may hypothesize that i) either milk whey inhibits 
bacterial adhesion to eukaryotic cells or ii) that the number of viable bacteria was decreased, 
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because of AMP interactions. This might subsequently reduce their overall adhesion rate (see also 
section V.3.1).  
On the other hand, the latter hypothesis is unlikely due to the fact that mastitis isolate E. coli 1303 
showed no decreased survival when incubated in up to 50 % milk whey (Figure 9). Moreover, the 
growth characteristics of both mastitis strains E. coli 1303 and ECC-1470 revealed equal fitness when 
grown in milk whey (Figure 8). We, therefore, presume that milk whey directly inhibits bacterial 
adhesion to eukaryotic cells by other mechanisms than antimicrobial ones. This is further 
corroborated by the fact that whole milk has been previously observed to inhibit the adhesion of 
E. coli to cells in vitro (Harper et al., 1978). The molecular mechanism of inhibition of fimbria-
mediated E. coli cell adhesion is thought to be provided by milk fat-globule membrane components 
and glycosphingolipids (Sánchez-Juanes et al., 2009; Schroten et al., 1992; Atroshi et al., 1983). We 
might, however, highlight the fact that cell debris and milk globules were almost completely removed 
from raw milk during processing to milk whey (see section III.4.1) indicating that fat globules are 
unlikely to cause the effect we observed. It is, however, interesting that the inhibitory capacity of 
bacterial cell adhesion is suggested to depend on host species. For example, bovine, goat and human 
milk have been shown to markedly reduce bacterial binding and invasion relative to controls. 
Specifically, the fat globules derived from bovine milk were observed to provide weaker protective 
traits than those derived from goat or human (Guri et al., 2012; Tellez et al., 2012; Schroten et al., 
1992).  
Our results strongly suggest that milk properties conferring protection against bacterial adhesion 
might be also provided by other components in milk. The particular mechanism of the inhibition of 
E. coli adhesion to bovine mammary gland cells in milk whey remains unclear. Thus, an inhibitory 
effect provided by components other than milk fat-globule membrane components and 
glycosphingolipids might contribute to the overall inhibitory effect. Vice versa, particular E. coli 
strains might resist either one of the adhesion inhibitory traits and might thus outcompete strains, 
which are not resistant. It is, however, necessary to comprehensively investigate whether milk fat 
globule components are the only inhibitory agent in E. coli cell adhesion by milk whey while there is 
reason to doubt. We therefore suggest testing of different milk fractions, respectively, in 
comparative cell adhesion assays. 
V.4. Autotransporter genes in mastitis isolates 
A marked prevalence of many known virulence-associated genes of ExPEC and IPEC among E. coli 
mastitis isolates has not yet been published. Instead, E. coli mastitis isolates commonly lack known 
virulence markers (Blum and Leitner, 2013; Silva et al., 2013; Cheng et al., 2012; Dogan et al., 2012; 
Kerro Dego et al., 2012; Fernandes et al., 2011; Suojala et al., 2011; Ghanbarpour and Eric Oswald, 
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2010; Dyer et al., 2007; Wenz et al., 2006; Bean et al., 2004; Lehtolainen et al., 2003; Kaipainen et al., 
2002; Wise et al., 2002; Lipman et al., 1995; Sanchez-Carlo et al., 1984). 
In former studies autotransporter (AT) proteins were repeatedly considered virulence- associated 
factors (Ulett et al., 2007; Allsopp et al., 2010 and 2012; Totsika et al., 2012). The functional 
redundancy and wide distribution of many ATs among pathogenic and non-pathogenic E. coli 
indicates that ATs cannot generally be regarded as specific biomarkers and virulence factors (VFs) per 
se (Zude et al., 2014). Nonetheless, AT proteins promote colonization of intestinal and extraintestinal 
sites by ExPEC and thus AT expression can be considered advantageous in mastitis pathogenesis. 
We, therefore, evaluated the prevalence of selected AT-encoding genes among E. coli isolates from 
bovine mastitis in order to elucidate whether a possible accumulation of AT genes might promote 
colonization of the udder. Furthermore, we extended this evaluation to include E. coli isolates from 
faeces of healthy cows as E. coli is considered an environmental pathogen of mastitis (Radostits et 
al., 2007; Bradley and Green, 2001). Based on differences between E. coli mastitis isolates and such 
from the environment of the cow, it has been suggested that clinical bovine mastitis E. coli isolates 
may form a subset of the environmental E. coli population. Moreover, mastitis isolates seemed to 
better multiply in the udder medium and to evade the host cellular innate immune response. 
Mastitis isolates were also anticipated to be genetically distinct from most environmental strains 
(Blum et al., 2008). Interestingly, the genetic distinction failed in a more recent study of the same 
working group (Blum and Leitner, 2013). However, we were interested in determining whether there 
is a difference in AT prevalence between mastitis and faecal isolates. For this purpose we performed 
a PCR-screening to screen the selected E. coli isolates (Table 6) for the presence of the AT genes 
upaB, upaC, upaI and upaJ. The primers were designed from specific nucleotide sequence sections 
(of the α-domain-encoding region of the respective AT genes,) with a low prevalence of repetitive 
sequences (Table 7). 
Additionally, we tried to elucidate whether the prevalence of the examined ATs in mastitis isolates 
and isolates from bovine faeces would be similar in a strain collection comprising mainly human 
pathogenic isolates (amongst others various IPEC, UPEC, sepsis and faecal isolates; Table 6). 
Therefore, the strain collection of the Institute of Molecular Infection-Microbiology (IMIB) of the 
University of Würzburg was investigated as well which comprises different clinical isolates from 
various non-bovine sources. 
 Distribution of autotransporter genes among mastitis and bovine faecal isolates 
The PCR screening of 218 mastitis isolates and 72 isolates from bovine faeces resulted in the data 
shown in Table 10. Of the 218 mastitis isolates, 65 (29.82 %) had at least one AT gene detected by 
PCR. The most common AT of mastitis, bovine faecal and non-bovine IMIB isolates was upaB, which 
was detected in 55 (25.23 %) of the mastitis isolates. All AT genes were either present alone or in 
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combination with each other. Although the mastitis, bovine faecal and non-bovine IMIB isolates were 
not of comparable number, the mastitis and bovine faecal isolates did significantly differ in the 
presence of the four AT genes. Between the isolates of the IMIB collection and the bovine faecal 
isolates, the AT genes upaC, upaI and upaJ, but not upaB significantly differed in their prevalence. 
Notably, the prevalence of upaB was exceptional in that it did not differ that much between these 
groups. In general, the prevalence of all four AT genes declined from the IMIB isolates to bovine 
faecal isolates and from bovine faecal isolates to mastitis isolates. 
Table 10: Presence of selected autotransporter genes in bovine mastitis, bovine faecal and other 
non-bovine isolates 
Number of tested isolates   upaB  upaC   upaI   upaJ 
218 mastitis isolates   55 [25.23 %] 15 [  6.88 %] 10 [  4.59 %]   2 [0.92 %] 
  72 bovine faecal isolates   24 [33.33 %] 11 [15.28 %]   8 [11.11 %]   0 [0.00 %] 
183 isolates of IMIB collection   65 [35.52 %] 51 [27.87 %] 51 [27.87 %]   8 [4.37 %] 
Total isolates (473) 144 [30.44 %] 77 [16.28 %] 69 [14.59 %] 10 [2.11 %] 
 
In order to compare these observations with data from an AT gene screening of a strain collection 
with emphasis on the AT distribution in the known major pathotypes, we took advantage of and re-
illustrated data from another screening performed in parallel (Table 11). Notably, these data were 
achieved by an in silico analysis of publicly available complete genome datasets of a comparable 
number of pathogenic and non-pathogenic isolates. Our first observation was the significantly higher 
prevalence of all four AT genes among ExPEC isolates relative to IPEC and non-pathogenic isolates. 
Nevertheless, the presence of these AT genes was still much higher in comparison to the mastitis, 
bovine faecal and non-bovine isolates (Table 10). Of note, the prevalence of upaB was fairly the same 
in the IPEC and non-pathogenic isolates according to the complete genome sequence screening 
(Table 10) and the isolates from bovine faeces and non-bovine isolates of the IMIB collection 
screened by PCR (Table 9).  
Table 11: Distribution of individual AT homologs in relation to pathotype (data from Zude et al., 
2013) 
Number of analyzed genomes  upaB  upaC  upaI  upaJ 
  9 ExPEC isolates   6 [66.66 %]   8 [88.88 %]   7 [77.77 %]   2 [22.22 %] 
52 IPEC isolates 18 [34.62 %] 24 [46.15 %] 11 [21.15 %]   6 [11.54 %] 
50 non-pathogenic isolates 18 [36.00 %] 28 [56.00 %] 13 [26.00 %]   2 [  4.00 %] 
Total isolates (111) 42 [37.84 %] 60 [54.05 %] 31 [27.93 %] 10 [  9.00 %] 
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 No crucial role of autotransporters in mastitis 
The low prevalence of the selected AT genes upaB, upaC, upaI and upaJ among the 218 mastitis 
isolates suggests that they may not play a crucial role for the development of mastitis. Isolates from 
bovine faeces were investigated as well to find out whether mastitis and faecal isolates differ in the 
presence of virulence-associated genes. It has been suggested that mastitis strains originate from the 
faecal flora of the cow (Radostits et al., 2007). Moreover, the genetic as well as phenotypic variability 
of E. coli mastitis isolates seems not to be reflected by E. coli environmental isolates of the cow, but 
might be a product of adaptation to an intramammary lifestyle (Bradley and Green, 2001; Dogan et 
al., 2006; Blum et al., 2008). Our data could neither proof nor refute this suggestion. 
On the one hand, the screened mastitis isolates revealed a significantly lower AT prevalence in 
comparison to the bovine faecal isolate as well as all the different sets of major E. coli pathotypes 
examined. This is in contradiction to the hypothesized accumulation of AT genes, in case of 
advantageous fitness provided by ATs. Hence, the colonization of the udder is likely to rely on other 
factors than ATs.  
On the other hand, we do know that ATs often promote functions which are redundant to other AT 
functions (Zude et al., 2014). Furthermore, the total virulence potential of a pathogen is often 
greater than the sum of the individual contributions of virulence-associated traits, what is most likely 
due to, at least in part, their synergy. Thus, AT proteins might still improve the colonization of 
extraintestinal sites. Additionally, the relatively low frequencies of other virulence-associated factors 
should be considered, which often not exceeding 30 % prevalence of genes as reported in various 
studies of E. coli mastitis, (Blum and Leitner, 2013; Silva et al., 2013; Cheng et al., 2012; Dogan et al., 
2012; Kerro Dego et al., 2012; Fernandes et al., 2011; Suojala et al., 2011; Ghanbarpour and Oswald, 
2010; Dyer et al., 2007; Wenz et al., 2006; Lehtolainen et al., 2003; Kaipainen et al., 2002; Wise et al., 
2002; Lipman et al., 1995; Sanchez-Carlo et al., 1984). It can be concluded that the 29.82 % AT 
prevalence among mastitis isolates may not be neglected, but anticipate ATs to take place in a much 
bigger set of factors that promote a successful colonization of the udder. Nevertheless, an 
application as biomarkers for a presumed MPEC pathotype cannot be proposed for either one of the 
four AT genes. 
 AT prevalence influenced by phylogeny rather than pathotype classification  
The significantly lower prevalence of the three AT genes upaC, upaI and upaJ, but not upaB, among 
the isolate groups shown in Table 10 in comparison to the isolate groups shown in Table 11 seems to 
be inconsistent. Several studies try to explain this kind of discrepancy between studies with either 
different sampling techniques or different assessment methods (Blum and Leitner, 2013; Blum et al., 
2008). In our case, the data set of the present work was achieved by PCR-screening (Table 10) 
whereas the data shown in Table 11 were achieved by an in silico query. Nevertheless, both methods 
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proved to be reliable (Zude et al., 2014; Wells et al., 2009). In the present work, AT gene-specific 
primers were designed and repeatedly proven to be functional in PCR-screenings, leaving no doubt of 
the presence of AT genes as revealed in Table 10. Thus, we might exclude a marked influence by the 
two diverse assessment methods. We rather suggest an influence on AT prevalence caused by the 
strain selection and its implied phylogenetic diversity. This is supported by the general distribution of 
E. coli mastitis and bovine environmental isolates, mainly into the phylogeny groups A and B1 (Blum 
and Leitner, 2013; Ghanbarpour and Oswald, 2010). Another study even reported both persistent 
and transient isolates of E. coli of group A exclusively (Dogan et al., 2006). It is common knowledge 
nowadays that group A comprises mostly commensal E. coli while group B1 constitutes an 
assortment of different pathotypes and commensals. Both phylogeny groups, A and B1, are sister 
taxa of the youngest lineages in E. coli phylogeny whereas the earlier emerged group B2 comprises 
many ExPEC strains (Leimbach et al., 2013; Clermont et al., 2000). Interestingly, the study by Zude et 
al. determined the highest AT prevalence per strain in isolates of phylogroup B2, followed by B1. 
Moreover, it has been shown that AT distribution correlates rather with phylogenetic lineages than 
with pathotypes (Zude et al., 2014). Speaking of E. coli mastitis isolates as a group of ExPEC strains 
that resemble UPEC in pathogenesis and invasive properties (Kaipainen et al., 2002; Dogan et al., 
2006 and 2012), one would expect them to be comprised of group B2 strains. 
To summarize the composition of our datasets: First, the E. coli isolates of bovine mastitis and bovine 
faeces were mainly classified to groups A and B1 (unpublished data). This is in accordance to 
collections of mastitis isolates reported elsewhere (Blum and Leitner, 2013; Ghanbarpour and 
Oswald, 2010; Dogan et al., 2006). Secondly, we included the so-called IMIB collection, which 
includes a broad variety of isolates from various different pathotypes and phylogenetic groups. 
Thirdly, the 111 isolates included into the in silico whole genome sequence screening (Zude et al. 
2013, Table 11) mirror the variety of the E. coli phylogenetic groups. Thus, our data indicate that 
among the E. coli isolates from mastitis and bovine faeces, the phylogroup B2 is underrepresented in 
comparison to the selection of isolates included into the in silico genome sequence analysis (Zude et 
al. 2013). 
 
From our data, it can be concluded that AT proteins are less prevalent among the bovine E. coli 
populations and more specifically, among mastitis isolates. This supports either the idea that ATs do 
not play a crucial role in mastitis. 
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V.5. Differential gene expression of mastitis E. coli 1303 and ECC-1470 in the 
presence of MAC-T epithelial cells in vitro 
In order to investigate aspects of host-pathogen interaction of E. coli 1303 and ECC-1470, in vitro cell 
culture experiments were performed. MAC-T immortalized bovine mammary gland epithelial cells 
were co-cultivated with mastitis E. coli isolate 1303 and ECC-1470, respectively. As a reference, the in 
vitro transcriptome of E. coli 1303 and ECC-1470 grown in cell culture medium without MAC-T cells 
was determined using DNA microarrays. In Figure 15, a schematic overview of the performed 
investigation procedure is given: 
Figure 15: Basic work flow of the DNA microarray analysis performed to analyze the bacterial 
transcriptome. Samples of E. coli 1303 and ECC 1470 were acquired from cultivation at 37°C in 
DMEM in the presence or absence of MAC-T bovine mammary gland epithelial cells, respectively.  
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 Study design appropriate to capture the transcriptomic response to present host cells  
The cocultivation was performed according the culturing conditions described in section IV.2.3 . 
Briefly, approximately 1.5 x 107 MAC-T cells were present per cell culture flask during the 
cocultivation. The wells were infected with a MOI of 100. Therefore 2 x 109 bacteria of an overnight 
culture were co-cultivated with the MAC-T cells for one and three hours, respectively. Thus, bacteria 
had appropriate time to get into direct contact with the epithelial cells as we have also confirmed in 
section V.3.6. Total RNA samples were prepared from planktonic bacteria and bacteria in contact 
with MAC-T cells as described in sections IV.2.3 and IV.2.4. All DNA microarray experiments were 
performed in triplicates including the overnight culture. Comparative gene expression analysis was 
performed by DNA microarray hybridization with cy3- and cy5-labelled cDNA from total RNA extracts 
from E. coli 1303 and ECC-1470 grown in the presence of MAC-T epithelial cells relative to the 
absence of epithelial cells. A customized Operon Array was employed, which contains probe sets for 
all ORFs present in the genomes of E. coli strains MG1655, EDL933, O157:H7 Sakai, CFT073, 536 and 
UTI89. The results of the statistical analyzes were aligned to E. coli 1303 and ECC-1470 genome 
sequence data (Leimbach, unpublished data) and followed by the identification of differentially 
regulated genes at 1 h and 3 h after infection of the cell culture. Gene lists are provided in the 
appendix section in Table 18, Table 25. 
V.5.1. Significant changes in the expression pattern 
The mastitis E. coli strains 1303 and ECC-1470 exhibited differentially regulated genes when 
cultivated in presence of MAC-T bovine epithelial cells. Of approximately 5,155 CDS of E. coli 1303 
and approximately 4,703 CDS of strain ECC-1470, we identified a total of 255 and 300 differentially 
regulated genes, respectively, during three hours cocultivation in the presence of MAC-T epithelial 
cells relative to the absence of epithelial cells. The individual number of up- and down-regulated 
genes at the different time points is shown in Figure 16. E. coli ECC-1470 exhibited a substantially 
higher total number of deregulated genes relative to E. coli 1303 at one hour time point.  
Figure 16: Deregulated genes in E. coli strain 1303 and ECC-1470 during cocultivation with MAC-T 
epithelial cells relative to the absence of epithelial cells. The diagram indicates the numbers of 
significantly up (red) and down (green) regulated genes (P < 0.05).  
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This is indicating a stronger transcriptional response of ECC-1470 to bovine mammary gland epithelial 
cells. Although the same parameters have been applied in all arrays an influence by poor microarray 
hybridizations cannot be excluded completely. The number of up-regulated genes exceeded twofold 
and that of the down-regulated genes exceeded tenfold the number of deregulated genes in E. coli 
1303. At three hours after inoculation, the total number of genes deregulated by ECC-1470 
decreased. At the same time the total number of genes deregulated by E. coli 1303 almost doubled 
upon ongoing cocultivation. Notably, the ratio between up- and down-regulated genes also differed 
considerably between both isolates (Figure 16). 
 Genes involved in metabolism represent one quarter of all deregulated genes  
Differentially regulated genes were categorized according to a functional classification system 
(Hancock and Klemm, 2007) to summarize the main functional categories. As shown in Figure 17, the 
majority of the genes with significant changes during three hours of cocultivation clustered in the 
following functional categories: energy metabolism (22-28 %), proteins involved in intracellular 
transport and binding (11-16 %), cellular processes (9-10 %), DNA binding, replication, repair, 
restriction modification, transcription, RNA processing and degradation (8-10 %), and cell surface-
associated proteins including such involved in transport and binding (7-9 %). 
Figure 17: Functional classification of differentially up-regulated genes of mastitis E. coli 1303 and 
ECC-1470 during 3 h cocultivation in the presence of MAC-T epithelial cells relative to the absence of 
epithelial cells. Each slice of the pie chart represents a major functional group of genes. Numbers 
shown represent the percentage of the functional groups.  
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As in most microarrays, genes coding for hypothetical proteins or genes of unknown function 
accounted for a marked portion (24-27 %) of all differentially regulated genes identified. Genes that 
were functionally classified into the categories “amino acid synthesis” and “mobile genetic elements” 
represent the smallest portions of deregulated genes. At the first glance, bona fide virulence factors 
could not be identified among the significantly deregulated genes, though some genes are virulence-
associated (see page 104). One could hypothesize, that strain ECC-1470 is not as dependent on 
metabolic adaptation as E. coli 1303, but rather deregulated transporters, probably to compensate 
for nutrient shortage due to the lack of other metabolic pathways. To confirm this hypothesis further 
investigation on nutrient utilization properties of both strains are required.  
 Commonly deregulated genes at 1 h and 3 h time in response to mammary gland epithelial 
cells 
A hierarchical cluster analysis of the global transcription profile at one hour and three hours of the 
respective isolate indicated, that E. coli 1303 and ECC-1470 exhibited remarkable differences in their 
gene expression profiles as is shown in Figure 18. Genes that exhibited the same or a similar 
expression pattern were grouped together. The transcriptional response of the bacteria to the 
presence of bovine mammary gland epithelial cells resulted in commonly deregulated genes and, in 
case of E. coli 1303, revealed two subclusters whereas ECC-1470 showed five subclusters. 
In both mastitis isolates, the majority of genes deregulated at either the 1-hour or 3-hour time point 
after inoculation differed in their transcriptional response by distinct expression levels or revealed no 
deregulation. Only a few genes of E. coli strain 1303 were commonly regulated at both time points 
whereas most genes were either regulated after one or three hours, but not at both time points. In 
contrast, E. coli ECC-1470 exhibited a higher number of commonly regulated genes as indicated by 
the bigger clusters. About 50 % of all deregulated genes of strain ECC-1470 were deregulated at one 
hour and also at three hours. A number of mainly down-regulated genes in E. coli ECC-1470 were 
either regulated at one or three hours but not at both time points. Altogether, this illustrates the 
very distinct transcriptional patterns of both strains. In E. coli 1303, the transcriptional patterns after 
one hour or three hours of cocultivation with bovine mammary gland epithelial cells were specific for 
both time points. The total number of deregulated genes almost doubled with ongoing cocultivation. 
In contrast, in strain ECC-1470 nearly half of the deregulated genes were commonly deregulated at 
both time points, indicating that the early and late transcriptional response was not that distinct in 
this strain. The mastitis isolates E. coli 1303 and ECC-1470 differ in their gene expression profiles in 
response to MAC-T cells. Whether this reflects the difference between a transient and a persistent 
lifestyle or whether this is a strain-specific phenomenon needs to be further investigated.  
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Figure 18: Transcriptional response of mastitis E. coli strains 1303 and ECC-1470 upon cocultivation 
with MAC-T cells. The hierarchical cluster plot shows the relative gene expression patterns of both 
strains upon cocultivation with MAC-T epithelial cells relative to the absence of MAC-T cells. Each bar 
represents one gene and its expression level corresponding to the color bar. The datasets for each 
strain and time point are mean values of the expression ratio from at least three independent 
microarray experiments. Genes without statistically significant changes in their expression profile are 
shown in black (P < 0.05).  
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The hierarchical cluster analysis revealed individually and commonly deregulated genes of each 
strain. Particular genes, which were commonly deregulated at both time points, might indicate the 
same bacterial reaction in response to the presence of bovine mammary gland epithelial cells. In 
contrast, individually deregulated genes might indicate strain-specific properties. Genes deregulated 
in both strains and possibly also deregulated within the same time period were examined and 
depicted in a Venn diagram shown in Figure 19. In addition to the visual output of the Venn 
algorithm a corresponding textual output is given in showing which genes in particular were 
deregulated at distinct conditions or were uniquely deregulated in a certain condition (data on 
compact disk: Supplemental Table S1). E. coli strain 1303 exhibited a comparably small number of 
individually deregulated genes after one hour of cocultivation relative to the other samples. 
Interestingly, the Venn diagram revealed 24 genes that were commonly deregulated after one and 
three hours of cocultivation in both strains E. coli 1303 and ECC-1470 and among them various 
regulatory determinants. Additionally, a considerable number of genes were commonly deregulated 
in both strains, but not necessarily at the same time as indicated by the overlapping areas of three 
samples (Figure 19). This suggests that the same processes are affected in both strains though up or 
down regulation in this Venn diagram has to be followed in the textual output in Supplemental Table 
S1 on the compact disk. In Figure 19 it is clearly shown that both strains individually regulated the 
transcription of a high number of genes at particular time points as indicated by the non-overlapping 
areas. These genes might represent strain-specific responses to the presence of bovine mammary 
gland epithelial cells. 
Figure 19: Commonly deregulated genes in bovine mastitis E. coli strains 1303 and ECC-1470 upon 
cocultivation with host cells in vitro. The Venn diagram shows the numbers of significantly 
deregulated genes in E. coli strains 1303 and ECC-1470 during cocultivation with MAC-T epithelial 
cells, relative to the absence of epithelial cells (P < 0.05). The numbers displayed in ellipses indicate 
the number of genes shared between the overlapping areas which represent the time of 
cocultivation and the strain, respectively.  
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It can be hypothesized that at least some of these genes might be involved in the different 
aetiological outcome caused by the transient E. coli strain 1303 relative to persistant strain ECC-1470. 
V.5.2. Deregulated bacterial determinants in response to cocultivation with MAC-T cells 
To better understand which cellular processes of mastitis E. coli 1303 and ECC-1470 were in 
particular reflected by the transcriptional response to the presence of MAC-T cells in vitro, we 
investigated representative deregulated transcriptional units and regulators selected from the Venn 
diagrams textual output (data on compact disk: Supplemental Table S1).The selected bacterial 
determinants and regulators that were deregulated during three hours cocultivation were depicted 
in Figure 20.  
Figure 20: Selected determinants of mastitis E. coli strains 1303 and ECC-1470, which were up-
regulated upon 3 hours of cocultivation with MAC-T cells. Black frames of the Venn diagram depict 
the overlap (number of shared features) of significantly deregulated determinants (blue), 
transcriptional regulators (red) and (green) down-regulated transcriptional regulator (P < 0.05).  
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 Changes in energy metabolism indicating competition for nutrients 
The majority of selected deregulated genes in Figure 20 could be assigned to the category “Energy 
metabolism”. In both strains we identified the menFD-yfbB-menBCE operon which is known to be 
specific to the menaquinone biosynthetic pathway (Dahm et al., 1998). Consequently up-regulated 
men expression suggests a preliminary production of menaquinones (vitamin K2 homologues), which 
can subsequently be used as the electron mediator between enzyme complexes involved in 
anaerobic respiration. Similarly, the expression of malY encoding a bifunctional protein with a 
regulatory and an enzymatic function (Reidl and Boos, 1991) was up-regulated in both strains. MalY 
is involved in the degradation of small carbon molecules and is a regulator of the maltose regulon. 
The transcription factor RbsR ("Ribose Repressor") controls the transcription of the operon involved 
in ribose catabolism and is induced when E. coli is grown in the absence of glucose (Laikova et al., 
2001; Mauzy and Hermodson, 1992). This indicates a competition between E. coli and host cells for 
glucose, which is the main carbon source in the DMEM cell culture medium. Thus, this finding 
supports on the one hand the idea that the bacteria responded to nutrient limitation during the 
cocultivation with MAC-T cells in vitro. On the other hand, rbsR is presumably vital in vivo as well, 
because it is also involved in the utilization of lactose as one of the main carbon sources in mammary 
secretions. 
Apart from commonly up-regulated genes involved in energy metabolism, we evaluated those 
specifically expressed in either E. coli 1303 or ECC-1470. Interestingly, all the identified 
transcriptional units and regulators were involved in (i) carbon utilization under limited glucose 
availability (e.g. the yia and gud operons, the deo operon as well as the regulatory genes galS, deoR 
and ygbI) or (ii) utilization of amino acids as nitrogen source (e.g. arginine utilization by the AST 
pathway including the ast and art transcriptions units). With exception of the AST pathway, which 
was specific to strain ECC-1470, we did not observe any remarkable differences regarding the 
transcription of these genes between both mastitis strains. Accordingly, we demonstrate that three 
hours cocultivation with MAC-T cells resulted in glucose shortage and that E. coli consequently 
switches to other pathways involved in respiration and utilization of carbohydrates. This is further 
reflected by significantly up-regulated genes which are usually expressed under anaerobic conditions. 
 Deregulated genes reflecting anaerobic conditions during cocultivation 
We identified up-regulated determinants and regulators that are functionally related to bacterial 
processes under anaerobic conditions (Figure 20). Of these, some were assigned to anaerobic 
conditions though they are also involved in the energy metabolism. This is exemplified by frd, which 
encodes the fumarate reductase, an enzyme that catalyzes a reaction allowing fumarate to serve as a 
terminal electron acceptor when E. coli is growing under anaerobic conditions (Iverson et al., 1999). 
Thus, the frdABCD transcriptional unit was assigned to anaerobic conditions, but the encoded gene 
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products serve in energy metabolism. Nonetheless, our classification links the function to the 
conditions observed by the bacteria in the presence of MAC-T cells.  
In both strains we identified the hyaABCDEF operon which codes for the E. coli hydrogenase 1 and 
which is induced under anaerobic conditions, but is repressed by nitrate (Richard et al., 1999). 
Interestingly, we identified the transcriptional regulator gene arcA to be up-regulated only in strain 
ECC-1470, but not in E. coli 1303. ArcA is known to antagonize repression of the hydrogenase-1 
operon (hyaABCDEF) under anaerobic conditions (Nesbit et al., 2012). ArcA represent a 
transcriptional response regulator of two-component systems, which serve in bacterial signal 
transduction by sensing and responding to environmental stimuli and facilitate bacterial adaption to 
changing environmental conditions. In E. coli, the quinone-dependent ArcA/B two-component 
system mediates the response to changing respiratory conditions and functions as global 
transcriptional regulator under microaerobic and anaerobic conditions. When activated under 
anaerobic conditions, ArcA regulates the expression of numerous operons involved in respiratory and 
fermentative metabolism. 
Also exclusively up-regulated in E. coli ECC-1470 was the napF operon encoding a ferredoxin-type 
protein. Another study reported a growth defect under anaerobic conditions on glycerol/nitrate 
medium when napF is missing (Brondijk et al., 2002). This suggests that NapF plays a role in energy 
conservation rather than a direct role in nitrate reduction. In this context it was also possible to 
successfully assign the other determinants hyd, hyc, and also hyf, which were significantly up-
regulated in both strains, to anaerobic nitrate respiration. In detail, the hydN-hypF operon is known 
to be maximally transcribed under anaerobic conditions in the presence of formate and is dependent 
on FhlA (Maier et al., 1996). In line with this, hycA which codes for the regulator of the 
transcriptional regulator FhlA was up-regulated as well. HycA controls the expression of several 
genes involved in the formate hydrogen lyase system. The specific regulatory mechanism by HycA is, 
however, unknown. It is known, that HycA expression is activated by formate and may interact 
directly with the FhlA protein and/or prevent the binding of FhlA to activator sequences (Suppmann 
and Sawers, 1994; Sauter et al., 1992; Leonhartsberger et al., 2000; Skibinski et al., 2002). We 
identified the hyf locus (hyfABCDEFGHIJR-focB) to be significantly up-regulated. The hyf locus 
encodes a hydrogenase-4 complex including a potential sigma (54)-dependent transcriptional 
activator HyfR (related to FhlA) and a putative formate transporter, FocB. Hyf expression is induced 
under fermentative conditions by formate at a low pH and FhlA-dependent. Its expression can be 
inhibited by HycA, the negative transcriptional regulator of the formate regulon (Skibinski et al., 
2002). Supported by the notion that NAD-dependent formate dehydrogenases are important in 
prokaryotic anaerobic metabolism (Jormakka et al., 2003), our results clearly demonstrate that 
anaerobic metabolism was vital when the E. coli mastitis strains were co-cultivated with bovine host 
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cells. The comprehensive regulation of hydrogenase-associated genes was further supported by up-
regulation of genes of the nik transcriptional unit encoding proteins essential for hydrogenase 
activity by nickel transport, which is required by E. coli when growing under anaerobic conditions 
(Rowe et al., 2005). 
When it comes to regulators exclusively up-regulated in E. coli strain 1303, there is still little known 
about the regulatory gene abrB except that it might elevate the expression of the AidB CoA 
dehydrogenase when grown under anaerobic conditions. Because abrB mutations were too unstable 
for analyses abrB has not been further studied yet (Volkert et al., 1994). We also identified the well-
examined regulatory gene aer to be up-regulated. Aer represents one of two sensory flavoproteins, 
which mediate the aerotactic response in E. coli. Specifically, the Aer protein senses the oxygen and 
energy state of the cell and mediates tactic responses towards rapidly oxidizable substrates such as 
ribose, galactose, maltose, malate, proline, alanine, glucose, mannitol, mannose, sorbitol, and 
fructose (Bibikov et al., 1997; Horne et al., 2009). Expression of aer by E. coli 1303 can be considered 
useful during mastitis pathogenesis due to the Aer-dependent activation of a number of genes 
involved in anaerobic respiration and the Entner-Doudoroff pathway (Prüss et al., 2003). Thus, 
increased Aer expression might enable quick utilization of available nutrients in mammary secretions.  
 Deregulated genes indicating extracytoplasmic stress 
Another well-represented functional category of deregulated genes in E. coli strains 1303 and 
ECC-1470 represented ”extracytoplasmic stress” (Figure 20). This might result from either shortage 
of essential elements (e.g. sulfur starvation induces expression of the tauABCD operon) or 
inappropriate osmotic conditions, which induce expression of osmoregulatory determinants such as 
ompR and kdpD (van der Ploeg et al., 1996; Jo et al., 1986; Wood, 1999). The sensor kinase KdpD is 
part of the two-component system KdpD/E responsible for signal transduction in osmoregulation 
caused by changes in the intra- and/or extracellular K+ concentration (Wood, 1999). 
In particular, but not exclusively, vis-à-vis extracytoplasmic stress is indicated by up-regulated 
expression of cpxP encoding the regulator of the Cpx response and putative chaperone which is 
involved in resistance to extracytoplasmic stress. Specifically, cpxP transcription is induced by alkaline 
pH (Danese and Silhavy, 1998). This is on the one hand contradicting, because one would expect 
rather acidic than alkaline pH in cell culture resulting in expression of factors to maintain pH 
homeostasis and provide acidic resistance (e.g. gadBC and rutR). This has been shown at least in case 
of E. coli ECC-1470. On the other hand, CpxP overproduction turns off the Cpx response by feedback 
inhibition (Raivio et al., 1999) supporting the notion that protection to alkaline conditions is not 
necessary. Interestingly, the Cpx system is also involved in adhesion and virulence of pathogenic 
E. coli, where cpxP expression is induced upon biofilm formation relative to planktonic growth in 
both exponential and stationary phase. In contrast isogenic cpxP mutants were impaired in biofilm 
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formation (Hung et al., 2001; Otto and Silhavy, 2002; Beloin et al., 2004). Moreover, the Cpx system 
may affect the bacterial ability to survive during or immediately after internalization. Alternatively, 
the invasion efficacy can be altered by transcriptional influence on how ExPEC modulate their surface 
characteristics (Debnath et al., 2013). More specifically, the Cpx system revealed the ability of UPEC 
to modulate P-fimbriae expression (Hernday et al., 2004; Hung et al., 2001; Jones et al., 1997). 
Therefore, it seems obvious, that deregulation of cpxP coding for a regulator of the Cpx response is 
involved in host-pathogen interaction. 
The E. coli strains 13030 and ECC-1470 exhibited a strongly up-regulated expression of oxyR at one 
and three hours after inoculation. OxyR is a major transcriptional regulator for the expression of 
antioxidant genes in response to oxidative stress, in particular at elevated levels of hydrogen 
peroxide (Storz et al., 1990). The OxyR regulon comprises genes involved in peroxide metabolism, 
redox balance and protection against reactive oxygen species (ROS). Additionally, OxyR activates the 
synthesis of the small noncoding RNA oxyS, which regulates about 40 additional gene products (Storz 
et al., 1990; Zheng et al., 2001; Mongkolsuk and Helmann, 2002; Altuvia et al., 1997). The oxyR 
expression is induced during exponential growth by the cAMP-activated Crp protein, which we 
identified to be up-regulated in E. coli ECC-1470 during the three hours cocultivation. In contrast, 
oxyR expression is negatively regulated by RpoS when cells enter stationary phase (González-Flecha 
and Demple, 1997). Notably, E. coli 1303, but not ECC-1470 showed increased transcriptional levels 
of rpoS at three hours cocultivation. Recently, a novel function of OxyR unrelated to oxidative stress 
has been reported: OxyR might operate as regulator of a nitrosative stress regulon under anaerobic 
conditions exhibiting about 60 genes or operons dependent on OxyR under anaerobic conditions 
(Seth et al., 2012). We detected various other genes up-regulated during in vitro cocultivation with 
MAC-T cells, supporting the notion of anaerobic conditions meanwhile. Anyhow, whether OxyR is 
required for protection to either oxidative or nitrosative stress in our experimental setup has not 
been evaluated yet. 
In summary, at least during in vitro cocultivation with MAC-T bovine mammary gland epithelial cells, 
the significantly up-regulated genes in both mastitis strains indicate extracytoplasmic stress. We 
emphasize, that this stress is probably caused by metabolic competition for nutrients and the 
secretion of products of metabolism into the cell culture medium by both, bacteria and host cells. 
 Expression of virulence-associated factors in response to the presence of MAC-T cells 
In addition to up-regulated gene expression reflecting a more indirect response to MAC-T cells by 
adaptation to the changing environmental conditions during cocultivation, we have focused on the 
identification of up-regulated genes coding for virulence-associated factors. We identified two 
virulence-associated regulatory genes (baeS and mlrA) and different genes encoding virulence-
associated factors (Figure 20). 
RESULTS AND DISCUSSION  105 
 
 Multidrug tolerance 
The expression of the regulator-encoding gene baeS was up-regulated in both, E. coli 1303 and 
ECC-1470, at one hour as well as at three hours of co-incubation. The proteins BaeS and BaeR 
represent the sensor kinase and response regulator of the E. coli BaeS/R two-component system 
(Nagasawa et al., 1993). Both genes belong to an operon comprising the multidrug resistance gene 
cluster mdtABCD. BaeR binds to and thus stimulates the activity of the mdtA promoter (Baranova and 
Nikaido, 2002). Although we were not able to detect up-regulation of genes of the mdtABCD gene 
cluster, we identified several other genes encoding components of multidrug efflux systems to be up-
regulated in both strains (e.g. mdtG, mdtI, mdtL, (mdt= multi drug transporter)). It has been reported 
, that the overexpression of mdtG (also called yceE) and mdtL (also designated yidY), respectively, in a 
drug-sensitive background resulted in an up to four-fold increase in resistance to various 
antimicrobial agents (mdtL: deoxycholate and fosfomycin; mdtL: chloramphenicol, ethidium bromide 
and TPP) (Nishino and Yamaguchi, 2001). In contrast, mdtI is a yet uncharacterized components 
multidrug efflux transport system. 
 Fimbrial adhesins and flagella 
In both mastitic strains mlrA was up-regulated, encoding the transcriptional regulator MlrA. The 
MerR-like regulator A has been reported to facilitate curli production in an APEC strain and also in 
Salmonella (Brown et al., 2001). In APEC, the mlrA gene is regulated by RpoS, which we determined 
to be slightly up-regulated at three hours of cocultivation in E. coli strain 1303, probably to repress 
oxyR expression while bacterial cells enter the stationary phase. This might also affect the up-
regulation of mlrA, which has been detected after three hours of coincubation in both strains, but 
exclusively at one hour cocultivation in E. coli ECC-1470. Consequently, upcoming enhanced 
expression of RpoS might result in mlrA down-regulation at three hours of cocultivation in E. coli 
strain 1303 and ongoing. 
In contrast to the up-regulation of mlrA expression, we identified repression of genes involved in 
regulation, production and assembly of curli (csgD, csgC and csgF) specifically in strain ECC-1470. 
Curli are encoded by the csg operon and it was previously suggested that these adhesins may be 
involved in the pathogenesis of bovine mastitis (Karczmarczyk et al., 2008). Moreover, curli are 
known to promote bacterial adherence to multiple cell lines. Curli fibers themselves interact with 
many host proteins and are potent inducers of the host inflammatory response (Barnhart and 
Chapman, 2006). Their role in mastitis pathogenesis remains unclear to date. The down-regulation of 
csg gene transcription including that of the transcriptional regulator CsgD in E. coli ECC-1470 after 
three hours coincubation with MAC-T cells is unexpected and differs from the situation in E. coli 
1303. One would hypothesize that curli would be advantageous upon close contact to host cells. On 
the one hand, the down-regulation of curli gene expression in strain ECC-1470 in the presence of 
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cells indicates that there is no more need for curli. It may be that the persistent mastitis isolate 
ECC-1470 adopts upon prolonged coincubation with MAC-T cells to an inconspicuous lifestyle by 
progressive reduction of surface structures that became irrelevant in this advanced stage of 
cocultivation. On the other hand, it can be speculated, that energy became so limited that curli 
production is repressed for energy saving issues.  
Besides the down-regulation of curli genes, we identified the up-regulated genes ECP_2970 (in both 
strains) and Z3599 (only in strain ECC-1470) encoding for components required for the biogenesis of 
fimbriae via the 'chaperone-usher' pathway. Z3599 encodes for YfcS, a fimbrial chaperone first 
identified in E. coli O157:H7 strain EDL933, while ECP_2970 encodes for fimbrial usher protein PixC 
first identified in E. coli 536. Whether common up-regulation of these fimbrial genes results in a 
functional fimbria of mastitic E. coli needs to be verified. 
Another membrane-associated component, which might be involved in host-pathogen-interaction of 
mastitis E. coli, is the flagellum. We found significantly up-regulated gene expression levels (flhB, 
flhE, fliR and motA) in both strains, although not all of them were up-regulated at the same time 
(Figure 20). The fliR transcript was only identified in the early (1 h) transcriptional response of E. coli 
1303 and encodes the flagellar biosynthesis protein FliR. FliR is one of the six integral membrane 
components of the flagellar export apparatus as is FlhB (Minamino and Namba, 2004; Fan et al., 
1997; Kutsukake et al., 1994), which we identified to be up-regulated in both mastitis strains. 
Additionally, we identified motA that along with motB encodes the stator element of the flagellar 
motor complex (Ridgway et al., 1977). Moreover, we found flhE transcript levels to be up-regulated 
in E. coli ECC-1470. flhE, whose gene product may also be involved in the regulation of proton flow 
through the flagellar basal body, forms an operon with flhB and flhA which encode components of 
the flagellar type 3 export apparatus (Lee and Harshey, 2012; Liu and Ochman, 2007). It is, therefore, 
remarkable that although a statistically significant up-regulation of flhE and flhA transcription in 
E. coli 1303 could not be detected, this was the case for fhlB in both strains. This problem will be 
discussed in the next section, but in principal, we can state that we found evidence for the up-
regulation of flagella in response to MAC-T bovine mammary gland epithelial cells. Thus, it can be 
presumed that flagella are involved in adhesion/invasion to mammary epithelial cells. Supporting this 
hypothesis, earlier studies reported that E. coli flagella were required for colonization of the 
gastrointestinal tract, including adhesion and subsequent invasion into intestinal epithelial cells of 
domestic animals (Xu et al., 2013; Duan et al., 2012 and 2013; Girón et al., 2002; Murinda et al., 
2004). Besides the flagella-associated T3SS, we found up-regulated transcript levels of genes of 
another T3SS in E. coli strains 1303 and ECC-1470 during the early phase (1 h) of cocultivation. The 
genes Z4186 and Z4188 encode integral membrane protein-components of the ETT-2 type III 
secretion apparatus also present in E. coli O157:H7 strain EDL933. 
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 Factors, which could be involved in the persistence of mastitis isolate ECC-1470 
Interestingly, we identified the hipA gene to be up-regulated in E. coli ECC-1470. The hipA gene 
encodes the ‘high persistence factor A’, a serine/threonine kinase mediating persistence and 
multidrug tolerance in E. coli. Except for a small fraction of dormant persister cells, E. coli would be 
killed by prolonged inhibition of peptidoglycan synthesis. But persisters are neither more resistant to 
inhibition of peptidoglycan synthesis, nor more likely to persist than normal bacterial cells. The 
molecular mechanism behind HipA-mediated persistence is to respond to the inhibition of the 
peptidoglycan synthesis by antibiotics (e.g. ampicillin) or by metabolic block. Thus, HipA induces 
consequent switching into a persister state of bacterial cell, characterized by growth arrest and 
strongly inhibited translation, transcription and replication (Moyed and Bertrand, 1983; Schumacher 
et al., 2012; Korch and Hill, 2006). Moreover, HipA, together with its antagonist HipB, are encoded by 
two genes organized as a transcriptionally autoregulated operon (hipAB), which constitutes a type II 
toxin-antitoxin locus. Most type II toxin-antitoxin loci are supposed to play a role in persistence and 
many of their mRNAs were significantly increased in persister cells (Germain et al., 2013; Keren et al., 
2004; Shah et al., 2006). When the 11 type II toxin-antitoxin loci of E. coli were progressively deleted, 
a gradual reduction in persistence capability was detected, indicating their importance in E. coli 
persistence (Maisonneuve et al., 2011). We conclude that by monitoring the significantly up-
regulated expression of hipA in response to MAC-T bovine mammary gland epithelial cells, we 
identified a bacterial factor, which, at least in part, contributes to the persistence capability of E. coli 
ECC-1470. 
 Factors, which could be involved in immune evasion of mastitis isolates 
Significant up-regulation of wcaB and ypdI transcript levels was observed for both mastitis strains. 
The protein WcaB is believed to be an acetyl transferase involved in colanic acid synthesis based on 
sequence similarity and its presence in a colanic acid exopolysaccharide biosynthesis operon 
(Stevenson et al., 1996). Moreover, its expression was shown to be up-regulated in sessile bacteria 
relative to planktonic bacteria (Prigent-combaret et al., 1999). The same study reported that in 
addition to wcaB, also the ompC porin and the nickel high-affinity transport system-encoding gene 
nikA were stronger expressed in sessile bacteria. The expression of these genes was also up-
regulated in the mastitis strains 1303 and ECC-1470 after 3 hour cocultivation with MAC-T cells. Like 
WcaB, the membrane lipoprotein YpdI has been shown to play a role in colanic acid synthesis 
(Stevenson et al., 1996), and its gene expression was also up-regulated in both strains. Together with 
the observed extensive induction of gene expression associated with microaerophilic and anaerobic 
conditions, we suggest that many of the initially planktonic bacteria turned into a sessile state and 
within a biofilm or microcolonies or in close contact with eukaryotic cells. Increased expression of 
genes involved in amino acid biosynthesis possibly releases nitrogen limitation or stress response 
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In both strains the expression of the hisLGDCBHAFI and ilvLXG_1G_2MEDA operons was up-
regulated. The encoded gene products are involved in the biosynthesis of histidine, isoleucine and 
valine. It can be hypothesized that histidine, isoleucine and valine, which are glucogenic amino acids, 
might be converted into glucose through gluconeogenesis in order to compensate for the dwindling 
glucose in the cell culture medium due to the eukaryotic cells present.  
We have not specifically evaluated the deregulated operons because they did not reveal any 
remarkably cellular processes which could be associated to the presence of MAC-T bovine mammary 
gland epithelial cells. Other up-regulated genes encode for proteins of arginine ABC transporter (Ast) 
and the arginine succinyltransferase pathway (Art) which is induced by nitrogen limitation and 
enables faster growth with arginine and aspartate (Schneider et al., 1998) or might be associated to 
stress response. A more detailed discussion on arginine metabolic pathways to stress response is 
discussed on page 150. 
 Valid analyses: misinterpretations and error sources in DNA-microarray analysis 
 Interpretation of “missing” genes in operons 
We identified various two-component systems and different deregulated genes organized in operon 
structures. Unfortunately, some genes that were expected to be deregulated have not been 
determined although they belong to the same transcriptional units. Prokaryotic genomes are 
commonly organized in operons, meaning that in these operons several genes are co-transcribed 
resulting in “polycistronic mRNAs”. It is known that a particular gene, which is transcribed as a part of 
a polycistronic transcript under one condition might also be individually transcribed as a single gene 
in another condition (Koide et al., 2009). Accordingly, it can be difficult to identify all members of 
operon structures under a given condition, but other explanations have to be considered as well. 
Alternative explanations for at least some of the non-detected genes are provided below, followed 
by a discussion of these data. 
One possible explanation might be that some gene probes were simply missing on the microarray. 
Individual genes are not represented by corresponding probes, e.g. the fhl operon is not completely 
covered by probes. Although the arrays have been designed to cover the complete genomes of six 
E. coli strains (6 genomes and four plasmids), the individual genome annotations used at the 
production date were not as complete as they may be today. Consequently, this is one reason 
leading to individual “missing” genes.  
Another explanation might be that some of the longmer oligonucleotide probes hybridized less 
properly. This may result in underrepresented signal intensity. Consequently, this adds bias to further 
analyses. The corresponding signal ratios might be excluded in statistical analyses due to repeated 
experiments or did not pass the stringent threshold. We suppose this explanation supported by 
following example: The genes baeS and baeR are part of an operon comprising the multidrug 
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resistance cluster mdtABCD of which we did not identified any gene to be deregulated under the 
conditions tested. Of the BaeSR two-component system, we identified only one encoding gene, baeS. 
According to the literature, baeS codes for the membrane-associated sensor kinase, which usually 
autophosphorylates in response to an environmental signal and transfers a phosphoryl group to the 
response regulator BaeR, which then becomes activated (Nagasawa et al., 1993). At the first glance 
this looks like an incomplete detection of the expression of the genes of this two-component system, 
but it truly is a misinterpretation due to bad signal quality. As a result, these bad quality signals for 
baeR were excluded from further analysis. While the BaeSR two-component system would not be 
functional with baeS expression alone, our assumption is corroborated by the significant up-
regulation of yicO in strain ECC-1470. Expression of yicO is known to be positively regulated by BaeR 
(Baranova and Nikaido, 2002). This means, in consequence, that albeit significant changes in baeR 
transcript levels could not be detected by the microarray hybridization, increased yicO transcription 
indicates the expression of a functional BaeR/S two-component system.Similarly, the curli regulator-
encoding gene csgD and some of the genes included in CsgD-dependent transcriptional units were 
also detected to be deregulated (csgD, csgC and csgF) while others seemed not to be significantly 
deregulated according to the microarray data (csgE, csgG, csgA and csgB). In Figure 21 selected 
transcriptional units regulated by CsgD are shown. It was a general problem to interpret inconsistent 
results from microarray hybridizations, when particular genes were identified to be deregulated, but 
other genes of the same transcriptional unit have not been detected. By assessing the genetic 
organization of the operons and the analysis of corresponding regulons, we could gain sufficient 
information to predict other significantly deregulated genes that further supported our match. In this 
case, we also identified wrbA and yccJ to be deregulated based on DNA-microarray data. In total, we 
were able to identify the determinants and regulators presented in Figure 20 by not only single 
indications, but due to corroborating results of other commonly deregulated genes. 
Figure 21: Schematic overview of selected transcriptional units regulated by CsgD. Genes highlighted 
(yellow) were deregulated during cocultivation upon MAC-T bovine mammary gland epithelial cells 
according to microarray hybridizations. Significantly deregulated transcript levels of genes colored in 
blue could not be detected. Elements are depicted as follows: Activator (magenta), inhibitor 
(orange), repressor (turquoise), small regulatory RNAs (red dashed line).  
CsgD wrbA yccJCsgD
CsgD csgD csgECra csgF csgG
CsgD csgB csgA csgCCpxR
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 Good RNA quality and accurate microarray hybridizations, but bad signals: What happened? 
Competitive DNA microarray hybridization involves numerous working steps accompanied by 
controls to ensure sample quality and attempts to normalize the cDNA amount of the competitive 
samples prior to the hybridization step. Our RNA isolation resulted in sufficient amounts of good 
quality RNA. We confirmed the RNA quality using the RNA integrity number (RIN). RIN values > 7.0 
were considered to meet the requirements for gene expression analyses (Schroeder et al., 2006; 
Imbeaud et al., 2005; Wilkes et al., 2010). RNA concentration and sample purity of the preparations 
were determined using the NanoDrop® instrument and were considered sufficiently pure when the 
ratio A260/A280 was higher than 2.0.  
 
So far, no obvious failures would have influenced competitive DNA microarray hybridizations. But 
what was not taken into account a priori was that total RNA samples were prepared from planktonic 
bacteria and from bacteria, which have been in contact with MAC-T cells as described in sections 
IV.2.3 and IV.2.4. Most of our initial array scans resulted in shifted ratio signals and bad signal-to-
noise ratios. This specific problem was identified to result from eukaryotic total RNA contaminations 
present exclusively in the total RNA samples obtained from cocultivation with host cells, but from 
those cultivations in absence of host cells (Figure 22).  
 
Figure 22: Quality control of bacterial total RNA isolated from E. coli 1303 cultures in the absence of 
host cells (A) relative to E. coli 1303 cultures from cocultivation with host cells (B). The RNA integrity 
curves/electropherograms and gel images are shown. Peaks indicate ribosomal RNA (rRNA) and 
residual eukaryotic rRNA is indicated by red arrows. The RNA integrity was determined by capillary 
electrophoresis using the Agilent 2100 Bioanalyzer instrument (RIN > 7.0). 
 
 
Eukaryotic RNA cannot be completely avoided from RNA preparations with co-cultures of bacteria 
and host cells. As a consequence, the mixture of pro-and eukaryotic RNA negatively affects the 
competitive microarray hybridization. This results in slightly shifted signal ratios when attempting to 
16S rRNA 16S rRNA
23S rRNA 23S rRNA
18S rRNA 28S rRNA
E. coli 1303 total RNA
(reference sample)
E. coli 1303 total RNA
from co-cultivation
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normalize labeled cDNA amounts of sample and reference sample. In our final microarray 
hybridizations we considered this effect. Nevertheless, we emphasize that this effect, which affected 
the bioinformatical analyses (Figure 15), had a lasting effect on ratio quality and subsequently 
resulted in semi-quantitative analyses. Consequently, we have not elaborated on quantification of 
deregulated gene expression, but made only qualitative statements regarding deregulation of genes. 
For the same reason we made no use of fold-change estimations. Fold change is often used, because 
of its simplicity (e.g. in rankings), but alone does not take into account variance and offers no 
associated level of confidence (Allison et al., 2006).  
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V.6. RNA-Seq: High throughput E. coli transcriptome sequencing 
To comprehensively analyze the transcriptional response of the isolates E. coli 1303 and ECC-1470 in 
a setting mimicking the environment during initial pathogenesis, we cultivated the strains in native 
milk whey. Milk whey contains complement and defensins. As antimicrobial effects of raw milk and 
milk whey were observed, we used DMEM cell culture medium as a reference control mediating no 
antimicrobial effects, but allowing unrestricted bacterial growth. Moreover, the use of DMEM should 
allow comparison of the results of the RNA-Seq approach with those of the microarray-based 
approach to assess putative overlaps with the in vitro transcriptional response in response to 
cocultivation with bovine mammary gland epithelial cells (section V.5). Figure 23 shows the general 
flow chart underlying the RNA-Seq experiment.  
Figure 23: Basic flowchart of the RNA-Seq pipeline used to analyze the bacterial transcriptome in 
response to growth in raw milk whey relative to growth in DMEM. Samples of E. coli 1303 and 
ECC-1470 were taken upon cultivation at 37°C in DMEM, milk whey or milk whey from an udder 
challenged with LPS, respectively.  
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In this approach RNA-Seq was used to study differential gene expression of mastitis isolates 
E. coli 1303 and ECC-1470. The strains (1 x 109 CFU/ml of bacteria) were statically incubated for 1 h at 
37 °C (body temperature) in three different media, respectively: i) milk whey from an udder-healthy 
cow, ii) milk whey from a cow´s udder infused with LPS, and iii) DMEM. Subsequently, RNA 
extraction, purification, mRNA enrichment and conversion to cDNA of the 6 samples, was performed 
before the cDNA libraries were sequenced using a HiScan sequencer (Illumina). 
 
V.6.1. Quality of the sequence reads from E. coli transcriptome sequencing 
The cDNA synthesis was carried out by vertis Biotechnologie AG and the sequencing of the cDNA 
pools was carried out at the core facility of the Leibnitz Institut für Arterioskleroseforschung (LIfA), 
Münster following the Illumina protocol 1.7. The sequences of the sequencing reads obtained were 
demultiplexed and the barcode was trimmed. Per sample, a total of 15.6 to 31.9 million reads 
representing fragments of RNAs were obtained and further processed using the CLC Genomics 
Workbench 6.0.3 for identification of expressed genomic regions based on their read coverage.  
 Quality assessment and depletion of sequence reads covering rRNA genes  
The resulting 101-bp sequence reads of the six cDNA samples were quality controlled with FastQC to 
assess the Sanger variant Phred scores (Figure 24). For example, a Phred score of 20 means that the 
base call is 99% accurate and vice versa a 1% error rate is equal to a Phred score of 20 (-
10 x log 0.01). Figure 24 shows that with increasing read length also the quality of the base call 
decreased. It is clearly visible that the RNA obtained from DMEM resulted in sequence reads with 
higher quality cDNA (Phred score < 20) until bp position 80, while those samples derived from milk 
whey and milk whey challenged with LPS merely reached bp position 70 with a Phred score > 20. This 
suggests that the specialized RNA extraction and purification protocol, required to obtain RNA from 
milk whey, is responsible for the difference in sequence quality. However, consistent sequence 
quality is important for comparative analysis. Consequently Phred scores below 20 (depicted by the 
red area) do not provide high discriminative power among base calls and were excluded. Therefore, 
the sequencing data were submitted to CLC Genomics Workbench 6.0.3 and quality trimmed with a 
cut-off Phred score of 20. Additionally, trimming of the sequence reads included removal of 
sequence beyond 90 bp of the sequences. The resulting sequences were filtered by length and 
sequences shorter than 15 nt were discarded. Assessing the Phred scores in this way guaranteed an 
ample read quality and additionally influenced the read mapping (section V.6.2). 
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Figure 24: Read quality across all bases of the individual sequence reads. Sanger variant Phred scores 
mirror the sequence read quality of the six samples as assessed by FastQC software. The Phred 
scores Q assess the reliability of a base call and are defined as a property that is logarithmically 
related to the base calling error probabilities P. (QSanger = − 10 log10 P).   
Ec 1303 in DMEM Ec 1303 in milk whey +LPS
Ec 1303 in milk whey ECC-1470 in DMEM
ECC-1470 in milk whey +LPS ECC-1470 in milk whey 
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V.6.2. Mapping of the sequence reads to the E. coli 1303 and ECC-1470 genome sequences 
After read length adjustment and quality trimming the reads were mapped. The term mapping refers 
to an alignment of short sequence reads. Usually a reference sequence is used to which the reads 
can be mapped, but reads might also be assembled de novo what refers to the computational 
reconstruction of a longer sequence from smaller sequence reads. Generally mapping assemblies, 
even to rather phylogenetically distant reference genomes, provided more accurate gene expression 
levels and outperformed differential expression inference of de novo assemblies (Vijay et al., 2013). 
The specific reference genome sequences of E. coli isolates 1303 and ECC-1470 (Leimbach 
unpublished data) were used to map the sequence reads of these strains, respectively. Initial 
mappings revealed that up to 63 % of the obtained total reads covered ORFs encoding for rRNA 
genes. As normalization between the different samples by the amount of reads or bases is included 
in downstream data analysis, we filtered the reads covering genes of 16S and 23S rRNA according to 
Kopylova et al., 2012. Following this procedure, between 7.7 and 14.6 million reads were obtained 
per sample for further transcript analysis.  
These remaining high-quality sequence reads of each sample were again submitted to CLC Genomics 
Workbench 6.0.3 and mapped to their respective reference sequence. Reads that were not removed 
by the rRNA read filtering, but which mapped to one of the 22 rRNA genes (rrfABCDEFGH, 
rrlABCDEGH and rrsABCDEGH) were removed manually. The selected read mapping parameters were 
modified to fit the combination of the used cDNA synthesis method, Illumina sequencing protocol 
and prokaryotic reference sequence obtained by 454 sequencing, because most protocols and preset 
mapping parameters are adjusted to handle data obtained from eukaryotic organisms with defined 
and fully annotated reference sequences. The method to obtain the reference genome sequences of 
E. coli 1303 and ECC-1470 and its annotation status at that time greatly influenced the outcome of 
the present analyses. 
Table 12 includes the summarized mapping statistics and Figure 25 shows the match specificity of 
our RNA-Seq data. Sequence reads matching zero (0.0) times failed the mapping parameters (section 
.0.0 mapping) although they can be mapped to the reference sequence. Between 5.0 and 6.8 % of 
the total reads per sample can be referred to as counted reads defining the reads that fit the 
parameters. They can be distinguished into specific and non-specific reads. The vast majority are 
“specific counted reads” which matched to only one position in the reference sequence. In contrast, 
the number of reads, which were equally matched to other positions in the reference sequence, is 
called “non-specific counted reads”. This histogram shown on Figure 25 serves as an example of the 
match specificity acquired for all samples. The match specificity shown in Figure 25 graphically 
exemplifies the number of reads that match, by the chosen parameters, at one or more positions. It 
has been demonstrated that approximately 0.99 - 1.97 million reads could be correctly mapped.   
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Table 12: Summary of mapping statistics from RNA-Seq data 
Sample Total reads 
Reads after rRNA 
read filtering 
Counted reads 
Specific 
counted reads 
Non-specific 
counted reads 
Ec 1303 
DMEM 25,392,624 14,583,645 [57.4%] 1,376,757 [5.4%] 1,256,305 [91.3%] 120,452 [ 8.7%] 
milk whey 31,590,658 11,770,074 [37.3%] 1,567,442 [5.0%] 1,379,462 [88.0%] 187,980 [12.0%] 
milk 
whey +LPS 
30,328,686 11,218,479 [37.0%] 1,969,927 [6.5%] 1,713,996 [87.0%] 255,931 [13.0%] 
ECC-1470 
DMEM 20,405,112 13,007,005 [63.7%] 1,181,715 [5.8%] 1,085,496 [91.9%]   96,219 [ 8.1%] 
milk whey 22,780,194 12,453,415 [54.7%] 1,559,539 [6.8%] 1,405,507 [90.1%] 154,032 [ 9.9%] 
milk 
whey +LPS 
15,543,923 7,703,133 [49.6%]   998,786 [6.4%]   896,847 [89.8%] 101,939 [10.2%] 
                                 % refers to total reads as 100% % refers to counted reads as 100% 
 
Figure 25: Match specificity of sequence reads from cDNA sample “E. coli 1303 cultivated in DMEM”. 
Uncounted reads: The sequence reads matching zero (0.0) times. Specific reads: The sequence reads 
that match one position (1.0) in the reference sequence. Non-specific reads: Sequence reads that 
match equally to more than one position in the reference sequence (2.0 to 8.0 positions).   
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 Sequencing depth of the cDNA samples 
The optimal sequencing depth is varying based on the study´s objective. As we did not intend to 
characterize the full transcriptome including all weakly expressed genes, but to analyze the 
differential expression of genes (DEG), we questioned whether the achieved sequencing depth is 
deep enough.  
In the present analysis, we achieved a 16-fold genome coverage of E. coli 1303 corresponding to a 
per sample average of 328 reads per gene (at 5,155 annotated genes). In case of E. coli ECC-1470 a 
per sample average of 249 reads per gene was achieved corresponding to a 19-fold genome coverage 
(at 4,703 annotated genes). Notably, counted reads have been mapped to annotated genes 
exclusively. 
In order to allow for comparison with other studies, we provided the sequencing depth as sequence 
reads per gene and fold coverage of the coding genome sequences. In contrast to a coverage 
exceeding 10 million reads per sample, when analyzing comprehensive transcriptome profiles, it has 
been reported that 5 to 10 million reads per sample are sufficient for most applications of E. coli 
RNA-Seq (Haas et al., 2012). It has further been reported that 4 million non-rRNA reads were 
sufficient to identify unannotated genes of V. cholerae or that even 30 thousand non-rRNA reads 
allowed for identification of only twofold deregulated genes in E. coli EDL933 (Mandlik et al., 2011; 
Haas et al., 2012).  
In our RNA-Seq experiments, we acquired a sequencing depth of 7.7 to 14.6 million non-rRNA reads 
per sample after filtering (Table 12). Out of these, 9.1 to 17.6 % turned out to be mappable reads 
according to the final mapping parameters. Thus, 0.99 to 1.97 million “counted reads” could be 
correctly mapped providing accuracy and inferential power for the present RNA-Seq-based 
identification of differential gene expression. The achieved sequencing depth is appropriate. 
One may wonder why only 5.0 to 6.8 % of the total reads or 9.1 to 17.6 % of the non-rRNA reads 
were mappable. Why could so many reads not be aligned to the respective reference sequences?  
In fact, a vast number of reads would be mappable and considered “counted reads” upon 
modification of the mapping parameters. Instead, we decided for more stringent parameters in order 
to reduce the proportion of erroneously mapped reads and to identify truly differentially regulated 
genes even if their expression was not markedly deregulated. As discussed earlier, the efficacy of 
extraction and purification of the total bacterial RNA and the quality of cDNA synthesis remain 
variables in transcriptome analyses. They affect the outcome of the RNA-Seq read data quality 
(Figure 24). This causes interference between the sequence identity of the read and the reference 
sequence. In addition, combining different sequencing technologies might considerably affect the 
study by adding bias to the bioinformatical processing during both mapping and read allocation.  
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 Effect of non-specific read matches on gene expression levels 
The extent to which a particular gene is transcribed into mRNA is indicated in expression levels. 
Analog expression data, such as those derived from competitive DNA microarray hybridizations, 
reveal the ration of transcript levels present under the two different conditions compared, whereas 
the expression level derived from RNA-Seq is measured by the number of sequence reads mapped to 
the reference genome of the individual cDNA sample. 
A major issue in selecting the appropriate mapping parameters is whether to include non-specific 
reads in the RNA-Seq analysis or not. Non-specific reads match equally well to more than one 
position on the reference genome sequence. Therefore, taking non-specific reads into account might 
cause serious failure in computation of gene expression levels, but cannot simply be discarded, 
because the expression of the assigned genes will be underestimated or not even be reported (Roy et 
al., 2011). In contrast, including non-specific but possibly mismapped reads would result in an 
overestimation of gene expression levels as well. This raises the question as how to handle non-
specific reads in the present study? 
The sample´s read mappings to the respective reference genome were performed with both i) 
parameters set for including specifically matching reads only and ii) parameters set for including non-
specific reads. The former mapping algorithm (i) discards ambiguously mapped reads and only keeps 
uniquely mapped reads. The latter mapping algorithm (ii) distributes non-specific reads in relative 
proportion according to the number of uniquely mapped reads of the assigned features, normalized 
by feature length. Basically this means that first the expression of each gene is estimated by reads 
that map uniquely and then this information is used to weight the distribution of the non-specific 
reads.  
In order to visualize how this mapping algorithm qualitatively and quantitatively affected the 
computation of expression values, a scatter plot was created for each sample (Figure 26). The scatter 
plots show the reads match specificity by plotting the expression levels (number of total reads 
mapped per feature/gene) of a mapping with only specific reads against the same sample mapped 
with inclusion of non-specific reads. Since the mappings were run on the same data set with the only 
difference being the consideration of non-specific reads, one can focus on the very few features 
influenced by the read distribution. Most genes had close to identical expression values what was 
expected due to the utilization of the same data set. However, some genes in the mappings including 
non-specific reads exhibited much higher expression levels (as indicated by the red spots in Figure 
26). But also the visible portion of outliers is rather small compared to the number of total genes for 
each of the reference genomes (Ec 1303 comprises 5,155 genes; ECC-1470 comprises 4,703 genes).  
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Figure 26: Effect of non-specific read matches on quantification of gene expression levels. Expression 
levels were depicted in scatter plots. Blue spots indicate similar read counts revealing similar 
estimated expression levels and red spots highlight specific outliers between mappings of only 
specific reads relative plotted against mapping including non-specific reads. The scatter plots were 
created from expression data (read counts) of annotated genes. 
 
 
The expression levels of only a few genes (outliers) were vastly increased because of the total 
number of reads assigned including non-specific reads. These genes are suggested to be either 
paralogous genes, pseudogenes instead of highly expressed functional genes or genes containing 
many repeat regions, which are most likely uniquely covered by specific reads. In fact, some of these 
genes have a repeat-rich region (e.g. the rhs genes). Furthermore, some genes are partly covered by 
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higher numbers of non-specific reads due to overlapping regions (e.g. flmC and flmA), which means 
that all reads that map to the flmC gene, also map equally well to the overlapping part of the other 
gene (flmA). 
In bacterial genomes, neighboring genes can often overlap. Therefore, distinguishing the start of one 
transcript from the end of another transcript adds complexity to transcriptome analysis (McClure et 
al., 2013). At least in part, this obstacle was overcome by the utilization of a strand-specific protocol 
for read generation allowing a valid distribution of reads to the overlapping genes through detection 
of overlapping transcripts coded in opposite orientations.  
Another explanation arises from incorrectly sequenced homopolymer stretches, which are common 
artefacts of the 454 sequencing technology (Wolf, 2013), which has been used to generate the 
reference genome sequences of E. coli strains 1303 and ECC-1470 (Leimbach unpublished). In 
contrast, the sequence reads of the RNA-Seq samples were derived from Illumina sequencing 
technology. The reference 454-generated genome sequences were more prone to miss-alignment 
and therefore affected regional read coverage. In contrast, the sequence reads obtained from the 
Illumina platform were not that affected by incorrectly homopolymer sequences. This causes a bias 
during Illumina-read alignment and read allocation to a sequence of 454-origin. Consequently, the 
mapping parameters have to allow for some variability to enable a sufficient coverage at all. 
Generally, this issue resulted in a lower number of total reads mapped, but reads that covered 
intercepted genes due to bad reference sequence quality were then determined non-specific reads 
either. One option to overcome this problem would be to (yet manually) correct the alignment using 
the Illumina data. As this study focused on differential gene expression, this issue has not necessarily 
to be addressed and it has thus not been considered for further analysis in this study. 
 Including non-specific reads 
In all samples, the most outlying gene was flmC, which was not in the range of the plot scale. The 
flmC gene product is known to modulate and start translation of host killing protein FlmA. Assigning a 
great number of non-specific reads to flmC would lead to a marked overestimation of expression and 
thus to an erroneous interpretation. To avoid misinterpretations, the genes whose expression levels 
exhibited a marked alteration upon the inclusion of non-specific read matches have been identified 
and listed according to their presence in each of the samples. Furthermore, the intersections from 
each sample-list containing genes of markedly altered expression levels have been determined. 
Table 13 lists which genes were in each intersection or were unique to a certain sample. The 
enormously high flmC expression level would lead to the expectation that also flmA expression levels 
were high. This was true in all of the six samples tested. In addition, srnB transcription has been 
identified to be up-regulated. snrB is supposed to be a paralogous gene showing similarity to flmC, 
but also to the mokC gene. The latter gene was identified to be markedly expressed only in the 
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ECC-1470 milk whey sample. The genes (srnB, flmC, and mokC) share sufficient sequence similarity to 
allow mismapping of non-specific reads.  
Furthermore, tufA and its duplicate tufB code for elongation factor Tu (EF-Tu) and also showed 
enormously high expression levels. EF-Tu is considered to be the most abundant protein in E. coli 
while being maximally expressed during stress response (Muela et al., 2008). The expression of the 
aforementioned tufA and tufB genes in all samples would add an interesting aspect to the present 
analysis of differential gene expression. They, however, have to be excluded from further analysis 
due to the following reasons: i) any expression measure of a paralogous gene will be biased because 
currently there is no mapping algorithm available that can correctly include sequence data from 
paralogues, and ii) misestimated expression levels can neither allow nor support a reliable 
identification of differential gene expression. 
Table 13: Non-specific read matches which led to markedly altered gene expression levels under 
different growth conditions 
Sample / Intersection Total genes Annotated CDS 
Ec 1303 DMEM 
Ec 1303 milk whey 
Ec 1303 milk whey +LPS 
ECC-1470 DMEM 
ECC-1470 milk whey 
ECC-1470 milk whey +LPS 
5 srnB, tufB, flmA, tufA, flmC 
Ec 1303 DMEM 
Ec 1303 milk whey 
Ec 1303 milk whey +LPS 
3 EPE_c45090, EPE_c23190, EPE_c27300 
ECC-1470 DMEM 
ECC-1470 milk whey 
ECC-1470 milk whey +LPS 
1 ECN_c20070 
Ec 1303 milk whey 
Ec 1303 milk whey +LPS 
6 EPE_c01610, EPE_c28560, EPE_c28550, 
EPE_c28540, EPE_c28530, EPE_c01630 
ECC-1470 DMEM 
ECC-1470 milk whey 
3 ECN_c13870, ECN_c07910, ECN_c07890 
ECC-1470 milk whey 
ECC-1470 milk whey +LPS 
3 ECN_c24260, ECN_c24250, ECN_c24270 
Ec 1303 DMEM 2 tnpA, EPE_109p0260 
Ec 1303 milk whey 6 EPE_c01640, EPE_c16190, EPE_c14090, 
EPE_c13670, EPE_c01650, EPE_c29260 
Ec 1303 milk whey +LPS 2 EPE_c31140, EPE_c31150 
ECC-1470 DMEM 6 EPE_c24260, EPE_c24250, ECN_c11680, 
ECN_c42470, ECN_c12070, EPE_c24270 
ECC-1470 milk whey 2 mokC, ECN_c07900 
ECC-1470 milk whey +LPS 4 ECN_c25580, ECN_07900, ECN_c25590, ydcM 
 
 
Of all CDS that exhibited markedly altered expression levels upon inclusion of non-specific reads 
(Table 13), particular genes might be of interest for our analysis of genes contributing to mastitis. 
Specifically, genes that are present in an intersection of the Venn diagram comprising neither all 
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samples, nor all strain-specific samples (here growth conditions), or are unique to a certain sample. 
Their altered gene expression, even if biased, seemed to be exclusively altered in particular samples 
or under specific conditions mirrored by their allocation to individual intersections. Table 13 
summarizes a selection of genes, which for the above mentioned reasons should be further 
investigated.  
There is, nevertheless, disagreement in the literature on whether to include non-specific reads in the 
RNA-Seq analysis or not. Aiming to discover mastitis-relevant candidate genes by analysis of 
differential gene expression rather than by performing a quantitative global expression analysis, the 
bias does not necessarily compromise our analysis. The consideration of including non-specific reads 
might avoid overlooking certain genes. Hence, we decided that the approximately 8-12 % non-
specific reads per sample (Table 12) should be included into the downstream RNA-Seq analysis. 
 Read distribution, variability and similarity across samples 
The different probe sets had to be examined according to their overall read distribution, variability 
and similarity. Therefore, the original expression values (total reads per gene) had to be transformed 
or normalized in order to allow comparability across samples. 
 Sample distributions of gene expression levels 
When analyzing gene expression values of different genes within a sample, the coding sequence 
(CDS) of all the genes is usually not of the same length. A long transcript is, therefore, expected to be 
covered by more reads than a short transcript of equal expression level. Thus, instead of the original 
expression values (total reads per CDS) the 'reads per kilobase of gene' model (RPKM) was applied, 
which takes the gene length into account (Mortazavi et al., 2008). Additionally, the data were 
log2-transformed in order to remove the expression values´ dependence on the variance of the 
mean. The distributions of the log2(RPKM) expression values for the 5,155 genes of E. coli 1303 and 
4,703 genes of E. coli ECC-1470 defined as annotated CDS are shown in Figure 27. All RPKM 
distributions are approximately normal. A uniform read coverage across the annotated CDS is not 
provided, what is in accordance to previously performed RNA-Seq analyses on both, eukaryotic and 
prokaryotic organisms (Kertesz et al., 2010; Wilhelm et al., 2008; Chaudhuri et al., 2011; Perkins et 
al., 2009). 
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Figure 27: Distribution of expression values for annotated CDS of the genomes of E. coli strains 1303 
and ECC-1470. Histograms display log2-transformed RPKM expression values that show a normal 
distribution in all of the six samples.  
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According to Figure 27, the overall level of gene expression was similar under the different 
conditions (DMEM, milk…etc.), and only a small fraction of CDSs exhibited marked deviations of their 
expression level. For further analyses, the normalization according to sample size was, nevertheless, 
indispensable. 
V.6.3. Gene expression of E. coli strain 1303 and ECC-1470 in milk whey 
From the histograms it cannot unambiguously be observed whether the number of genes that are 
highly or even not expressed under the different growth conditions was similar or not. Thus, a textual 
output was generated with gene expression categorized according to Wickramasinghe et al., 2012.  
Table 14 groups the genes of E. coli strains 1303 and ECC-1470 according to their expression level 
upon growth in DMEM, milk whey and milk whey after LPS challenge. The annotated reference 
genome of E. coli strain 1303 comprises 5,155 CDSs. while the genome of E. coli ECC-1470 includes 
4,703 annotated CDSs. The 22 genes coding for rRNAs were removed from further analyses as stated 
before. Thus, a total of 5,133 annotated CDSs of E. coli strain 1303 and a total of 4,681 annotated 
CDS of strain ECC-1470 remained. For 2.1 to 3.0 % of the annotated CDSs per genome no reads could 
be mapped and they were thus defined as “non-expressed genes”. In summary,  
Table 14 shows that the ratio of the total expressed genes and non-expressed genes between E. coli 
strains 1303 and ECC-1470 was quite similar.  
 
Table 14: Grouping of genes of E. coli strains 1303 and ECC-1470 according to their expression level 
in DMEM, milk whey and milk whey upon LPS challenge. Expression values are indicated as RPKM. 
Category Strain  
Condition 
 
DMEM Milk whey Milk whey +LPS 
Highly expressed genes 
( > 500 RPKM ) 
  Ec 1303    400  
†
[  8.0%]     417  
†
[  8.3%]      372  
†
[  7.4%] 
ECC-1470    427  
†
[  9.3%]     435  
†
[  9.5%]      419  
†
[  9.1%] 
Medium expressed genes 
( ≥ 10 RPKM to 500 RPKM ) 
  Ec 1303 4,089  
†
[81.7%]  3,826  
†
[76.5%]   3,667  
†
[73.3%] 
ECC-1470 3,755  
†
[82.0%]  3,662  
†
[79.9%]   3,626  
†
[79.2%] 
Lowly expressed genes 
( < 10 RPKM ) 
  Ec 1303    644  
†
[12.9%]     890  
†
[17.8%]   1,094  
†
[21.9%] 
ECC-1470    499  
†
[10.9%]     584  
†
[12.7%]      636  
†
[13.9%] 
Total expressed genes 
  Ec 1303 5,003  
*
[97.5%]  4,994  
*
[97.3%]   4,978  
*
[97.0%] 
ECC-1470 4,581  
*
[97.9%]  4,576  
*
[97.8%]   4,560  
*
[97.4%] 
Non-expressed genes 
  Ec 1303    130  
*
[  2.5%]     139  
*
[  2.7%]      155  
*
[  3.0%] 
ECC-1470    100  
*
[  2.1%]     105  
*
[  2.2%]      121  
*
[  2.6%] 
†
 % refers to total expressed genes as 100% 
*
 % refers to total CDS per strain as 100% 
 
Interestingly, E. coli strain 1303 exhibited less highly expressed and less medium expressed genes 
than strain ECC-1470 under all conditions tested. This is even more remarkable, because the 
reference genome of mastitis isolate E. coli 1303 comprises 452 CDS more than E. coli ECC-1470. In 
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return, this reveals an unproportional higher number of highly expressed genes in E. coli ECC-1470 
relative to the genome size. This indicates a stronger transcriptional response of this strain to milk 
whey and milk whey +LPS. In contrast, strain ECC-1470 revealed significantly less weakly expressed 
genes than E. coli 1303 under all growth conditions. In both strains, the number of highly and 
medium expressed genes decreased upon growth in milk whey or milk whey +LPS samples relative to 
growth in DMEM. To the same extent, the fraction of weakly expressed genes increased in milk whey 
and in milk whey +LPS samples relative to the DMEM samples. 
In order to not identify only the genes with the highest expression level in a single sample (data on 
compact disk: Supplemental Tables S2-S7), but to identify differentially expressed genes within 
different samples, the samples needed to be investigated by statistical experiments. As a 
prerequisite, the comparability of the samples had to be ensured. 
 Quantile normalization of original expression values is required for sample comparison 
A different sequencing depth affects the total read count per transcript of a sample. Consequently, 
this will result in inaccurate determination of differentially expressed genes when expression is 
quantified by read counts per transcript. In order to quantitatively and comparatively examine the 
number of reads per CDS in each sample, normalized sets of expression values of the samples were 
required. Therefore, the read counts might be divided by the total number of mapped reads or its 
quantile. In the present study, the data were normalized for sample size by quantile normalization. In 
quantile normalization, the distribution of read counts per sample (sequencing depth) is matched to 
a reference distribution defined in terms of median counts across the samples to compare (Gupta et 
al., 2012; Bullard et al., 2010). As it is assumed that gene expression in both strains may differ under 
the three conditions tested, two-group experiments were conducted (e.g. DMEM IRT milk whey or 
DMEM IRT milk whey +LPS or milk whey IRT milk whey +LPS). Due to the lack of technical replicates 
of RNA-Seq data sets, both strains 1303 and ECC-1470 were considered as biological replicates. The 
Box-Whisker-plot shown in Figure 28 depicts the pairwise distributions of the samples´ expression 
values at different conditions compared to each other. Although the samples´ median values were 
quite similar, their quartiles differed. This indicated a variation across the samples. The same also 
applied to the whiskers outside the upper and lower quartiles; indicating variability. Notably, the 
gene expression data sets of mastitis E. coli strains 1303 and ECC-1470 appeared quite similar in  
value distribution and variation when incubated in DMEM, but exhibited marked differences in the 
variation of values, when cDNA have been investigated which resulted from incubations in milk whey 
or milk whey +LPS.  
While the distributions of RPKM values (Figure 27) were in some degree normalized by the transcript 
size, the non-normalized read count distributions (Figure 28, before normalization) indicated that 
normalization was required before the sample could be compared to each other. Especially the 
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sample representing the gene expression data set of E. coli ECC-1470 upon incubation in 
milk whey +LPS, required normalization. This could also be expected according to the comparably 
low fraction of mappable reads (Table 12), which in turn resulted from poor PHRED scores (Figure 
24). After quantile normalization, none of the normalized sample distributions differed from those of 
the other samples. Consequently, none of the samples had to be excluded and thus comparability 
between samples in statistical experiments was ensured. 
 
Figure 28: Box-Whisker-plot for two-group experiments with data sets from two samples of strain 
E. coli strains 1303 and ECC-1470 at different conditions, respectively. The left column depicts the 
data sets before normalization. The right column depicts the corresponding data sets after 
normalization.   
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V.6.4. Identification of differentially expressed genes in milk whey and milk whey +LPS 
For RNA-Seq-based transcriptome analyses the quantification of expression values should be as 
accurate as possible and thus correct mapping of the reads is mandatory. While the RPKM-model 
was utilized to measure expression levels of different genes across different strains and conditions, 
the transcript length is not of importance when testing for differential gene expression. Here, the 
expression of the same gene is compared across samples (i.e. condition or strain), but not compared 
to other genes. Moreover, the RPKM model might result in biased estimates in determining 
differential gene expression across conditions tested due to the small portion of highly-expressed 
genes (Bullard et al., 2010). Thus, the transcript length should not be regarded for differential gene 
expression analysis, and instead of the RPKM-model, the total read count of each transcript/CDS was 
chosen to measure DEG.  
 Differentially expressed genes in milk whey and milk whey +LPS 
Differential gene expression was discovered by performing two-group experiments using the 
bootstrapped Receiver Operating Characteristic algorithm (bROC) on quantile normalized read 
counts. The total read count of each gene was determined and the transcriptome of both 
E. coli strains 1303 and ECC-1470 were treated as biological replicates per state/condition. Sample 
data from both isolates at the corresponding condition were used for bROC analysis. Following this, 
the data were log2 –transformed and unity shifted (+1), because the data included null values as well. 
The transformed read counts for both isolates cultivated in either milk whey or LPS-challenged milk 
whey were compared to the transformed read counts measured upon incubation in DMEM (or milk 
whey) in order to determine the log2-fold change of gene expression. Genes with a discrimination 
score of CONF > 0.95 were considered to be differentially expressed (supplemental Tables S8-S10 on 
compact disc). As depicted in Figure 29, both mastitis E. coli strains 1303 and ECC-1470 exhibited 
deregulated genes when incubated in either milk whey or milk whey from a cow´s udder challenged 
with LPS relative to incubation in DMEM (or milk whey). Individual numbers of up- and down-
regulated genes in both strains at the respective conditions are shown. 
Figure 29: Deregulated genes in both E. coli strains 1303 and ECC-1470 after 1 h incubation at 37°C 
in: i) milk whey relative to DMEM cell culture medium, ii) ) LPS-challenged milk whey relative to 
DMEM cell culture medium, and iii) LPS-challenged milk whey relative to milk whey. The diagram 
shows the numbers of significantly up- (red) and down- (blue) regulated genes (CONF > 0.95).  
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When incubated in milk whey from a cow´s udder challenged with LPS, both mastitis strains 
commonly exhibited an increased number of significantly deregulated genes relative to milk whey 
from an udder-healthy cow or to DMEM cell culture medium. This strongly suggests a specific 
response to components that are present in milk whey after contact to bacterial LPS. 
In order to investigate which genes were deregulated in one condition as well as in another 
condition, the Venn algorithm was utilized. Therefore, the number of differentially expressed genes 
of mastitis strains E. coli 1303 and ECC-1470 at the respective conditions was visualized in a Venn 
diagram shown in Figure 30. A considerable number of genes were commonly deregulated in both 
strains, but not necessarily in response to the same condition as indicated by the overlapping areas 
(intersections) of three samples. Of approximately 5,155 CDS of E. coli 1303 and approximately 4,703 
CDS of ECC-1470, the Venn algorithm identified a total of 88 different genes that were 
simultaneously deregulated in both strains after incubation in either milk whey or milk whey +LPS 
relative to DMEM. The particular intersections demonstrate, however, a transcriptional response by 
the same genes suggesting that the very same processes were affected in both strains though it is 
not possible to follow either up or down regulation in this Venn diagram. 18 genes were deregulated 
in milk whey as well as in milk whey +LPS. The number of genes exclusively deregulated in milk 
whey +LPS relative to DMEM (40 genes) was twofold higher than the number exclusively deregulated 
in milk whey +LPS in reference to DMEM (20 genes). No gene was detected to be uniquely 
deregulated in milk whey +LPS relative to milk whey while 10 genes were also deregulated in either 
milk whey or milk whey +LPS relative to DMEM. It is suggested, that the response to components, 
which are present or increased in milk whey after the cow´s contact to LPS (e.g. defensins or iron-
binding proteins), resulted in a marked response of the gene expression levels in both mastitis E. coli 
strains relative to cell culture medium compared to milk whey without LPS challenge.  
 
Figure 30: Impact of DMEM cell culture medium, 
milk whey or milk whey + LPS on gene expression of 
mastitis E. coli isolates as determined by RNA-Seq. 
The Venn diagram shows the numbers of 
significantly deregulated genes in E. coli strains 
1303 and ECC-1470 upon incubation in milk whey or 
milk whey +LPS in relation to (IRT) DMEM cell 
culture medium/milk whey (CONF > 0.95). The 
numbers displayed in circles indicate the number of 
genes shared between the overlapping areas, which 
represent the sample-specific incubation medium.  
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If only the LPS challenge would have markedly affected deregulation of genes in response to milk 
whey, one would have identified genes deregulated uniquely in milk whey +LPS relative to milk whey 
as well (Figure 30). 
In addition to the visual output of the Venn algorithm, it is also possible to investigate whether the 
88 different genes were up- or down-regulated in milk whey or milk whey +LPS, respectively. 
Therefore, a corresponding textual output is given in Table 15 showing which genes were (i) 
deregulated at distinct conditions or (ii) uniquely deregulated under a certain condition. Significantly 
deregulated genes (CONF >0.95) are listed according to their presence in each of the samples. Their 
corresponding fold log2-fold change is indicated in either red (up-regulated) or blue 
(down-regulated). 
While the Venn diagram’s central intersection Figure 30 revealed only one gene that was diversely 
deregulated between all conditions, it can now be identified as the artJ gene encoding the ABC 
transporter arginine binding protein 1. According to Table 15 the log2-fold change of artJ revealed an 
approximately twofold higher up-regulation in milk whey compared to its up-regulation in milk 
whey +LPS. This is corroborated by the negative ratio of the expression levels in milk whey +LPS in 
relation to milk whey. Besides artJ, nine other genes were repressed in milk whey +LPS relative to 
milk whey only. One of these particular genes was iscR, which was down-regulated not only in milk 
whey +LPS relative to milk whey but also in milk whey +LPS relative to DMEM. The 18 genes 
deregulated in milk whey and milk whey +LPS showed a consistent expression pattern in that they 
were either uniquely up- or down- but not differently regulated. These genes can be considered as 
deregulated in response to components of milk whey rather than components appearing or 
increasing after pathogen recognition. In contrast, eight genes were up-regulated in milk whey 
relative to DMEM, but were down-regulated in milk whey +LPS relative to milk whey. These genes 
are suggested to be especially useful in milk whey, which does not contain any host factors as a 
response to pathogen recognition (e.g. defensins or iron-binding proteins). It can be speculated that 
milk whey from an udder healthy cow still offers sufficient conditions for bacterial multiplication 
while milk whey from a cow´s udder challenged with LPS represents more aggressive growth 
conditions. Consequently, a normal response of the bacteria may be inhibited and instead bacterial 
countermeasure may be induced.  
In summary it can be stated that both mastitis strains commonly deregulated a number of genes 
when they were incubated either in milk whey or in milk whey +LPS. These genes might represent 
specific bacterial responses to milk whey comprising e.g., antimicrobial components and these 
components increased upon LPS challenge. It can be hypothesized that at least some of the 
differentially expressed genes identified might be involved in the pathogenesis caused by the 
transient mastitis strain 1303 and persistent mastitis isolate ECC-1470.  
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Table 15: Deregulated genes of mastitic E. coli in milk whey or milk whey +LPS.  
Sample / Intersection 
 
Gene 
 
             Locus tags 
       Ec 1303 / ECC-1470 
Annotations - Protein product 
 
Fold change 
Sample 1    Sample 2     Sample 3 
Sample 1: milk whey IRT DMEM 
Sample 2: milk whey +LPS IRT 
DMEM; Sample 3: milk 
whey +LPS IRT milk whey 
artJ EPE_c00350 ECN_c44210 ABC transporter arginine-binding protein 1 5.05 2.70 -2.73 
Sample 1: milk whey IRT DMEM 
Sample 2: milk whey +LPS IRT 
DMEM 
 
              18 genes total 
bioB EPE_c01290 ECN_c45060 Biotin synthase -4.09 -4.15 no DE 
citF EPE_c02920 ECN_c00830 citrate lyase,  citrate-ACP transferase (alpha) subunit 3.41 4.71 no DE 
ecnB EPE_c12150 ECN_c10250 entericidin B membrane lipoprotein -2.69 -3.83 no DE 
entC EPE_c03140 ECN_c01060 Isochorismate synthase entC -3.87 -5.41 no DE 
entE EPE_c03130 ECN_c01050 
2, 3-dihydroxybenzoate-AMP  
ligase component of enterobactin synthase complex 
-3.70 -3.69 no DE 
entF EPE_c03210 ECN_c01130 Enterobactin synthase component F -2.93 -2.99 no DE 
fes EPE_c03230 ECN_c01150 enterobactin/ferric enterobactin esterase -3.51 -3.94 no DE 
fhuF EPE_c10050 ECN_c07930 ferric iron reductase involved in ferric hydroximate transport -2.73 -4.39 no DE 
fruK EPE_c33350 ECN_c30700 1-phosphofructokinase -2.45 -2.27 no DE 
glnH EPE_c00890 ECN_c44690 Glutamine-binding periplasmic protein 4.09 3.74 no DE 
glnP EPE_c00900 ECN_c44700 Glutamine transport system permease protein glnP 3.14 3.77 no DE 
gltI EPE_c02530 ECN_c00440 Glutamate/aspartate periplasmic-binding protein 3.08 2.85 no DE 
lipA EPE_c02800 ECN_c00710 Lipoyl synthase 2.48 2.25 no DE 
mntH EPE_c31230 ECN_c28450 manganese/divalent cation transporter -2.73 -3.32 no DE 
nrdH EPE_c28740 ECN_c25760 Hydrogen donor for NrdEF electron transport system -3.43 -5.29 no DE 
rmf EPE_c47870 ECN_c43280 Ribosome modulation factor -3.47 -4.74 no DE 
yhaO EPE_c23830 ECN_c20770 Inner membrane transport protein YhaO -4.43 -4.11 no DE 
yncE EPE_c41690 ECN_c38770 hypothetical protein YncE -3.15 -3.87 no DE 
Indicated “Fold change” refers to bROC analysis log2-fold change (CONF > 0.95). Significantly deregulated genes are indicated red (up) and blue (down). 
Fold change of 1) milk whey IRT DMEM, 2) milk whey +LPS IRT DMEM, or 3) milk whey +LPS IRT milk whey. 
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Sample / Intersection 
 
Gene 
 
             Locus tags 
       Ec 1303 / ECC-1470 
Annotations - Protein product 
 
Fold change 
Sample 1    Sample 2     Sample 3 
Sample 1: milk whey IRT DMEM 
Sample 3: milk whey +LPS IRT 
milk whey 
 
               8 genes total 
argC EPE_c14200 ECN_c12200 N-acetyl-gamma-glutamyl-phosphate reductase 4.39 no DE -3.66 
argI EPE_c11060 ECN_c09170 Ornithine carbamoyltransferase 5.14 no DE -3.39 
cysH EPE_c27860 ECN_c24810 Phosphoadenosine phosphosulfate reductase 3.13 no DE -3.37 
cysJ EPE_c27840 ECN_c24790 Sulfite reductase [NADPH] flavoprotein alpha-component 4.06 no DE -4.42 
cysP EPE_c30910 ECN_c28160 Thiosulfate-binding protein 4.11 no DE -4.25 
cysU EPE_c30920 ECN_c28170 sulfate/thiosulfate transporter subunit 5.52 no DE -4.16 
iaaA EPE_c00710 ECN_c44520 Isoaspartyl peptidase 2.87 no DE -3.08 
ydjN EPE_c38090 ECN_c35610 Uncharacterized symporter ydjN 2.93 no DE -3.31 
Sample 2: milk whey +LPS IRT 
DMEM 
Sample 3: milk whey +LPS IRT 
milk whey 
iscR EPE_c29880 ECN_c27130 DNA-binding transcriptional repressor no DE -4.18 -2.77 
Sample 1: milk whey IRT DMEM 
 
              20 genes total 
argT EPE_c31910 ECN_c29380 lysine/arginine/ornithine transporter subunit 2.83 no DE no DE 
bioF EPE_c01280 ECN_c45050 8-amino-7-oxononanoate synthase -4.02 no DE no DE 
citE EPE_c02910 ECN_c00820 citrate lyase,  citryl-ACP lyase (beta) subunit 4.43 no DE no DE 
citX EPE_c02930 ECN_c00840 Apo-citrate lyase phosphoribosyl-dephospho-CoA transferase 7.57 no DE no DE 
cpxP EPE_c14640 ECN_c12690 
inhibitor of the cpx response 
/ periplasmic adaptor protein 
-2.39 no DE no DE 
cysA EPE_c30940 ECN_c28190 Sulfate/thiosulfate import ATP-binding protein CysA 2.91 no DE no DE 
cysD EPE_c27920 ECN_c24940 Sulfate adenylyltransferase subunit 2 2.58 no DE no DE 
fepA EPE_c03240 ECN_c01160 iron-enterobactin outer membrane transporter -4.05 no DE no DE 
gdhA EPE_c37770 ECN_c35280 NADP-specific glutamate dehydrogenase 2.98 no DE no DE 
hycA EPE_c28210 ECN_c25250 regulator of the transcriptional regulator FhlA 3.51 no DE no DE 
metF EPE_c14370 ECN_c12370 5, 10-methylenetetrahydrofolate reductase 3.61 no DE no DE 
nrdI EPE_c28730 ECN_c25750 flavodoxin required for NrdEF cluster assembly -3.91 no DE no DE 
nuoA EPE_c32130 ECN_c29600 NADH:ubiquinone oxidoreductase,  membrane subunit A 2.55 no DE no DE 
potF EPE_c00410 ECN_c44270 Putrescine-binding periplasmic protein 3.59 no DE no DE 
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Sample / Intersection 
 
Gene 
 
             Locus tags 
       Ec 1303 / ECC-1470 
Annotations - Protein product 
 
Fold change 
Sample 1    Sample 2     Sample 3 
Sample 1: milk whey IRT DMEM 
 
              20 genes total 
sufA EPE_c39030 ECN_c36060 Fe-S cluster assembly protein -3.35 no DE no DE 
yagU EPE_c06020 ECN_c04360 Inner membrane protein yagU 2.83 no DE no DE 
ygeO EPE_c26830 ECN_c23580 type III secretion apparatus system protein -3.40 no DE no DE 
yjiH EPE_c10630 ECN_c08310 hypothetical protein yjiH 3.59 no DE no DE 
yjjZ EPE_c10040 ECN_c07920 hypothetical protein -4.13 no DE no DE 
ylaC EPE_c04300 ECN_c02670 Inner membrane protein ylaC 3.84 no DE no DE 
Sample 2: milk whey +LPS IRT 
DMEM 
 
              40 genes total 
aceE EPE_c07950 ECN_c06390 pyruvate dehydrogenase, decarboxylase component E1 no DE 1.88 no DE 
argB EPE_c14190 ECN_c12190 Acetylglutamate kinase no DE -2.40 no DE 
artI EPE_c00320 ECN_c44180 Putative ABC transporter arginine-binding protein 2 no DE 2.47 no DE 
cirA EPE_c33480 ECN_c30830 catecholate siderophore receptor CirA,  colicin I receptor no DE -2.42 no DE 
citC EPE_c02890 ECN_c00800 [Citrate [pro-3S]-lyase] ligase no DE 4.04 no DE 
citG EPE_c02940 ECN_c00850 2-(5''-triphosphoribosyl)-3'-dephosphocoenzyme-A synthase no DE 3.70 no DE 
codA EPE_c05470 ECN_c03820 Cytosine deaminase no DE 2.28 no DE 
cutC EPE_c36540 ECN_c34020 Copper homeostasis protein CutC no DE -1.79 no DE 
fecI EPE_c25370 ECN_c08760 
KpLE2 phage-like element 
/ RNA polymerase,  sigma 19 factor 
no DE -3.55 no DE 
fecR EPE_c25380 ECN_c08770 
KpLE2 phage-like element 
/ transmembrane signal transducer for ferric citrate transport 
no DE -2.61 no DE 
fhuA EPE_c07570 ECN_c06030 Ferrichrome-iron receptor no DE -1.85 no DE 
flhC EPE_c36370 ECN_c33850 DNA-binding transcriptional dual regulator with FlhD no DE 2.61 no DE 
frdD EPE_c12110 ECN_c10210 fumarate reductase (anaerobic),  membrane anchor subunit no DE 2.32 no DE 
ftnA EPE_c36250 ECN_c33730 ferritin iron storage protein (cytoplasmic) no DE 3.37 no DE 
glnQ EPE_c00910 ECN_c44710 Glutamine transport ATP-binding protein GlnQ no DE 3.49 no DE 
gpmA EPE_c01510 ECN_c45270 2, 3-bisphosphoglycerate-dependent phosphoglycerate mutase no DE -2.74 no DE 
osmC EPE_c41380 ECN_c38470 
Lipoyl-dependent Cys-based peroxidase,  hydroperoxide 
resistance 
no DE -2.97 no DE 
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Sample / Intersection 
 
Gene 
 
             Locus tags 
       Ec 1303 / ECC-1470 
Annotations - Protein product 
 
Fold change 
Sample 1    Sample 2     Sample 3 
Sample 2: milk whey +LPS IRT 
DMEM 
 
              40 genes total 
pepE EPE_c13530 ECN_c11560 (alpha)-aspartyl dipeptidase no DE 3.07 no DE 
potD EPE_c45310 ECN_c41570 
polyamine transporter subunit 
/ periplasmic-binding component of ABC superfamily 
no DE 2.28 no DE 
ptsG EPE_c45530 ECN_c41790 
fused glucose-specific PTS enzymes: IIB component 
/ IIC component 
no DE 2.34 no DE 
rplB EPE_c21710 ECN_c18670 50S ribosomal subunit protein L2 no DE 3.10 no DE 
rplD EPE_c21690 ECN_c18650 50S ribosomal subunit protein L4 no DE 3.20 no DE 
rplF EPE_c21830 ECN_c18790 50S ribosomal subunit protein L6 no DE 2.48 no DE 
rplI EPE_c11590 ECN_c09700 50S ribosomal protein L9 no DE 2.73 no DE 
rplR EPE_c21840 ECN_c18800 50S ribosomal subunit protein L18 no DE 2.60 no DE 
rplS EPE_c29100 ECN_c26380 50S ribosomal subunit protein L19 no DE 2.67 no DE 
rplV EPE_c21730 ECN_c18690 50S ribosomal subunit protein L22 no DE 2.34 no DE 
rplW EPE_c21700 ECN_c18660 50S ribosomal subunit protein L23 no DE 3.42 no DE 
rpmC EPE_c21760 ECN_c18720 50S ribosomal subunit protein L29 no DE 2.76 no DE 
rpmI EPE_c38220 ECN_c35740 50S ribosomal subunit protein L35 no DE 2.12 no DE 
rpsE EPE_c21850 ECN_c18810 30S ribosomal subunit protein S5 no DE 2.45 no DE 
rpsG EPE_c21450 ECN_c18570 30S ribosomal protein S7 no DE 2.81 no DE 
rpsI EPE_c22600 ECN_c19530 30S ribosomal subunit protein S9 no DE 2.21 no DE 
rpsN EPE_c21810 ECN_c18770 30S ribosomal subunit protein S14 no DE 2.74 no DE 
rpsR EPE_c11600 ECN_c09710 30S ribosomal protein S18 no DE 2.92 no DE 
rpsS EPE_c21720 ECN_c18680 30S ribosomal subunit protein S19 no DE 2.27 no DE 
tsx EPE_c04770 ECN_c03160 nucleoside channel,  receptor of phage T6 and colicin K no DE 2.24 no DE 
ybgE EPE_c01730 ECN_c45470 hypothetical protein ybgE no DE 2.67 no DE 
ydiY EPE_c38160 ECN_c35680 predicted outer membrane protein,  acid-inducible no DE 2.62 no DE 
yjbJ EPE_c13260 ECN_c11260 UPF0337 protein yjbJ no DE -2.60 no DE 
IRT in reference to 
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V.6.5. Commonly deregulated genes in response to milk whey 
Hierarchical clustering of deregulated genes 
In order to identify commonly deregulated genes of both E. coli mastitis strains 1303 and ECC-1470 
when incubated in either milk whey or milk whey +LPS or DMEM, hierarchical cluster analyses of the 
identified deregulated genes were performed. Genes, which exhibited the same or a similar 
expression profile, were grouped together. The significantly deregulated genes after one hour 
incubation in the respective medium differed in their expression levels across both mastitis isolates 
(also visible in Table 15 on page 130). This is indicating a distinct transcriptional response of the two 
different strains. 
The isolates´ transcriptional response to milk whey relative to DMEM resulted in commonly 
deregulated genes and revealed five subclusters shown in Figure 31. Most genes of E. coli strains 
1303 and ECC-1470 were not only commonly, but also evenly regulated after one hour in DMEM. In 
contrast, in milk whey relative to DMEM most deregulated genes showed distinct expression levels 
between isolates although their regulation is following a common underlying trend (up or down).  
Specifically, the first subcluster identified upon growth in milk whey includes down-regulated genes 
involved in iron acquisition (fhuF, entF, mntH, fepA and yncE) and ecnB encoding for the lipoprotein 
entericidin, which plays a role in programmed cell death under high osmolarity conditions. Down-
regulation of iron-associated genes was further supported by the second subcluster of deregulated 
genes include many genes coding for components of the enterobactin synthase complex (entC, entE 
and fes). It is somehow notable but not surprising that entF is allocated to subcluster one whereas 
the fold total expression level is still much higher in comparison to entC and entE.  
Of the three remaining subclusters, two included a majority of up-regulated genes involved in amino 
acid metabolism as well as the inner membrane proteins ylaC and yjiH as well as the genes citE and 
citF whose gene products are required for citrate utilization. Interestingly, potF, which is coding for a 
putrescine-binding periplasmic protein was commonly up-regulated as well. It has been previously 
discussed that amino acid synthesis, especially that of glutamate, and putrescine release are signals 
of hyperosmotic stress (Koegel, 2008). We identified positively deregulated genes associated with 
glutamine/glutamate synthesis as well (glnH, glnP and gltI) corroborating that the common 
deregulation of potF is not a coincidence. The fifth and last subcluster of commonly deregulated 
genes in milk whey relative to DMEM included mainly genes of comparably high expression levels. Of 
these, the most expressed genes were artJ, glnH and metF associated with arginine, glutamate and 
methionine synthesis while expression of gdhA and iaaA was also up-regulated and required for 
amino acid transport and processing. Furthermore, genes whose encoded proteins are involved in 
energy metabolism (lipA) as well as membrane/associated proteins (nuoA, yagU and ydjN) showed a 
common intense expression. 
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Figure 31: Differential expression of E. coli genes in DMEM and milk whey. 
Hierarchical cluster plot showing differentially expressed genes of mastitis E. coli strains 1303 and 
ECC-1470 upon 1 h incubation at 37°C in DMEM cell culture medium in comparison to milk whey 
from an udder-healthy cow. Each bar represents one gene and its normalized expression level is 
colored according to the color bar. The datasets for each strain and condition are obtained from 
bROC analysis to discover differentially expressed genes. Genes with CONF > 0.95 are considered to 
be differentially expressed. 
 
 
While the individual expression levels of commonly deregulated genes differed in milk whey, the 
transcriptional response to milk whey from an LPS-challenged cow was more uniform in both strains 
(Figure 32). The genes deregulated in E. coli strains 1303 and ECC-1470 were not only commonly 
deregulated, but revealed also similar expression levels in both strains when incubated one hour in 
either DMEM or milk whey +LPS. The average expression level of the genes in milk whey +LPS was 
comparably higher relative to that observed in pure milk whey (Figure 31). Commonly deregulated 
genes were allocated to two main clusters and various subclusters.  
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Figure 32: Differential expression of E. coli genes in DMEM and milk whey +LPS. 
Hierarchical cluster plot showing differentially expressed genes of mastitis E. coli strains 1303 and 
ECC-1470 upon 1 h incubation at 37°C in DMEM cell culture medium in comparison to milk whey 
from a cow´s udder challenged with LPS. Each bar represents one gene and its normalized expression 
level is colored according to the color bar. The datasets for each strain and condition are obtained 
from bROC analysis to discover differentially expressed genes. Genes with CONF > 0.95 are 
considered to be differentially expressed. 
 
 
Highest expression has been identified within the subclusters comprising genes coding for 
components of the 50S and 30S ribosomal subunits (rpl, rpm and rps). Further commonly 
deregulated genes among these subclusters included the hypothetical protein-encoding gene ydiY 
0 12027
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and the genes aceE, lipA and ptsG required for energy metabolism. Although not really clustered, we 
again identified repression of gene expression associated with amino acid synthesis (argB, artJ, glnH, 
glnP, gltI and pepE).  
Down-regulated genes involved in iron acquisition clustered in the second main cluster (bioB, cirA, 
entE, entF, fecI, fecR, fes, fhuA, fhuF and mntH). In contrast, ftnA encoding a cytoplasmic iron storage 
protein was not commonly down-regulated, but significantly up-regulated. The gene ftnA thereby 
represents the only gene associated to iron processing, that was exclusively up-regulated in milk 
whey +LPS, but not in pure milk whey. The cluster analysis also revealed a common up-regulation of 
genes (citC, citF and citG) involved in citrate utilization. Up-regulation of these genes was already 
identified in milk whey, but clustering occurred only when deregulated milk whey +LPS. 
 
In order to examine whether genes were commonly deregulated in milk whey +LPS relative to milk 
whey, a third heat map depicts the deregulated genes between these two conditions (Figure 33). As 
much as both mastitis isolates displayed distinct transcriptional levels of the deregulated genes when 
incubated in milk whey (Figure 31), the transcriptional pattern of differentially expressed genes 
between milk whey +LPS and milk whey was highly erratic. Nevertheless, the cluster analysis 
revealed two subclusters of commonly deregulated genes depicting the general trend of either up- or 
down-regulation of these genes and whether their expression was comparably high or low. 
The first (blue) subcluster reflects mainly down-regulated genes involved in amino acid synthesis and 
–utilization (Figure 33). Notably, artJ encoding the arginine binding protein 1 was also negatively 
deregulated but was not assigned to the same cluster, but to cluster two instead. This may be due to 
the still much higher expression level in milk whey +LPS than in milk whey despite the -2.7 fold 
change relative to milk whey (also noted in Table 15 on page 130). 
The second cluster shows a down-regulation of the peptidase encoding gene iaaA reflecting catabolic 
amino acid processes. This might vice versa support the notion of enhanced amino acid biosynthesis 
as suggested by increased gene expression of relevant genes. Cluster 2 comprised the DNA-binding 
transcriptional repressor gene iscR but also ydjN coding for an uncharacterized symporter protein. 
Both genes were negatively deregulated.  
The hierarchical cluster analysis of the transcriptional response of E. coli strains 1303 and ECC-1470 
to DMEM, milk whey and milk whey +LPS revealed not only commonly deregulated genes relative to 
DMEM, but also sample-specific differences in gene expression patterns. Deregulated genes that 
were clustered indicate a common deregulation of genes associated with amino acid metabolism and 
iron utilization. 
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Figure 33: Differential expression of E. coli genes in milk whey and milk whey +LPS. 
Hierarchical cluster plot showing differential expression of genes of mastitis E. coli strains 1303 and 
ECC-1470 upon 1 h incubation at 37°C in milk whey from an udder-healthy cow in comparison to milk 
whey from a cow´s udder challenged with LPS. Each bar represents one gene and its normalized 
expression level is coloured according to the colour bar. The datasets for each strain and condition 
are obtained from bROC analysis to discover differentially expressed genes. Genes with CONF > 0.95 
are considered to be differentially expressed. 
 
 
In contrast, genes associated with carbon utilization (e.g. citrate) or energy metabolism, change of 
growth phase (including programmed cell death), as well as genes encoding inner membrane 
proteins and hypothetical proteins have not been grouped together by hierarchical clustering. Genes 
associated with stress response (oxidative, osmotic or acidic), however, clustered together. The 
distinct high expression level of particular commonly deregulated genes (Figure 31, Figure 33) may 
reflect that both strains were not really biological replicates. Individually deregulated genes might 
rather indicate strain-specific properties than a common transcriptional response. Besides their 
distinct genome content, E. coli strains 1303 and ECC-1470 are diverse in that both isolates caused a 
different aetiological outcome of mastitis. It has been shown that they, nevertheless, employ a 
common transcriptional activity in response to milk whey. This has been depicted by the heat maps. 
Genes that were commonly deregulated indicate expression of the same or related cellular processes 
in response to growth in DMEM or milk whey or milk whey +LPS. 
 Functional classification of deregulated genes 
In order to examine what cellular processes were reflected by the transcriptional response to milk 
whey and milk whey +LPS, we evaluated the differentially expressed genes according to their 
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functional classification. The deregulated genes were assigned to functional categories (Figure 34) 
based on the Clusters of Orthologous Genes (COG) designations as suggested by (Yoder-Himes et al., 
2009). It is further suggested that the COG categories might reflect bacterial expression patterns in 
response to the environmental or bactericidal conditions in milk whey, or milk whey +LPS to 
countermeasure the cow´s immune response. The biggest fraction of genes deregulated under both 
conditions was assigned to category “Amino acid metabolism and transport” (E). Interestingly, 
differentially expressed genes representing “Translational associated functions” (J) were exclusively 
deregulated upon growth in milk whey +LPS. Besides categories C, G, J, K and M, the amount of 
deregulated genes was always higher when bacteria were incubated in milk whey than in milk 
whey +LPS. Thus, this suggests that bacterial growth in milk whey +LPS required more energy 
production and conversion as well as carbohydrate metabolism and transport than in milk whey. 
 
Figure 34: Functional classification of deregulated genes of E. coli mastitis isolates 1303 and 1470 in 
milk whey and milk whey +LPS. The numbers of genes belonging to the individual COG categories are 
depicted as total number of deregulated genes in the respective experimental set. Grey bars 
represent the total portion of the 88 different deregulated genes as revealed by the Venn diagram 
and may comprise genes deregulated in more than one of the experimental sets. COG designations 
are listed in Table 16. 
 
Table 16: Clusters of Orthologous Genes COG classification 
C Energy production and conversion M Cell wall/membrane/envelop biogenesis 
E Amino acid metabolism and transport O Post-transl. modification, protein turnover, chaperone funct. 
F Nucleotide metabolism and transport P Inorganic ion transport and metabolism 
G Carbohydrate metabolism and transport Q Secondary structure 
H Coenzyme metabolism U Intracellular trafficking and secretion 
J Translation R General functional prediction only 
K Transcription S Function unknown 
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V.6.6. The transcriptional response to milk whey and milk whey +LPS 
Investigating the transcriptional response of mastitis E. coli isolates 1303 and ECC-1470 to milk whey 
and milk whey +LSP one could expect diverse adaptations to the conditions conveyed by these media 
in contrast to a less hostile environment. The functional classification based on COG designations 
defined cellular processes, which were affected by growth under these conditions. However, specific 
cellular processes, which could be interpreted as a response to milk whey or milk whey + LPS, could 
not be revealed by this. In order to gain insight into the particular processes involved, it was 
necessary to categorize the identified deregulated genes according to their biological role. In Table 
17, the genes that were deregulated in milk whey and milk whey +LPS are listed according to (i) their 
gene symbol, (ii) the cellular compartment(s) of the encoded protein and (iii) their molecular 
function. The same color code indicates the assigned categories. The correlation of up- or down-
regulation of the expression of genes with their function and cellular localization made it possible to 
gain a surprisingly detailed view of what actually occurred in the mastitis E. coli isolates 1303 and 
ECC-1470 when grown in milk whey or in milk whey +LSP. 
 Iron utilization 
Bacterial determinants that were categorized to be involved in iron uptake and -utilization 
represented the major fraction of deregulated genes. It has been suggested before, that mastitis 
isolates need to cope with harsh nutritional conditions in mammary secretions like iron shortage 
mediated by lactoferrin (Latorre et al., 2010). Surprisingly, both strains exhibited a marked repression 
of genes involved in iron uptake and utilization (Table 17). Among them, genes of the siderophore 
gene clusters encoding the components of the enterobactin (ent) and the ferric di-citrate transport 
system (fec) as well as siderophore receptor gene cirA were determined. Especially, we identified 
negatively deregulated regulatory determinants of the fec siderophore cluster. fecI encodes a 
specialized sigma factor and fecR is known to encode the regulator of the fec operon (Enz et al., 
1995). Due to our assumption, that iron acquisition might be advantageous for survival and growth in 
mammary secretions, especially in presence of lactoferrin, it was rather surprising to find iron uptake 
systems to be down-regulated in E. coli in milk whey or in milk whey +LPS. Notably, ftnA which 
encodes a ferritin iron storage protein was the only gene associated with iron utilization that was 
positively deregulated in milk whey +LPS, but was not deregulated in milk whey relative to DMEM. At 
least, ftnA expression might indicate an increase in iron scavenging host proteins dissolved in 
mammary secretions when LPS has been sensed. De facto, we state that iron availability did not 
represent a key factor for E. coli mastitis isolates in mammary secretions at this stage. The expression 
of genes involved in iron utilization appeared to be of rather minor importance during the initial 
growth of E. coli than at later stages of infection.   
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Table 17: Functional processes important for growth of E. coli genes in milk whey and milk whey +LPS 
as reflected by differential gene expression relative to growth in DMEM medium 
Gene Annotations - Protein product Category Compartment 1) 2) 3) 
yhaO transport protein Yha, AA/proton symporter amino acid transport inner membrane       
argB acetylglutamate kinase arginine biosynth. cytosol       
argC N-acetyl-gamma-glutamyl-phosphate reductase arginine biosynth. cytosol       
argI ornithine carbamoyltransferase arginine biosynth. cytosol       
argT lysine/arginine/ornithine transporter subunit arginine biosynth. perplasmic space       
artI putative ABC transporter arginine-binding protein 2 arginine biosynth. perplasmic space       
artJ ABC transporter arginine-binding protein 1 arginine biosynth. perplasmic space       
gdhA NADP-specific glutamate dehydrogenase glutamate biosynth. cytosol       
glnQ glutamine transport ATP-binding protein GlnQ glutamine biosynth. inner membrane       
glnP glutamine transport system permease protein glnP glutamine biosynth. inner membrane       
glnH glutamine-binding periplasmic protein glutamine biosynth. perplasmic space       
gltI glutamate/aspartate periplasmic-binding protein glutamine biosynth. perplasmic space       
metF 5, 10-methylenetetrahydrofolate reductase methionine biosynth. cytosol       
iaaA isoaspartyl peptidase peptidase cytosol       
pepE (alpha)-aspartyl dipeptidase peptidase cytosol       
fruK 1-phosphofructokinase energy metabolism cytosol       
gpmA 2, 3-bisphosphoglycerate-dependent phosphoglycerate mutase energy metabolism cytosol       
lipA lipoyl synthase, cofactor of pyruvate dehydrogenase energy metabolism cytosol       
aceE pyruvate dehydrogenase, decarboxylase component E1 energy metabolism cytosol, membrane       
frdD fumarate reductase (anaerobic),  membrane anchor subunit energy metabolism inner membrane       
ptsG 
fused glucose-specific PTS enzymes: IIB component 
/ IIC component 
energy metabolism inner membrane       
nuoA NADH:ubiquinone oxidoreductase,  membrane subunit A energy metabolism inner membrane       
citC [citrate [pro-3S]-lyase] ligase citrate utilization cytosol       
citE citrate lyase,  citryl-ACP lyase (beta) subunit citrate utilization cytosol       
citF citrate lyase,  citrate-ACP transferase (alpha) subunit citrate utilization cytosol       
citG 2-(5''-triphosphoribosyl)-3'-dephosphocoenzyme-A synthase citrate utilization cytosol       
citX apo-citrate lyase phosphoribosyl-dephospho-CoA transferase citrate utilization cytosol       
ygeO type III secretion apparatus system protein virulence associated 
inner membrane, 
outer membrane  
      
tsx nucleoside channel, receptor of phage T6 and colicin K, porine virulence associated 
inner membrane, 
outer membrane  
      
rplB 50S ribosomal subunit protein L2 exponential growth cytosol       
rplD 50S ribosomal subunit protein L4 exponential growth cytosol       
rplF 50S ribosomal subunit protein L6 exponential growth cytosol       
rplI 50S ribosomal protein L9 exponential growth cytosol       
rplR 50S ribosomal subunit protein L18 exponential growth cytosol       
rplS 50S ribosomal subunit protein L19 exponential growth cytosol       
rplV 50S ribosomal subunit protein L22 exponential growth cytosol       
rplW 50S ribosomal subunit protein L23 exponential growth cytosol       
rpmC 50S ribosomal subunit protein L29 exponential growth cytosol       
rpmI 50S ribosomal subunit protein L35 exponential growth cytosol       
rpsE 30S ribosomal subunit protein S5 exponential growth cytosol       
rpsG 30S ribosomal protein S7 exponential growth cytosol       
rpsI 30S ribosomal subunit protein S9 exponential growth cytosol       
rpsN 30S ribosomal subunit protein S14 exponential growth cytosol       
rpsR 30S ribosomal protein S18 exponential growth cytosol       
rpsS 30S ribosomal subunit protein S19 exponential growth cytosol       
Up-regulation (red) or down-regulation (blue) of two-group comparison experiments of deregulated genes                                                   
1) milk whey IRT DMEM, 2) milk whey +LPS IRT DMEM, or 3) milk whey +LPS IRT milk whey. 
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Gene Annotations - Protein product Category Compartment 1) 2) 3) 
entE 2, 3-dihydroxybenzoate-AMP iron acquisition 
inner membrane, 
cytosol, membrane 
      
entE ligase component of enterobactin synthase complex iron acquisition 
inner membrane, 
cytosol, membrane  
      
entF enterobactin synthase component F iron acquisition 
inner membrane, 
cytosol, membrane  
      
fhuF ferric iron reductase involved in ferric hydroximate transport iron acquisition 
 inner membrane, 
cytosol, membrane  
      
bioB biotin synthase iron acquisition cytosol       
bioF 8-amino-7-oxononanoate synthase iron acquisition cytosol       
fecI 
KpLE2 phage-like element 
/ RNA polymerase,  sigma 19 factor 
iron acquisition cytosol       
fes enterobactin/ferric enterobactin esterase iron acquisition cytosol       
sufA Fe-S cluster assembly protein iron acquisition cytosol       
mntH manganese/divalent cation transporter iron acquisition inner membrane       
cirA catecholate siderophore receptor CirA,  colicin I receptor iron acquisition 
inner membrane, 
outer membrane 
      
entC / 
fepF 
isochorismate synthase entC iron acquisition 
inner membrane, 
cytosol, membrane 
      
fepA iron-enterobactin outer membrane transporter iron acquisition outer membrane       
fhuA ferrichrome-iron receptor iron acquisition outer membrane       
fecR 
KpLE2 phage-like element 
/ transmembrane signal transducer for ferric citrate transport 
iron acquisition perplasmic space       
yncE protein YncE involved in iron acquisition iron acquisition perplasmic space       
ftnA ferritin iron storage protein (cytoplasmic) iron storage cytosol       
cpxP 
inhibitor of the cpx response 
/ periplasmic adaptor protein 
REGULATOR 
periplasmic space, 
cytosol 
      
flhC DNA-binding transcriptional dual regulator with FlhD RGEULATOR cytosol       
hycA regulator of the transcriptional regulator FhlA REGULATOR cytosol       
iscR DNA-binding transcriptional repressor of the iron sulfur cluster REGULATOR cytosol       
rmf ribosome modulation factor REGULATOR cytosol       
potF putrescine-binding periplasmic protein stress, multiple 
periplasmic space, 
membrane  
      
potD polyamine transp. Subunit/ binding compon. of ABC superfamily stress, multiple perplasmic space       
ydiY predicted outer membrane protein,  acid-inducible stress, acid outer membrane       
yagU inner membrane protein yagU stress, acid resist inner membrane       
cutC copper homeostasis protein CutC stress, detoxific. cytosol       
yjbJ UPF0337 protein yjbJ stress, osmotic cytosol       
nrdH hydrogen donor for NrdEF electron transport system stress, oxidative cytosol       
nrdI flavodoxin required for NrdEF cluster assembly stress, oxidative cytosol       
osmC lipoyl-dependent Cys-based peroxidase, hydroperoxide resist. stress, oxidative cytosol       
ecnB entericidin B membrane lipoprotein stress, cell death inner membrane       
cysD sulfate adenylyltransferase subunit 2 sulfate assimilation cytosol       
cysH phosphoadenosine phosphosulfate reductase sulfate assimilation cytosol       
cysJ sulfite reductase [NADPH] flavoprotein alpha-component sulfate assimilation cytosol       
cysA sulfate/thiosulfate import ATP-binding protein CysA sulfate assimilation 
cytosol, inner 
membr. 
      
cysU sulfate/thiosulfate transporter subunit sulfate assimilation inner membrane       
cysP thiosulfate-binding protein sulfate assimilation perplasmic space       
codA cytosine deaminase nucleotide synth. cytosol       
yjjZ uncharacterized protein involved in nitrogen metabolism uncharact. protein cytosol       
ybgE hypothetical protein ybgE uncharact. protein inner membrane       
ydjN uncharacterized symporter ydjN uncharact. protein inner membrane       
yjiH hypothetical protein yjiH uncharact. protein inner membrane       
ylaC inner membrane protein ylaC uncharact. protein inner membrane       
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 Exponential growth 
14 genes were allocated to COG category J (translation) and two more genes (rpmC and rpmI) could 
be identified to encode components of ribosomal subunits as well, meaning that they have to be 
assigned to the same functional category. The common positive deregulation of genes (rpl, rpm and 
rps) encoding components of ribosomal subunits indicates a markedly increased translational 
activity. It, therefore, has to be assumed that cultivation in milk whey rather than in DMEM resulted 
in increased growth of both mastitic isolates. One explanation might be that DMEM initially provided 
good nutritional conditions while E. coli that were introduced into milk whey needed more time to 
adapt to the altered nutrient composition and availability. Consequently, this might have caused an 
extended lag-phase relative to that of E. coli grown in DMEM. Another possibility might be that E. coli 
mastitis isolates sense the presence of particular components of milk whey and react in a way trying 
to outrun the antimicrobial conditions by increased growth rates.  
 Carbon compound and energy metabolism  
Increased growth rates are a common and advantageous attribute of ExPEC when new niches have to 
be colonized. It has been suggested that adaptation to new main carbon sources also alters the 
transcriptional profile of carbon metabolism-related genes. The fruK gene represents the only gene 
associated with carbon catabolism, which was negatively deregulated in milk whey or in milk 
whey +LPS relative to DMEM. Specifically, fruK encodes the 1-phosphofructokinase, which is not only 
one of the most important regulatory enzymes of glycolysis, but also essential for the utilization of 
fructose as a carbon source (Buschmeier et al., 1985). It should be noted that glucose and fructose 
phosphotransferase systems (PT-systems) are constitutively expressed in E. coli. The decreased 
expression of fruK suggests that both E. coli mastitis strains have indeed adapted to altered carbon 
sources during 1h of incubation in milk whey where glucose concentrations are substantially lower 
than in DMEM. Additionally, the phosphoglycerate mutase-encoding gene gpmA, which is also 
involved in glycolysis, was down-regulated in milk whey after LPS challenge. On the contrary, other 
genes involved in primary carbon energy metabolism, such as aceE, frdD, lipA and ptsG were 
positively deregulated mainly in milk whey +LPS. A possible explanation may be that these genes 
were required for the utilization of carbon sources that have become available or that were 
preferred in contrast to carbon sources that were diminished. Moreover, it can be speculated that 
E. coli which encountered increased adverse conditions, at least in comparison to growth in DMEM, 
are likely to be in need for more energy to compensate for the adaptation to these conditions and 
the increased transcription. The required energy might be provided by the pyruvate dehydrogenase 
AceE (supported by cofactor lipoate from LipA lipoatesynthase) linking the glycolysis to the citric acid 
cycle and, consequently, releasing energy via NADH. At least nuoA encoding for NADH:ubiquinone 
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oxidoreductase subunit A was positively deregulated in pure milk whey as well and further 
corroborates the impression of enhanced energy metabolic activity. 
 Citrate: a readily available and utilized carbon source in mammary secretions 
Besides deregulated genes of the primary carbon energy metabolism, genes of the cit operon (citM-
citCDEFXG) have been positively deregulated in milk whey and in milk whey +LPS. Increased 
expression of the cit operon, which encodes the citrate lyase complex, implies that its transcription 
enabled utilization of citrate as a carbon source. In the past, different coliform bacteria that cause 
mastitis were characterized by their mobility and their ability to utilize citrate. Accordingly, E. coli was 
supposed to be a citrate-negative microorganism which cannot grow on citrate as the sole carbon 
source (Hogan and Smith, 2003; Hogan et al., 1999). However, citrate-positive E. coli isolates from 
the environment, humans, feral birds, domestic animals and cattle have been reported decades 
before (Ishiguro et al., 1979; Ishiguro et al., 1978). In E. coli, the cit cluster comprises the genes 
encoding the citrate lyase (citDEF), which we found to be up-regulated and citT coding for the 
citrate/succinate antiporter CitT (Figure 35). In contrast to E. coli, other bacteria are able to grow on 
citrate as the sole carbon and energy source (Martín et al., 2004). Because E. coli lacks the genes 
encoding the oxaloacetate decarboxylase, its citrate fermentation is dependent on an oxidizable co-
substrate (Lütgens and Gottschalk, 1980). Lütgens and Gottschalk found that citrate was fermented 
by citrate-positive E. coli if a second substrate, such as glucose, lactose or lactate, was present. 
Knowing that citrate and lactose are abundant in mammary secretions, the deregulation of the cit 
cluster in milk whey and milk whey +LPS reflects a metabolic adaptation to citrate as a substantial 
carbon source in mammary secretions. It is further suggested that the presence of the cit cluster 
enables E. coli to multiply independently from carbon and energy sources other than citrate and 
lactose, thus providing a growth advantage over E. coli that lack the cit cluster.  
It has, nonetheless, to be admitted that neither citA nor citB were deregulated in milk whey or milk 
whey +LPS compared with the DMEM sample, although the cit cluster is known to be regulated by 
the sensor kinase CitA and the response regulator CitB (Bott, 1997). Thus, it is recommended to 
investigate various E. coli isolates, from bovine mastitis and bovine faecal samples, particularly with 
regard to a correlation of the presence and deregulation of the cit cluster with an increased fitness of 
E. coli mastitis isolates. 
Figure 35: E. coli genes required for citrate fermentation. Genes shaded in light gray are those 
present only in the E. coli cit cluster, but not in cit clusters of K. pneumoniae, L. mesenteroides, 
W. paramesenteroides and L. lactis. The citDEF genes, coding for the citrate lyase, are highly 
conserved in the different cit clusters. Modified scheme as published by (Pos et al., 1998).  
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 Amino acid biosynthesis 
As shown in Figure 34, the majority of the genes with significant changes after incubation in milk 
whey and in milk whey +LPS were required for amino acid biosynthesis or -utilization. In contrast to 
the 19 deregulated genes, that have been associated with amino acid biosynthesis, transport and 
metabolism according to the COG classification, four genes of that category were reassigned to other 
processes, because of their biological functions: cysD and cysH were allocated to sulfate assimilation, 
and potD and potF were grouped to stress related determinants. The 15 remaining genes were 
individually assigned to different amino acid pathways  
Arginine biosynthesis: The deregulated genes argB, argC, argI, argJ, argT, artI and artJ reflect 
arginine biosynthesis. Most genes (argC, argI, argJ, argT and artJ) were up-regulated, whereas argB 
was exclusively down-regulated and artI was exclusively up-regulated in milk whey +LPS relative to 
DMEM. Both genes were not deregulated in milk whey compared to DMEM. As mentioned before, 
artJ expression was approximately two-fold increased in milk whey compared to its up-regulation in 
milk whey +LPS (corroborated by its down-regulation in milk whey +LPS relative to milk whey). Thus, 
arginine biosynthesis has clearly been influenced to a greater extend by incubation in milk whey 
while the same influence was apparently abolished, at least altered, in milk whey +LPS. We propose 
that arginine biosynthesis is considered subordinate when mastitic E. coli are forced to cope with the 
conditions in LPS-challenged mammary secretions, in which the concentration of antimicrobial 
components are increased. Nevertheless, genes involved in arginine biosynthesis were deregulated 
in both milk whey and milk whey +LPS, suggesting that the ability to synthesize or acquire arginine in 
milk whey is important. It raises the question what virulence- or fitness-associated function arginine 
biosynthesis may convey during the initial stages of E. coli mastitis? Regarding its role in human 
ExPEC, a previous study on UPEC reported a marked increase in artJ expression when grown in 
human urine. Because arginine concentrations are limited in urine, they emphasized that the ability 
of E. coli to synthesize or acquire arginine is important for virulence in the urinary tract (Russo et al., 
1999). This was supported by the notion that experimentally determined arginine concentrations in 
adult urine ranged from 3.8 to 90 nmol/ml and resulted in reduced growth of E. coli, decreased by 50 
to 90 % of the maximum population density (Russo et al., 1996). Nevertheless, arginine limitation is 
unlikely to occur in mammary secretions. Although the de facto arginine concentration of the milk 
whey used in the present study has not been evaluated, the approximate arginine concentration in 
nonfat milk is about 7.3 µmol / ml according to http://nutritiondata.self.com. Thus, it can be 
assumed that it is 245-fold higher in milk whey than in human urine. Here, a better explanation for 
increased arginine biosynthesis would probably be that arginine is prerequisite for one of the three 
main enzyme-based acid resistance pathways comprising the arginine-decarboxylase pathway (Zhao 
and Houry, 2010). The increased transcription of biosynthetic enzymes providing arginine for further 
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utilization in the acid stress response would also be in line with the positively deregulated genes ydiY 
and yagU in milk whey.  
Glutamine / glutamate biosynthesis: 
Besides the arginine-decarboxylase pathway, the glutamine- and lysine-decarboxylase pathways are 
utilized in acid resistance. We found a 3 to 4-fold increase of the transcriptional level of deregulated 
genes involved in glutamine biosynthesis (glnH, glnP, glnQ, gltI and gdhA) in milk whey and in milk 
whey +LPS relative to DMEM. A marked difference between the corresponding expression levels in 
milk whey and milk whey +LPS was not detected. Utilization of glutamine in enzyme-based acid 
resistance pathways is in line with other observations described before. Moreover, E. coli temporarily 
accumulates glutamate, which can be obtained from glutamine, as a compatible solute to outweigh 
the K+-ions influx due to hyperosmotic conditions (Koegel, 2008). This is further in line with the 
positively deregulated expression of gdhA, which is involved in glutamate biosynthesis. Expression of 
gdhA is increased upon hyperosmotic stress when glutamate dehydrogenase encoded by gdhA can 
provide a steady-state to external pH effects. 
 
Increased peptidase activity is reflected by increased transcriptional level of the genes iaaA and 
pepE which both encode peptidases specific for N-terminal aspartic dipeptides. The in vivo 
contribution of the iaaA and pepE gene products to the utilization of N-terminal aspartic peptides is 
unknown, but allowed Salmonella strains not deficient of N-terminal aspartyl hydrolyzing peptidases 
to grow on aspartyl-leucine as a leucine source. Moreover, iaaA represents the first gene of an 
operon that also encodes a putative ATP-binding cassette transporter suggesting that peptide 
catabolism is an additional function of IaaA (Larsen et al., 2001). As the complex nutritional 
conditions in milk whey and in milk whey +LPS remain to be analyzed in detail, we might emphasize 
that the iaaA and pepE gene products contribute to the transport and utilization of aspartic peptides 
in E. coli to enable the utilization of additional sources of amino acids. The idea that E. coli 1303 and 
ECC-1470 have to rely on other amino acid sources in mammary secretions is supported by the 
marked negative deregulation of yhaO in milk whey and in milk whey +LPS. The yhaO gene encodes a 
still uncharacterized member of the STP transporter family, which is located downstream of the tdc 
operon including the gene for the TdcC threonine transporter of the STP family. It can be speculated, 
that the utilization of compounds transported by YhaO, is less beneficial in milk whey than it might 
be in DMEM.  
Altogether we can state, that the deregulated genes that can be correlated with amino acid 
biosynthesis or processing reflect first processes associated to stress response, and secondly an 
adaptation to altered nutritional conditions. Whether the particular transcriptional profiles in milk 
whey and in milk whey +LPS have been influenced by either the inhibitory traits conveyed by milk 
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whey or whether they represent a more general adaptation to the growth medium in terms of 
nutrition and biochemical milieu, needs to be verified. 
 Sulfate assimilation 
Several genes under control of the cysteine regulon were found to be positively deregulated in milk 
whey compared to DMEM, but showed no deregulation in milk whey +LPS relative to DMEM. 
cysAUWcysP codes for a sulfate transporter that belongs to the ATP-Binding Cassette (ABC) 
superfamily of transporters (Wu and Mandrand-Berthelot, 1995). Its expression enables utilization of 
both sulfate and thiosulfate as a sole sulfur source, but does not correspond to the challenges 
provided by milk whey or milk whey +LPS discussed before. Moreover, the expression of the genes 
cysJH was in line with expression of the other deregulated cys genes, though they belong to a 
different transcriptional unit. Expression of cysJH is known to be inhibited by oleanolic and ursolic 
acid which in turn affect the expression of the cysteine regulon and the stress response (Grudniak et 
al., 2011). So far, a possible role in stress response is the only function that can be anticipated in the 
present context. The expression profile of the deregulated cys genes can, nonetheless, not be 
correlated to particular processes other than stress. 
 Virulence associated factors 
Virulence factors could not be identified as to be encoded among the significantly deregulated genes, 
although two genes (ygeO and tsx) with a virulence-associated function appeared to be deregulated. 
The gene ygeO  encodes a type three secretion system (T3SS) apparatus protein, but its gene product 
was also found to be involved in the generation of an E. coli extracellular death factor (EDF) 
(Kolodkin-Gal et al., 2007). Its negative deregulation in milk whey relative to DMEM leads to the 
suggestion that a conversion of EDF release occurred, specifically the MazF-MazE toxin-antitoxin 
system. It will have to be further elucidated what particular role the deregulation of ygeO expression 
plays in this context, especially because the MazF-MazE system causes programmed cell death in 
response to stresses including starvation and antibiotics (Aizenman et al., 1996; Sat et al., 2001). 
The virulence-associated gene tsx was found to be positively deregulated in milk whey +LPS relative 
to DMEM, suggesting a specific bacterial response to compounds increased after LPS challenge. An 
early study reported that tsx encodes a nucleoside channel and functions as a receptor for 
bacteriophages and colicins (Hantke, 1976). The tsx gene product represents a porin protein and 
forms a channel that crosses cellular membrane. The structure, location and distribution on the 
bacterial surface convey different survival strategies to evade immune pressure and to respond to 
antibiotics, which is suggesting a significant role as a pathogenicity effector (Achouak et al., 2001). 
While down-regulation of tsx is not only related to, but also required for iron homeostasis in E. coli 
(Lin et al., 2008), consequences of tsx up-regulation are ill-defined. In addition to the negative 
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deregulation of genes associated with iron assimilation, the tsx down-regulation is in line with the 
finding that iron shortage appears to be no issue for E. coli mastitis strains in milk whey or milk 
whey +LPS. 
 Expression of bacterial regulators in milk whey and milk whey +LPS 
Besides the expression of deregulated determinants, which are grouped together because of either 
biological function or localization in transcriptional units, specific transcriptional regulators were 
deregulated in response to milk whey and milk whey +LPS.  
The cpxP gene product is a highly inducible, negative regulator of the cpx regulon. While 
extracytoplasmic stress is indicated by up-regulated expression of cpxP (Danese and Silhavy, 1998), 
its down-regulation in milk whey might indicate other hostile conditions to the bacterial cell 
envelope. Decreasing CpxP abundance caused has been shown important in Cpx pathway activation 
(Raivio et al., 2000). As CpxP overproduction turns off the cpx response by feedback inhibition (Raivio 
et al., 1999), a cpx response may be induced in turn when cpxP expression is down-regulated. It is 
possible that the Cpx system in E. coli is likewise involved in modulation of cell surface characteristics 
as has been suggested for UPEC strains. There, amongst other functions, the Cpx systems regulates P-
fimbriae expression (Hernday et al., 2004; Hung et al., 2001; Jones et al., 1997). Therefore, 
deregulation of cpxP, as an inducible regulator of the Cpx response, seems to be involved in host-
pathogen interaction although it remains hard to discern its particular contribution to ExPEC 
pathogenicity in general and mastitis in particular. Besides up-regulation of master regulator gene 
flhC required for motility and flagella biogenesis (Stafford et al., 2005; Claret and Hughes, 2002), we 
found no indications for deregulation of cell-surfaces appendages like flagella, pili and fimbria. It can 
be hypothesized that the down-regulation of cpxP in milk whey might be involved in resistance to 
extracytoplasmic stresses (Danese and Silhavy, 1998). Whether the Cpx system regulates expression 
of virulence traits or maintains and modulates the bacterial cell surface in the presence of 
antimicrobial compounds in mammary secretions needs to be elucidated. The Cpx system is at least 
part of a complex network of signaling cascades linked to virulence, various biosynthetic and 
metabolic pathways (Debnath et al., 2013; Hunke et al., 2012; Jung et al., 2012; Buelow and Raivio, 
2010; Gerken et al., 2010; Price and Raivio, 2009; Wolfe et al., 2008; Dorel et al., 2006; Raivio et al., 
2000; Raivio et al., 1999). 
The flhC gene was positively deregulated in milk whey +LPS, but not in milk whey relative to DMEM. 
The FlhC protein is part of the transcriptional dual regulator FlhC-FlhD, which constitutes the master 
regulator of gene expression required for motility and flagella biogenesis (Stafford et al., 2005; Claret 
and Hughes, 2002). Although both traits were discussed to be advantageous for E. coli when passing 
the teat canal as a physical barrier, the genes belonging to the flagellar operons have not been 
detected to be deregulated in E. coli mastitis isolates 1303 and ECC-1470. We might speculate that 
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increased expression of flhC is affecting cell division, biofilm formation and virulence as reported for 
EHEC. In earlier physiological experiments it was confirmed that FlhC reduced the cell division rate, 
the amount of biofilm biomass and pathogenicity in a chicken embryo lethality model (Sule et al., 
2011). The deregulation of flhC as part of the flhDC master operon can, however, be induced in 
response to various stimuli including synthesis of type 1 fimbriae, quorum sensing, high osmolarity 
and catabolic repression (Lehnen et al., 2002; Sperandio et al., 2002; Shin and Park, 1995; Soutourina 
et al., 1999). Our transcriptome analysis could neither confirm nor exclude any of these possibilities. 
Besides flhC, the only positively deregulated regulator-encoding gene was hycA, which was 
exclusively deregulated in milk whey, but not in milk whey +LPS. The hycA gene product is known to 
be the regulator of the transcriptional regulator FhlA. It participates in controlling several genes 
involved in production of the formate hydrogenlyase system. The specific regulative mechanism by 
HycA is unknown. Expression of hycA is activated by formate. HycA may directly interact with the 
FhlA protein and/or prevent the binding of FhlA to activator sequences (Suppmann and Sawers, 
1994; Sauter et al., 1992; Leonhartsberger et al., 2000; Skibinski et al., 2002). Consequently, we 
emphasize that hycA expression of E. coli in mammary secretions might be involved in anaerobic 
respiration. Its regulation target FhlA is required for regulation of expression of the hydN-hypF 
operon, which has been discussed on page 101. 
The DNA-binding transcriptional repressor gene iscR was down-regulated not only in milk whey +LPS 
relative to milk whey, but also in milk whey +LPS relative to DMEM. In particular the “Iron sulfur 
cluster Regulator” is negatively autoregulated and comprises an iron-sulfur cluster that acts as a 
sensor of iron-sulfur cluster assembly (Fleischhacker et al., 2012). In this way, IscR regulates 
expression of more than 40 genes and further expression of operons responsible for a secondary 
pathway of iron-sulfur cluster assembly, iron-sulfur proteins, anaerobic respiration enzymes and also 
biofilm formation (Tokumoto and Takahashi, 2001; Schwartz et al., 2001; Giel et al., 2006; Lee et al., 
2008; Yeo et al., 2006; Wu and Outten, 2009). It has been reported that iscR expression is up-
regulated during biofilm growth of UPEC in urine compared to that during planktonic growth in 
MOPS and urine (Hancock and Klemm, 2007). Considering these functions, it is hard to discern which 
role IscR particularly plays in milk whey +LPS.  
The rmf gene has been negatively deregulated in milk whey samples. This gene does not encode a 
transcriptional regulator, but a “Ribosome modulation factor”. Rmf reversibly converts active 70S 
ribosomes into dimers during the transition from exponential growth to stationary phase. This 
conversion is associated with a decrease in overall translation activity (Wada et al., 1990 and 1995). 
In this analysis, up-regulation of ribosomal subunit genes (rpl, rpm and rps) indicated exponential 
growth in milk whey samples relative to DMEM. Therefore, the decreased transcription rates of rmf 
in milk whey and milk whey +LPs relative to DMEM are in line with this observation. 
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We successfully identified regulator gene codA to be increased in expression in milk whey +LPS in 
comparison to the DMEM samples although no deregulation was determined in milk whey. The codA 
gene is encoding for a cytosine deaminase, which has an enzymatic function in nucleotide and 
nucleoside conversions of the pyrimidine salvage pathway (Ahmad and Pritchard, 1972; de Haan et 
al., 1972). It is known that codA expression is increased by growth on poor nitrogen availability 
(Andersen et al., 1989). The regulation of the codBA operon was more recently described to be 
dependent on the nitrogen assimilation control protein NAC (Muse et al., 2003). However, 
deregulation of the nac gene was not determined in any of the samples investigated in this study. No 
deregulation of nac suggests another reason for codA deregulation, but on the other hand it is ill-
defined whether nac deregulation is required for regulation of codBA expression. Apart from that, 
the codBA operon seems to be regulated as well by the UTP level of the bacterial cell (Turnbough and 
Switzer, 2008). Accordingly, it is difficult to determine exactly which condition led to up-regulation of 
codA expression. Nevertheless, codA up-regulation in the context of LPS-challenged milk whey 
represents an interesting approach to interfere with E. coli growth in udder tissue. In detail, the codA 
gene product is present in prokaryotes, but not in eukaryotes and, thus, CodA may represent a target 
for antimicrobial agents. So far, the cytosine deaminase is being used for suicide gene therapy 
against tumors (Mullen et al., 1992; Austin and Huber, 1993; Dong et al., 1996; Springer and 
Niculescu-Duvaz, 1996). While antibodies against cytosine deaminase are commercially available and 
codA is currently utilized as a negative selection marker for gene disruption in Streptomyces and 
other bacteria (Dubeau et al., 2009), the use of CodA for controlling E. coli mastitis should be 
considered. 
 Stress-related bacterial determinants 
It is postulated that E. coli colonizing the mammary gland, will take advantage of fitness traits, which 
they already possess. It has also been discussed that once present in mammary secretions, E. coli is 
challenged by host factors and altered nutritional conditions that cause stress. Several examples of 
stress response have been observed in our study based on differential expression of particular 
determinants or regulators such as Cpx were discussed in this chapter. Additionally, we successfully 
identified stress-specific determinants that were deregulated as well. 
 Acid stress 
Only two deregulated genes directly associated with stress were up-regulated. In milk whey +LPS it 
was ydiY, which has not been characterized so far. The sequence similarity of hypothetical protein 
YdiY suggests that it is a member of the outer membrane receptor (OMR) family (Zhai and Saier, 
2002). Various virulence-associated determinants appear to be membrane-associated or even 
exposed on the bacterial cell surface. Due to the fact that ydiY was reported as one of two genes, 
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which were induced when E. coli was grown at acidic pH (Stancik et al., 2002), it is likely involved in 
bacterial adaptation by sensing environmental conditions. While acid stress response dependent on 
the ompC and ompF gene products is well described (Pratt et al., 1996; Heyde et al., 2000; Sato et al., 
2000), there is no further information about the biological role of YdiY by today. This and its up-
regulation in response to milk whey +LPS, makes it an interesting candidate that possibly confers 
increased fitness to mastitis and other pathogenic E. coli isolates. We have to admit, however, that 
no deregulation of ompC and ompF could be determined in either E. coli 1303 or ECC-1470 when 
incubated in milk whey or milk whey +LPS, although the presence of these genes in both genomes 
has been confirmed. This is not necessarily a contradiction, because the bacterial stress response 
results from a complex regulatory network allowing the bacteria to fine tune their response to the 
external environment. 
Another gene that could be associated to acid stress and that has been positively deregulated in pure 
milk whey is yagU. Like for ydiY, there is no information about yagU other than that its encoded 
protein comprises a transmembrane region and the gene itself is induced by acidic pH (Kannan et al., 
2008; Hayes et al., 2006). As both ydiA and yagU appear to be up-regulated, in either milk whey or 
milk whey +LPS, it might be interesting to investigate whether the encoded membrane-associated 
proteins confer sensitivity or even resistance to hostile conditions within the mammary gland. On the 
other hand, it has to be admitted that mastitis E. coli, unlike many IPEC, do not have to encounter 
gastric acid or bile salts. 
In contrast to ydiA and yagU, the majority of deregulated genes that could be directly related to 
stress exhibited consequent negative deregulation. Unfortunately we cannot offer an explanation for 
the negative deregulation of cutC in milk whey +LPS. This gene codes for a copper homeostasis 
protein, but there is no information available that connects to detoxification traits advantageous in 
coliform mastitis. 
 Osmotic stress 
Another gene that was negatively deregulated in milk whey +LPS is yjbJ. Under control of the σS 
regulon, its expression is induced under hyperosmotic stress imposed by NaCl under aerobic and 
anaerobic conditions (Weber et al., 2005 and 2006). This seems to be contradictory to the 
consequent up-regulation that was observed for genes of the arginine- and glutamine-decarboxylase 
pathways when incubated in milk whey and milk whey +LPS. Additionally, we did not determine any 
deregulation of rpoS encoding σS. Again, we refer to the fact that E. coli stress response does not rely 
on single determinants, but includes a complex network, which reacts to different stresses. The yjbJ 
gene product has been identified as an appropriate biomarker for matrix-assisted laser desorption 
ionization (MALDI) time-of-flight mass spectrometry (TOF-MS) and, thus, contributes to protein-
taxonomic classification of pathogenic bacteria (Fagerquist et al., 2010). 
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Another osmotic stress-associated gene that we found to be negatively deregulated in milk whey and 
milk whey +LPS, is ecnB, which is part of the entericidin locus of E. coli. While the entericidin A 
lipoprotein EcnA represents the antidote, EcnB is the bacteriolytic entericidin B lipoprotein of EcnAB, 
a linked toxin-antitoxin "addiction module" (Bishop et al., 1998). Together, EcnAB enables regulation 
of bacterial programmed cell death under high osmolarity conditions. The marked down-regulation 
of ecnB in milk whey, relative to DMEM, is once more suggesting that no osmotic stress is about to 
elicit a corresponding response, probably due to the physiologic composition of milk whey itself. 
 Oxidative stress 
It can be anticipated that bacteria approaching mammary secretions are exposed to reactive oxygen 
species (ROS), produced by phagocytes, which directly and indirectly support killing of the 
approaching bacteria (Thannickal and Fanburg, 2000). Moreover, ferrous iron is oxidized by ROS and, 
thus, causes inactivation of iron-cofactored key enzymes in metabolic redox-reactions (Jang and 
Imlay, 2007; Park et al., 2005). Specifically, the E. coli nrdHIEF operon encodes for the alternative 
ribonucleotide reductase NrdEF. The manganese-dependent enzyme NrdEF allows for cell replication 
during iron starvation caused by ROS when the iron-dependent ribonucleotide reductase NrdAB is 
functionally diminished (Martin and Imlay, 2011). We found that nrdH and nrdI, both members of the 
nrdHIEF operon, have been negatively deregulated in milk whey and milk whey +LPS. Specifically, 
nrdH encodes a thiol-based redoxin, which replaces the thioredoxin in ribonucleotide reduction, 
while nrdI encodes the flavodoxin NrdI involved in cofactor maintenance of the ribonucleotide 
reductase (Jordan et al., 1997; Cotruvo and Stubbe, 2008). As the nrdHIEF operon is highly expressed 
during oxidative stress (Monje-Casas et al., 2001; Martin and Imlay, 2011), down-regulation of both 
these genes suggests that no oxidative stress existed in our samples, at least after 1h incubation in 
mammary secretions. This is further corroborated by the negative deregulation of mntH in milk whey 
and milk whey +LPS. Its gene product, the manganese importer MntH, is required by the manganese-
dependent NrdEF. During oxidative stress conditions mntH is strongly induced (Martin and Imlay, 
2011; Kehres et al., 2002). At least, the isogenic mutants of regulatory gene iscR, which we as well 
determined to be down-regulated in milk whey +LPS, have been shown to elicit a decrease in nrdHIEF 
operon transcription (Martin and Imlay, 2011).It has been further suggested that the regulators Fur 
and IscR are opposed regulators for nrdHIEF when oxidative stress mutilates the bacteria. In this 
case, IscR might activate while Fur represses transcription of nrdHIEF. Furthermore, the negative 
deregulation of osmC is in line with the finding of no oxidative stress conditions at 1h in milk 
whey +LPS. The osmC gene product confers peroxidase activity and has been determined sensitive to 
oxidative stress (Lesniak et al., 2003; Conter et al., 2001). We suggest that at least 1h hour after the 
beginning of the incubation in milk whey and milk whey +LPS, the transcriptional response of E. coli 
mastitis strains 1303 or ECC-1470 does not indicate any oxidative stress. Albeit the presence of ROS 
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in milk whey can be anticipated, their concentration may be below the harming threshold. This may 
be due to the fact that milk whey does not comprise any macrophages for ROS production. In this 
case, the negative deregulation of genes associated to oxidative stress can be seen as a feedback 
signal. Thus, it can be concluded that oxidative stress has been overcome by both mastitis strains at 
the very onset of incubation in milk whey.  
 Multiple stresses 
The genes potD and potF belong to the potFGHI operon of the putrescine transport system in E. coli 
(Pistocchi et al., 1993). These genes have been positively deregulated in milk whey and milk 
whey +LPS. Due to the ill-defined relation of putrescine transport, a particular role in putrescine 
catabolism or anabolism is difficult to anticipate. From what is known, putrescine facilitates mRNA 
translation and, thus, contributes to cell viability controlled by Rmf (Terui et al., 2010). Anyhow, the 
Rmf-encoding gene was down-regulated as well in our E. coli transcriptome samples from milk whey 
and milk whey +LPS, the putrescine transport system has also been referred to as a bacterial 
periplasmic transport system. While ribosome modulation occurs in the cytosol, it can be emphasized 
that transcription of the putrescine transport system is more related to another function conferred 
by putrescine. It has been discussed previously, that in addition to amino acid synthesis, the release 
of putrescine is indicating hyperosmotic stress (Koegel, 2008). Furthermore, putrescine is a 
polyamine, which can confer various functions apart from effecting bacterial growth. For example, 
polyamines seem to be involved in the regulation of biofilm development in bacteria (Wortham et 
al., 2007). It is common knowledge that biofilm formation is a protective encasement method to 
shield the bacteria against harsh environmental conditions. This way or another, the identified 
expression of the putrescine transport genes might reflect stress-associated processes in both 
mastitis E. coli strains. A recent study supports that putrescine catabolism is a metabolic response to 
several stresses in E. coli. Among others, nitrogen-limited growth often involves utilization of 
nitrogen sources other than an ammonium salt, such as putrescine or arginine (Schneider et al., 
2013). At least the particular role of polyamines during anaerobic growth is still unknown. 
  
154  RESULTS AND DISCUSSION 
 
V.6.7. Remarks on RNA-Seq 
In the present study we have used high-throughput Illumina sequencing of cDNA, referred to as 
RNA-Seq to comprehensively analyze the transcriptomes of two E. coli isolates from bovine mastitis. 
Previous studies have already proven that RNA-Seq expression measures are highly reproducible by 
qRT-PCR, DNA-microarray and protein expression data obtained by shotgun mass-spectrometry 
(Nookaew et al., 2012; Marioni et al., 2008; Fu et al., 2009). The transcriptome data of the present 
study provided sufficient mRNA expression levels for the successful identification of DEG in mastitic 
E. coli incubated in milk whey to mimic conditions during mastitis infection.  
It should, nevertheless, be noted that serious difficulties might appear when combining different 
sequencing technologies in RNA-Seq-based identification of differentially expressed genes: The 
identification of differentially expressed genes requires high quality genome data and RNA-Seq data, 
since it is well known that accurate mapping is mandatory to estimate gene expression levels 
(Nookaew et al., 2012). From our investigation we can conclude that sequence reads obtained by the 
Illumina platform can hardly be mapped to reference sequences acquired by 454 sequencing 
technology, because the 454 reference sequences are commonly corrupted by incorrect 
homopolymer runs. In consequence, the mapping parameters have to be widened and this 
subsequently affects correct read mapping and inflicts bias to the estimation of expression levels. 
Finally, not only the identification of differentially expressed genes, but the whole transcriptome 
analysis might be biased as well.  
Bottom line, RNA-Seq based transcriptomic is a great advantage in understanding the molecular basis 
of infection and disease caused by E. coli. Furthermore, we hope that the acquired transcriptome 
datasets will be a useful resource to broaden the knowledge of the E. coli research community. 
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VI. GENERAL DISCUSSION 
The present study aimed at the characterization of virulence-associated traits from E. coli model 
mastitis isolates 1303 (acute mastitis) and ECC-1470 (persistent mastitis). It is assumed that 
virulence-associated traits of E. coli mastitis isolates are deregulated during E. coli growth and 
colonization of the bovine udder. Multiple parameters can affect the transcriptional profiles of E. coli 
during adaption. E. coli invading the bovine udder encounter drastically altered environmental 
conditions as well as several host defense mechanisms. Besides the cellular components of the 
immune response, the invading bacteria are challenged by soluble components of the immune 
system. These components mainly comprise numerous defensins, lysozyme, lactoferrin and 
lactoglobulin (Kawai et al., 2013; Piccinini et al., 1999; Chaneton et al., 2008). Moreover, nutritional 
limitations (e.g. iron, nitrogen, carbohydrates etc.) and altered environmental cues, such as oxidative 
agents, osmotic and pH changes, might even challenge the highly versatile E. coli. By facing these 
harsh conditions, E. coli has to successfully sense and quickly adapt. Therefore, E. coli needs to 
respond by appropriate regulation of fitness and virulence-associated traits. 
In order to identify relevant phenotypes or subgroups among the E. coli isolates from mastitis cases 
and from bovine faeces, phenotypic assays have been employed. Additionally, the effect of selected 
milk components was tested. We generated reproducible data by phenotypic assays and 
transcriptome analyses from bacteria incubated in milk whey. Last but not least, the bacterial 
transcriptome in the presence of bovine mammary gland epithelial cells was evaluated. 
VI.1.1. E. coli 1303 and ECC-1470 lack particular virulence-associated genes 
By focusing on two well-known E. coli mastitis strains, E. coli strain 1303 (acute mastitis isolate) and 
ECC-1470 (persistent mastitis isolate), we screened for the presence of virulence factors previously 
associated with mastitis (Table 9). It was found that E. coli 1303 and ECC-1470 differ in their 
individual virulence gene content. Specifically, E. coli 1303 and ECC-1470 lack particular virulence 
genes, which have been correlated with mastitis isolates in previous studies. On the one hand, the 
literature consequently reports rather low frequencies of virulence-associated factors that often do 
not exceed 30 % prevalence (Blum and Leitner, 2013; Silva et al., 2013; Cheng et al., 2012; Dogan et 
al., 2012; Kerro Dego et al., 2012; Fernandes et al., 2011; Suojala et al., 2011; Ghanbarpour and 
Oswald, 2010; Dyer et al., 2007; Wenz et al., 2006; Lehtolainen et al., 2003; Kaipainen et al., 2002; 
Wise et al., 2002; Lipman et al., 1995; Sanchez-Carlo et al., 1984). On the other hand, the total 
virulence potential of a pathogen is often greater than the sum of the individual contributions of 
virulence associated traits. Considering the fact that pathotypes have been defined by the site of 
infection / the niche in which they cause disease, it is widely accepted that virulence and fitness traits 
act synergistically and enable the pathogen to thrive. It can, therefore, be anticipated that the 
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bacterial determinants found to be deregulated in this study belong to a much bigger set of factors 
that promote a successful colonization of the udder. Regarding our transcriptome data from 
incubation in milk whey, the lack of positively deregulated and also of true virulence-associated 
determinants in both of the mastitis isolates indicated that E. coli might have adapted by other 
means to the udder (or at least mammary secretion) as an inflammatory site. We added interesting 
aspects and further knowledge to this topic. 
VI.1.2. Environmental isolates provide a reservoir of potential mammary pathogenic E. coli 
A previous study reported about a subset of environmental isolates, isolated from cows’ 
environment in dairy farms, resembling mastitis isolates according to their growth, but the authors 
used pasteurized milk so that antimicrobial factors were probably neutralized (Blum et al., 2008). 
Thus, a particular causality remains unclear. In the present study, it has been focused on the 
phenotypic characterization of mastitis E. coli isolates relative to isolates from bovine faeces. We 
specifically addressed the question whether mastitis and faecal strains differ in their individual 
fitness traits under selected conditions mimicking those in mammary secretions. Antimicrobial 
factors that E. coli has to encounter during colonization of the udder originate either from blood 
serum or are synthesized in the mammary gland (Sordillo and Streicher, 2002). It is known that all of 
them are heat labile to different degrees and will be inactivated during milk processing, which 
includes severe heat treatment and drying, so that antibacterial factors are probably neutralized or 
confer decreased efficiency (Reiter and Brock, 1975). 
In the present study, native milk whey was prepared from raw whole milk to assess the different 
phenotypic properties and transcriptional changes of selected E. coli isolates upon growth in 
mammary secretions. It has clearly been demonstrated that milk whey exhibits antimicrobial effects 
that are not provided by milk fat compounds or components of the cellular immune response. These 
antimicrobial effects are thought to result from either defensins, lysozyme, lactoferrin and 
lactoglobulin (Kawai et al., 2013; Isobe, Nakamura, et al., 2009; Piccinini et al., 1999; Chaneton et al., 
2008), whereas E. coli revealed to be unsusceptible to lactoglobulin (Chaneton et al., 2011). We also 
challenged selected isolates with iron shortage, lactose as sole carbon source and LAP as a main 
defensin of milk, respectively. 
 Different outcomes of selected E. coli mastitis and faecal isolates in various phenotypic assays  
It has been shown that in terms of fitness in milk whey, E. coli isolates from bovine faeces represent a 
heterogeneous group of which some isolates showed a substantially reduced ability to survive in milk 
whey (group 1), whereas others (group 2) phenotypically resemble mastitis isolates. In contrast, the 
E. coli mastitis isolates represented a phenotypically homogeneous group in that they showed similar 
survival and growth characteristics in milk whey. Interestingly, mastitis isolates did not exhibit such a 
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uniform phenotype in different other phenotypic assays conducted suggesting that these traits other 
than resistance to antimicrobial factors in milk whey are not critical for the establishment of mastitis, 
but they contribute to the overall fitness in milk whey. We clearly demonstrated that faecal isolates 
did not reveal any characterisitic, distinctive features which distinguish them from mastitis isolates 
except the reduced ability of group 1 isolates to survive in milk whey. Neither growth on lactose as 
the sole carbon source, the lactoferrin growth inhibition assay, nor the LAP resistance assay, was able 
to clearly distinguish group 2 isolates from mastitis isolates.  
Following the individual growth characteristics of selected E. coli isolates in milk whey, it became 
obvious that initial survival is more important than growth rates. This can be concluded from the fact 
that the growth curves of mastitis and bovine faecal isolates turned out to resemble each other while 
the initial survival rates considerably differed. Milk whey includes a combination of antimicrobial 
components which may act synergistically or have additive effects. While of the determinants tested, 
LAP as a defensin contributed markedly to decreased bacterial counts, but had only weak effect on 
particular group 2 isolates, it has to be assumed that LAP and other defensins might act in synergy. It 
should be noted that resistance to defensins might be not a general molecular mechanism, but can 
be highly specific to the particular defensin. Besides LAP, there are several other defensins present in 
mammary secretions such as bovine neutrophil β-defensin, tracheal antimicrobial peptide, enteric β-
defensin and bovine β-defensin, while the number of discovered defensins is still increasing (Kawai et 
al., 2013). Their synergistic action in contributing to the total antimicrobial effect of mammary 
secretions can be expected.  
So far, we clearly demonstrated that bovine faecal E. coli isolates represent a heterogeneous group 
of which some isolates showed a substantially reduced ability to survive in mammary secretions 
(group 1), whereas others (group 2) resembled mastitis isolates that constitute a homogeneous 
group regarding their successful survival and growth characteristics in raw milk whey. Our results 
further corroborate the suggestion that some environmental isolates may provide a subgroup of 
E. coli with the potential to thrive in the bovine udder (Blum et al., 2008). Furthermore, we can 
summarize that encountering mammary secretions is a critical step of E. coli intramammary 
colonization. Ongoing bacterial growth and multiplication might be inhibited by components which 
are induced due to host response. Vice versa, bacterial fitness determinants have to be regulated 
during survival in milk whey.  
VI.1.3. Encountering mammary secretions is a critical step to E. coli intramammary 
colonization 
The primary colonization of the host or the inflammatory site in particular is regarded to be a critical 
step of an infection. Before mastitis causing E. coli are able to colonize the milk ducts and mammary 
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tissue, it is first of all important to survive and multiply in mammary secretions, which are known to 
contain antimicrobial compounds.  
In the present study, we clearly demonstrated that milk whey provides antimicrobial effects 
independently from that of milk fat compounds or components of the cellular immune response. The 
bacterial transcriptional response to incubation in milk whey and milk whey +LPS has been assessed 
by RNA-Seq. Both, the total number and the number of exclusively deregulated genes in milk 
whey +LPS were considerably higher than those determined in milk whey in relation to the reference 
sample. Due to increased concentration of antimicrobial factors, because of the LPS challenge, this 
was expected and demonstrated that regulation of bacterial gene expression occurred in response to 
these antimicrobial factors. The identified differentially expressed genes of E. coli strains 1303 and 
ECC-1470 reflected distinct cellular processes including regulatory processes, amino acid biosynthesis 
and utilization, exponential growth, carbon energy metabolism, decreased iron utilization, sulfate 
assimilation, virulence and extracytoplasmic stress. 
 Stress response plays a vital role for initial survival 
Encountering milk whey, the bacteria are challenged by multiple factors that simultaneously exert 
selective pressure. Consequently, E. coli isolates have to induce stress responses. The findings of the 
present study demonstrate regulation on various bacterial stress response genes including the Cpx 
stress response system. The observed deregulation of the expression of the glutamate and arginine 
pathways further corroborates the induction of stress responses upon incubation in milk whey. These 
pathways represent the main enzyme-based acid resistance pathways of ExPEC to compensate for 
acidic pH (Zhao and Houry, 2010).The release of glutamate and putrescine as solutes compensate for 
hyperosmotic stress (Koegel, 2008). The up-regulation of the putrescine transporter gene potF might 
support this suggestion. In line with this, acidic pH can be usually observed during exponential (and 
competitive) growth. We observed acidic pH as well in the presence of bovine mammary gland 
epithelial cells. Furthermore, we identified deregulation of ydiY expression that was reported as one 
of two genes induced when E. coli grows at acidic pH (Stancik et al., 2002). YdiY is likely to be 
involved in survival by sensing environmental conditions. Sensing environmental conditions is a 
prerequisite for pathogenic bacteria, as many of the newly encountered environments or niches 
confer potentially lethal mechanisms and the bacteria have to quickly sense and induce resistance 
against these lethal factors. 
We anticipate that mastitis E. coli isolates modulate their cell surface characteristics by the Cpx 
system in order to improve resistance to extracytoplasmic stress. A similar situation has been 
observed in ExPEC in order to increase fitness and virulence (Debnath et al., 2013).  
Interestingly, all deregulated genes identified, that account for oxidative stress response, were down-
regulated at one hour after inoculation in milk whey and milk whey+LPS. We conclude, that oxidative 
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conditions caused by, e.g. ROS and/or NOS cannot be properly studied in milk whey, because ROS 
and/or iNOS are situationally expressed by cellular components of the host’s immune response, 
which are depleted in milk whey. The obtained growth characteristics revealed similar curve shapes 
that suggest continued bacterial multiplication after the initial time period after inoculation in milk 
whey when defensins seem to be most active.  
On the one hand, it is questionable whether these conclusions on antimicrobial effects in milk whey 
can be simply transferred to the in vivo situation. We emphasize that the causative agents that 
confer antimicrobial effects might constantly be released to different degrees in the mammary gland. 
The release of particular components such as defensins will even be increased (Isobe, Morimoto, et 
al., 2009). In contrast, in milk whey an initial concentration of these antimicrobial agents is provided 
which might be unleashed immediately. Consequently, the antimicrobial activity might be to some 
extent expended and provides a weak or even no further effect.  
Bacterial entry into the udder will immediately elicit a bacterial response depending on the bacterial 
ability to sense the adverse conditions and regulate appropriate fitness traits. It is, therefore, also 
possible that quick adaptation and/or spontaneous, inheritable resistance to antimicrobial agents 
enable unimpeded growth although or even because these agents are further released. Interestingly, 
a previous study demonstrated that E. coli can become spontaneously resistant to AMPs upon in 
vitro exposure to slowly increasing peptide concentrations (Perron et al., 2006). It will be an 
interesting task to follow the bacterial resistance potential to different defensins. Thus far, we have 
not found any evidence for deregulation of genes encoding for extracellular proteases (such as DegP 
or EspP), which constitute obvious bacterial factors, which degrade AMPs. There are several other 
strategies to confer resistance to AMPs besides proteases. These mechanisms are often specific for 
certain peptides, relying on recognition and extracellular capturing or active extrusion of Cationic 
Antimicrobial Peptides (CAMPs) from the bacterial membrane (Peschel and Sahl, 2006). Although 
neither resistance mechanisms nor their deregulation have been determined in the present study, it 
is likely that there is one or more that yet remain unexplored. To which extent such traits will be 
induced by the Cpx stress response system, as it has been reported for Tat-dependent peptidoglycan 
amidases conferring resistance to AMPs in E. coli and Salmonella (Weatherspoon-Griffin et al., 2011), 
remains to be investigated. Against this background, it remains a task to further discern the 
individual contribution of single factors in the milk whey to the total antimicrobial effect of milk 
whey. Together, multiple factors apply simultaneous selective pressure on E. coli initial survival and 
consequent growth. It has been successfully demonstrated for the first time that the initial thriving in 
milk whey represents a critical step in colonizing the bovine udder. 
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VI.1.4. Traits improving bacterial growth in mammary sectretion 
Apart from antimicrobial agents, the limitation of essentials (i.e. by lactoferrin) represents an 
imminent inhibitory factor for bacterial multiplication. 
 Iron shortage does not occur to E. coli during first hours in mammary secretion 
In our lactoferrin growth-inhibition assay, it has been shown that during 7 hours of incubation, 
lactoferrin provides no growth inhibiting effects to E. coli isolates either from mastitis (acute and 
persistent) or bovine faeces. Other studies reported on lactoferrin mediated bacteriostasis after 
markedly longer incubation (Rainard, 1986; Chaneton et al., 2011). Additionally, our transcriptional 
data on E. coli incubation in milk whey and milk whey+LPS indicate rather negative deregulation of 
genes associated with iron assimilation than an increased expression of iron uptake systems. 
Amongst others, genes of the enterobactin iron acquisition system were down-regulated. This is 
somehow surprising, because a previous study reported growth inhibition of E. coli in mammary 
secretions by blocking iron uptake with an antibody specific for the enterobactin receptor (Lin et al., 
1999). This indicates the importance of iron uptake systems in the context of mastitis whereas it can 
be anticipated that other iron uptake or storage properties compensate for the reduced expression 
of enterobactin.  
Furthermore, it has been hypothesized that bacteria approaching mammary secretions are exposed 
to ROS. ROS, produced by phagocytes, directly and indirectly support killing bacteria (Thannickal and 
Fanburg, 2000). Moreover, ferrous iron is oxidized by ROS and, thus, causes inactivation of metabolic 
key enzymes dependent on iron-redox-reactions (Jang and Imlay, 2007; Park et al., 2005). 
Consequently, alternative determinants are required to compensate for that. Vice versa, it can be 
concluded that the down-regulation of determinants that compensate for iron shortage indicates 
sufficient availability of iron. This might be a reasonable explanation for the fact that all differentially 
expressed genes associated with iron assimilation exhibited down-regulation in milk whey and in milk 
whey+LPS. This conclusion is supported by the fact that expression of the alternative ribonucleotide 
reductase NrdEF, which can compensate for the standard ribonucleotide reductase NrdAB during 
iron shortage, was down-regulated. In contrast to the iron-dependent NrdAB, the non-redox enzyme 
NrdEF uses imported manganese to replace iron (Martin and Imlay, 2011). A functional 
ribonucleotide reductase is, however, mandatory for aerobic growth (Jordan et al., 1996). The NrdEF 
supplementary manganese importer MntH can be considered as an indication for iron deficiency and 
it has been down-regulated as well in milk whey. 
Altogether, we conclude that E. coli growth is not impaired by iron shortage in early stages of mastitis 
pathogenesis. Nevertheless, biologically accessible iron might be limited due to lactoferrin. Due to 
the fact that functional iron acquisition systems are considered to be essential in virulence, the 
observed negative deregulation of iron uptake associated genes is surprising. It has been shown 
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previously that iron availability altered the susceptibility of E. coli mastitis isolates to phagocytosis by 
neutrophils, but had no effect on their susceptibility to the bactericidal activity of blood serum (Wise 
et al., 2002). Whether a similar scenario can be assumed for mammary secretions remains yet 
unclear. Our observations suggest that either there is apparently no iron shortage to E. coli in milk 
whey or it confers less impact than initially thought. Especially, rather high concentrations of 
lactoferrin revealed no significant impact on vitality or growth of the isolates tested. These 
observations account for short term incubation in iron-limited media. Martin and colleagues 
reported that the manganese symporter protein MntH, required by NrdAB, failed to be expressed for 
several hours in iron-limited isogenic nrdAB mutants. They concluded that this might be the time 
needed for depletion of E. coli´s cellular iron stores (Martin and Imlay, 2011). 
We have reasons to believe that iron may, however, become limited during later phases of E. coli 
growth in the mammary tissue. In parallel, a recent study reported that the inactivation of the 
biosynthetic pathways of several siderophores (enterobactin, salmochelin and yersiniabactin) 
abolished virulence of ExPEC in a mouse sepsis model indicating that these pathways are essential for 
the survival of ExPEC in vivo (Martin et al., 2013). Thus, we emphasize that expression of genes 
involved in iron assimilation might considerably differ between the initial and ongoing stages of 
mastitis pathogenesis. A first supplementary indication has been described by Lin and colleagues 
who reported that E. coli mastitis isolates share a specific enterochelin-iron retrieval system that 
includes the surface exposed protein FepA. It was expressed on all clinical mastitis isolates tested. A 
FepA-specific vaccine caused immune response in cows and blocked growth of E. coli in synthetic 
medium and dry mammary secretion (Lin et al., 1998 and 1999). Supporting our finding that iron is 
sufficient during initial bacterial growth in milk whey, we observed negative deregulation of the fepA 
gene in milk whey in relation to the DMEM reference sample. The only strictly iron-associated gene 
that was evidently up-regulated in milk whey +LPS, in contrast to the reference samples DMEM and 
milk whey, has been ftnA. The FtnA protein accounts for iron storage and might preserve iron, 
possibly in order to extent the time needed for depletion of E. coli´s cellular iron stores. We suggest 
that down-regulation of genes associated with iron uptake systems, when iron is still accessible or 
sufficient, might save energy costs to the pathogen. It can be anticipated that intramammary E. coli 
will quickly induce the down-regulated determinants that we determined, when iron becomes 
limited in ongoing stages of infection. A confirmation that rather late than early expression of iron 
uptake systems takes place is nonetheless required.  
Together our results changed our view concerning the impact of iron on initial colonization during 
mastitis. It is also conceivable that this model of initial iron independency during transition from the 
environment to the host can be adapted to other ExPEC-caused diseases. 
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 Citrate utilization might be a key factor to E. coli intramammary fitness 
The milk ducts are a physiological environment with loads of antibacterial components and constant 
flow of mammary secretions which requires adhesion capability. From adhesion and invasion assays, 
it is suggested that a rather small portion of bacteria is internalized into the mammary tissue. In 
contrast, a major portion of the bacteria stays and multiplies in the milk ducts and caverns. 
Therefore, successful growth in mammary secretion requires adaptation to the nutritients available 
in milk. It is common knowledge that carbohydrates constitute a main energy source of E. coli. During 
our cocultivation experiments in the presence of host cells, the competition between the host cells 
and the bacteria for glucose and oxygen in the cell culture medium was a dominant feature. In vivo 
host cells are supplied by blood vessels while growing bacteria are initially depending on the 
carbohydrates present in mammary secretion. This suggests that an in vivo competition for nutrients 
is unlikely.  
Citrate and lactose represent the main energy source available in mammary secretions in general. 
Due to the preparation of the milk whey from raw milk, both should have the same carbohydrate 
content. It has been discussed that the ability to utilize citrate might be important for mastitis E. coli 
isolates. Citrate and iron can be imported by the same way via the ferric di-citrate transport system 
(Fec) which we found to be deregulated upon growth in milk whey. By this, high citrate levels can 
compensate for the bactericidal effect of lactoferrin in milk due to the fact that citrate chelates iron 
and can then be taken up by the bacteria. Already imported, citrate becomes a valuable energy 
source, which itself depends on the ability to utilize iron. This trait is mediated by the cit operon. In 
the present study, a strong positive deregulation of the cit operon has been observed when mastitis 
E. coli isolates 1303 and ECC-1470 were incubated in either milk whey or milk whey +LPS. It should be 
noted that normally E. coli cannot grow on citrate as a sole carbon source under aerobic conditions 
and that this phenotypic trait, which has frequently been used to distinguish E. coli from other 
bacterial mastitis isolates (Quandt et al., 2014; Hogan and Smith, 2003; Hogan et al., 1999). However, 
citrate-positive isolates of E. coli from different environments, humans, feral birds, domestic animals 
and, moreover, cattle have been reported decades before (Ishiguro et al., 1979; Ishiguro et al., 1978). 
From the observed deregulation, we conclude that the presence of the cit cluster does enable E. coli 
to multiply independently from carbon and energy sources other than citrate and lactose. Lactose is 
a necessary co-factor for citrate fermentation in E. coli (Lütgens and Gottschalk, 1980). E. coli strains 
that possess the ability to ferment citrate possess a growth advantage relative to E. coli that lack the 
cit cluster, because citrate and lactose are abundant in mammary secretions. This might be 
corroborated by the deregulation observed for genes associated with iron-sulfur cluster biosynthesis, 
which is also mandatory for citrate metabolism. Accordingly, the deregulation of the expression of 
the cit cluster, in milk whey and milk whey+LPS, reflects a metabolic strategy to utilize citrate, which 
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is as a major carbon source in mammary secretions and which might be correlated to increased 
fitness of mastitic E. coli. This trait might also enable mastitic E. coli to outrun many of the host´s 
antibacterial defense measures. Recent in vitro evolution experiments showed that E. coli might gain 
the ability to use abundant citrate in the growth medium after several thousand generations and 
thereby were able to reach a much higher population density in this environment (Quandt et al., 
2014). In summary, we propose that the ability to utilize citrate could represent a critical bacterial 
fitness factor of mastitis isolates required for successful intramammary survival. 
 Role of well-known virulence-associated traits in milk 
In the present study, only a very few genes have been identified to be deregulated upon cultivation 
in milk whey, which could also have a virulence-associated function. These include several outer 
membrane proteins, or proteins associated with the bacterial membrane. Especially those genes that 
encode for protein with a leader sequences required for the Sec-dependent secretion pathway are 
likely to be involved in host-pathogen interaction. Some of them might be therapeutic targets for the 
development of antibiotics or vaccines. The only gene, with a reported virulence-associated function, 
which was positively deregulated in milk whey +LPS, was the tsx gene. Its gene product is a porin that 
is presumably involved in different survival strategies to evade immune pressure and to respond to 
antibiotics. This suggests a significant role as pathogenicity factor (Achouak et al., 2001). The tsx gene 
might be a candidate for further investigation. 
VI.1.5. E. coli adhesion to cultured mammary gland epithelial cells 
This This study clearly demonstrated for the first time that mammary secretions, deficient of cellular 
components and fat, significantly reduced the ability to adhere to mammary gland epithelial cells. 
Given the fact that in vivo adhesion during mastitis is still questionable, the inhibitory effects on 
bacterial adhesion have been almost exclusively related to milk fat (globules) and its components 
(Sánchez-Juanes et al., 2009; Guri et al., 2012; Schroten et al., 1992; Atroshi et al., 1983; Harper et 
al., 1978). In the present study, it has been demonstrated that rather synergistic effects of mammary 
secretion compounds account for the inhibition of bacterial adhesion-inhibition than milk fat alone 
(page 88). 
In order to shed light on which non-cellular components contributed to inhibition of E. coli cell 
adhesion, it was required to test different fractions of whole milk for inhibitory components. 
Assuming that the composition of mammary secretions accounts for growth inhibition, it 
corroborates the hypothesis of the so called “cow factors”. In contrast, distinct growth characteristics 
of mastitis isolates in vitro have been frequently observed (Döpfer et al., 2000; Dogan et al., 2006; 
and the present study). Based on their different adhesion and invasion characteristics, it has been 
hypothesized that E. coli strain 1303 differs from isolate ECC-1470 in either its genome content or the 
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transcriptional activity. Our data indicated that the diverse adhesive properties probably rely on 
other factors than LpfA, which has been formerly presumed to be an important adherence factor 
(Dogan et al., 2012). We found that lpfA has either been missing in genome of Ec 1303 and was not 
expressed in E. coli ECC-1470. Hence, the colonization of the udder is likely to rely on other factors.  
VI.1.6. E. coli 1303 and ECC-1470 differed in their gene expression profiles in the presence 
of mammary gland epithelial cells 
The transient mastitis isolate E. coli 1303 and the persistent mastitis isolate ECC-1470 differed in 
their gene expression profiles in presence of mammary gland epithelial cells (Figure 20). The analysis 
of the bacterial transcriptome under conditions mimicking the presence of udder epithelial cells 
revealed numerous differentially regulated genes relative to the absence of host cells. The identified 
determinants mainly represent cellular processes that indicate competition for nutrients and growth 
under anaerobic or at least oxygen-limited conditions. Nevertheless, the description of deregulated 
gene clusters identified by microarray hybridization requires further confirmation by qRT-PCR. 
 Competitive growth in presence of mammary gland cells activates stress response 
A fraction of the deregulated genes including the Cpx stress response system indicates 
extracytoplasmic stress. Mastitis E. coli isolates may modulate their cell surface characteristics when 
they encounter host contact. In this context, the Cpx system has been recently reported to 
potentiate fitness and virulence of ExPEC (Debnath et al., 2013). In contrast, we could neither identify 
significant deregulation of the csrA gene expression, which is involved in the oxidative stress 
response and host cell invasion (Fields and Thompson, 2008). Instead, expression of the oxyR gene 
was highly up-regulated. OxyR is a major transcriptional regulator required for oxidative stress 
response. It´s up-regulation was accompanied by up-regulation, although not differentially, of crp 
encoding the cyclic AMP receptor protein Crp. On the one hand Crp is involved in catabolite 
repression, meaning that as long glucose is available for E. coli, the metabolic onversion to other 
carbohydrate sources is under repression (Deutscher, 2008). Therefore, transcription of catabolic 
genes involved in energy metabolism is switched on by cAMP-CRP, especially in a setting of 
cocultivation where epithelial cells and bacteria are competing for glucose. On the other hand it has 
also been reported that Crp regulate various virulence genes, such as fim, hly, tib (adherence locus) 
and the pet AT toxin-encoding gene, in different E. coli pathotypes such as ETEC and UPEC (Müller et 
al., 2009; Fuentes et al., 2009; Espert et al., 2011; Rossiter et al., 2011; Kansal et al., 2013; Donovan 
et al., 2013). Furthermore, it is known that rpoS might be involved in Crp response(Fuentes et al., 
2009). Notably, we found the corresponding gene to be deregulated after three hours of 
cocultivation of strain ECC-1470 with MAC-T cells. Due to recent findings (Seth et al., 2012), we 
suggest that this might reflect oxidative or/and nitrosative stress caused by reactive species of either 
one. However, a presumed regulation of catabolite repression should not be excluded. 
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The regulators Cpx, CsrA, OxyR, and RpoS belong to a complex regulatory network that has by today 
not entirely been uncovered. This network comprises cell contact-sensing, signaling cascades and 
regulation of virulence or fitness-associated factors. Whether the up-regulation of members of this 
regulatory network is solely reflecting stress response that promotes adaption and survival of E. coli 
under the novel growth conditions or actively contributes to pathogenesis of E. coli in the mammary 
gland requires further investigation. 
We can conclude that at least during in vitro cocultivation with bovine mammary gland epithelial 
cells, significantly deregulated genes in both mastitic strains indicate the exposure to 
extracytoplasmic stress. This is probably caused by metabolic competition for nutrients and the 
accumulation of metabolic end products of both, bacteria and host cells, in the cell culture medium. 
Whether this kind of competition also occurs in vivo might be questioned, because the mammary 
gland epithelial cells, which are lining the alveolar space, are supplied by surrounding blood vessels. 
Given the fact that mainly genes assigned to energy metabolism differed in their expression between 
the strains, it can be assumed that both strains used different strategies to metabolize under the 
conditions of cocultivation with MAC-T cells.  
 Virulence potential of E. coli strains 1303 and ECC 1470 in the presence of host cells 
We successfully identified common differential down-regulation of genes related to fimbrial adhesins 
and flagella. Up-regulated genes involved in protection against host defenses have been observed in 
both mastitis isolates. Furthermore, a multidrug tolerance system has been up-regulated in both 
strains. But both mastitis strains also revealed differences in virulence-associated gene expression. 
The high persistence factor HipA was up-regulated in E. coli isolate ECC-1470 suggesting a 
contribution to the strain’s persistence abilities. We also found differentially expressed genes 
involved in the regulation of curli fimbriae expression. This may contribute to host-pathogen 
interaction. Further investigations will be necessary to further confirm this correlation between the 
E. coli cell adhesion and/or invasion potential and mastitis pathogenesis. 
We hypothesize that there might be correlation between the ability to efficiently adhere to 
mammary epithelial cells in the presence of milk whey, resistance to the antimicrobial activities of 
milk whey and an increased mastitis virulence potential. This hypothesis is corroborated by our RNA-
Seq-based transcriptome data revealing a marked up-regulation of the expression of determinants 
involved in the adaptation to growth conditions common in mammary secretions. It might therefore 
be promising to perform adhesion assays in the presence of milk whey and test different mastitis 
strains in comparison to faecal isolates.  
Whether the different gene expression profiles of E. coli strains 1303 and ECC-1470 reflect relevant 
geno- and phenotypic differences between the pathogenesis of transient and persistent mastitis 
isolates, or represent strain specific traits, remains to be addressed in the future.  
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VI.1.7. Peroration / Epilog 
Many of the determinants, which we identified to be deregulated under conditions mimicking those 
during initial stages of mastitis can promote the colonization of extraintestinal niches. 
In the past, a putative mammary pathogenic pathotype (MPEC) has been suggested (Shpigel et al., 
2008). Based on the data, which we obtained from our phenotypic and transcriptomic analyses, we 
could rather refuse this suggestion than add further evidence. By employing milk whey and cell 
culture experiments, the ability to mimic the mammary gland as a niche is a great advantage for 
understanding the molecular basis of E. coli mammary gland infections. We observed that the 
deregulated bacterial determinants mostly reflected either metabolic adaptation to altered 
nutritional conditions or adaptation and stress response to environmental conditions. Many of these 
deregulated determinants cannot be suggested to be mastitis-specific, because they did not reveal 
any remarkable processes which could be specifically related to either the interaction with host cells 
or the survival in mammary secretions. Of the determinants that have been differentially expressed 
in response to intramammary-like conditions, only a few may have the potential to be used as 
therapeutic targets for the development of antibiotics or vaccines against mastitis E. coli. Specific 
resistance genes against antimicrobial effects of mammary secretion could not be detected.  
We anticipate that the definition of a “mammary pathogenic E. coli“ pathotype that differens from 
other pathotypes becomes more and more less reasonable. It seems more that mastitis E. coli can 
efficiently sense the presence of particular components of milk whey and respond in a way that they 
trying to outrun the host response by fast growth. 
 
VI.2. Outlook 
In the present study, various determinants involved in adaptation during the transition from the 
environment into the host have been identified by comparative analysis of differentially expressed 
genes. These corresponding genes might be located on mobile genetic elements such as genomic 
islands and prophages that have been recently identified in the genomes of mastitis E. coli strains 
1303 and ECC-1470 (Dobrindt, unpublished data). If so, this may suggest that specific adaptation, 
fitness and competitiveness in the intramammary habitat might select for certain mobile genetic 
elements. Their identification might be useful in therapeutic application and epidemiology. 
Regarding our RNA-Seq analyses, the sequencing reads were only mapped to annotated coding 
sequences. Coding sequences that have not been annotated in the reference genomes, such as 
intercistronic regions, regions coding for transfer-messenger RNA, regulatory RNAs, such 
riboswitches, have not been included into our analysis. 10-fold of the amount of reads mapped in the 
RNA-Seq analysis has not been mapped to the annotated ORFs of our reference genome. Some of 
these reads might align to intergenic regions or coding sequences that were not or not correctly 
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annotated. A mapping to the whole reference genome sequence might represent an exciting task 
also to study differential expression of untranslated coding sequences including regulatory RNAs, 
etc. . Moreover, it would be interesting to perform a comprehensive alignment and clustering of the 
unmapped reads to similar sequences of the E. coli pangenome. Consequently, this might reveal 
either one, i) novel expressed protein-coding sequences, or ii) putative non-coding RNAs. The 
identification of novel non-coding RNAs or riboswitches may be expected. Whether these regulatory 
elements contribute to the bacterial ability to successfully cause mastitis remains yet unrevealed. 
Last but not least, the RNA-Seq data obtained can be used to uncover unknown transcriptional start 
sides as well as antisense transcripts and SNPs in the reference genomes.  
 
Another important task will be to study the in-depth-role of the particular determinants that have 
been deregulated during either cocultivation with mammary gland epithelial cells or in response to 
milk whey. Specifically, the impact of citrate utilization should be addressed in comparative growth 
assays with E. coli isolates from bovine mastitis and bovine faeces. This is even more interesting 
when focusing on comparison to the specific faecal isolates that showed reduced fitness in milk whey 
(section V.3.1).  
 
Mastitis E. coli strains are exposed to selective pressure during growth in the mammary gland. In 
order to identify determinants that are critical for survival in mammary secretions, a transposon 
mutagenesis approach will be performed. Therefore, a mastitis E. coli transposon mutant library in 
will be subjected to prolonged growth in milk whey to allow for the enrichment of mutants with 
improved growth or survival characteristics. As shown in the present study, the antimicrobial effects 
preserved in milk whey represent an obstacle to bacterial survival. This approach might therefore 
help to uncover important functional determinants, novel effectors and regulators that are involved 
in survival in mammary secretions. 
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VIII.2. Transcriptome data 
 
VIII.2.1. Transcriptome data of microarray analyses 
Data derived from differential gene expression profiling of mastitis E. coli 1303 and ECC-1470 in the 
presence of MAC-T epithelial cells in vitro relative to the absence of cells, sorted according to their 
level of expression. 
Table 18: E. coli 1303 up-regulated genes at 1 h cocultivation with MAC-T cells 
Gene Description Ratio p-value 
c3719  Hypothetical protein 5.794 0.000490 
c4838  Hypothetical protein 5.646 0.000450 
hypF carbamoyl phosphate phosphatase for [NiFe] hydrogenases  4.671 0.000638 
metR Transcriptional activator protein metR 4.482 0.002368 
cpsB mannose-1-phosphate guanyltransferase  4.297 0.002090 
yliL hypothetical protein  4.199 0.000296 
oxyR DNA-binding transcriptional dual regulator  3.892 0.001078 
Z4188 type III secretion apparatus protein  3.569 0.001735 
bglF enzyme; Transport of small molecules: Carbohydrates, organic acids, alcohols 3.312 0.001376 
ybaT predicted transporter  3.308 0.004683 
c3354  Hypothetical protein 3.241 0.002973 
yeaJ predicted diguanylate cyclase  3.231 0.002499 
yehV MerR-like regulator A 3.219 0.001612 
pppA putative prepilin peptidase A 3.079 0.002971 
L7078 hypothetical protein 3.046 0.000189 
c4059  Hypothetical protein 3.024 0.000756 
yfaT hypothetical protein  3.011 0.004204 
ECP_3840 putative transposase 2.973 0.000124 
c3873  Putative conserved protein 2.931 0.000001 
ECs3006  putative C4-type zinc finger protein  2.920 0.000050 
hydN formate dehydrogenase-H, [4Fe-4S] ferredoxin subunit  2.859 0.002034 
tauB transport; Transport of small molecules: Amino acids, amines 2.853 0.001307 
c3951  Hypothetical protein 2.848 0.000867 
c1956  Putative outer membrane protein yieC precursor 2.793 0.000054 
yiaY predicted Fe-containing alcohol dehydrogenase  2.763 0.000373 
c3902  Hypothetical protein 2.748 0.000338 
rbn ribonuclease BN  2.736 0.000960 
hycG hydrogenase 3 and formate hydrogenase complex, HycG subunit  2.649 0.002770 
tauA transport; Transport of small molecules: Amino acids, amines 2.532 0.000280 
mdtG predicted drug efflux system  2.433 0.002238 
lldD L-lactate dehydrogenase, FMN-linked  2.427 0.000035 
yigM predicted inner membrane protein  2.410 0.000634 
ycdH predicted oxidoreductase, flavin: NADH component  2.393 0.000652 
caiB crotonobetainyl-CoA: carnitine CoA-transferase  2.345 0.000442 
c1620  Hypothetical protein 2.310 0.000197 
htpX orf; Adaptations, atypical conditions 2.306 0.001447 
c4556 Conserved hypothetical protein 2.250 0.000437 
c0467  Hypothetical protein yaiO 2.233 0.002603 
tsr methyl-accepting chemotaxis protein I, serine sensor receptor  2.231 0.001665 
secA transport; Protein, peptide secretion 2.225 0.000035 
hycH protein required for maturation of hydrogenase 3  2.203 0.004783 
c4942  Hypothetical protein 2.200 0.001512 
c5192 Conserved hypothetical protein 2.171 0.000946 
hycD hydrogenase 3, membrane subunit  2.129 0.000051 
ygjO predicted methyltransferase small domain  2.124 0.000688 
ybhI predicted transporter  2.113 0.002998 
yjgB predicted alcohol dehydrogenase, Zn-dependent and NAD(P)-binding  2.042 0.000792 
c1463  Hypothetical protein 2.010 0.000361 
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Gene Description Ratio p-value 
yciG hypothetical protein  1.948 0.004322 
c1589 putative tail component of prophage 1.937 0.003162 
astC succinylornithine transaminase, PLP-dependent  1.920 0.002398 
galS DNA-binding transcriptional repressor  1.918 0.001912 
ygfU Putative purine permease ygfU 1.876 0.000591 
ygeD predicted inner membrane protein  1.855 0.000222 
kdpD fused sensory histidine kinase in two-component regulatory system with KdpE 1.831 0.001854 
ilvL ilvG operon leader peptide  1.830 0.000804 
c0317 Conserved hypothetical protein 1.826 0.000576 
hisF imidazole glycerol phosphate synthase subunit HisF  1.820 0.000268 
Z2343 putative outer membrane protein Lom precursor of prophage CP-933O  1.818 0.001498 
uidC predicted outer membrane porin protein  1.772 0.000168 
fsaB fructose-6-phosphate aldolase 2  1.767 0.002446 
c1989  Putative acid shock protein 1.762 0.001511 
bioB biotin synthase  1.761 0.000023 
umuC DNA polymerase V subunit UmuC  1.746 0.001525 
wcaB Putative colanic acid biosynthesis acetyltransferase wcaB 1.742 0.002575 
gmr modulator of RNase II stability  1.725 0.003046 
yhhW hypothetical protein  1.714 0.000374 
yqhD alcohol dehydrogenase, NAD(P)-dependent  1.686 0.000390 
ybjJ predicted transporter  1.678 0.000529 
cpxP periplasmic protein combats stress  1.667 0.000372 
ytjA hypothetical protein  1.654 0.000358 
c0463  Hypothetical protein 1.645 0.002619 
rbsR DNA-binding transcriptional repressor of ribose metabolism  1.643 0.004083 
ymgE predicted inner membrane protein  1.632 0.000446 
metB cystathionine gamma-synthase  1.617 0.000855 
ompW Outer membrane protein W precursor 1.614 0.000270 
UTI89_C5126 putative tail component of prophage CP-933K 1.601 0.001454 
ycfA hypothetical protein 1.559 0.000382 
Z3309 putative tail fiber protein encoded within prophage CP-933V 1.545 0.000127 
traD DNA binding protein TraD 1.543 0.003224 
yfaZ Hypothetical protein yfaZ precursor 1.516 0.000941 
ECP_4322 multidrug efflux system protein MdtO 1.496 0.003216 
flhB flagellar biosynthesis protein B  1.491 0.000847 
malY bifunctional beta-cystathionase, PLP-dependent/ regulator of maltose regulon  1.486 0.001431 
tauB taurine transporter subunit  1.458 0.000210 
ompN outer membrane pore protein N, non-specific  1.447 0.001406 
c4999  Hypothetical protein 1.446 0.001097 
menD enzyme; Biosynthesis of cofactors, carriers: Menaquinone, ubiquinone 1.433 0.000095 
yraQ predicted permease  1.422 0.000250 
c3166  putative head-tail joining protein of prophage 1.412 0.001365 
aer fused signal transducer for aerotaxis sensory  1.400 0.004466 
aaeX membrane protein of efflux system  1.374 0.000102 
menD 2-succinyl-6-hydroxy-2, 4-cyclohexadiene-1-carboxylate synthase  1.325 0.000397 
fliR Flagellar biosynthetic protein fliR 1.302 0.000315 
c1584 putative tail component of prophage | putative tail component of prophage 1.285 0.004092 
hyfG hydrogenase 4, subunit  1.281 0.002185 
yegS hypothetical protein  1.250 0.001462 
yihQ alpha-glucosidase  1.244 0.000783 
grxA glutaredoxin 1, redox coenzyme for ribonucleotide reductase (RNR1a)  1.232 0.000165 
sbmC DNA gyrase inhibitor  1.230 0.000412 
c0315  Hypothetical protein 1.227 0.000409 
ECP_4339 phosphonates transport ATP-binding protein PhnL 1.224 0.001376 
srlA glucitol/sorbitol-specific enzyme IIC component of PTS  1.219 0.001728 
yohL hypothetical protein  1.194 0.004174 
yiiM hypothetical protein  1.187 0.004260 
nhoA N-hydroxyarylamine O-acetyltransferase  1.183 0.003742 
maeB malic enzyme  1.159 0.004774 
ycdS predicted outer membrane protein  1.157 0.001420 
ybbY predicted uracil/xanthine transporter  1.152 0.000967 
aqpZ aquaporin Z  1.149 0.000040 
yhcM conserved protein with nucleoside triphosphate hydrolase domain  1.147 0.000136 
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Z3626 sucrose specific transcriptional regulator  1.139 0.004344 
ECP_2815 hypothetical protein 1.135 0.000311 
ydcU predicted spermidine/putrescine transporter subunit  1.124 0.002334 
ECP_2970 fimbrial usher protein PixC 1.115 0.001174 
phnE phosphonate/organophosphate ester transporter subunit 1.114 0.002051 
yidL predicted DNA-binding transcriptional regulator  1.109 0.004146 
baeS sensory histidine kinase in two-component regulatory system with BaeR  1.104 0.000079 
ypdI Hypothetical lipoprotein ypdI precursor 1.093 0.000074 
ubiA 4-hydroxybenzoate octaprenyltransferase  1.077 0.000037 
hycC NADH dehydrogenase subunit N  1.077 0.000301 
ECP_0718 hypothetical protein 1.071 0.000450 
ubiF 2-octaprenyl-3-methyl-6-methoxy-1,4-benzoquinol hydroxylase  1.067 0.000481 
mhpC 2-hydroxy-6-ketonona-2,4-dienedioic acid hydrolase  1.046 0.004197 
c2987  Ethanolamine utilization protein eutS 1.020 0.000077 
ygbF hypothetical protein  1.019 0.000300 
ypdI predicted lipoprotein involved in colanic acid biosynthesis  1.009 0.000313 
ydhP predicted transporter  1.007 0.000092 
 
Table 19: E. coli 1303 down-regulated genes at 1 h cocultivation with MAC-T cells 
Gene Description Ratio p-value 
narZ nitrate reductase 2 (NRZ), alpha subunit  -1.903 0.003663 
ydhY predicted 4Fe-4S ferridoxin-type protein  -1.760 0.002152 
yhhH hypothetical protein  -1.571 0.004907 
Z2101 putative endonuclease encoded within prophage CP-933O  -1.471 0.000275 
Z2118 putative endopeptidase Rz of prophage CP-933O  -1.421 0.004356 
ycfJ hypothetical protein  -1.249 0.001798 
citG triphosphoribosyl-dephospho-CoA transferase  -1.243 0.002905 
ECP_3800 putative regulatory protein -1.224 0.002555 
yjiX hypothetical protein  -1.219 0.002110 
yjiY predicted inner membrane protein  -1.188 0.002450 
cspA major cold shock protein  -1.168 0.003196 
guaD guanine deaminase  -1.148 0.000830 
yohM membrane protein conferring nickel and cobalt resistance  -1.120 0.000324 
yieL predicted xylanase  -1.102 0.002387 
ydhK conserved inner membrane protein  -1.079 0.001907 
sufC cysteine desulfurase ATPase component  -1.004 0.000830 
 
Table 20: E. coli 1303 up-regulated genes at 3 h cocultivation with MAC-T cells 
Gene Description Ratio p-value 
L7057 replication protein 3.044 0.027619 
c4838  Hypothetical protein 3.003 0.023735 
ybhI predicted transporter  2.306 0.007027 
oxyR DNA-binding transcriptional dual regulator  2.218 0.023817 
c3719  Hypothetical protein 2.072 0.042827 
hypF carbamoyl phosphate phosphatase [NiFe] hydrogenases  1.985 0.017999 
bglF enzyme; Transport of small molecules: Carbohydrates, organic acids, alcohols 1.975 0.001430 
UTI89_C2967 bacteriophage V tail protein 1.851 0.012296 
amtB ammonium transporter  1.820 0.020194 
tauB transport; Transport of small molecules: Amino acids, amines 1.733 0.008654 
ydcU predicted spermidine/putrescine transporter subunit  1.649 0.001534 
napA nitrate reductase, periplasmic, large subunit  1.645 0.025310 
gltI glutamate and aspartate transporter subunit  1.640 0.015068 
nuoM NADH dehydrogenase subunit M  1.606 0.007986 
ynfJ putative voltage-gated ClC-type chloride channel ClcB  1.601 0.023349 
ygbI predicted DNA-binding transcriptional regulator  1.585 0.044468 
yfcB hypothetical protein 1.564 0.003798 
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nirB nitrite reductase, large subunit, NAD(P)H-binding  1.549 0.032192 
c4556 Conserved hypothetical protein 1.513 0.012680 
c0317 Conserved hypothetical protein 1.485 0.001379 
c5192 Conserved hypothetical protein 1.483 0.001783 
yjgB predicted alcohol dehydrogenase, Zn-dependent and NAD(P)-binding  1.466 0.000480 
UTI89_C3197 ClpB protein 1.461 0.006134 
yebU Hypothetical protein yebU 1.457 0.042089 
menD enzyme; Biosynthesis of cofactors, carriers: Menaquinone, ubiquinone 1.453 0.007420 
c2130  Hypothetical protein 1.436 0.032182 
yeaG conserved protein with nucleoside triphosphate hydrolase domain  1.433 0.026552 
Z3951 hypothetical protein  1.418 0.049730 
ycjB hypothetical protein 1.416 0.042036 
holE DNA polymerase III, theta subunit  1.413 0.027867 
baeS sensory histidine kinase in two-component regulatory system with BaeR  1.407 0.000517 
uidC predicted outer membrane porin protein  1.398 0.028717 
pabA para-aminobenzoate synthase component II  1.388 0.026282 
tauA transport; Transport of small molecules: Amino acids, amines 1.383 0.021129 
poxB pyruvate dehydrogenase  1.372 0.008276 
cysU sulfate/thiosulfate transporter subunit  1.366 0.032848 
hyfF NADH dehydrogenase subunit N  1.364 0.021507 
ubiF 2-octaprenyl-3-methyl-6-methoxy-1,4-benzoquinol hydroxylase  1.364 0.010392 
yccJ hypothetical protein  1.363 0.009016 
yhhK hypothetical protein  1.349 0.036169 
adhP enzyme; Energy metabolism, carbon: Anaerobic respiration 1.341 0.043940 
deoB phosphopentomutase  1.332 0.030176 
hemG protoporphyrin oxidase, flavoprotein  1.331 0.023380 
motA flagellar motor protein MotA  1.325 0.037545 
ECP_0962 outer membrane protein A 1.321 0.040723 
paaB predicted multicomponent oxygenase/reductase subunit for phenylacetic acid 
degradation  
1.318 0.016941 
narV nitrate reductase 2 (NRZ), gamma subunit  1.313 0.032679 
yeiM predicted nucleoside transporter  1.306 0.032445 
asnB asparagine synthetase B  1.305 0.039901 
rpoD RNA polymerase sigma factor  1.292 0.034000 
ycdL predicted enzyme  1.292 0.008046 
ybjJ predicted transporter  1.284 0.001312 
ECP_0718 hypothetical protein 1.277 0.013351 
ECP_4773 DNA repair protein RadA 1.274 0.014811 
fbaA fructose-bisphosphate aldolase  1.263 0.039281 
ycdX hypothetical protein  1.257 0.041226 
glgA glycogen synthase  1.244 0.015200 
rpmD 50S ribosomal protein L30  1.242 0.039472 
appB cytochrome bd-II oxidase, subunit II  1.240 0.018357 
yjbO phage shock protein G  1.221 0.027524 
cfa cyclopropane fatty acyl phospholipid synthase unsaturated-phospholipid 
methyltransferase 
1.219 0.033955 
gyrB DNA gyrase subunit B  1.215 0.015575 
feoB ferrous iron transport protein B  1.212 0.031098 
aqpZ aquaporin Z  1.202 0.004755 
hisB imidazole glycerol-phosphate  1.200 0.041844 
ldcC Energy metabolism, carbon: Pyruvate dehydrogenase 1.199 0.035472 
kdpB potassium-transporting ATPase subunit B  1.198 0.021652 
yeaH Hypothetical protein yeaH 1.189 0.025011 
hycG hydrogenase 3 and formate hydrogenase complex, HycG subunit  1.187 0.036814 
Z1099 hypothetical protein  1.180 0.028565 
ompC outer membrane porin protein C  1.177 0.002938 
yqhD alcohol dehydrogenase, NAD(P)-dependent  1.170 0.010367 
ypfG hypothetical protein  1.166 0.027078 
frdA fumarate reductase  1.164 0.010756 
mlrA DNA-binding transcriptional regulator  1.164 0.007277 
dld D-lactate dehydrogenase, FAD-binding, NADH independent  1.163 0.033742 
ygdD conserved inner membrane protein  1.162 0.016316 
hisF imidazole glycerol phosphate synthase subunit HisF  1.158 0.046363 
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ydhQ hypothetical protein  1.156 0.004553 
glgB glycogen branching enzyme  1.154 0.039485 
phoP DNA-binding response regulator in two-component regulatory system with 
PhoQ  
1.154 0.019834 
yrbB hypothetical protein  1.151 0.040928 
insF IS3 element protein InsF 1.150 0.033735 
rpsS 30S ribosomal protein S19  1.150 0.042759 
paaC predicted multicomponent oxygenase/reductase subunit for phenylacetic acid 
degradation  
1.149 0.026871 
psb1 putative regulator of SOS induction 1.148 0.014526 
ygeD predicted inner membrane protein  1.146 0.041707 
insF IS3 element protein InsF 1.144 0.007049 
nhoA N-hydroxyarylamine O-acetyltransferase  1.144 0.045176 
yleB - 1.140 0.027949 
c3164 putative factor; DNA packaging, phage assembly (Phage or Prophage Related) 1.139 0.048254 
ompR osmolarity response regulator  1.136 0.018228 
menD 2-succinyl-6-hydroxy-2, 4-cyclohexadiene-1-carboxylate synthase  1.135 0.001747 
paaE predicted multicomponent oxygenase/reductase subunit for phenylacetic acid 
degradation  
1.132 0.033189 
phnI carbon-phosphorus lyase complex subunit  1.132 0.027304 
lysU lysine tRNA synthetase, inducible  1.131 0.047845 
ECs5484  hypothetical protein  1.126 0.042031 
c3158  putative tail component of prophage 1.123 0.027113 
ilvE branched-chain amino acid aminotransferase  1.120 0.017555 
hybF protein involved with the maturation of hydrogenases 1 and 2  1.117 0.007163 
yeaH hypothetical protein  1.115 0.037149 
insF IS3 element protein InsF 1.114 0.007586 
menE O-succinylbenzoic acid--CoA ligase  1.113 0.025990 
pgi glucose-6-phosphate isomerase  1.112 0.017892 
blc outer membrane lipoprotein (lipocalin)  1.106 0.044586 
abrB AbrB protein (AidB regulator) 1.103 0.004759 
nhoA N-hydroxyarylamine O-acetyltransferase  1.100 0.037641 
nlpE lipoprotein involved with copper homeostasis and adhesion  1.099 0.047162 
c2748  Hypothetical protein 1.098 0.015183 
prlC oligopeptidase A  1.098 0.005893 
deoA thymidine phosphorylase  1.097 0.010418 
Z0970 putative tail component of prophage CP-933K  1.092 0.023533 
dnaJ chaperone Hsp40, co-chaperone with DnaK  1.092 0.017940 
ydfR hypothetical protein 1.091 0.026310 
ygbE conserved inner membrane protein  1.089 0.034185 
yhdY predicted amino-acid transporter subunit  1.087 0.014403 
Z0980 putative tail component of prophage CP-933K  1.086 0.036482 
yehW predicted transporter subunit: membrane component of ABC superfamily  1.084 0.018854 
c4837  Hypothetical protein 1.082 0.039611 
frdB fumarate reductase (anaerobic), Fe-S subunit  1.071 0.028053 
hyaF protein involved in nickel incorporation into hydrogenase-1 proteins  1.070 0.006551 
narH enzyme; Energy metabolism, carbon: Anaerobic respiration 1.068 0.014442 
cpxP periplasmic protein combats stress  1.067 0.006446 
yhbS predicted acyltransferase with acyl-CoA N-acyltransferase domain  1.066 0.036482 
cyoB cytochrome o ubiquinol oxidase subunit I  1.061 0.037608 
menC enzyme; Biosynthesis of cofactors, carriers: Menaquinone, ubiquinone 1.060 0.024643 
yhfG hypothetical protein  1.060 0.035312 
manY mannose-specific enzyme IIC component of PTS  1.059 0.043016 
yhhW hypothetical protein  1.051 0.007211 
ybeX predicted ion transport  1.050 0.004095 
ydhH anhydro-N-acetylmuramic acid kinase  1.050 0.048120 
yedP hypothetical protein  1.050 0.035910 
gadC predicted glutamate:gamma-aminobutyric acid antiporter  1.047 0.035811 
yjbE hypothetical protein  1.044 0.002949 
ymgG hypothetical protein  1.044 0.040853 
gudD (D)-glucarate dehydratase 1  1.043 0.046464 
moeA molybdopterin biosynthesis protein  1.042 0.022639 
lomR Rac prophage; predicted protein, N-ter fragment pseudogene 1.041 0.002790 
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ptsG fused glucose-specific PTS enzymes: IIB  1.041 0.029970 
ECP_0724 hypothetical protein 1.039 0.020607 
astB succinylarginine dihydrolase  1.036 0.015323 
ybhC predicted pectinesterase  1.036 0.023371 
asnA asparagine synthetase AsnA  1.035 0.013957 
fbp fructose-1,6-bisphosphatase  1.035 0.008513 
fimC chaperone, periplasmic  1.035 0.027329 
ybeY hypothetical protein  1.031 0.006340 
sufA iron-sulfur cluster assembly scaffold protein  1.028 0.037932 
gudP predicted D-glucarate transporter  1.027 0.039662 
Z4045 hypothetical protein  1.021 0.040670 
ubiA 4-hydroxybenzoate octaprenyltransferase  1.020 0.000353 
rpmJ 50S ribosomal protein L36  1.018 0.034127 
torY TMAO reductase III (TorYZ), cytochrome c-type subunit  1.018 0.033727 
frdC fumarate reductase subunit C  1.015 0.027717 
yfeH predicted inner membrane protein  1.013 0.015005 
rnr exoribonuclease R, RNase R  1.011 0.023250 
wrbA TrpR binding protein WrbA  1.011 0.018289 
hyaA hydrogenase 1, small subunit  1.007 0.005126 
cadA lysine decarboxylase 1  1.006 0.018937 
rpoS RNA polymerase sigma factor  1.005 0.021264 
c1462  putative factor; DNA packaging, phage assembly (Phage or Prophage Related) 1.004 0.047156 
ldcC positive control 1.004 0.043481 
yggR predicted transporter  1.004 0.026766 
cbpM modulator of CbpA co-chaperone  1.002 0.010852 
ybhQ predicted inner membrane protein  1.001 0.031647 
 
Table 21: E. coli 1303 down-regulated genes at 3 h cocultivation with MAC-T cells 
Gene Description Ratio p-value 
c5000  Hypothetical protein -3.647 0.027907 
Z2101 putative endonuclease encoded within prophage CP-933O  -3.546 0.024686 
yddA fused predicted multidrug transporter subunits  -2.946 0.019734 
torS enzyme; Energy metabolism, carbon: Anaerobic respiration -2.789 0.040084 
yibD predicted glycosyl transferase  -2.384 0.010253 
yjaI Zinc resistance-associated protein precursor -2.383 0.036959 
malF maltose transporter subunit  -2.260 0.006608 
cynT carbonic anhydrase  -2.238 0.039457 
c3219  Hypothetical protein -2.185 0.041744 
yehR hypothetical protein  -2.131 0.013630 
cusC copper/silver efflux system, outer membrane component  -2.084 0.045023 
cspG DNA-binding transcriptional regulator  -2.075 0.038116 
c0670  Hypothetical protein -2.038 0.046628 
yfgI hypothetical protein  -2.026 0.047741 
flgC flagellar basal-body rod protein C  -1.978 0.049963 
ydhI predicted inner membrane protein  -1.860 0.045241 
narY nitrate reductase 2 (NRZ), beta subunit  -1.826 0.047165 
tnaB tryptophan transporter of low affinity  -1.714 0.032191 
sfmA predicted fimbrial-like adhesin protein  -1.697 0.005352 
dos cAMP phosphodiesterase, heme-regulated  -1.673 0.042243 
trpD Anthranilate synthase component II -1.656 0.042104 
ycgF Hypothetical protein ycgF -1.655 0.042258 
ycfJ hypothetical protein  -1.631 0.024190 
yliE conserved inner membrane protein  -1.631 0.034862 
tdcA DNA-binding transcriptional activator  -1.614 0.030906 
mgtA magnesium transporter  -1.610 0.032254 
ybcS DLP12 prophage; predicted lysozyme  -1.599 0.044947 
yhcC predicted Fe-S oxidoreductase  -1.577 0.048241 
torC enzyme; Energy metabolism, carbon: Anaerobic respiration -1.503 0.047567 
yaiS hypothetical protein  -1.464 0.024833 
ytfQ predicted sugar transporter subunit: periplasmic-binding component of ABC -1.459 0.047644 
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superfamily  
yidI predicted inner membrane protein  -1.453 0.034156 
ycaO hypothetical protein  -1.443 0.020393 
c3831  Hypothetical protein -1.415 0.018194 
yoaG hypothetical protein  -1.415 0.044636 
L7046 ORFB of IS911 -1.393 0.021846 
ulaC L-ascorbate-specific enzyme IIA component of PTS  -1.371 0.006725 
suhB inositol monophosphatase  -1.369 0.026031 
c5233  Hypothetical protein -1.362 0.045485 
dgoD galactonate dehydratase  -1.361 0.041268 
yciW predicted oxidoreductase  -1.360 0.001883 
phnH carbon-phosphorus lyase complex subunit  -1.348 0.001862 
emrB multidrug efflux system protein  -1.336 0.019879 
pinR Rac prophage; predicted site-specific recombinase  -1.318 0.040083 
Z1627 hypothetical protein -1.309 0.040993 
yiaM predicted transporter  -1.283 0.035292 
Z4360 hypothetical protein  -1.280 0.030250 
ycdQ predicted glycosyl transferase  -1.277 0.003520 
dinI DNA damage-inducible protein I  -1.273 0.036503 
trbE inner membrane protein TrbE -1.269 0.031204 
narY nitrate reductase 2 (NRZ), beta subunit  -1.264 0.022200 
xdhD fused predicted xanthine/hypoxanthine oxidase:  -1.258 0.029038 
Z2343 putative outer membrane protein Lom precursor of prophage CP-933O  -1.242 0.043015 
yfiP hypothetical protein  -1.242 0.032926 
ydeP predicted oxidoreductase  -1.201 0.024745 
ybdN hypothetical protein  -1.200 0.037550 
yigN DNA recombination protein rmuC -1.194 0.045339 
fadL long-chain fatty acid outer membrane transporter  -1.192 0.009722 
c1824  Hypothetical protein -1.171 0.029865 
yfcT predicted outer membrane export usher protein  -1.157 0.041684 
yhhQ conserved inner membrane protein  -1.156 0.014234 
yeaA hypothetical protein -1.153 0.019970 
ygjJ hypothetical protein  -1.150 0.034512 
ydiR predicted electron transfer flavoprotein, FAD-binding  -1.145 0.029607 
pinQ Qin prophage; predicted site-specific recombinase -1.141 0.023897 
cheR chemotaxis regulator, protein-glutamate methyltransferase  -1.139 0.002576 
ybdL putative aminotransferase  -1.131 0.008954 
yncC predicted DNA-binding transcriptional regulator  -1.130 0.019183 
c2318  Hypothetical protein -1.116 0.012856 
flgN export chaperone for FlgK and FlgL  -1.110 0.036724 
ydiE Hypothetical protein ydiE -1.108 0.012708 
fliS flagellar protein FliS  -1.099 0.003092 
yfeD predicted DNA-binding transcriptional regulator  -1.085 0.045178 
narZ nitrate reductase 2 (NRZ), alpha subunit  -1.084 0.034313 
ybfC hypothetical protein  -1.068 0.003355 
insB CP4-6 prophage; IS1 transposase InsAB' -1.067 0.022609 
tnaA tryptophanase/L-cysteine desulfhydrase, PLP-dependent  -1.064 0.001795 
ypeC hypothetical protein  -1.062 0.045315 
phoA bacterial alkaline phosphatase  -1.023 0.013970 
c4140  Hypothetical protein -1.021 0.002267 
uxaB tagaturonate reductase  -1.019 0.048286 
ygeV predicted DNA-binding transcriptional regulator  -1.017 0.035001 
yedQ predicted diguanylate cyclase  -1.009 0.017396 
ycjQ Hypothetical zinc-type alcohol dehydrogenase-like protein ycjQ -1.008 0.048391 
 
Table 22: ECC-1470 up-regulated genes at 1 h cocultivation with MAC-T cells 
Gene Description Ratio p-value 
L7057 replication protein 6.538 0.000309 
hypF carbamoyl phosphate phosphatase and maturation protein for [NiFe] 
hydrogenases  
5.844 0.000428 
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hycG hydrogenase 3 and formate hydrogenase complex, HycG subunit  5.227 0.000465 
bglF enzyme; Transport of small molecules: Carbohydrates, organic acids, alcohols 4.922 0.000270 
c3719  Hypothetical protein 4.824 0.001407 
metR Transcriptional activator protein metR 4.619 0.000164 
tauB transport; Transport of small molecules: Amino acids, amines 4.244 0.000166 
nfrA bacteriophage N4 receptor, outer membrane subunit  4.192 0.004571 
molR - 4.152 0.008823 
gsp bifunctional glutathionylspermidine amidase/glutathionylspermidine synthetase 4.080 0.002106 
ybaT predicted transporter  3.942 0.002652 
yfaT hypothetical protein  3.889 0.001320 
ygjD Probable O-sialoglycoprotein endopeptidase 3.751 0.004062 
c1620  Hypothetical protein 3.727 0.001073 
oxyR DNA-binding transcriptional dual regulator  3.633 0.004445 
c3354  Hypothetical protein 3.588 0.013434 
yliL hypothetical protein  3.531 0.002085 
c3549  - 3.528 0.017049 
c1584 putative tail component of prophage | putative tail component of prophage 3.510 0.004948 
c3902  Hypothetical protein 3.494 0.005234 
yjgB predicted alcohol dehydrogenase, Zn-dependent and NAD(P)-binding  3.489 0.003475 
ppdA hypothetical protein  3.479 0.003744 
c4942  Hypothetical protein 3.458 0.004752 
ygjO predicted methyltransferase small domain  3.423 0.002768 
c4303  Putative conserved protein 3.407 0.007162 
c1956  Putative outer membrane protein yieC precursor 3.362 0.001255 
yiaY predicted Fe-containing alcohol dehydrogenase  3.325 0.000864 
mdtG predicted drug efflux system  3.323 0.002465 
yehV MerR-like regulator A 3.274 0.018437 
ycdH predicted oxidoreductase, flavin:NADH component  3.218 0.001378 
hydN formate dehydrogenase-H, [4Fe-4S] ferredoxin subunit  3.168 0.005405 
c0703  Hypothetical protein 3.121 0.002688 
c4250  Hypothetical protein 3.032 0.040438 
ECP_3840 putative transposase 3.000 0.001275 
wcaB Putative colanic acid biosynthesis acetyltransferase wcaB 2.919 0.000674 
yiaO Putative ABC transporter periplasmic binding protein yiaO precursor 2.883 0.008031 
Z3309 putative tail fiber protein of prophage CP-933V 2.851 0.004688 
yfaZ Hypothetical protein yfaZ precursor 2.804 0.031826 
UTI89_C5126 putative tail component of prophage CP-933K 2.791 0.002948 
tauA transport; Transport of small molecules: Amino acids, amines 2.785 0.000705 
hycD hydrogenase 3, membrane subunit  2.730 0.009915 
c4059  Hypothetical protein 2.724 0.000994 
ECs3006  putative C4-type zinc finger protein  2.722 0.001439 
Z4188 type III secretion apparatus protein  2.701 0.000710 
ymgE predicted inner membrane protein  2.692 0.000237 
astC succinylornithine transaminase, PLP-dependent  2.644 0.001769 
holE DNA polymerase III, theta subunit  2.626 0.002266 
c3873  Putative conserved protein 2.611 0.018204 
ygeZ dihydropyrimidinase  2.611 0.005451 
ybhI predicted transporter  2.596 0.001574 
c5192 Conserved hypothetical protein 2.537 0.000388 
uidC predicted outer membrane porin protein  2.535 0.001451 
c1463  Hypothetical protein 2.524 0.000459 
c0317 Conserved hypothetical protein 2.519 0.000515 
ycdC predicted DNA-binding transcriptional regulator  2.515 0.001495 
ompN outer membrane pore protein N, non-specific  2.436 0.002921 
yqhD alcohol dehydrogenase, NAD(P)-dependent  2.424 0.000896 
menD enzyme; Biosynthesis of cofactors, carriers: Menaquinone, ubiquinone 2.376 0.003283 
yjfC predicted synthetase/amidase  2.371 0.001891 
caiB crotonobetainyl-CoA:carnitineCoA-transferase  2.354 0.002784 
yhhW hypothetical protein  2.344 0.004952 
ydcU predicted spermidine/putrescine transporter subunit  2.337 0.011795 
c1589 putative tail component of prophage 2.314 0.003065 
menD 2-succinyl-6-hydroxy-2, 4-cyclohexadiene-1-carboxylate synthase  2.280 0.003246 
c4556 Conserved hypothetical protein 2.269 0.002831 
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L7078 hypothetical protein 2.207 0.041672 
ycfA hypothetical protein 2.152 0.000461 
rbsR DNA-binding transcriptional repressor of ribose metabolism  2.101 0.002637 
ECP_3061 hypothetical protein 2.094 0.008766 
yihQ alpha-glucosidase  2.091 0.005240 
c0784  Hypothetical protein 2.026 0.032363 
glcD glycolate oxidase subunit, FAD-linked  2.008 0.006334 
sgbH 3-keto-L-gulonate 6-phosphate decarboxylase  1.989 0.008983 
baeS sensory histidine kinase in two-component regulatory system with BaeR  1.957 0.001856 
hyfI hydrogenase 4, Fe-S subunit  1.949 0.016407 
hycH protein required for maturation of hydrogenase 3  1.925 0.003074 
ygjG Probable ornithine aminotransferase | Hypothetical protein 1.921 0.000881 
c3164 putative factor; DNA packaging, phage assembly (Phage or Prophage Related) 1.900 0.004407 
c0463  Hypothetical protein 1.885 0.020708 
mdtI multidrug efflux system transporter  1.866 0.006324 
yraQ predicted permease  1.860 0.007672 
c1109  Hypothetical protein 1.851 0.002810 
ygcP predicted anti-terminator regulatory protein  1.831 0.039243 
umuC DNA polymerase V subunit UmuC  1.828 0.027895 
c3166  putative head-tail joining protein of prophage 1.809 0.007384 
yaaI hypothetical protein  1.782 0.002347 
ypdI predicted lipoprotein involved in colanic acid biosynthesis  1.771 0.002269 
cpxP periplasmic protein combats stress  1.770 0.002871 
mlrA DNA-binding transcriptional regulator  1.768 0.000863 
yjbO phage shock protein G  1.764 0.001199 
tauB taurine transporter subunit  1.743 0.000183 
c0467  Hypothetical protein yaiO 1.737 0.003283 
hipA regulator; Murein sacculus, peptidoglycan 1.712 0.016415 
arcA DNA-binding response regulator in two-component regulatory system with ArcB 
or CpxA  
1.695 0.044330 
insF IS3 element protein InsF 1.693 0.046772 
ECP_2815 hypothetical protein 1.691 0.002401 
insF IS3 element protein InsF 1.684 0.022644 
yhaR hypothetical protein  1.682 0.023635 
rbn ribonuclease BN  1.673 0.039971 
yigE hypothetical protein  1.672 0.034821 
lldD L-lactate dehydrogenase, FMN-linked  1.660 0.043321 
yhdX predicted amino-acid transporter subunit  1.653 0.012202 
yidL predicted DNA-binding transcriptional regulator  1.649 0.002750 
kdpD fused sensory histidine kinase in two-component regulatory system with KdpE: 
signal sensing protein  
1.640 0.017473 
yjgH predicted mRNA endoribonuclease  1.640 0.008030 
ilvL ilvG operon leader peptide  1.621 0.019819 
yaaI Hypothetical protein yaaI precursor 1.619 0.048608 
insF IS3 element protein InsF 1.611 0.037185 
klcA KlcA 1.608 0.030307 
ygjQ Hypothetical protein ygjQ 1.606 0.007918 
ypdI Hypothetical lipoprotein ypdI precursor 1.602 0.000014 
ydiY hypothetical protein  1.588 0.005281 
nuoM NADH dehydrogenase subunit M  1.582 0.002840 
flhB flagellar biosynthesis protein B  1.569 0.017055 
potH putrescine transporter subunit: membrane component of ABC superfamily  1.563 0.048324 
hyfG hydrogenase 4, subunit  1.548 0.016458 
hyaA hydrogenase 1, small subunit  1.534 0.005247 
sbmC DNA gyrase inhibitor  1.531 0.023853 
argD bifunctional acetylornithine aminotransferase/ succinyldiaminopimelate 
aminotransferase  
1.524 0.010162 
ECP_2970 fimbrial usher protein PixC 1.519 0.004684 
ybjJ predicted transporter  1.506 0.032003 
Z2371 putative lysozyme R of prophage CP-933R  1.505 0.001012 
mutH DNA mismatch repair protein  1.495 0.040984 
c0315  Hypothetical protein 1.490 0.020204 
nikE ATP-binding protein of nickel transport system  1.488 0.021870 
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malY bifunctional beta-cystathionase, PLP-dependent/ regulator of maltose regulon  1.487 0.000233 
yahC predicted inner membrane protein  1.464 0.000360 
ECP_4322 multidrug efflux system protein MdtO 1.457 0.005585 
ygfU Putative purine permease ygfU 1.456 0.011685 
srmB ATP-dependent RNA helicase  1.445 0.004211 
murI glutamate racemase  1.439 0.024540 
yihM Hypothetical protein yihM 1.435 0.040718 
murI glutamate racemase  1.427 0.025648 
ymgG hypothetical protein  1.423 0.003612 
nhoA N-hydroxyarylamine O-acetyltransferase  1.420 0.003969 
ygeD predicted inner membrane protein  1.419 0.023052 
ubiF 2-octaprenyl-3-methyl-6-methoxy-1,4-benzoquinol hydroxylase  1.418 0.016729 
yegS hypothetical protein  1.414 0.005603 
artM arginine transporter subunit  1.398 0.006017 
astB succinylarginine dihydrolase  1.385 0.040620 
crp DNA-binding transcriptional dual regulator  1.383 0.018503 
artM transport; Transport of small molecules: Amino acids, amines 1.379 0.003453 
gamW putative factor; Integration, recombination (Phage or Prophage Related) 1.375 0.019589 
yfcS putative fimbrial chaperone  1.369 0.023554 
yciG hypothetical protein  1.361 0.000820 
yfcB hypothetical protein 1.360 0.000657 
insF IS3 element protein InsF 1.352 0.032161 
insF IS3 element protein InsF 1.350 0.029820 
yeiM predicted nucleoside transporter  1.339 0.006366 
lsrC AI2 transporter  1.333 0.003747 
nhoA N-hydroxyarylamine O-acetyltransferase  1.333 0.002624 
c1036  Hypothetical protein 1.332 0.003587 
c2987  Ethanolamine utilization protein eutS 1.326 0.002779 
ymgD hypothetical protein  1.324 0.005204 
ydjR hypothetical protein  1.300 0.007177 
kdpB potassium-transporting ATPase subunit B  1.294 0.004052 
ydeD hypothetical protein  1.293 0.017149 
c2440  Hypothetical protein 1.278 0.002465 
chbA N,N'-diacetylchitobiose-specific enzyme IIA component of PTS  1.275 0.015801 
yohL hypothetical protein  1.264 0.007885 
yebB hypothetical protein  1.263 0.010261 
UTI89_C1520 hypothetical protein 1.258 0.001566 
c5221  Hypothetical protein 1.247 0.000370 
UTI89_C2967 bacteriophage V tail protein 1.246 0.005864 
ydgI predicted arginine/ornithine antiporter transporter  1.244 0.007824 
fixX predicted 4Fe-4S ferredoxin-type protein  1.232 0.000799 
ECs5296  hypothetical protein  1.229 0.017066 
mdtL multidrug efflux system protein  1.228 0.002782 
yebK predicted DNA-binding transcriptional regulator  1.223 0.044433 
flhE hypothetical protein  1.212 0.008942 
Z0415 putative periplasmic binding protein, probable substrate ribose  1.207 0.007037 
ybjG undecaprenyl pyrophosphate phosphatase  1.206 0.039326 
hyfF NADH dehydrogenase subunit N  1.205 0.000394 
yfeW hypothetical protein  1.205 0.012251 
ivbL ilvB operon leader peptide  1.204 0.008047 
rhsD rhsD element protein  1.204 0.013136 
ECs0808  hypothetical protein  1.199 0.028575 
dppC dipeptide transporter  1.199 0.011236 
argB Acetylglutamate kinase 1.179 0.001893 
UTI89_C2969 bacteriophage V tail/DNA circulation protein 1.178 0.003561 
ycjB hypothetical protein 1.178 0.018251 
ssuC alkanesulfonate transporter subunit  1.168 0.046501 
xdhB xanthine dehydrogenase, FAD-binding subunit  1.164 0.041121 
nikB nickel transporter subunit  1.160 0.001111 
yphB hypothetical protein 1.159 0.002899 
yeeF Hypothetical transport protein yeeF 1.150 0.008800 
ybbI putative transcriptional regulator  1.149 0.023045 
traD DNA binding protein TraD 1.148 0.016531 
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citE enzyme; Central intermediary metabolism: Pool, multipurpose conversions 1.137 0.011713 
ddpC D-ala-D-ala transporter subunit  1.136 0.003102 
rluA pseudouridine synthase for 23S rRNA (position 746) and tRNAphe(position 32)  1.135 0.000834 
suhB inositol monophosphatase  1.133 0.003198 
fis DNA-binding protein Fis  1.132 0.029532 
fadH 2,4-dienoyl-CoA reductase, NADH and FMN-linked  1.129 0.003623 
ygfQ predicted transporter  1.126 0.008347 
UTI89_C3197 ClpB protein 1.122 0.002514 
mokB  regulatory peptide  | "toxic polypeptide, small " 1.120 0.020108 
ECs0727  KdpF protein of high-affinity potassium transport system  1.119 0.006816 
ybcC DLP12 prophage; predicted exonuclease  1.117 0.001304 
gpmB phosphoglycerate mutase  1.116 0.010526 
mglB methyl-galactoside transporter subunit  1.113 0.008778 
gatB galactitol-specific enzyme IIB component of PTS  1.111 0.008108 
yhaH predicted inner membrane protein  1.109 0.048315 
yjaB predicted acetyltransferase  1.105 0.001774 
hycC NADH dehydrogenase subunit N  1.103 0.016189 
Z0980 putative tail component of prophage CP-933K  1.095 0.007918 
yeaN predicted transporter  1.094 0.023882 
c4837  Hypothetical protein 1.093 0.004382 
napA nitrate reductase, periplasmic, large subunit  1.092 0.000868 
kefA fused conserved protein  1.083 0.003683 
artP arginine transporter subunit  1.080 0.026064 
Z0976 putative tail component of prophage CP-933K  1.079 0.005703 
eutJ predicted chaperonin, ethanolamine utilization protein  1.079 0.020978 
argD Acetylornithine aminotransferase 1.078 0.005165 
htpX orf; Adaptations, atypical conditions 1.073 0.042162 
cysE Serine acetyltransferase 1.070 0.017315 
Z4186 putative integral membrane protein-component of typeIII secretion apparatus  1.068 0.001604 
nlpE lipoprotein involved with copper homeostasis and adhesion  1.063 0.004385 
yhcM conserved protein with nucleoside triphosphate hydrolase domain  1.062 0.042335 
deoR DNA-binding transcriptional repressor  1.059 0.014503 
aer fused signal transducer for aerotaxis sensory  1.058 0.018864 
lysP lysine transporter  1.058 0.002089 
rffA TDP-4-oxo-6-deoxy-D-glucose transaminase  1.057 0.003916 
potI putrescine transporter subunit: membrane component of ABC superfamily  1.055 0.010077 
yhhX predicted oxidoreductase with NAD(P)-binding Rossmann-fold domain  1.055 0.032840 
moaD molybdopterin synthase, small subunit  1.054 0.007634 
ubiA 4-hydroxybenzoate octaprenyltransferase  1.053 0.002326 
yaeQ hypothetical protein  1.050 0.005008 
suhB inositol monophosphatase  1.049 0.008531 
ypfE predicted carboxysome structural protein with predicted role in ethanol 
utilization  
1.049 0.000463 
fecD KpLE2 phage-like element; iron-dicitrate transporter subunit  1.043 0.009066 
ECP_0718 hypothetical protein 1.036 0.021118 
yeaS neutral amino-acid efflux system  1.034 0.008381 
yehD Hypothetical protein yehD precursor 1.027 0.002433 
c1368 Hypothetical protein | Hypothetical protein 1.026 0.001625 
c1846  Putative conserved protein 1.014 0.012133 
yabI conserved inner membrane protein  1.012 0.017029 
phnO predicted acyltransferase with acyl-CoA N-acyltransferase domain  1.010 0.022996 
mdaB NADPH quinone reductase  1.009 0.014804 
 
Table 23: ECC-1470 down-regulated genes at 1 h cocultivation with MAC-T cells 
Gene Description Ratio p-value 
yjgG hypothetical protein  -4.775 0.010795 
citC citrate lyase synthetase  -4.400 0.035696 
glvB arbutin specific enzyme IIB component of PTS  -3.902 0.007404 
ybiM Hypothetical protein ybiM -3.858 0.003070 
yaiT - -3.733 0.040758 
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ybeQ hypothetical protein  -3.690 0.040218 
ybeR hypothetical protein  -3.529 0.002737 
ydfK Qin prophage; predicted DNA-binding transcriptional regulator  | Rac prophage; 
predicted DNA-binding transcriptional regulator  
-3.352 0.011855 
ygfO predicted transporter  -3.154 0.002954 
c3915  Hypothetical protein -3.116 0.004858 
araD L-ribulose-5-phosphate 4-epimerase  -3.056 0.002394 
yibG hypothetical protein  -2.976 0.039470 
yccE hypothetical protein  -2.906 0.005079 
Z3104 putative endolysin of prophage CP-933U -2.894 0.002457 
citD citrate lyase, acyl carrier (gamma) subunit  -2.869 0.001104 
phnH carbon-phosphorus lyase complex subunit  -2.838 0.025851 
ygeX diaminopropionate ammonia-lyase  -2.745 0.047480 
yadD predicted transposase  -2.713 0.018260 
Z5489 hypothetical protein  -2.615 0.045145 
ycaM predicted transporter  -2.600 0.002487 
ypeA Hypothetical protein ypeA -2.461 0.004545 
rspB predicted oxidoreductase, Zn-dependent and NAD(P)-binding  -2.395 0.013347 
ycaC predicted hydrolase  -2.391 0.001508 
csgF predicted transport protein  -2.356 0.000741 
ydiF fused predicted acetyl-CoA:acetoacetyl-CoA  -2.349 0.005614 
yibJ predicted Rhs-family protein  -2.342 0.008111 
- - -2.314 0.023797 
ygaQ hypothetical protein  -2.294 0.015992 
ydcC hypothetical protein  -2.253 0.020139 
lsrA fused AI2 transporter subunits of ABC superfamily: ATP-binding components  -2.251 0.002760 
yahF predicted acyl-CoA synthetase with NAD(P)-binding domain and succinyl-CoA 
synthetase domain  
-2.232 0.002067 
dgoD galactonate dehydratase  -2.206 0.000475 
ygfK predicted oxidoreductase, Fe-S subunit  -2.164 0.023550 
ygeW hypothetical protein  -2.152 0.040243 
ybiW predicted pyruvate formate lyase  -2.052 0.008228 
stfR Rac prophage; predicted tail fiber protein  -2.031 0.010701 
yddV predicted diguanylate cyclase  -2.025 0.047055 
c1955  6-phospho-beta-glucosidase bglA -1.979 0.019067 
ydhV predicted oxidoreductase  -1.968 0.039711 
arpB - -1.963 0.004391 
fixB predicted electron transfer flavoprotein,  -1.915 0.037769 
c3841  Hypothetical protein -1.881 0.033211 
ycdT predicted diguanylate cyclase  -1.830 0.030914 
yqeJ hypothetical protein  -1.819 0.024178 
ykgB conserved inner membrane protein  -1.810 0.003069 
htrC heat shock protein  -1.808 0.028469 
phnE phosphonate/organophosphate ester transporter pseudogene)  -1.797 0.008906 
bglF fused beta-glucoside-specific PTS enzymes: IIA  -1.789 0.012194 
rbsA fused D-ribose transporter subunits of ABC superfamily: ATP-binding 
components  
-1.781 0.018725 
phnG carbon-phosphorus lyase complex subunit  -1.762 0.040161 
yjcC predicted signal transduction protein (EAL domain containing protein)  -1.757 0.003271 
yjfF predicted sugar transporter subunit: membrane component of ABC superfamily  -1.740 0.008509 
rarA predicted hydrolase  -1.722 0.022445 
c3163  putative tail component of prophage -1.681 0.040005 
ykgK predicted regulator  -1.658 0.025115 
ybfL predicted transposase (pseudogene)  -1.656 0.017117 
citG triphosphoribosyl-dephospho-CoA transferase  -1.645 0.033387 
yedP hypothetical protein yedP -1.639 0.034703 
xdhA xanthine dehydrogenase, molybdenum binding subunit  -1.638 0.015282 
yqeA predicted amino acid kinase  -1.631 0.000686 
yzgL hypothetical protein  -1.621 0.019928 
c0697  - -1.596 0.037141 
yicO predicted xanthine/uracil permease  -1.578 0.012919 
yqeI predicted transcriptional regulator  -1.571 0.000181 
Z3956 hypothetical protein  -1.567 0.025559 
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guaD guanine deaminase  -1.567 0.007993 
hofB conserved protein with nucleoside triphosphate hydrolase domain  -1.560 0.008706 
ygeI hypothetical protein  -1.555 0.004821 
yibI predicted inner membrane protein  -1.535 0.010711 
ylbH conserved protein, rhs-like  -1.529 0.023590 
cusC copper/silver efflux system, outer membrane component  -1.518 0.010628 
recE Exodeoxyribonuclease VIII -1.513 0.000905 
ybfC hypothetical protein  -1.513 0.020506 
- - -1.503 0.042245 
dmsC dimethyl sulfoxide reductase, anaerobic, subunit C  -1.501 0.016040 
lacZ beta-D-galactosidase  -1.491 0.000209 
ygfJ hypothetical protein  -1.491 0.001366 
ydhW hypothetical protein  -1.482 0.011972 
ycbJ hypothetical protein  -1.479 0.006475 
yacH hypothetical protein  -1.467 0.006206 
ybbD hypothetical protein  -1.450 0.030979 
csgD DNA-binding transcriptional activator in two-component regulatory system  -1.420 0.027703 
acs acetyl-coenzyme A synthetase  -1.419 0.018361 
ECs1172  hypothetical protein  -1.413 0.009671 
phnD phosphonate/organophosphate ester transporter subunit  -1.413 0.032096 
ybhP predicted DNase  -1.400 0.008249 
gadE DNA-binding transcriptional activator  -1.394 0.034200 
ycgX hypothetical protein  -1.390 0.016818 
eutG predicted alcohol dehydrogenase in ethanolamine utilization  -1.370 0.007222 
c2118  Putative conserved protein -1.363 0.013760 
ycaP conserved inner membrane protein  -1.358 0.000027 
yqiI hypothetical protein  -1.355 0.031472 
c2257  Hypothetical protein -1.354 0.016817 
ytfA predicted transcriptional regulator  -1.352 0.013852 
ycfT predicted inner membrane protein  -1.341 0.043545 
yeaH Hypothetical protein yeaH -1.328 0.030154 
c0446  Hypothetical protein -1.326 0.032283 
sfmA predicted fimbrial-like adhesin protein  -1.308 0.018815 
hyaD protein involved in processing of HyaA and HyaB proteins  -1.304 0.002184 
yncC predicted DNA-binding transcriptional regulator  -1.304 0.011955 
yfgH predicted outer membrane lipoprotein  -1.290 0.035459 
ybiA hypothetical protein  -1.286 0.017401 
yedK Hypothetical protein yedK -1.269 0.000844 
yehZ Hypothetical protein yehZ precursor -1.265 0.005711 
c1465  putative factor; DNA packaging, phage assembly (Phage or Prophage Related) -1.243 0.041976 
Z1687 hypothetical protein  -1.235 0.000994 
vgrE unknown protein associated with Rhs element  -1.227 0.003164 
tnaC tryptophanase leader peptide  -1.220 0.007233 
yhiX Transcriptional regulator gadX -1.217 0.031439 
gadW DNA-binding transcriptional activator  -1.216 0.021935 
Z5430 hypothetical protein  -1.215 0.023973 
rusA DLP12 prophage; endonuclease RUS  -1.210 0.009166 
ydhY predicted 4Fe-4S ferridoxin-type protein  -1.209 0.009199 
hlyE hemolysin E  -1.207 0.036128 
melA alpha-galactosidase, NAD(P)-binding  -1.202 0.004292 
nirD enzyme; Energy metabolism, carbon: Anaerobic respiration -1.201 0.026541 
ysaB hypothetical protein  -1.192 0.025419 
ydfO Qin prophage; predicted protein  -1.190 0.048916 
yeaH hypothetical protein  -1.184 0.024511 
yadE predicted polysaccharide deacetylase lipoprotein  -1.182 0.042611 
ydiQ hypothetical protein  -1.181 0.019205 
yfeG predicted DNA-binding transcriptional regulator  -1.179 0.018008 
Z5852 hypothetical protein  -1.178 0.033637 
hyfB NADH dehydrogenase subunit N  -1.178 0.034393 
ybhJ Hypothetical protein ybhJ -1.169 0.043826 
yidI predicted inner membrane protein  -1.169 0.000487 
ybcF predicted carbamate kinase  -1.154 0.028872 
yphH predicted DNA-binding transcriptional regulator  -1.153 0.038796 
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yaaJ predicted transporter  -1.151 0.040073 
yhhI predicted transposase  -1.151 0.001580 
melR DNA-binding transcriptional dual regulator  -1.145 0.037517 
ECs5537  hypothetical protein  -1.139 0.021976 
c4010  Hypothetical protein -1.137 0.034508 
crcA palmitoyl transferase for Lipid A  -1.135 0.029276 
ykgC pyridine nucleotide-disulfide oxidoreductase  -1.124 0.006169 
ydaM predicted diguanylate cyclase, GGDEF domain signalling protein  -1.119 0.016123 
c0640  Conserved hypothetical protein -1.117 0.019244 
ygjV conserved inner membrane protein  -1.115 0.004444 
mhpR DNA-binding transcriptional activator, 3HPP-binding  -1.112 0.010268 
ybdM hypothetical protein  -1.112 0.013886 
ydiM predicted transporter  -1.105 0.012265 
yebN conserved inner membrane protein  -1.105 0.034131 
c4175  Conserved hypothetical protein -1.102 0.032028 
ycgF Hypothetical protein ycgF -1.101 0.019561 
ydiL hypothetical protein  -1.094 0.049093 
ybhD predicted DNA-binding transcriptional regulator  -1.090 0.011749 
mhpE 4-hydroxy-2-ketovalerate aldolase  -1.081 0.041483 
yjfM hypothetical protein  -1.070 0.014448 
cbl DNA-binding transcriptional activator of cysteine biosynthesis  -1.069 0.042550 
yddV predicted diguanylate cyclase  -1.067 0.016753 
cysC adenylylsulfate kinase  -1.065 0.049261 
c2220  Hypothetical protein -1.064 0.046919 
dhaR predicted DNA-binding transcriptional regulator, dihydroxyacetone  -1.064 0.040124 
c1185  Hypothetical protein -1.062 0.030081 
eutQ hypothetical protein  -1.058 0.032359 
yciW predicted oxidoreductase  -1.055 0.031997 
c2070  Hypothetical protein -1.050 0.025263 
gadX DNA-binding transcriptional dual regulator  -1.042 0.009075 
yjiN Hypothetical protein yjiN -1.039 0.013456 
ydeJ competence damage-inducible protein A  -1.029 0.031857 
uxaA altronate hydrolase  -1.027 0.030313 
yjiL predicted ATPase, activator of R)-hydroxyglutaryl-CoA dehydratase  -1.025 0.016041 
ydhK conserved inner membrane protein  -1.021 0.002014 
yhiW Hypothetical transcriptional regulator yhiW -1.010 0.010194 
dcuS sensory histidine kinase in two-component regulatory system with DcuR, 
regulator of anaerobic fumarate respiration  
-1.008 0.033020 
wcaL predicted glycosyl transferase  -1.000 0.008156 
 
Table 24: ECC-1470 up-regulated genes at 3 h cocultivation with MAC-T cells 
Gene Description Ratio p-value 
L7057 replication protein 5.790 0.002231 
hypF carbamoyl phosphate phosphatase and maturation protein for [NiFe] 
hydrogenases  
5.457 0.000136 
bglF enzyme; Transport of small molecules: Carbohydrates, organic acids, alcohols 4.821 0.000549 
hycG hydrogenase 3 and formate hydrogenase complex, HycG subunit  4.739 0.001432 
c3719  Hypothetical protein 4.516 0.000504 
metR Transcriptional activator protein metR 4.483 0.000550 
gsp bifunctional glutathionylspermidine amidase/glutathionylspermidine synthetase 4.306 0.000579 
tauB transport; Transport of small molecules: Amino acids, amines 3.965 0.000699 
ygjO predicted methyltransferase small domain  3.727 0.002154 
ygjD Probable O-sialoglycoprotein endopeptidase 3.673 0.002181 
c1620  Hypothetical protein 3.656 0.000051 
yiaY predicted Fe-containing alcohol dehydrogenase  3.582 0.000580 
oxyR DNA-binding transcriptional dual regulator  3.537 0.001237 
molR - 3.535 0.001965 
nfrA bacteriophage N4 receptor, outer membrane subunit  3.530 0.000549 
c4303  Putative conserved protein 3.462 0.000503 
yfaZ Hypothetical protein yfaZ precursor 3.455 0.001876 
APPENDIX  209 
 
Gene Description Ratio p-value 
yjgB predicted alcohol dehydrogenase, Zn-dependent and NAD(P)-binding  3.233 0.002593 
c1956  Putative outer membrane protein yieC precursor 3.090 0.000090 
hycD hydrogenase 3, membrane subunit  2.984 0.000592 
ppdA hypothetical protein  2.964 0.000619 
c4942  Hypothetical protein 2.942 0.000048 
c3549  - 2.914 0.000527 
ybhI predicted transporter  2.909 0.005099 
hydN formate dehydrogenase-H, [4Fe-4S] ferredoxin subunit  2.896 0.007841 
c3902  Hypothetical protein 2.869 0.000158 
yehV MerR-like regulator A 2.865 0.025096 
ECP_3840 putative transposase 2.837 0.001371 
uidC predicted outer membrane porin protein  2.835 0.002436 
astC succinylornithine transaminase, PLP-dependent  2.792 0.000176 
tauA transport; Transport of small molecules: Amino acids, amines 2.780 0.002972 
Z3309 putative tail fiber protein of prophage CP-933U 2.692 0.000359 
c1584 putative tail component of prophage 2.637 0.007049 
ybaT predicted transporter  2.605 0.006390 
menD enzyme; Biosynthesis of cofactors, carriers: Menaquinone, ubiquinone 2.555 0.001016 
ECs3006  putative C4-type zinc finger protein  2.547 0.000432 
c3873  Putative conserved protein 2.542 0.006465 
caiB crotonobetainyl-CoA:carnitineCoA-transferase  2.539 0.001708 
c0703  Hypothetical protein 2.506 0.001508 
holE DNA polymerase III, theta subunit  2.471 0.001682 
ycdH predicted oxidoreductase, flavin:NADH component  2.421 0.000258 
yliL hypothetical protein  2.356 0.013033 
c3354  Hypothetical protein 2.317 0.002785 
c5192 Conserved hypothetical protein 2.314 0.002924 
c4059  Hypothetical protein 2.303 0.001040 
menD 2-succinyl-6-hydroxy-2, 4-cyclohexadiene-1-carboxylate synthase  2.299 0.001156 
c0317 Conserved hypothetical protein 2.262 0.008413 
c1463  Hypothetical protein 2.248 0.000672 
yqhD alcohol dehydrogenase, NAD(P)-dependent  2.216 0.000985 
yfaT hypothetical protein  2.185 0.003653 
mdtG predicted drug efflux system  2.147 0.010446 
ycdC predicted DNA-binding transcriptional regulator  2.145 0.003293 
ompN outer membrane pore protein N, non-specific  2.112 0.010365 
c0463  Hypothetical protein 2.092 0.010073 
UTI89_C5126 putative tail component of prophage CP-933K 2.084 0.001359 
yiaO Putative ABC transporter periplasmic binding protein yiaO precursor 2.082 0.010065 
c1589 putative tail component of prophage 2.060 0.007499 
ybbW predicted allantoin transporter  2.042 0.015666 
yraQ predicted permease  2.027 0.003642 
hycH protein required for maturation of hydrogenase 3  2.009 0.000028 
ydcU predicted spermidine/putrescine transporter subunit  1.999 0.007402 
c4556 Conserved hypothetical protein 1.968 0.005309 
nuoM NADH dehydrogenase subunit M  1.941 0.006237 
L7078 hypothetical protein 1.915 0.021250 
ymgE predicted inner membrane protein  1.884 0.000866 
c3166  putative head-tail joining protein of prophage 1.871 0.004055 
wcaB Putative colanic acid biosynthesis acetyltransferase wcaB 1.866 0.001338 
baeS sensory histidine kinase in two-component regulatory system with BaeR  1.854 0.004573 
yjbO phage shock protein G  1.801 0.002748 
cadB predicted lysine/cadaverine transporter  1.796 0.047206 
ypdI predicted lipoprotein involved in colanic acid biosynthesis  1.790 0.007311 
c2440  Hypothetical protein 1.774 0.005553 
flhB flagellar biosynthesis protein B  1.771 0.001443 
cpsB mannose-1-phosphate guanyltransferase  1.762 0.009126 
mlrA DNA-binding transcriptional regulator  1.762 0.006350 
lldD L-lactate dehydrogenase, FMN-linked  1.761 0.002179 
srmB ATP-dependent RNA helicase  1.743 0.000091 
ybjJ predicted transporter  1.743 0.006605 
c1036  Hypothetical protein 1.742 0.002821 
yjfC predicted synthetase/amidase  1.729 0.004470 
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hyfI hydrogenase 4, Fe-S subunit  1.718 0.000613 
torC enzyme; Energy metabolism, carbon: Anaerobic respiration 1.716 0.009041 
yihQ alpha-glucosidase  1.711 0.006721 
klcA KlcA 1.705 0.024550 
insF IS3 element protein InsF 1.692 0.009986 
ycfA hypothetical protein 1.686 0.000897 
c0467  Hypothetical protein yaiO 1.668 0.002921 
fdhF formate dehydrogenase-H, selenopolypeptide subunit  1.668 0.010215 
hycF formate hydrogenlyase complex iron-sulfur protein  1.642 0.018023 
sgbH 3-keto-L-gulonate 6-phosphate decarboxylase  1.637 0.016103 
yjaB predicted acetyltransferase  1.607 0.009422 
mdtI multidrug efflux system transporter  1.588 0.008813 
arcA DNA-binding response regulator in two-component regulatory system with ArcB 
or CpxA  
1.581 0.000107 
yegS hypothetical protein  1.580 0.005754 
yhhW hypothetical protein  1.559 0.008664 
fadA 3-ketoacyl-CoA thiolase 1.546 0.015743 
hyaA hydrogenase 1, small subunit  1.542 0.007352 
nhoA N-hydroxyarylamine O-acetyltransferase  1.539 0.009754 
insF IS3 element protein InsF 1.530 0.001892 
hycC NADH dehydrogenase subunit N  1.522 0.003785 
potH putrescine transporter subunit: membrane component of ABC superfamily  1.522 0.015898 
insF IS3 element protein InsF 1.515 0.007252 
mglB methyl-galactoside transporter subunit  1.501 0.006562 
yhcM conserved protein with nucleoside triphosphate hydrolase domain  1.500 0.010056 
hyfF NADH dehydrogenase subunit N  1.499 0.016042 
yehD Hypothetical protein yehD precursor 1.492 0.017652 
pflB pyruvate formate lyase I  1.491 0.005179 
c2092  Hypothetical protein 1.490 0.026718 
yidL predicted DNA-binding transcriptional regulator  1.482 0.011844 
c5302  Hypothetical protein 1.478 0.005414 
rbn ribonuclease BN  1.478 0.012602 
Z0980 putative tail component of prophage CP-933K  1.467 0.012893 
rbsR DNA-binding transcriptional repressor of ribose metabolism  1.452 0.013740 
insF IS3 element protein InsF 1.445 0.010733 
ypfE predicted carboxysome structural protein with predicted role in ethanol 
utilization  
1.444 0.012797 
gadC predicted glutamate:gamma-aminobutyric acid antiporter  1.429 0.004421 
ygjQ Hypothetical protein ygjQ 1.427 0.007707 
glcD glycolate oxidase subunit, FAD-linked  1.405 0.002116 
c0784  Hypothetical protein 1.391 0.001195 
ompW Outer membrane protein W precursor 1.388 0.000607 
yhhK hypothetical protein  1.380 0.005911 
hipA regulator; Murein sacculus, peptidoglycan 1.378 0.027696 
insF IS3 element protein InsF 1.376 0.006192 
ygfQ predicted transporter  1.367 0.010043 
malY bifunctional beta-cystathionase, PLP-dependent/ regulator of maltose regulon  1.363 0.001670 
kdpD fused sensory histidine kinase in two-component regulatory system with KdpE: 
signal sensing protein  
1.358 0.000920 
hycE hydrogenase 3, large subunit  1.353 0.001815 
crp DNA-binding transcriptional dual regulator  1.352 0.000107 
ydiY hypothetical protein  1.348 0.004095 
gadB glutamate decarboxylase B, PLP-dependent  1.336 0.002298 
glnP glutamine ABC transporter permease protein  1.333 0.024318 
ddpC D-ala-D-ala transporter subunit  1.332 0.022925 
Z3082 putative tail fiber component L of prophage CP-933U 1.332 0.010098 
yfeW hypothetical protein  1.322 0.006524 
nhoA N-hydroxyarylamine O-acetyltransferase  1.317 0.008270 
cusS sensory histidine kinase in two-component regulatory system with CusR, senses 
copper ions  
1.308 0.033305 
napA nitrate reductase, periplasmic, large subunit  1.308 0.011477 
menE O-succinylbenzoic acid--CoA ligase  1.304 0.016058 
yjiH Hypothetical protein yjiH 1.297 0.017380 
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metE 5-methyltetrahydropteroyltriglutamate-- homocysteine methyltransferase  1.295 0.004490 
ybhM conserved inner membrane protein  1.270 0.017594 
ECP_2970 fimbrial usher protein PixC 1.269 0.001881 
ypdI Hypothetical lipoprotein ypdI precursor 1.266 0.001286 
bcsE hypothetical protein  1.262 0.008006 
mdtL multidrug efflux system protein  1.255 0.009388 
citE enzyme; Central intermediary metabolism: Pool, multipurpose conversions 1.254 0.014851 
ycjB hypothetical protein 1.254 0.005623 
gamW putative factor; Integration, recombination (Phage or Prophage Related) 1.247 0.008788 
ygeD predicted inner membrane protein  1.247 0.001942 
Z3143 hypothetical protein  1.240 0.015019 
yihM Hypothetical protein yihM 1.238 0.025905 
nikE ATP-binding protein of nickel transport system  1.234 0.010987 
malG maltose transporter subunit  1.233 0.012644 
ulaA ascorbate-specific PTS system enzyme IIC  1.224 0.012695 
Z4186 putative integral membrane protein-component of typeIII secretion apparatus  1.216 0.005120 
c3663  Hypothetical protein 1.215 0.016870 
gltD glutamate synthase, 4Fe-4S protein, small subunit  1.215 0.025390 
deoR DNA-binding transcriptional repressor  1.209 0.001210 
sbmC DNA gyrase inhibitor  1.208 0.006187 
yfeU Protein yfeU 1.207 0.008644 
gatB galactitol-specific enzyme IIB component of PTS  1.205 0.012821 
c4837  Hypothetical protein 1.203 0.003203 
umuC DNA polymerase V subunit UmuC  1.200 0.016061 
ECs1173  hypothetical protein  1.199 0.004441 
tauB taurine transporter subunit  1.197 0.003452 
ccmD cytochrome c biogenesis protein  1.196 0.007642 
ilvC enzyme; Amino acid biosynthesis: Isoleucine, Valine 1.195 0.022177 
ivbL ilvB operon leader peptide  1.192 0.003412 
c3164 putative factor; DNA packaging, phage assembly (Phage or Prophage Related) 1.186 0.005155 
nikB nickel transporter subunit  1.179 0.013204 
argD bifunctional acetylornithine aminotransferase/ succinyldiaminopimelate 
aminotransferase  
1.175 0.035302 
argB Acetylglutamate kinase 1.164 0.009083 
hdeD HdeD protein 1.164 0.003032 
rluA pseudouridine synthase for 23S rRNA (position 746) and tRNAphe(position 32)  1.146 0.005095 
yeiM predicted nucleoside transporter  1.144 0.029193 
astB succinylarginine dihydrolase  1.142 0.015883 
yabI conserved inner membrane protein  1.135 0.024346 
yjgH predicted mRNA endoribonuclease  1.135 0.021796 
hisD Histidinol dehydrogenase 1.129 0.002684 
yjbG hypothetical protein  1.126 0.009933 
- positive control stringency: 90% identity to oligo b2965 1.124 0.002593 
yohL hypothetical protein  1.122 0.004686 
cysU sulfate/thiosulfate transporter subunit  1.120 0.019483 
yghD Putative general secretion pathway protein M-type yghD 1.120 0.018123 
galE UDP-galactose-4-epimerase  1.116 0.002901 
ymgG hypothetical protein  1.112 0.009072 
UTI89_C1520 hypothetical protein 1.110 0.001982 
yhdX predicted amino-acid transporter subunit  1.108 0.003997 
ybjH hypothetical protein  1.104 0.027399 
c4868  Hypothetical protein 1.102 0.003302 
cysE Serine acetyltransferase 1.097 0.004214 
dppC dipeptide transporter  1.096 0.019518 
ubiF 2-octaprenyl-3-methyl-6-methoxy-1,4-benzoquinol hydroxylase  1.096 0.014956 
hyfG hydrogenase 4, subunit  1.094 0.003590 
yeaJ predicted diguanylate cyclase  1.085 0.005876 
ycjX conserved protein with nucleoside triphosphate hydrolase domain  1.083 0.011332 
yedF hypothetical protein  1.079 0.008902 
UTI89_C3197 ClpB protein 1.075 0.001114 
ECs5296  hypothetical protein  1.074 0.018692 
torY TMAO reductase III (TorYZ), cytochrome c-type subunit  1.074 0.012790 
htrG predicted signal transduction protein (SH3 domain)  1.073 0.003127 
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speC ornithine decarboxylase, constitutive  1.073 0.008918 
ycaI conserved inner membrane protein  1.073 0.002607 
ccmF - 1.071 0.047346 
hisF imidazole glycerol phosphate synthase subunit HisF  1.059 0.019141 
ybbI putative transcriptional regulator  1.050 0.022351 
rhaT L-rhamnose:proton symporter  1.048 0.012595 
c0315  Hypothetical protein 1.047 0.001187 
rhsA_B rhsA element core protein RshA  | rhsB element core protein RshB  1.047 0.012295 
yjiS hypothetical protein  1.047 0.021365 
hycA regulator of the transcriptional regulator FhlA  1.046 0.023478 
UTI89_C2967 bacteriophage V tail protein 1.034 0.004356 
yhaR hypothetical protein  1.032 0.016815 
narV nitrate reductase 2 (NRZ), gamma subunit  1.030 0.022004 
hdeB protein hdeB precursor (10K-L protein) 1.029 0.029747 
menC enzyme; Biosynthesis of cofactors, carriers: Menaquinone, ubiquinone 1.028 0.021598 
msrA methionine sulfoxide reductase A  1.027 0.011569 
ygfU Putative purine permease ygfU 1.027 0.005518 
hisF imidazole glycerol phosphate synthase subunit HisF  1.026 0.000399 
c2748  Hypothetical protein 1.023 0.009643 
c3404  Hypothetical protein 1.023 0.020023 
fadH 2,4-dienoyl-CoA reductase, NADH and FMN-linked  1.019 0.011222 
lsrC AI2 transporter  1.018 0.009215 
flhE hypothetical protein  1.012 0.010775 
gadA glutamate decarboxylase A, PLP-dependent  1.012 0.032270 
c5221  Hypothetical protein 1.010 0.003017 
phnI carbon-phosphorus lyase complex subunit  1.010 0.019953 
yegH fused predicted membrane protein/predicted membrane protein  1.009 0.014991 
Z0961 putative endopeptidase protein Rz of prophage CP-933K  1.008 0.013013 
yhhX predicted oxidoreductase with NAD(P)-binding Rossmann-fold domain  1.007 0.002372 
 
Table 25: ECC-1470 down-regulated genes at 3 h cocultivation with MAC-T cells 
Gene Description Ratio p-value 
ybiM Hypothetical protein ybiM -4.300 0.012010 
yjgG_2 hypothetical protein  -4.082 0.009680 
citD citrate lyase, acyl carrier (gamma) subunit  -4.070 0.013448 
Z3104 putative endolysin of prophage CP-933U -4.034 0.009911 
araD L-ribulose-5-phosphate 4-epimerase  -3.976 0.007142 
tnaC tryptophanase leader peptide  -3.824 0.025220 
yccE hypothetical protein  -3.643 0.003228 
yibJ predicted Rhs-family protein  -3.626 0.006475 
htrE predicted outer membrane usher protein  -3.227 0.030739 
yahF predicted acyl-CoA synthetase with NAD(P)-binding domain and succinyl-CoA 
synthetase domain  
-3.063 0.016091 
cusC copper/silver efflux system, outer membrane component  -2.928 0.017598 
phnH carbon-phosphorus lyase complex subunit  -2.848 0.027044 
ycgX hypothetical protein  -2.807 0.026261 
ybeQ hypothetical protein  -2.785 0.036663 
yadD predicted transposase  -2.609 0.006534 
ycaM predicted transporter  -2.601 0.010163 
tfaQ Qin prophage; predicted tail fibre assembly protein -2.445 0.004050 
tdcE pyruvate formate-lyase 4/2-ketobutyrate formate-lyase  -2.326 0.049898 
dgoD galactonate dehydratase  -2.245 0.001587 
lsrA fused AI2 transporter subunits of ABC superfamily: ATP-binding components  -2.218 0.001154 
ybbD hypothetical protein  -2.192 0.026042 
csgC predicted curli production protein  -2.163 0.015114 
lamB maltoporin precursor  -2.037 0.039822 
ydiF fused predicted acetyl-CoA:acetoacetyl-CoA  -1.990 0.006219 
Z2118 putative endopeptidase Rz of prophage CP-933O  -1.898 0.009605 
yncK - -1.871 0.029613 
ybcM DLP12 prophage; predicted DNA-binding transcriptional regulator  -1.870 0.014808 
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c3104  Hypothetical protein -1.846 0.034249 
dmsC dimethyl sulfoxide reductase, anaerobic, subunit C  -1.842 0.004755 
molR - -1.836 0.001920 
rbsA fused D-ribose transporter subunits of ABC superfamily: ATP-binding 
components  
-1.809 0.045647 
ydhV predicted oxidoreductase  -1.743 0.038687 
ykgK predicted regulator  -1.739 0.013657 
hofB conserved protein with nucleoside triphosphate hydrolase domain  -1.725 0.009491 
Z1879 putative envelope protein of prophage CP-933X  -1.695 0.002700 
ydhW hypothetical protein  -1.688 0.037369 
ydhK conserved inner membrane protein  -1.688 0.012888 
argI ornithine carbamoyltransferase 1  -1.647 0.015689 
yqeJ hypothetical protein  -1.621 0.024657 
phnE phosphonate/organophosphate ester transporter pseudogene)  -1.620 0.029698 
c1893  Hypothetical protein -1.620 0.004923 
guaD guanine deaminase  -1.604 0.021913 
alx predicted inner membrane protein, part of terminus  -1.593 0.017622 
ybbS DNA-binding transcriptional activator of the allD operon  -1.583 0.017958 
fdnH formate dehydrogenase-N, Fe-S (beta) subunit, nitrate-inducible  -1.571 0.040879 
yeaT predicted DNA-binding transcriptional regulator  -1.562 0.012233 
yqeA predicted amino acid kinase  -1.557 0.023517 
ydfO Qin prophage; predicted protein  -1.552 0.007130 
ybcF predicted carbamate kinase  -1.525 0.040903 
ECs4865  hypothetical protein  -1.510 0.030855 
ycaC predicted hydrolase  -1.486 0.000411 
c1465  putative factor; DNA packaging, phage assembly (Phage or Prophage Related) -1.471 0.001336 
htrC heat shock protein  -1.468 0.003033 
ycaI hypothetical protein  -1.452 0.020957 
cynT carbonic anhydrase  -1.443 0.030744 
dgoA 2-dehydro-3-deoxy-6-phosphogalactonate aldolase  -1.441 0.024391 
aaeA p-hydroxybenzoic acid efflux system component  -1.441 0.008529 
Z2145 putative tail component of prophage CP-933O  -1.428 0.006892 
uidR DNA-binding transcriptional repressor  -1.428 0.033644 
ybhD predicted DNA-binding transcriptional regulator  -1.421 0.017823 
ydhY predicted 4Fe-4S ferridoxin-type protein  -1.414 0.006821 
bglH carbohydrate-specific outer membrane porin, cryptic  -1.402 0.038043 
potE putrescine/proton symporter:  -1.400 0.034283 
mtlR DNA-binding repressor  -1.374 0.029068 
ymgB hypothetical protein  -1.366 0.041345 
ybfC hypothetical protein  -1.366 0.004805 
eutG predicted alcohol dehydrogenase in ethanolamine utilization  -1.349 0.004543 
ydiP predicted DNA-binding transcriptional regulator  -1.338 0.029553 
chbF cryptic phospho-beta-glucosidase, NAD(P)-binding  -1.337 0.000827 
sbp sulfate transporter subunit  -1.336 0.002818 
ytfA predicted transcriptional regulator  -1.333 0.019656 
dmsB dimethyl sulfoxide reductase, anaerobic, subunit B  -1.314 0.002435 
yiaW hypothetical protein  -1.300 0.012544 
lysA diaminopimelate decarboxylase, PLP-binding  -1.275 0.018981 
fumC fumarate hydratase  -1.267 0.047930 
ybeF predicted DNA-binding transcriptional regulator  -1.256 0.012955 
ydcP predicted peptidase  -1.254 0.015597 
ybfL predicted transposase (pseudogene)  -1.238 0.029371 
c2235  Conserved hypothetical protein -1.222 0.013779 
c1936  - -1.220 0.048299 
c1138  Hypothetical protein -1.214 0.031859 
bglG transcriptional antiterminator of the bgl operon  -1.210 0.033472 
glvG predicted 6-phospho-beta-glucosidase pseudogene)  -1.204 0.010783 
aegA fused predicted oxidoreductase: FeS binding  -1.200 0.001871 
c3702  Hypothetical protein -1.188 0.027166 
ycaL predicted peptidase with chaperone function  -1.187 0.008718 
ylbH conserved protein, rhs-like  -1.182 0.017094 
ECs2713  hypothetical protein  -1.171 0.014653 
yhaR TdcF protein -1.167 0.015581 
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Gene Description Ratio p-value 
glpT sn-glycerol-3-phosphate transporter  -1.160 0.027285 
Z0722 hypothetical protein  -1.156 0.007267 
glcC DNA-binding transcriptional dual regulator, glycolate-binding  -1.152 0.008660 
hyaD protein involved in processing of HyaA and HyaB proteins  -1.146 0.000404 
pheM phenylalanyl-tRNA synthetase operon leader peptide  -1.144 0.018139 
c0690  Hypothetical protein ybdN -1.137 0.043568 
ybcL DLP12 prophage; predicted kinase inhibitor  -1.136 0.040394 
prpR DNA-binding transcriptional activator  -1.136 0.031221 
cpxP periplasmic protein combats stress  -1.132 0.009376 
dos cAMP phosphodiesterase, heme-regulated  -1.130 0.014659 
ybhJ Hypothetical protein ybhJ -1.129 0.003394 
sprT hypothetical protein  -1.129 0.000123 
yfaZ predicted outer membrane porin protein  -1.127 0.049902 
ycjD hypothetical protein  -1.123 0.030185 
edd phosphogluconate dehydratase  -1.115 0.016328 
yhhI predicted transposase  -1.110 0.018119 
Z2208 hypothetical protein  -1.105 0.040136 
yfgH predicted outer membrane lipoprotein  -1.104 0.017593 
astA arginine succinyltransferase  -1.104 0.009231 
rus endodeoxyribonuclease RUS (Holliday junction resolvase) of prophage CP-933X  -1.101 0.017612 
creD inner membrane protein  -1.100 0.005758 
yadL predicted fimbrial-like adhesin protein  -1.097 0.001078 
yobD Hypothetical protein yobD -1.091 0.012583 
ibpB heat shock chaperone  -1.085 0.028868 
Z5924 hypothetical protein  -1.084 0.003007 
rusA DLP12 prophage; endonuclease RUS  -1.083 0.022880 
melA alpha-galactosidase, NAD(P)-binding  -1.078 0.003420 
yciW predicted oxidoreductase  -1.072 0.006564 
ylcE DLP12 prophage; predicted protein  -1.069 0.001720 
recE Exodeoxyribonuclease VIII -1.069 0.032374 
c5065  Hypothetical protein -1.067 0.031807 
c2318  Hypothetical protein -1.065 0.007308 
ECs2770  hypothetical protein  -1.058 0.021718 
yidP predicted DNA-binding transcriptional regulator  -1.046 0.021587 
pflD predicted formate acetyltransferase 2 (pyruvate formate lyase II)  -1.046 0.032995 
paaJ acetyl-CoA acetyltransferase  -1.043 0.031153 
ybiU hypothetical protein  -1.037 0.016855 
yjgI predicted oxidoreductase with NAD(P)-binding Rossmann-fold domain  -1.034 0.019497 
ytfE predicted regulator of cell morphogenesis and cell wall metabolism  -1.032 0.041299 
ybiA hypothetical protein  -1.029 0.017831 
ybdM hypothetical protein  -1.025 0.003990 
Z0964 putative DNA packaging protein of prophage CP-933K  -1.016 0.030727 
thiH thiamine biosynthesis protein ThiH  -1.005 0.000352 
ccmB heme exporter subunit  -1.005 0.018704 
yieK hypothetical protein  -1.002 0.010502 
 
 
VIII.2.2. Transcriptome data of RNA-Seq 
Data derived from differential gene expression profiling of mastitis E. coli 1303 and ECC-1470 
cultivated in DMEM, milk whey and LPS challenged milk whey, respectively, sorted according to their 
level of expression. Data are presented on compact disk: 
Supplemental Tables S2 – S7:  Expression values of the individual samples from RNA-Seq 
Supplemental Tables S8 – S10:  Differential expression of genes from RNA-Seq by bROC algorithm  
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VIII.5. Abbreviations 
μg  microgram 
μl  microliter 
μM  micromolar 
μm  micrometer 
A  adenine 
Amp  ampicillin 
bp  base pairs 
BSA  bovine serum albumin 
C  cytosine 
CFU  colony forming unit 
DE  differential expression 
DEPC  diethyl pyrocarbinate 
DNA  deoxyribonucleic acid 
DNase  deoxyribonuclease 
EAEC  enteroaggregative E. coli 
Ec  Escherichia coli 
EDTA  ethylendiamintertraacetat 
e.g.  exempli gratia (for example) 
EHEC  enterohemorrhagic E. coli 
EIEC  enteroinvasive E. coli 
EPEC  enteropathogenic E. coli 
et al.  et altera (and others) 
ETEC  enterotoxigenic E. coli 
EtOH  ethanol 
ExPEC  extraintestinal pathogenic E. coli 
g  gram 
G  guanine 
GEI  genomic island 
h  hour 
IL  Interleukin 
IPEC  intestinal pathogenic E. coli 
kb  kilo bases 
Km  kanamycin 
l  liter 
LB  lysogeny broth 
LPS  lipopolysaccharide acid 
mg  milligram 
min  minute 
ml  milliliter 
mm  millimeter 
mM  millimolar 
ng  nanogramm 
NO  nitric oxide 
nt  nucleotides 
OD  optical density 
ORF  open reading frame 
PAI  pathogenicity island 
PBS  phosphate buffered saline 
PCR  polymerase chain reaction 
RNA  ribonucleic acid 
RNase  ribonuclease 
rpm  rounds per minute 
RT  reverse transcription 
RT-PCR reverse transcription PCR 
SD  standard deviation 
SDS  sodium dodecyl sulfate 
sec  second 
SEM  standard error of the mean 
SNP  single nucleotide polymorphism 
ß-ME  beta-mercaptoethanol 
T  thymine 
TAE  Tris-acetate-EDTA 
TLR4  toll like receptor 4 
UPEC  uropathogenic E. coli 
UTI  urinary tract infection 
wt  wild type 
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